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Abstract	  
Mycobacterium	  tuberculosis,	  the	  causative	  agent	  of	  tuberculosis,	  results	  in	  over	  1.5	  million	  
deaths	   every	   year.	   An	   estimated	   third	   of	   the	   world’s	   population	   may	   harbour	   a	   latent	  
infection	  with	  risk	  of	  reactivation	  under	  permissive	  conditions.	  M.	  tuberculosis	  expresses	  a	  
number	   of	   homologous	   resuscitation	   promoting	   factors	   (Rpfs)	   believed	   to	   facilitate	  
resuscitation	   from	   dormancy.	   However,	   little	   is	   known	   about	   the	   regulation	   of	   Rpf	  
expression.	   This	   study	   identifies	   a	   putative	   novel	   riboswitch	   in	   the	   5’UTR	   of	   rpfB,	   which	  
appears	   to	   be	   conserved	   in	   pathogenic	  mycobacteria,	   but	   not	   in	   non-­‐pathogenic	   species.	  
Northern	   blot	   analysis	   of	  M.	   tuberculosis	   RNA	   reveals	   short	   terminated	   transcripts	   and	  
longer	   read-­‐through	   transcripts	   suggesting	   transcription	   attenuation	   mediated	   by	   a	  
transcriptional	  riboswitch.	  This	  has	  been	  further	  supported	  by	  3’RACE,	  reporter	  gene	  assays	  
and	   in	  vitro	   transcription.	  Findings	   indicate	   that	   rpfB	   is	   co-­‐transcribed	  with	   the	  universally	  
conserved	   rRNA	   methyltransferase	   ksgA,	   implicating	   the	   riboswitch	   in	   ksgA	   expression	  
regulation,	   thereby	   linking	   resuscitation	   with	   ribosome	   maturation.	   Moreover,	   through	  
translation	  start	  site	  mapping	  the	  RpfB	  start	  codon	  has	  been	  re-­‐annotated	  and	  a	  ribosome	  
binding	   site	   has	   been	   validated.	   This	   ribosome	   binding	   site	   is	   likely	   targeted	   by	   an	   rpfB	  
antisense	  RNA	  produced	  from	  an	  antisense	  promoter	  that	  may	  also	  serve	  to	  regulate	  rpfB	  
expression	   either	   by	   RNA	   polymerase	   clashing,	   sense-­‐antisense	   interaction,	   mRNA	  
processing	   or	   all	   of	   the	   above.	   Expression	   of	   the	   rpfB	   locus	   has	   been	   investigated	   under	  
multiple	   physiological	   stresses	   and	   throughout	   biofilm	   formation.	   Collectively,	   findings	  
support	   the	   presence	   of	   a	   novel	   rpfB	   riboswitch	   transcriptional	   ‘on-­‐switch’	   capable	   of	  
regulating	   expression	   through	   transcription	   attenuation.	   Understanding	   the	   stimuli	   and	  
regulation	  of	  Rpf	   gene	  expression	  will	   improve	  understanding	  of	   their	   role	   in	  disease	  and	  
resuscitation.	  
Impact	  statement	  |	  5	  
Impact	  statement	  
Every	  year	  approximately	  1.5	  million	  people	  die	  as	  a	   result	  of	  Mycobacterium	  tuberculosis	  
infection,	  making	  it	  the	  world	  leading	  cause	  of	  death	  due	  to	  a	  single	  infective	  agent	  (World	  
Health	   Organisation,	   2017).	   Whilst	   treatment	   is	   available,	   it	   requires	   a	   long	   6-­‐9	   month	  
multi-­‐drug	   regimen.	   Many	   infections	   may	   also	   exhibit	   drug	   resistance	   that	   can	   result	   in	  
treatment	   complications	   or	   failure.	   An	   estimated	   third	   of	   the	   world’s	   population	   may	  
harbour	   a	   latent	   infection;	   a	   non-­‐active,	   asymptomatic,	   ostensibly	   non-­‐infectious	   state.	  
However,	   latently	   infected	   individuals	   may	   have	   an	   estimated	   10%	   lifetime	   risk	   of	  
progressing	  to	  active	   infection	  from	  latency.	  Strong	  evidence	   implicates	  this	  progression	   is	  
attributed	  to	  the	  activity	  of	  resuscitation	  promoting	  factors	  (Rpfs).	  This	  study	  investigated	  a	  
novel	  example	  of	  a	  type	  of	  regulatory	  RNA	  known	  as	  a	  riboswitch,	  which	  has	  the	  potential	  to	  
regulate	  the	  resuscitation	  promoting	  factor,	  rpfB.	  	  
The	  work	   described	   in	   this	   thesis	   is	   the	   first	   instance	  of	   any	   such	   riboswitch	  having	  been	  
discovered	   for	   rpfB	   regulation	   in	   any	   species.	   The	   novel	   riboswitch	   is	   conserved	   in	  
pathogenic	  mycobacteria	  alone,	  where	   it	   regulates	   the	  expression	  of	   two	  genes,	   rpfB	   and	  
ksgA,	   the	   later	  of	  which	   is	   involved	   in	   ribosome	  maturation	   for	  protein	   synthesis.	  Both	  of	  
these	   genes	   contribute	   to	   processes	  well	   suited	   as	   targets	   for	   antibiotic	   therapies.	   As	   an	  
impact	   of	   this	   study,	   in	   future	   the	   rpfB	   riboswitch	   could	   be	   targeted	   for	   the	   rational	  
development	   of	   therapeutics	   with	   the	   potential	   to	   interfere	   with	   bacterial	   growth	   or	  
dormancy,	   possibly	   in	   combination	   with	   conventional	   therapies.	   Theoretically	   this	   could	  
help	  to	  reduce	  the	  reservoir	  of	  dormant	  M.	  tuberculosis	  that	  exists	  within	  latently	  infected	  
individuals,	  with	  the	  goal	  of	  decreasing	  the	  number	  of	  deaths	  attributed	  to	  M.	  tuberculosis	  
infection	  worldwide.	  
The	   research	   detailed	   within	   this	   thesis	   will	   have	   wider	   impacts	   for	   academia.	   The	  
translational	   start	   site	   mapping	   method	   developed	   by	   Smollett	   et	   al.	   (2009)	   has	   been	  
adapted,	  using	  a	  β-­‐galactosidase	  reporter	  to	  re-­‐annotate	  the	  rpfB	  protein	  coding	  sequence	  
and	  identify	  a	  ribosome	  binding	  site.	  Such	  a	  method	  could	  be	  employed	  in	  future	  studies	  to	  
investigate	   other	   potentially	   mis-­‐annotated	   open	   reading	   frames	   in	   mycobacteria.	   These	  
findings	  and	   the	  discovery	  of	   the	   rpfB-­‐ksgA	  bi-­‐cistron	  would	  very	   likely	  be	   reciprocated	   in	  
other	  related	  actinobacteria	  that	  share	  sequence	  conservation.	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The	  riboswitch	  has	  been	  further	  characterised	  through	   in	  vitro	  transcription	  assays	  using	  a	  
system	  that	  has	  been	  developed	  and	  optimised	  throughout	  this	  study.	  The	  M.	  tuberculosis	  
encoded	   rpfB	   riboswitch	   demonstrated	   unique	   interactions	   with	   recombinant	  
M.	  tuberculosis	  RNA	  polymerase	   in	  vitro,	   likely	  due	  to	  the	   folding	  of	  nascent	  RNA.	  Besides	  
highlighting	  the	  importance	  of	  using	  cognate	  systems	  to	  study	  riboswitches,	  the	  system	  that	  
has	  been	  developed	  in	  this	  study	  will	  be	  used	  in	  future	  research	  to	  screen	  candidate	  ligands	  
for	  the	  identification	  of	  the	  rpfB	  riboswitch	  cognate	  ligand.	  	  
Collectively	   the	   results	   of	   this	   study	   have	   been	   compiled	   into	   a	  manuscript	   for	   academic	  
publication	  (Schwenk	  et	  al.	  2018).	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  non-­‐culturable	  
Tris	   	   tris(hydroxymethyl)aminomethane	  
TSS	   	   transcription	  start	  site	  
TSSM	   	   transcription	  start	  site	  mapping	  
UTR	   	   un-­‐translated	  region	  
UV	   	   ultra	  violet	  
VBNC	   	   viable	  but	  non-­‐culturable	  
WT	   	   wild	  type	  




The	  following	  nomenclature	  has	  been	  used	  to	  refer	  to	  DNA,	  RNA	  and	  protein:	  
§ DNA	  –	  rpfB;	  italicised	  lowercase,	  uppercase	  italic	  for	  subtype	  
§ RNA	  –	  rpfB;	  non-­‐italicised	  lowercase,	  uppercase	  for	  subtype	   	  
§ Protein	  –	  RpfB;	  non-­‐italicised,	  uppercase	  first	  letter,	  uppercase	  subtype	  
	  
All	  nucleic	  acid	  sequences	  are	  written	  in	  a	  5’	  to	  3’	  direction	  unless	  otherwise	  stated.	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1 Introduction	  
1.1 Tuberculosis	  as	  a	  disease	  
Tuberculosis	   (TB)	   is	   the	   largest	   cause	   of	   death	   due	   to	   a	   single	   infective	   agent,	  
Mycobacterium	  tuberculosis	  (World	  Health	  Organisation	  2017).	  The	  M.	  tuberculosis	  acid-­‐fast	  
bacillus	   (see	  Figure	  1.I)	   is	  an	  obligate	  pathogen	   that	  has	   successfully	   co-­‐evolved	  alongside	  
humans	   as	   a	   crowd	   disease	   with	   droplet-­‐aerosol	   transmission	   (Comas	   et	   al.	   2013).	  
Treatment	   is	   available	   for	   tuberculosis	   as	   a	   6-­‐9	   month	   multi-­‐drug	   regimen	   (Bentrup	   &	  
Russell	  2001).	  The	  long	  time-­‐course	  of	  treatment	  and	  frequency	  of	  side	  effects	  often	  result	  
in	  non-­‐compliance	  of	  treatment	  that	  can	  lead	  to	  exacerbated	  infection.	  This	  is	  compounded	  
by	   increased	  prevalence	  of	  drug	   resistant	  and	  multi-­‐drug	   resistant	  M.	  tuberculosis,	   as	   few	  
alternative	   drugs	   are	   available.	   TB	   is	  more	   established	   in	   lesser-­‐developed	   regions	   of	   the	  
world	  where	  funding	  for	  treatment	  is	  limited,	  in	  addition	  there	  is	  often	  a	  stigma	  associated	  
with	  the	  disease	  that	  prevents	  treatment	  being	  sought.	  In	  2016	  there	  were	  6.3	  million	  new	  
cases	  of	  TB	  reported	  as	  part	  of	  a	  global	  estimated	  incidence	  of	  10.4	  million	  cases	  (see	  Figure	  
1.II).	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Figure	  1.I	  photomicrograph	  of	  M.	  tuberculosis	  
Photomicrograph	  shows	  acid-­‐fast	  M.	  tuberculosis	  bacilli	  visualised	  using	  Ziehl-­‐Neelsen	  staining;	  carbol	  fuchsin	  
stain	  is	  retained	  in	  the	  mycolic	  acids	  of	  the	  mycobacterial	  cell	  wall	  during	  acid-­‐alcohol	  de-­‐staining	  (acid-­‐fast).	  




Figure	  1.II	  estimated	  global	  TB	  incidence	  in	  2016	  
Diagram	  illustrates	  the	  global	  TB	  incidence	  in	  2016,	  estimated	  at	  10.4	  million	  new	  cases	  by	  the	  World	  Health	  
Organisation	  Global	  (World	  Health	  Organisation	  2017).	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An	  estimated	  third	  of	  the	  world’s	  population	  is	  either	  actively	  or	  latently	  infected	  with	  the	  
pathogen	  (Bentrup	  &	  Russell	  2001).	  Latent	   infection	  refers	  to	  a	  non-­‐active,	  asymptomatic,	  
ostensibly	  non-­‐infectious	  TB	  infection	  with	  a	  10%	  lifetime	  risk	  of	  progressing	  activation	  (10%	  
per	  year	  for	  those	  co-­‐infected	  with	  HIV)	  (Corbett	  et	  al.	  2003).	  Latently	   infected	   individuals	  
act	   as	   a	   reservoir	   of	   the	   disease,	   ensuring	   continuity	   of	   the	   pathogen	   and	   dissemination	  
within	  the	  host	  population	  once	  activated	  (Comas	  et	  al.	  2013).	  	  
1.2 Dormancy	  in	  mycobacteria	  
In	   natural	   environments	   bacteria	   can	   adopt	   ‘non-­‐growth’	   states	   to	   resist	   stress.	   For	  
example,	   viable	   but	   non-­‐culturable	   (VBNC)	   bacteria	   exhibit	   very	   low	   metabolic	   and	  
reproductive	   activity,	   although	   live/dead	   staining	   indicates	   they	   are	   still	   alive.	   The	   vast	  
majority	  of	  VBNC	  bacteria	  cannot	  be	  grown	  under	  standard	  laboratory	  conditions,	  however	  
some	   may	   be	   resuscitated	   to	   culturability	   by	   specific	   growth	   temperatures	   or	   with	  
supplementation	  with	  culture	  filtrate	  from	  growing	  cells	  (Oliver	  2005).	  	  
M.	  tuberculosis	   may	   persist	   within	   granulomas	   >30	   years	   before	   reactivating	   to	   cause	  
disease	   once	   again	   (Lillebaek	   et	   al.	   2002).	   It	   is	   therefore	   more	   appropriate	   to	   refer	   to	  
M.	  tuberculosis	  as	   transiently	  non-­‐culturable	   (TNC)	  because	   it	  does	  not	  necessarily	   remain	  
non-­‐culturable	   (Mukamolova	   et	   al.	   2003).	   It	   is	   not	   currently	   understood	   exactly	   what	  
conditions	   are	   permissive	   for	  mycobacterial	   resuscitation,	   but	   strong	   evidence	   implicates	  
the	  activity	  of	  resuscitation	  promoting	  factors	  (Rpfs).	  
1.3 Resuscitation	  promoting	  factors	  
Rpfs	  were	   originally	   identified	   in	  Micrococcus	   luteus	   (Mukamolova	   et	   al.	   1998).	  M.	  luteus	  
enters	   a	   dormant	   state	   after	   growth	   to	   stationary	   phase	   and	   starvation	   in	   nutritionally	  
depleted	  media.	  However,	  resuscitation	  occurs	  upon	  supplementation	  with	  filtered	  culture	  
supernatant	  from	  actively	  growing	  cells.	  Subsequent	  studies	  have	  revealed	  this	  is	  due	  to	  the	  
activity	  of	  a	  cell	  wall	  lytic	  enzyme	  named	  ‘Rpf’	  for	  which	  homologues	  exist	  in	  other	  G:C	  rich	  
bacteria,	  particularly	  mycobacteria	  (Mukamolova,	  Turapov,	  Young,	  et	  al.	  2002;	  Mukamolova	  
et	  al.	  2006).	  	  
M.	  tuberculosis	   encodes	   five	   resuscitation	   promoting	   factors,	   rpf(A-­‐E),	   which	   are	  
functionally	  redundant	  of	  each	  other	  to	  a	  certain	  extent	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Jacobs	  &	   Chan	   2004;	  Downing	  et	   al.	   2005;	   Tufariello	  et	   al.	   2006).	   Currently	   there	   is	   little	  
known	   about	   the	   regulation	   of	   rpf	   expression	   in	   M.	  tuberculosis,	   although	   findings	   do	  
indicate	  that	  regulation	  occurs	  in	  response	  to	  various	  stresses	  (Rickman	  et	  al.	  2005;	  Gupta,	  
Srivastava	  &	  Srivastava	  2010).	  There	  is	  evidence	  that	  M.	  tuberculosis	  Rpfs	  may	  also	  be	  linked	  
to	   virulence	   as	   mutants	   lacking	   multiple	   rpf	   genes	   lose	   virulence	   (Kana	   et	   al.	   2008;	  
Kondratieva	  et	  al.	  2011).	  Understanding	  the	  mechanisms	  and	  conditions	  through	  which	  rpf	  
gene	   expression	   is	   achieved	   may	   improve	   understanding	   of	   their	   role	   in	   disease	   and	  
resuscitation	  settings.	  
1.4 Transcription	  regulation	  
The	  central	  dogma	  of	  molecular	  biology	  describes	  a	  flow	  of	  genetic	  information	  from	  DNA	  to	  
RNA	   to	   protein.	   Transcription	   is	   the	   process	   by	   which	   DNA	   is	   copied	   to	   RNA	   by	   the	  
multi-­‐subunit	   enzyme	   RNA	   polymerase	   (RNAP).	   The	   cycle	   of	   transcription	   initiation,	  
elongation	   and	   termination	   is	   one	   of	   the	   earliest	   points	   at	   which	   regulation	   of	   gene	  
expression	  may	  be	  modulated.	  	  
1.4.1 Transcription	  initiation	  
The	   prokaryotic	   RNAP	   consists	   of	   two	   large	   subunits	   (β	   and	   β’)	   along	  with	   two	   alpha	   (α)	  
subunits	  which	  when	  combined	  are	  stabilised	  by	  an	  omega	   (ω)	  subunit	   to	   form	  the	  RNAP	  
core	  enzyme	  (ββ’α2ω).	  Core	  RNAP	  may	  interact	  with	  a	  number	  of	  sigma	  (σ)	  factors	  to	  form	  a	  
holoenzyme	   capable	   of	   binding	   DNA	   at	   promoter	   regions	   (Gusarov	   &	   Nudler	   1999;	   Ruff,	  
Record	   &	   Artsimovitch	   2015).	   In	   prokaryotes,	   promoter	   specificity	   is	   achieved	   almost	  
entirely	  through	  sigma	  factor	  recognition	  (Sachdeva	  et	  al.	  2010).	  The	  hexameric	  -­‐10	  and	  to	  a	  
lesser	  extent	  -­‐35	  promoter	  elements	  contain	  consensus	  sequences	  which	  are	  recognised	  by	  
specific	   sigma	   factors.	   Transcription	   of	   essential	   ‘housekeeping’	   genes	   is	   regulated	   by	   at	  
least	  one	  sigma	  factor	  with	  additional	  sigma	  factors	  regulating	  genes	  in	  response	  to	  specific	  
environmental	  changes	  or	  physiological	  stresses.	  Species	  that	  are	  subject	  to	  more	  variable	  
environments	  or	   those	   that	  have	   larger	   genomes	   tend	   to	  have	   a	   greater	   variety	  of	   sigma	  
factors	  than	  others.	  
M.	  tuberculosis	   is	   subject	   to	   multiple	   stresses	   and	   environments	   through	   the	   course	   of	  
transmission,	   infection,	   immune	  response	  attack,	  dormancy	  and	  resuscitation.	  To	  adapt	  to	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these	   changing	   environments	  M.	  tuberculosis	   has	   thirteen	   known	   sigma	   factors,	   a	   larger	  
number	   in	  relation	  to	   its	  genome	  size	  when	  compared	  with	  other	  pathogens	  (Sachdeva	  et	  
al.	  2010).	  SigA	  (σA)	  executes	  basal	  transcription	  of	  ‘housekeeping’	  genes	  whilst	  other	  factors	  
respond	  to	  stresses	  and	  environmental	  changes.	  Transcription	  initiation	  can	  also	  be	  further	  
regulated	  through	  binding	  of	  promoter	  proximal	  repressors	  or	  activators.	  
1.4.2 Transcription	  termination	  	  
Subsequent	  to	  transcription	  initiation,	  the	  polymerase	  dissociates	  from	  the	  sigma	  factor	  and	  
escapes	   the	   promoter	   region	   as	   a	   transcription	   elongation	   complex	   (TEC).	   The	   TEC	  
progresses	   along	   the	   DNA	   template,	   maintaining	   a	   transcription	   bubble	   of	   12-­‐14	  
nucleotides	  (nt)	  of	  single	  stranded	  DNA	  (ssDNA)	   inside	  of	  which	  a	  ~7-­‐9	  nt	  DNA:RNA	  hybrid	  
exists	  between	  the	  template	  DNA	  and	  nascent	  RNA	  being	  synthesised	  (Darst	  2001;	  Peters,	  
Vangeloff	  &	  Landick	  2011).	  Maintenance	  of	  the	  transcription	  bubble,	  DNA:RNA	  hybrid	  and	  
extrusion	   of	   the	   nascent	   RNA	   are	   critical	   to	   the	   stability	   and	   processivity	   of	   the	   TEC,	  
affecting	   the	   rate	   of	   RNA	   polymerisation	   as	   well	   as	   the	   frequency	   with	   which	   RNAP	  
dissociates	   from	   DNA.	   Transcription	   obstacles	   like	   repeating	   nucleotide	   motifs	   or	   DNA	  
damage	   may	   slow	   down,	   pause	   or	   arrest	   the	   TEC.	   The	   stability	   and	   processivity	   of	   the	  
complex	  may	  also	  be	  manipulated	   through	   the	  binding	  of	   additional	   transcription	   factors,	  
such	   as	  NusA	   and	  NusG	  which	   enhance	   pausing	   and	   termination	   (Artsimovitch	  &	   Landick	  
2000;	  Czyz	  et	  al.	  2014).	  Arrested	  complexes	  may	  be	  rescued	  by	  backtracking,	  where	  nascent	  
RNA	   is	   extruded	   from	   RNAP	   through	   a	   secondary	   exit	   channel	   and	   cleaved	   so	   that	  
transcription	   may	   be	   re-­‐initiated	   or	   damage	   repaired	   (Tetone	   et	   al.	   2017).	   Premature	  
transcription	  termination	  results	  in	  the	  loss	  of	  incomplete	  transcripts.	  This	  irreversible	  event	  
is	   deleterious	   to	   successful	   RNA	   transcription	   as	   incomplete	   transcripts	   cannot	   be	  
re-­‐initiated.	  TECs	  that	  cannot	  be	  re-­‐initiated	  will	  be	  terminated	  by	  either	  a	  factor	  dependent	  
or	  independent	  mechanism.	  	  
Factor-­‐dependent	  termination	  relies	  on	  the	  binding	  of	  Rho	  protein	  to	  C-­‐rich	  ‘rut	  sites’	  as	  a	  
homohexameric	   ring.	  The	  nascent	  RNA	   is	   then	  translocated	   in	  a	  5’	   to	  3’	  direction	  through	  
the	  ring,	  tautening	  the	  RNA	  to	  destabilise	  the	  DNA:RNA	  hybrid	  of	  the	  TEC	  (Richardson	  2002).	  
Rho	  may	  also	  enhance	  transcription	  termination	  when	  ribosomes	  are	  coupled	  to	  the	  TEC	  by	  
binding	  with	  NusG	  C-­‐terminal	  domain	  (CTD)	  (Peters,	  Vangeloff	  &	  Landick	  2011).	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Factor-­‐independent	  termination	  or	  intrinsic	  termination	  is	  facilitated	  by	  the	  formation	  of	  a	  
G:C	  rich	  RNA	  stem-­‐loop	  immediately	  followed	  by	  a	  7-­‐9	  nt	  poly-­‐uracil	  tract	  (Czyz	  et	  al.	  2014).	  
The	   stem-­‐loop	   poly(U)	   structure	   destabilises	   the	   TEC	   to	   cause	   transcription	   termination.	  
After	  the	  TEC	  has	  transcribed	  the	  G:C	  rich	  stem-­‐loop	  sequence	  it	  reaches	  the	  poly(U)	  tract.	  
Here	  the	  weak	  A:U	  basepair	   interactions	  that	  form	  between	  DNA:RNA	  hybrid	  at	  the	  active	  
site	  cause	  pausing	  of	  the	  elongation	  complex	  (Gusarov	  &	  Nudler	  1999).	  This	  pausing	  allows	  
time	  for	  stem-­‐loop	  nucleation	  which,	  depending	  on	  the	  sequence	  identity,	  may	  fold	  within	  
microseconds	  of	  exiting	  the	  polymerase	  (Peters,	  Vangeloff	  &	  Landick	  2011).	  The	  stem	  folds	  
until	  it	  physically	  pushes	  against	  RNAP	  causing	  both	  a	  deformation	  of	  the	  RNAP	  exit	  channel	  
as	   well	   as	   translocation	   of	   the	   nascent	   RNA	   from	   the	   active	   site,	   melting	   the	   DNA:RNA	  
hybrid	  within	  the	  complex	  (Gusarov	  &	  Nudler	  1999;	  Czyz	  et	  al.	  2014).	  It	  is	  possible	  that	  the	  
TEC	   may	   attempt	   backtracking	   once	   paused	   at	   the	   poly(U)	   site,	   however	   stem-­‐loop	  
formation	  would	  make	   it	   impossible	   for	   the	  TEC	   to	  backtrack	  >1-­‐2	  nt,	   effectively	   trapping	  
the	   TEC	   (Gusarov	   &	   Nudler	   1999).	   Unable	   to	   backtrack	   and	   lacking	   contacts	   with	   the	  
DNA:RNA	   hybrid,	   the	   paused	   TEC	   tends	  much	  more	   favourably	   towards	   dissociation	   thus	  
terminating	  transcription.	  	  
Mycobacterial	   TECs	   may	   terminate	   at	   imperfect	   poly(U)	   tracts	   of	   ≥4U	   residues,	   even	   if	  
subsequent	  nucleotides	  contain	  other	  bases,	  an	  effect	  known	  to	  be	  enhanced	  by	  binding	  of	  
NusG	   N-­‐terminal	   domain	   (NTD)	   (Czyz	   et	   al.	   2014).	   NusG-­‐NTD	   binds	   RNAP,	   stabilising	   its	  
clamp	  on	  the	  DNA	  to	  increase	  processivity,	  therefore	  making	  it	  easier	  for	  hypertranslocation	  
of	   the	   RNA	   from	   the	  DNA:RNA	   hybrid	   during	   stem-­‐loop	   formation.	   Conversely,	   NusA	   can	  
decrease	  processivity	  and	  increase	  intrinsic	  termination	  by	  prolonging	  the	  time	  with	  which	  
paused	   TECs	   dwell	   at	   the	   poly(U)	   tract,	   allowing	   a	   greater	   timeframe	   for	   stem-­‐loop	  
nucleation	  (Ha	  et	  al.	  2010).	  
1.5 Translation	  regulation	  
Translation	   is	   the	   synthesis	  of	  polypeptide	  using	   transcribed	  messenger	  RNA	   (mRNA)	  as	  a	  
template.	  The	  process	  of	  translation	  may	  also	  be	  manipulated	  to	  modulate	  gene	  expression.	  
Prokaryotic	   translation	   is	   coupled	  with	   transcription	   such	   that	   translation	   initiation	  occurs	  
on	   mRNA	   transcripts	   as	   they	   are	   being	   transcribed.	   Briefly,	   during	   canonical	   translation	  
initiation	  the	  ribosome	  associates	  with	  the	  mRNA,	  binding	  at	  a	  region	  complementary	  to	  the	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16S	  ribosomal	  RNA	  (rRNA)	  called	  the	  Shine-­‐Dalgarno	  (SD)	  sequence	  (Shine	  &	  Dalgarno	  1975;	  
Laursen	  et	  al.	  2005).	  The	  SD	  sequence	  constitutes	  a	  ribosomal	  binding	  site	  (RBS)	  where	  the	  
small	  30S	  and	  large	  50S	  ribosomal	  subunits	  bind	  to	  assemble	  the	  full	  70S	  ribosome.	  Coupled	  
to	  the	  RNAP	  by	  NusG-­‐CTD,	  the	  ribosome	  commences	  protein	  synthesis	  from	  the	  translation	  
start	  codon	  that	  marks	  the	  start	  of	  the	  coding	  region	  (Peters,	  Vangeloff	  &	  Landick	  2011).	  The	  
mRNA	   transcript	   upstream	   from	   the	   start	   codon	   is	   known	   as	   the	   5’un-­‐translated	  
region	  (UTR).	   Translation	   elongation	   continues	   from	   the	   start	   codon	   to	   synthesise	   the	  
polypeptide,	  terminating	  translation	  at	  the	  stop	  codon.	  The	  region	  between	  the	  start	  codon	  
and	   stop	   codon	   of	   DNA	   that	   encodes	   the	   polypeptide	   sequence	   is	   known	   as	   the	   open	  
reading	  frame	  (ORF).	  
Mycobacteria	   are	   capable	   of	   initiating	   translation	   from	   ATG	   (AUG	   in	   mRNA)	   as	   well	   as	  
uncommon	   start	   codons	   such	   as	   GTG	   (GUG)	   just	   as	   often	   and	   more	   rarely	   TTG	   (UUG);	  
although	  other	  prokaryotes	  may	  also	  utilise	  uncommon	  start	  codons,	  mycobacteria	  do	  so	  far	  
more	   frequently	   (DeJesus,	   Sacchettini	   &	   Ioerger	   2013).	   This	   is	   often	   a	   cause	   of	   incorrect	  
annotation	  of	  ORFs	  in	  mycobacterial	  genomes,	  which	  are	  often	  annotated	  by	  identification	  
of	  RBS	  or	  start	  codon	  (Smollett	  et	  al.	  2009;	  DeJesus,	  Sacchettini	  &	  Ioerger	  2013).	  In	  addition,	  
many	  mycobacterial	   genes	  are	   leaderless	  and	  do	  not	   contain	  a	  5’UTR,	   therefore	   lacking	  a	  
canonical	  RBS	  (Cortes	  et	  al.	  2013).	  	  
1.6 Regulatory	  RNA	  
Contrary	   to	   the	   central	   dogma	   of	  molecular	   biology,	   not	   all	   RNA	   encodes	   protein.	   Some	  
non-­‐coding	   RNAs	   may	   act	   as	   regulators	   of	   transcription	   and	   translation	   or	   influence	   the	  
stability	  of	  other	  RNA	   transcripts.	   Two	  major	   types	  of	   regulatory	  RNAs	  are	   those	  of	   small	  
RNAs	   (sRNAs)	   and	   riboswitches.	   There	   are	   also	   clustered	   regularly	   interspaced	   short	  
palindromic	  repeat	  (CRISPR)	  RNAs	  used	  by	  prokaryotes	  during	  phage	  infection,	  but	  these	  are	  
beyond	  the	  scope	  of	  the	  present	  study.	  Regulatory	  RNAs	  are	  important	  molecules	  utilised	  to	  
modulate	  gene	  expression	  at	  the	  transcriptional	  and	  post-­‐transcriptional	  level.	  	  
Small	   RNAs	   are	   relatively	   short	   non-­‐coding	   transcripts,	   generally	   ~55-­‐150	  nt	   in	   length	  
(Wagner,	   Altuvia	   &	   Romby	   2002).	   Though	   some	   protein	   binding	   sRNAs	   are	   known,	  most	  
basepair	  in	  a	  complementary	  fashion	  with	  other	  nucleic	  acids	  (Arnvig	  &	  Young	  2009).	  They	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are	   transcribed	   much	   like	   mRNA	   transcripts	   either	   cis	   or	   trans	   to	   their	   targets,	   yielding	  
molecules	  with	  diverse	  regulatory	  functions	  often	  associated	  with	  stress	  adaptation.	  	  
1.6.1 Trans-­‐encoded	  sRNA	  
Trans-­‐encoded	  sRNAs	  are	  not	  transcribed	  from	  their	  target-­‐binding	  region	  but	  rather	  from	  
chromosomally	   distant	   locations	   (Waters	   &	   Storz	   2009).	   As	   such,	   trans-­‐sRNAs	   may	   bind	  
multiple	   targets	   using	   limited	   sequence	   complementarity	   of	   ~10-­‐25	  nt	   with	   a	   core	   seed	  
region.	  Trans-­‐sRNA	  binding	  typically	  down-­‐regulates	  gene	  expression	  by	  occluding	  the	  RBS	  
and/or	  causing	  RNA	  instability	  through	  degradation	  (Papenfort	  &	  Vogel	  2010).	  Alternatively,	  
binding	  may	  serve	  to	  relieve	  secondary	  structures	  that	  occlude	  the	  SD	  sequence,	  permitting	  
translation	  initiation.	  Many	  trans-­‐sRNAs	  serve	  to	  regulate	  genes	  involved	  in	  stress	  response	  
and	   virulence,	   responding	   to	   stimuli	   to	   co-­‐ordinate	   regulation	   of	   multiple	   genes	   either	  
through	  direct	  basepairing	  or	  modulation	  of	  transcription	  factors	  and	  activators	  (Waters	  &	  
Storz	  2009;	  Papenfort	  &	  Vogel	  2010).	  
Due	   to	   their	   limited	   sequence	  complementarity,	   trans-­‐sRNA	  binding	   is	  often	   facilitated	  by	  
the	  chaperone	  protein	  Hfq.	  Characterised	   in	  Escherichia	  coli,	  this	  homohexameric	   ring	  has	  
orthologues	   in	   both	   Gram	   positive	   and	   negative	   bacteria	   (Storz,	   Opdyke	   &	   Zhang	   2004;	  
Brennan	   &	   Link	   2007).	   Hfq	   provides	   a	   platform	   onto	   which	   mRNAs	   and	   sRNAs	   may	  
assemble,	  melting	  secondary	  structures	  in	  the	  RNA.	  Binding	  also	  appears	  to	  increase	  sRNA	  
stability,	   as	   Hfq	   binding	   sites	   are	   similar	   to	   those	   of	   RNase	   E,	   protecting	   the	   sRNAs	   from	  
enzymatic	   degradation	   (Storz,	   Opdyke	   &	   Zhang	   2004).	   Conversely,	   it	   has	   been	   suggested	  
that	  once	  an	  sRNA	  binds	  its	  target	  Hfq	  may	  also	  recruit	  the	  degradosome	  to	  degrade	  both	  
the	   sRNA	   and	   bound	   target	   (Gottesman	   2005;	   Waters	   &	   Storz	   2009).	   Deletion	   of	   Hfq	  
attenuates	  virulence	  in	  many	  bacterial	  pathogens	  (Papenfort	  &	  Vogel	  2010).	  	  
Due	  to	  its	  abundance	  and	  known	  association,	  the	  use	  of	  co-­‐immunoprecipitation	  of	  Hfq	  has	  
aided	  identification	  of	  numerous	  sRNAs	  (Zhang	  et	  al.	  2003).	  However,	  some	  bacterial	  phyla	  
such	  as	  actinobacteria	  do	  not	  encode	  any	  known	  Hfq	  homologue	   (Storz,	  Opdyke	  &	  Zhang	  
2004).	  M.	  tuberculosis	  has	  no	  known	  homologue;	  although	  candidates	  have	  been	  suggested,	  
none	  are	  expressed	  at	  similar	  concentrations	  to	  Hfq	  in	  E.	  coli	  (Arnvig	  &	  Young	  2012).	  Due	  to	  
the	   high	   G:C	   content	   (67%)	   of	   M.	  tuberculosis	   DNA	   it	   may	   be	   that	   M.	  tuberculosis	  
trans-­‐sRNAs	  are	  capable	  of	  binding	  without	  chaperone	  assistance	  as	  the	  intermolecular	  and	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intramolecular	  forces	  of	  G:C	  basepairing	  allow	  stronger	  annealing	  of	  RNA	  duplexes	  than	  A:U	  
basepairing.	  
1.6.2 Cis-­‐encoded	  sRNA	  
Cis-­‐encoded	  sRNAs	  are	  transcribed	  from	  the	  antisense	  strand	  opposite	  their	  targets,	  often	  
being	   referred	   to	   as	   antisense	   small	   RNAs	   (asRNAs)	   (Brantl	   2007).	   asRNAs	   regulate	   gene	  
expression	  through	  a	  variety	  of	  mechanisms:	  binding	  may	   induce	   folding	  of	   target	  RNA	  so	  
that	  an	  intrinsic	  terminator	  forms	  to	  facilitate	  premature	  termination,	  alternatively	  binding	  
may	  occlude	  the	  SD	  sequence	  of	  mRNA	  or	  interfere	  with	  folding	  required	  to	  reveal	  the	  SD	  
sequence	   to	   inhibit	   translation	   initiation	   (Gottesman	   2005;	   Brantl	   2007).	   Sequence	  
complementarity	   between	   asRNA	   and	   target	   enables	   RNA	   duplex	   formation,	   which	   is	  
recognised	   and	   cleaved	   as	   RNase	  III	   substrate	   if	   >20	  basepairs	   (bp)	   double	   stranded	   RNA	  
(Brantl	  2007;	  Arnvig	  &	  Young	  2009).	  Conversely,	  binding	  may	  stabilise	  mRNA	  transcripts	  to	  
prevent	   their	   degradation	   (Brantl	   2007).	   The	   majority	   of	   asRNAs	   are	   associated	   with	  
prokaryotic	  mobile	   genetic	   elements	   such	   as	   plasmids,	   phages	   and	   transposons;	   however	  
those	  that	  are	  chromosomally	  encoded	  tend	  not	  to	  be	  cis-­‐acting	  but	  instead	  act	  trans	  to	  an	  
array	  of	  targets	  (Wagner,	  Altuvia	  &	  Romby	  2002).	  Nevertheless,	  there	  are	  exceptions	  with	  
chromosomally	   encoded	   asRNAs	   being	   discovered	   more	   recently	   through	   total	   RNA	  
transcriptomics	  (Brantl	  2012).	  
Cis-­‐encoded	  elements	  or	  cis-­‐acting	  elements	  that	  form	  within	  the	  coding	  mRNA	  5’UTR	  may	  
sense	   stimuli,	   changing	   folding	   conformation	   to	   sequester	   or	   reveal	   the	   SD	   sequence	   to	  
modulate	   translation	  or	   form	   intrinsic	   terminators	   to	  modulate	   transcription	   (Papenfort	  &	  
Vogel	   2010).	   One	   notable	   example	   is	   that	   of	   ‘RNA	   thermometers’.	   These	   regulatory	  
elements	   use	   specific	   physiological	   temperatures	   to	  melt	   secondary	   structures	  within	   the	  
5’UTR	   to	   reveal	   the	  SD	  sequence	   for	   ribosome	  binding,	   thus	  exerting	   translational	   control	  
(Johansson	   et	   al.	   2002).	   Such	   conformational	   changes	   in	   response	   to	   stimuli	   are	   also	  
observed	  in	  a	  more	  complex	  type	  of	  cis-­‐encoded	  elements	  known	  as	  riboswitches.	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1.7 Riboswitches	  
First	   coined	   in	   2002,	   the	   term	   riboswitch	   refers	   to	   regulatory	   elements	   of	   RNA	   that	   are	  
mostly	  situated	  within	  the	  5’UTR	  of	  mRNA	  transcripts	  (Nahvi	  et	  al.	  2002).	  Capable	  of	  binding	  
cognate	   ligands	   with	   high	   specificity	   and	   affinity,	   riboswitches	   modulate	   expression	   of	  
downstream	   coding	   regions	   through	   conformational	   changes	   (Nahvi	   et	   al.	   2002;	   Roth	   &	  
Breaker	  2009).	  Examples	  of	  riboswitches	  have	  been	  found	  throughout	  eubacteria	  along	  with	  
limited	   incidence	   in	   eukaryotes,	   suggesting	   an	   evolutionary	   conserved	   origin	   (Loh	   et	   al.	  
2009;	  Roth	  &	  Breaker	  2009).	  	  
1.7.1 Riboswitch	  architecture	  
Riboswitches	  are	  generally	   thought	   to	  be	   composed	  of	   two	  domains:	   an	  aptamer	  domain	  
that	  binds	  target	   ligands	  and	  an	  expression	  platform	  that	   is	  manipulated	  by	  ligand	  binding	  
events	   to	  affect	   regulation	  of	   gene	  expression	  via	  RNA	  conformational	   changes	   (Tucker	  &	  
Breaker	  2005).	  Expression	  platforms	  are	  highly	  specific	  for	  their	  associated	  ligands,	  many	  of	  
which	  are	  products	  of	  the	  regulated	  genes	  themselves	  thereby	  acting	  as	  feedback	  regulators	  
(Nudler	  &	  Mironov	  2004).	  
	  
Figure	  1.III	  example	  of	  riboswitch	  architecture	  
An	  example	  of	  a	  transcriptional	  riboswitch:	  in	  this	  example	  when	  ligand	  is	  not	  bound	  to	  the	  aptamer	  domain	  
the	  expression	  platform	  adopts	  the	  structure	  of	  an	   intrinsic	  terminator	  resulting	   in	  transcription	  termination	  
(left).	  Ligand	  binding	  in	  equilibrium	  results	  in	  a	  structural	  remodelling	  to	  form	  an	  anti-­‐terminator	  permissive	  of	  
transcriptional	  read-­‐through	  (right)	  as	  a	  transcriptional	  ‘on-­‐switch’.	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The	  majority	  of	   riboswitches	  employ	  one	  of	   two	  expression	  platforms,	  although	   there	  are	  
less	   common	   examples	   of	   ribozyme	   self-­‐cleavage	   expression	   platforms	   that	   render	  
transcripts	   vulnerable	   to	   RNase	   degradation	   (Winkler	   et	   al.	   2004).	   The	   first	  main	   type	   of	  
expression	   platform	   is	   that	   of	   the	   intrinsic	   terminator,	   a	   stem-­‐loop	   abutted	   by	   a	   poly(U)	  
tract	   (see	   Figure	   1.III).	   The	   default	   conformation	   of	   the	   riboswitch	   in	   absence	   of	   bound	  
ligand	  may	  be	  either	  a	   terminator	  or	  anti-­‐terminator.	  Upon	   ligand	  binding	  to	  the	  aptamer	  
domain	   the	   alternative	   conformation	   is	   induced	   in	   the	   expression	   platform,	   a	   terminator	  
conformation	  would	  become	  an	  anti-­‐terminator	  and	  vice	  versa.	   In	   this	   regard	  the	   intrinsic	  
terminator	   expression	   platform	   modulates	   transcriptional	   read-­‐through	   into	   the	   coding	  
region	  of	  mRNA	  in	  response	  to	  ligand	  binding.	  	  
The	   second	   type	   of	   expression	   platform	   is	   that	   of	   SD	   sequence	   sequestration.	   Here	   an	  
anti-­‐Shine-­‐Dalgarno	  sequence	  basepairs	  with	  the	  downstream	  SD	  sequence	  in	  the	  5’UTR,	  or	  
the	   secondary	   structure	   of	   the	   RNA	   is	   such	   that	   the	   SD	   sequence	   becomes	   sequestered,	  
inhibiting	   translation.	   The	   default	   state	   may	   be	   that	   of	   a	   sequestered	   or	   accessible	   SD	  
sequence.	   Upon	   ligand	   binding,	   the	   alternative	   conformation	   is	   adopted,	   such	   that	   the	  
sequestered	   SD	   sequence	   becomes	   accessible	   to	   ribosome	   binding	   and	   vice	   versa.	   This	  
mechanism	   allows	   the	   riboswitch	   to	   modulate	   translational	   attenuation	   in	   response	   to	  
ligand	  binding.	  
The	  architecture	  of	  riboswitches	  is	  generally	  a	  single	  specific	  aptamer	  domain	  coupled	  with	  
a	  single	  expression	  platform,	  though	  there	  are	  variations.	  Tandems	  of	  aptamer	  domains	  or	  
complete	  riboswitches	  specific	  for	  single	  or	  multiple	  ligands	  can	  be	  combined	  with	  tandem	  
expression	   platforms	   (Roth	   &	   Breaker	   2009).	   This	   allows	   highly	   specialised	   genetic	  
regulation	  capable	  of	  integrating	  multiple	  stimuli	  for	  multiple	  expression	  outputs.	  Recently	  a	  
flavin	  mononucleotide	   (FMN)	   sensing	   riboswitch	  was	   found	   in	  Escherichia	   coli,	   capable	   of	  
utilising	   a	   single	   aptamer	   domain	   with	   both	   an	   intrinsic	   terminator	   and	   SD	   sequence	  
sequestration	  expression	  platform,	  achieving	  maximum	  gene	  down-­‐regulation	  from	  a	  single	  
riboswitch	   (Pedrolli	   et	   al.	   2015).	   This	   modularity	   of	   riboswitches	   makes	   them	   powerful	  
regulators	   of	   gene	   expression	   at	   both	   the	   transcriptional	   and	   post-­‐translational	   level,	  
capable	  of	  executing	  regulation	  in	  response	  to	  very	  specific	  stimuli.	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1.7.2 Riboswitch	  switching	  mechanisms	  
Any	  given	  riboswitch	  will	  have	  a	  thermodynamically	  favourable	  default	  conformation	  that	  is	  
altered	  either	   in	   the	  presence	  or	  absence	  of	   ligand.	  The	   ligand	  concentration	  threshold	  at	  
which	  this	  switching	  event	  occurs	  is	  dictated	  by	  a	  thermodynamic	  equilibrium	  influenced	  by	  
a	  dissociation	  constant	  (Kd),	  “the	  ratio	  of	  the	  concentrations	  of	  free	  ligand	  and	  aptamer	  to	  
that	   of	   the	   aptamer-­‐ligand	   complex,	   measured	   at	   equilibrium”	   (Roth	   &	   Breaker	   2009).	  
Therefore	  if	  a	  sufficient	  concentration	  of	  ligand	  is	  available	  for	  binding	  –	  as	  dictated	  by	  the	  
Kd	  –	  the	  thermodynamic	  equilibrium	  will	  shift	  in	  favour	  of	  the	  alternative	  conformation.	  This	  
structural	  change	  will	  then	  be	  commuted	  through	  to	  the	  associated	  expression	  platform	  to	  
affect	  a	  change	  in	  gene	  expression.	  This	  makes	  riboswitch	  regulated	  gene	  expression	  highly	  
sensitive	   to	   the	   presence	   or	   absence	   of	   associated	   ligands;	   some	  may	   switch	   only	  within	  
specific	  concentration	  physiologically	  thresholds	  (Lutz	  et	  al.	  2014).	  
Notwithstanding,	  ligand	  binding	  dictated	  by	  thermodynamic	  equilibrium	  may	  not	  always	  be	  
the	  most	  important	  factor	  for	  switching	  events.	  As	  transcription	  occurs	  in	  a	  5’	  to	  3’	  direction	  
the	   aptamer	   domain	   of	   a	   riboswitch	   is	   synthesised	   first,	   upstream	   of	   the	   expression	  
platform.	   There	   is	   a	   limited	   timeframe	   in	   which	   the	   aptamer	   may	   adopt	   a	   secondary	  
structure,	  bind	  its	  cognate	  ligand	  and	  commute	  the	  binding	  event	  through	  to	  the	  expression	  
platform.	  If	  the	  expression	  platform	  folds	  before	  the	  thermodynamic	  equilibrium	  shifts	  then	  
the	   genetic	   decision	   may	   be	   inevitable,	   especially	   if	   the	   equilibrium	   is	   slow	   to	   equate	  
(Wickiser	  et	  al.	  2005).	  This	  is	  particularly	  true	  for	  intrinsic	  terminator	  expression	  platforms,	  
which	   require	   the	   poly(U)	   tract	   to	   be	   within	   the	   RNAP	   active	   site.	   In	   this	   regard	   some	  
riboswitches	  may	  sometimes	  operate	  under	  kinetic	  parameters	  determined	  by	  transcription	  
elongation	  rate	  or	  ligand	  binding	  kinetics	  (Wickiser	  et	  al.	  2005).	  
1.7.3 Trans-­‐acting	  riboswitches	  
It	   is	  not	  unprecedented	  that	  riboswitches	  may	  regulate	  other	  genes	   in	  trans.	  Riboswitches	  
that	  utilise	   intrinsic	   terminators	  may	  yield	  numerous	  short	  attenuated	  transcripts	   that	  are	  
very	   similar	   to	   sRNAs.	   Research	   has	   revealed	   that	   these	   short	   transcripts	   may	   have	   the	  
capacity	   to	   function	   as	   trans-­‐sRNAs,	   basepairing	   with	   other	   transcripts	   to	   modulate	  
expression	  of	  genes	  in	  addition	  to	  their	  cis-­‐acting	  regulatory	  capacity	  (Loh	  et	  al.	  2009).	  This	  
demonstrates	   that	   riboswitches	   may	   have	   a	   wider	   impact	   on	   gene	   expression.	   Several	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riboswitches	   have	   been	   discovered	   that	   do	   not	   control	   expression	   of	   coding	   genes	   but	  
rather	   transcription	   of	   regulatory	   sRNAs.	   These	   transcripts	   then	   affect	   the	   expression	   of	  
multiple	  genes,	  acting	  in	  trans	  as	  sRNAs	  or	  by	  sequestering	  regulatory	  proteins	  (DebRoy	  et	  
al.	  2014;	  Mellin	  et	  al.	  2014;	  Mellin	  &	  Cossart	  2015).	  	  
1.8 The	  rpfB	  locus	  
RpfB	   (Rv1009)	   is	   a	   cell	   wall	   hydrolase,	   one	   of	   the	   five	   Rpfs	   expressed	   by	  M.	  tuberculosis	  
(Mukamolova	  et	  al.	  2006).	  Evidence	  suggests	  that	  RpfB	  may	  be	  both	  membrane	  lipoprotein	  
anchored	  as	  well	  as	  secreted	  to	  act	  on	  neighbouring	  cell	  walls	  (Downing	  et	  al.	  2004).	  RpfB	  
has	  been	   found	   to	   interact	  with	  a	   second	  cell	  wall	  hydrolase,	  RipA,	   for	   increased	  cell	  wall	  
digestion	  and	   resuscitation	  activity	   (Hett	  et	  al.	  2007,	  2008).	   It	   is	  has	  been	  postulated	   that	  
activity	  on	  cell	  wall	  peptidoglycan	  may	  be	  key	  in	  its	  resuscitating	  activity,	  with	  muropeptide	  
digests	  acting	  as	  possible	  signalling	  molecules	  (Keep	  et	  al.	  2006).	  Global	  transcription	  start	  
site	   mapping	   (TSSM)	   of	   M.	  tuberculosis	   indicates	   that	   there	   are	   large	   5’UTR	   upstream	  
regions	   to	   some	   rpf	  mRNAs	   (Cortes	  et	   al.	   2013).	   Two	   transcription	   start	   sites	   (TSSs)	   have	  
been	   identified	   upstream	   of	   rpfB	   (see	   Figure	   1.IV)	   and	   used	   to	   annotate	   two	   putative	  
promoters	  designated	  P1	  and	  P2	  (Cortes	  et	  al.	  2013).	  In	  addition	  there	  appears	  to	  be	  signal	  
corresponding	  to	  an	  antisense	  transcript	  and	  promoter	  designated	  Pas.	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Figure	  1.IV	  diagram	  of	  rpfB	  RNA	  expression	  
Chart	  (A)	  shows	  global	  transcriptional	  start	  site	  analysis	  of	  sense	  (blue)	  and	  antisense	  (red)	  primary	  transcript	  
abundance	  in	  M.	  tuberculosis	  (Cortes	  et	  al.	  2013).	  Chart	  (B)	  shows	  the	  RNA-­‐seq	  transcript	  abundance	  of	  sense	  
(blue)	   and	   antisense	   (red)	   transcripts	   normalised	   to	   total	   reads	   (Cortes	  et	   al.	   2013).	  Diagram	   (C)	   shows	   the	  
organisation	   of	   genetic	   elements	   in	   alignment	   with	   the	   charts	   above	   it.	   Black	   arrows	   indicate	   putative	  
transcription	  start	  sites.	  
1.9 The	  rpfB	  riboswitch	  
Transcripts	  initiated	  at	  the	  rpfB	  P1	  TSS	  may	  be	  expected	  to	  yield	  a	  large	  5’UTR	  characteristic	  
of	  a	  cis-­‐acting	  regulatory	  RNA,	  encoding	  a	  potential	  intrinsic	  terminator.	  Since	  a	  terminator	  
would	  prevent	  further	  transcription	  into	  the	  rpfB	  coding	  sequence	  (CDS),	  it	  is	  possible	  it	  may	  
constitute	  the	  expression	  platform	  of	  a	  transcriptional	  riboswitch.	  Riboswitch	  regulation	  of	  
Rpfs	  is	  not	  unprecedented	  as	  a	  riboswitch	  has	  already	  been	  identified	  in	  the	  5’UTR	  of	  rpfA	  
(Block,	  Hammond	  &	  Breaker	  2010;	  Arnvig	  &	  Young	  2012;	  Nelson	  et	  al.	  2013;	  St-­‐Onge	  et	  al.	  
2015).	   Structural	   modelling	   (Zuker	   2003)	   of	   the	   rpfB	   riboswitch	   candidate	   region	   (which	  
shall	  forthwith	  be	  referred	  to	  as	  a	  riboswitch)	  predicts	  only	  a	  single	  structure	  that	  resembles	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stem-­‐loop	   poly(U)	   tract,	   the	   sequence	   of	   consecutive	   uracil	   residues	   would	   likely	   be	  
insufficient	  for	  recognition	  as	  an	  intrinsic	  terminator	  (Czyz	  et	  al.	  2014).	  Moreover,	  a	  lack	  of	  
any	  predicted	  alternative	  structure	  would	  make	  it	  unlikely	  the	  riboswitch	  region	  could	  adopt	  
conformational	  changes	  in	  response	  to	  ligand	  binding,	  a	  prerequisite	  of	  riboswitch	  function.	  
	  
Figure	  1.V	  unconstrained	  rpfB	  riboswitch	  predicted	  structure	  
Structural	   prediction	   of	   the	   rpfB	   riboswitch	   generated	   using	   Mfold	   (Zuker	   2003).	   The	   proposed	   intrinsic	  
terminator	  structure	  is	  highlighted	  in	  red.	  
During	   intrinsic	   termination,	   the	  poly(U)	   tract	  of	  an	   intrinsic	   terminator	   is	  precluded	   from	  
secondary	  structure	  formation	  as	  it	  is	  bound	  as	  part	  of	  the	  DNA:RNA	  hybrid	  within	  the	  RNAP	  
active	  site.	  Applying	  a	  single	  stranded	  basepairing	  constraint	  to	  the	  rpfB	  riboswitch	  poly(U)	  
tract	   for	   structural	   modelling	   results	   in	   only	   two	   predicted	   structures:	   a	   terminator	  
conformation	   and	   an	   anti-­‐terminator	   conformation	   (see	   Figure	   1.VI).	   The	   predicted	  
terminator	  conformation	  displays	  a	  poly(U)	  tract	  more	  representative	  of	  canonical	  intrinsic	  
terminator	   with	   four	   consecutive	   uracil	   immediately	   downstream	   of	   the	   stem-­‐loop.	  
Comparatively,	  the	  predicted	  free	  energy	  of	  these	  structures	  demonstrates	  the	  terminating	  
conformation	   is	   more	   thermodynamically	   stable	   compared	   to	   the	   anti-­‐terminating	  
terminator(
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conformation,	  suggesting	  that	  the	  terminating	  state	  is	  the	  default	  state.	  Therefore	  the	  rpfB	  
riboswitch	   likely	  represents	  a	  rarer	  example	  of	  a	  transcriptional	   ‘on-­‐switch’	  where	  the	   less	  
favourable	   anti-­‐terminator	   or	   read-­‐through	   conformation	  may	  be	   adopted	   through	   ligand	  
interactions	  (Tucker	  &	  Breaker	  2005).	  	  
	  
Figure	  1.VI	  rpfB	  riboswitch	  predicted	  structures	  with	  constrained	  poly(U)	  tract	  
Structural	   predictions	   of	   the	   rpfB	   riboswitch	   generated	   using	   Mfold	   (Zuker	   2003)	   with	   a	   single	   stranded	  
basepairing	  constraint	  applied	  to	  the	  poly(U)	  tract.	  Terminator	  (left)	  and	  anti-­‐terminator	  (right)	  conformations	  
with	  identical	  red	  and	  green	  sequences	  highlighted	  for	  comparison.	  
Multiple	  sequence	  alignment	  of	  the	  rpfB	  upstream	  region	  across	  mycobacteria	  reveals	  the	  
P2	  -­‐10	   promoter	   element	   is	   well	   conserved	   in	   numerous	   species	   (see	   Figure	   1.VII).	  
Conversely	  the	  P1	  -­‐10	  promoter	  element	  and	  downstream	  riboswitch	  sequence	  appears	  to	  
be	   conserved	   in	   pathogenic	   mycobacterial	   species	   alone,	   principally	   the	  M.	  tuberculosis	  
complex	   (Schwenk	   et	   al.	   2018).	   Therefore	   it	   seems	   the	   proposed	   rpfB	   riboswitch	   may	  
represent	  a	  novel	  riboswitch	  in	  mycobacteria,	  potentially	  associated	  with	  pathogenesis.	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Figure	  1.VII	  sequence	  alignment	  of	  rpfB	  promoter	  regions	  and	  5’UTR	  
Sequence	  alignment	  of	  M.	  tuberculosis	  (M.	  tb),	  three	  strains	  of	  M.	  canettii:	  CIPT	  140010059	  (M.	  ca0059),	  CIPT	  
140070017	  (M.	  ca0017)	  and	  CIPT	  140070010	  (M.	  ca0010),	  Mycobacterium	  marinum	  (M.	  ma),	  Mycobacterium	  
ulcerans	   (M.	  ul),	  Mycobacterium	   shinjukuense	   (M.	  sh),	  Mycobacterium	   kansasii	   (M.	  ka)	   and	  Mycobacterium	  
avium	   (M.	  av)	  constructed	   in	  Jalview.	  Adapted	  from	  (Schwenk	  et	  al.	  2018).	  Residues	  coloured	  by	  percentage	  
sequence	   conservation	   (darker	   blue	   indicates	   higher	   conservation).	   Putative	   P1,	   P2	   and	   Pas	   -­‐10	  promoter	  
elements	   are	   highlighted	   in	   black.	   First	   four	   codons	   of	   rpfB	   CDS	   highlighted	   in	   green,	  with	   alternative	   start	  
codons	  highlighted	  with	  dashed	   lines.	   Proposed	  SD	   sequence	   is	   highlighted	   in	  orange	   (see	   section	  3.4).	   Red	  
annotations	  denote	   the	  stem-­‐loop	  poly(U)	   tract	  of	   the	  proposed	   riboswitch	   intrinsic	   terminator	   identified	   in	  
M.	  tuberculosis.	  
1.10 Project	  objectives	  
The	  present	  study	  was	  based	  on	  the	  observation	  that	  M.	  tuberculosis	  rpfB	   locus	  encodes	  a	  
putative	   riboswitch	   region,	   potential	   regulatory	   asRNA	   and	   that	   these	   regulatory	   RNA	  
elements	   may	   modulate	   the	   expression	   of	   rpfB	   at	   the	   transcriptional	   and	  
post-­‐transcriptional	  level.	  	  
1.10.1 Mapping	  of	  the	  rpfB	  translational	  start	  site	  
Correct	   annotation	   of	   translational	   start	   sites	   can	   be	   achieved	   through	   translational	   start	  
site	  mapping	  (TLSM)	  (Smollett	  et	  al.	  2009).	  rpfB	  has	  three	  potential	  translational	  start	  sites,	  
most	   upstream	   of	   which	   is	   GTG	   (GUG	   in	   mRNA)	   followed	   by	   TTG	   (UUG)	   and	   finally	   the	  
annotated	   ATG	   (AUG)	   start	   codon	   (see	   Figure	   1.VII).	   This	   annotation	   had	   not	   been	  










































	  34	  |	  Introduction	  
decrease	   in	   rpfB-­‐lacZ	   translational	   reporter	  β-­‐galactosidase	  expression	  on	  mutation	  of	   the	  
ATG	  start	  codon	  to	  AAG.	  However,	  no	  other	  possible	  start	  sites	  were	  investigated.	  
In	   the	   Mycobacterium	   smegmatis	   rpfB	   homologue	   (MSMEG_5439)	   the	   annotated	   start	  
codon	   is	   further	   upstream,	   proximal	   to	   the	   TTG	   rather	   than	   ATG	   compared	   to	  
M.	  tuberculosis	  (see	  Appendix	  Figure	  10.I).	  In	  M.	  tuberculosis	  there	  is	  no	  apparent	  ribosome	  
binding	  site	  within	  a	  feasible	  distance	  upstream	  of	  the	  rpfB	  ATG	  start	  codon.	  If	  the	  CDS	  were	  
extended	  upstream	  to	  the	  TTG	  start	  codon	  it	  would	  be	  more	  closely	  situated	  to	  a	  potential	  
RBS	   (see	  Figure	  1.VII).	  Moreover,	   the	  CDS	  5’terminus	  would	  be	  closer	   to	   the	  5’end	  of	   the	  
proposed	  asRNA,	  a	   location	  more	  complementary	  of	  canonical	  asRNA	  function,	  potentially	  
serving	  to	  occlude	  the	  RBS.	  Therefore	  the	  project	  aimed	  to	  determine	  the	  translational	  start	  
site	  of	  rpfB	  through	  TLSM,	  to	  verify	  the	  Sharma	  et	  al.	  (2015)	  ATG	  annotation	  (see	  section	  3)	  
and	  investigate	  the	  additional	  possible	  upstream	  start	  codons.	  This	  research	  also	  served	  to	  
enable	  correct	  construction	  of	  transcriptional	  and	  translational	  reporter	  constructs.	  	  
1.10.2 A	  potential	  link	  between	  rpfB	  and	  ksgA	  
In	  M.	  tuberculosis	  there	  is	  a	  28	  bp	  overlap	  between	  the	  3’end	  of	  the	  rpfB	  CDS	  and	  the	  5’end	  
of	   a	   gene	   named	   ksgA,	   which	   encodes	   a	   universally	   conserved	   yet	   non-­‐essential	  
methyltransferase	   required	   for	   functional	   ribosome	   biogenesis	   (Mangat	   &	   Brown	   2008).	  
This	  proximity	  of	  cell	  wall	  enzymes	  with	  a	  ksgA	  methyltransferase	  is	  extensively	  conserved	  
in	   many	   firmicutes	   and	   actinobacteria	   (Ravagnani,	   Finan	   &	   Young	   2005).	   Inspection	   of	  
transcription	   start	   site	  mapping	   upstream	   of	   ksgA	   indicates	   a	   lack	   of	   a	   TSS	   for	   the	   gene	  
(Cortes	  et	  al.	  2013).	   It	   is	   therefore	  possible	  that	  ksgA	   is	  co-­‐transcribed	  from	  the	  upstream	  
rpfB	   P1	   or	   P2	   promoters,	   potentially	   linking	   resuscitation	   from	   dormancy	   by	   rpfB	   with	  
ribosome	  maturation	   by	   ksgA.	   Consequently	   this	   project	   aimed	   to	   explore	   any	   potential	  
regulatory	  or	  functional	  link	  between	  rpfB	  and	  ksgA	  at	  the	  transcriptional	  and	  translational	  
level.	  
	  Introduction	  |	  35	  
1.10.3 Characterisation	  of	  the	  rpfB	  riboswitch	  
This	   project	   aimed	   to	   characterise	   the	   putative	   rpfB	   riboswitch	   with	   the	   potential	   to	  
elucidate	   a	   previously	   un-­‐described	   post-­‐transcriptional	   regulation	   of	   rpfB	   in	  
M.	  tuberculosis.	   Research	   objectives	   included:	   ascertaining	   potential	   mechanisms	   of	  
riboswitch-­‐mediated	  attenuation,	  exploring	  conditions	  permissive	  of	   riboswitch	  expression	  
and	   regulation,	   and	  assaying	   riboswitch-­‐mediated	  attenuation	  both	   in	   vitro	  and	   in	   vivo	   to	  
aid	  the	  identification	  and	  validation	  of	  candidate	  ligands.	  
1.10.4 Understanding	  the	  rpfB	  transcriptional	  unit	  
In	   addition	   to	   the	  putative	  P1	   and	  P2	   promoters	   identified	   through	   transcription	   start	   site	  
mapping	  (Cortes	  et	  al.	  2013),	  recently	  an	  additional	  promoter	  was	  described	  upstream	  of	  an	  
alternative	  rpfB	  TSS.	  Sharma	  et	  al.	  (2015)	  described	  a	  SigB	  consensus	  -­‐10	  promoter	  element	  
downstream	   of	   the	   P1	   and	   P2	   promoters.	   Transcripts	   promoted	   by	   the	   proposed	   SigB	  
element	   would	   not	   encode	   the	   potential	   rpfB	   riboswitch	   and	   therefore	   preclude	   the	  
possibility	  of	   riboswitch-­‐mediated	   regulation	  of	  downstream	  genes.	  Therefore	   this	  project	  
aimed	   to	   understand	   the	   rpfB	   transcriptional	   unit	   by	   characterising	   putative	   promoter	  
elements	  and	  clarifying	  conflicting	  reports.	  
In	  addition	  to	  the	  identified	  sense	  stand	  promoters;	  the	  RNA-­‐seq	  data	  by	  Cortes	  et	  al.	  (2013)	  
indicates	   the	   possibility	   of	   an	   asRNA	   and	   associated	   promoter.	   This	   asRNA	   may	   allow	  
another	   layer	   of	   regulation	   to	   the	   rpfB	   locus	   either	   through	   occlusion	   of	   the	   RBS,	  
transcription	   down-­‐regulation	   through	   polymerase	   clashing	   or	   transcript	   degradation	   as	  
regulatory	   asRNA.	   Therefore	   the	   project	   also	   aimed	   to	   characterise	   the	   proposed	   Pas	  
promoter	  and	  possible	  asRNA	  transcript	  regulatory	  function.	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2 Materials	  and	  methods	  
2.1 Culture	  media	  
2.1.1 Luria-­‐Bertani	  (LB)	  broth	  
1	  L	  LB	  broth	  was	  made	  by	  dissolving	  10	  g	  tryptone	  (Bacto,	  BD	  diagnostics),	  10	  g	  NaCl	  (Fisher	  
Scientific),	  5	  g	  yeast	  extract	  (Bacto,	  BD	  diagnostics)	  in	  1000	  mL	  deionised	  H2O	  (dH2O)	  before	  
autoclaving	  at	  135°C,	  1.6	  bar	   for	  25	  min.	   LB	  agar	   contained	  an	  additional	  15	  g	   (1.5%	  w/v)	  
agar	   (Bacto,	   BD	   diagnostics)	   prior	   to	   autoclaving.	   Once	   cooled	   to	   ambient	   temperature,	  
supplements	   for	  antibiotic	   selection	  were	  added	  where	   required,	  and	   for	   liquid	  culture	  of	  
Mycobacterium	   smegmatis	   0.05%	   Tween80	   (v/v	   final,	   Sigma)	   was	   added	   to	   prevent	  
clumping	  (see	  section	  2.1.5).	  LB	  broth	  was	  stored	  at	  room	  temperature	  and	  solid	  agar	  was	  
stored	  at	  4°C.	  	  
2.1.2 SOC	  broth	  
250	  mL	  SOC	  (super	  optimal	  broth	  with	  catabolite	  repression)	  broth	  was	  made	  by	  dissolving	  
5	  g	  tryptone,	  1.25	  g	  yeast	  extract	  with	  500	  µL	  5	  M	  NaCl,	  625	  µL	  1	  M	  KCl,	  2.5	  mL	  1	  M	  MgCl2,	  
2.5	  mL	  1	  M	  MgSO4,	  0.9	  g	  glucose	  in	  250	  µL	  dH2O	  prior	  to	  filter	  sterilisation.	  SOC	  broth	  was	  
stored	  at	  -­‐20°C	  in	  10	  mL	  aliquots	  prior	  to	  use.	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2.1.3 7H9	  broth	  
7H9	   broth	   (Middlebrook)	   was	   made	   according	   to	   the	   manufacturer’s	   specification,	   for	  
1	  litre:	  4.7	  g	  7H9	  base	  and	  4	  mL	  glycerol	   (0.4%	  v/v	   final,	   Sigma)	  were	  dissolved	   in	  900	  mL	  
dH2O	   before	   autoclaving.	   Once	   cooled	   to	   ambient	   temperature	   100	   mL	   ADC	   (albumin	  
dextrose	  catalase	  supplement,	  10%	  v/v	  final,	  Middlebrook)	  was	  added	  with	  0.05%	  (v/v	  final)	  
Tween80	  and	  supplements	  for	  antibiotic	  selection	  where	  required	  (see	  section	  2.1.5).	  7H9	  
broth	  was	  stored	  at	  room	  temperature.	  
2.1.4 7H11	  agar	  
7H11	   agar	   (Middlebrook)	   was	   made	   according	   to	   the	   manufacturer’s	   specification,	   for	  
200	  mL:	  4.1	  g	  7H11	  base	  and	  1	  mL	  glycerol	  (0.5%	  v/v	  final)	  were	  dissolved	  in	  180	  mL	  dH2O	  
before	   autoclaving.	   Once	   cooled	   to	   ambient	   temperature	   20	   mL	   OADC	   (oleic	   albumin	  
dextrose	  catalase,	  10%	  v/v	   final,	  Middlebrook)	  was	  added	  with	  supplements	   for	  antibiotic	  
selection	  where	  required	  (see	  section	  2.1.5).	  7H11	  solid	  agar	  was	  stored	  at	  4°C.	  	  
2.1.5 Media	  supplements	  
The	  following	  supplements	  were	  added	  to	  media	  to	  enhance	  bacterial	  growth	  or	   facilitate	  
selection	  (see	  Table	  2.I).	  	  
	  
Table	  2.I	  media	  supplements	  
Supplement	   Storage	   [Stock]	  mg/mL	  
[Final]	  µg/mL	  
Escherichia	  coli	   mycobacteria	  
Liquid	   Solid	   Liquid	   Solid	  
Ampicillin	  (MP	  Bio	  Science)	   -­‐20°C	   100	  in	  dH2O	   100	   100	   -­‐	   -­‐	  
Hygromycin	  B	  (Cambridge	  Biosciences)	   -­‐20°C	   50	  in	  dH2O	   250	   250	   50	   50	  
Kanamycin	  monosulfate	  (MP	  Bio	  
Science)	   -­‐20°C	   50	  in	  dH2O	   50	   50	   50	   20	  
X-­‐gal	  (Sigma)	   -­‐20°C	   50	  in	  100%	  DMSO	   -­‐	   100	   -­‐	   100	  
Tween80	  (Sigma)	   4°C	   20%	  (v/v	  in	  dH2O)	   -­‐	   -­‐	   0.05%	   -­‐	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2.2 Bacterial	  culture	  
2.2.1 Culture	  strains	  
Transformed	   Escherichia	   coli	   were	   of	   a	   DH5α	   background	   (α-­‐select	   bronze,	   Bioline).	  
Transformed	  Mycobacterium	  smegmatis	   strains	  of	  a	  MC2_155	  background	   (Snapper	  et	  al.	  
1990),	  Mycobacterium	   bovis	   Bacillus	   Calmette-­‐Guérin	   (BCG)	   (Pasteur	   strain,	   ATCC	  35734)	  
and	  Mycobacterium	  tuberculosis	  of	  a	  H37Rv	  background	  (Cole	  et	  al.	  1998).	  
2.2.2 Growth	  phase	  definitions	  
For	  all	  mycobacterial	  species	  cultured,	  exponential	  growth	  phase	  was	  harvested	  between	  an	  
optical	   density	   (OD)	   of	   0.5	   and	   0.8	   as	  measured	   by	   light	   scattering	   at	   600	   nm	   (OD600	  nm).	  
Stationary	  growth	  phase	  was	  harvested	  1	  week	  after	  1.0	  OD600	  nm	  and	  late	  stationary	  growth	  
phase	  was	  defined	  as	  growth	  >2	  weeks	  after	  1.0	  OD600	  nm	  (Moores	  et	  al.	  2017).	  	  
2.2.3 Growth	  conditions	  
M.	  tuberculosis	   was	   grown	   using	   7H9	   broth	   in	   polypropylene	   roller	   bottles	   (Cell	   Master,	  
Griener	   Bio-­‐One),	   rolling	   at	   100	   rpm.	   Time-­‐course	   experiments	   were	   conducted	   as	  
indicated.	  	  
Nutrient	   starvation	   was	   carried	   out	   by	   centrifuging	   exponential	   growth	   phase	  
M.	  tuberculosis	   at	   5000	  g,	   21°C	   for	   10	  min.	   Following	   centrifugation,	   pellets	   were	  
re-­‐suspended	   in	   25	  mL	   pre-­‐warmed	   phosphate	   buffered	   saline	   (PBS)	   with	  0.05%	   (v/v	  
final)	  Tween80	  then	  centrifuged	  for	  a	  further	  10	  min,	  repeating	  this	  process	  twice.	  Following	  
the	   final	   wash,	   cells	   were	   re-­‐suspended	   in	   PBS	  with	  0.05%	   Tween80	   up	   to	   the	   original	  
volume	  of	  the	  culture.	  
Transcription	  inhibition	  of	  cultures	  was	  achieved	  with	  the	  addition	  of	  a	  final	  concentration	  
of	  200	  µg/mL	  rifampicin	  (LKT	  Laboratories).	  
Re-­‐growth	   from	   late	   stationary	   growth	   phase	   was	   carried	   out	   by	   diluting	   late	   stationary	  
growth	  phase	  culture	  to	  0.4	  OD600	  nm	  with	  fresh	  pre-­‐warmed	  7H9	  broth	  and	  incubated	  in	  a	  
new	  roller	  bottle	  at	  37°C.	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2.2.4 Mycobacterium	  bovis	  BCG	  biofilm	  formation	  
M.	  bovis	   BCG	  was	   cultured	   on	   7H11	   agar	   supplemented	  with	   OADC.	   A	   single	   colony	  was	  
picked	  using	  a	  2	  mm	  sterile	   loop	  and	  suspended	  in	  10	  mL	  7H9	  broth	  in	  a	  50	  mL	  centrifuge	  
tube.	   Cultures	  were	   incubated	   static	   at	   37°C	   for	   14	   days.	   Prior	   to	   inoculation	  media	  was	  
checked	   for	   contamination	   by	   inoculating	   Columbia	   blood	   agar	   (Oxoid)	   and	   observing	  
negative	  growth	  after	  48	  hours	  incubation	  at	  37°C.	  
Inoculum	  was	  added	  to	  achieve	  a	   final	   inoculated	  culture	  density	  of	  0.2	  OD600	  nm	   in	  10	  mL	  
7H9	  broth	   in	  50	  mL	  centrifuge	   tubes	  without	   the	  addition	  of	  Tween80,	  which	  would	  have	  
disrupted	  biofilm	  aggregation.	  Cultures	  were	  inoculated	  in	  parallel	  with	  triplicate	  biological	  
replicates	  for	  each	  time-­‐point.	  Following	  inoculation,	  samples	  were	  sealed	  airtight	  to	  allow	  
biofilm	   formation	   under	   non-­‐aerated	   static	   culture	   at	   37°C.	   Extracts	   for	   the	   ‘week	   0’	  
time-­‐point	   representative	   of	   planktonic	   growth	   were	   taken	   by	   centrifuging	   cultures	   at	  
5000	  g,	   4°C	   for	   10	  min.	   Following	   centrifugation	   supernatant	   was	   discarded	   and	   pellets	  
were	  re-­‐suspended	  in	  1	  mL	  ‘RNApro’	  (MP	  Bio	  Science)	  in	  a	  2	  mL	  screw	  cap	  tube	  containing	  
Lysing	  Matrix	  B	  (MP	  Bio	  Science)	  then	  stored	  at	  -­‐20°C	  prior	  to	  sample	  extraction.	  	  
Biofilms	   were	   harvested	   at	   3,	   5,	   8	   and	   12	   weeks	   following	   inoculation.	   Pellicles	   were	  
removed	   from	   the	   air-­‐surface	   interface	   of	   cultures	   using	   a	   10	  mm	   sterile	   loop	   and	  
suspended	   in	  1	  mL	   ‘RNApro’	   (MP	  Bio	  Science)	   in	  a	  2	  mL	  screw	  cap	   tube	  containing	  Lysing	  
Matrix	   B	   (MP	   Bio	   Science)	   by	   vigorous	   vortexing.	   Samples	   were	   stored	   at	   -­‐20°C	   prior	   to	  
extraction.	  RNA	  extraction	  of	  all	  samples	  was	  carried	  out	  in	  parallel	  as	  described	  below	  (see	  
section	  2.7.1).	  
2.3 Stock	  buffers	  
50x	  TAE	  buffer:	  242	  g	  Tris	  base	  (Trizma,	  Sigma)	  and	  18.6	  g	  Na2-­‐EDTA	  dissolved	  with	  57.1	  mL	  
acetic	  acid	  in	  1000	  mL	  dH2O.	  	  
10x	   TBE	   buffer:	   108	  g	   Tris	   base	   (Trizma,	   Sigma),	   55	  g	   boric	   acid	   and	   9.3	  g	   Na2-­‐EDTA	   in	  
1000	  mL	  dH2O.	  
10x	  PBS:	  80	  g	  NaCl,	  2	  g	  KCl,	  14.4	  g	  Na2HPO4	  and	  2.4	  g	  KH2PO4	  adjusted	  pH	  to	  7.4	  in	  1000	  mL	  
dH2O.	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Z-­‐buffer:	   40	  mM	   NaH2PO4.H2O,	   60	  mM	   Na2HPO4.7H2O,	   1	  M	   MgSO4.7H2O,	   10	  mM	   KCl	   in	  
dH2O	  (Miller	  1972).	  
5x	  oligo	  annealing	  buffer:	  10	  mM	  Tris	  HCl	  pH	  7.5	  Sigma,	  50	  mM	  NaCl,	  1	  mM	  EDTA	  in	  dH2O.	  
2x	   formamide	   stop	   buffer	   loading	   dye:	   95%	   (v/v)	   formamide,	   18	  mM	   EDTA,	   0.025%	   SDS	  
(sodium	  dodecyl	  sulphate,	  w/v)	  and	  trace	  amounts	  of	  xylene	  cyanol	  and	  bromophenol	  blue	  
in	  dH2O.	  
2.4 DNA	  isolation	  and	  manipulation	  
2.4.1 DNA	  isolation	  and	  sequencing	  
2.4.1.1 Plasmid	  DNA	  isolation	  
All	  plasmid	  DNA	  isolations	  were	  carried	  out	  using	  the	  ‘QIAprep	  Spin	  Miniprep	  Kit’	  (Qiagen)	  
following	  the	  manufacturer’s	  protocol.	  Overnight	  cultures	  of	  transformed	  E.	  coli	  were	  grown	  
in	   5	  mL	   LB	   broth	  with	   suitable	   antibiotic	   selection	   in	   20	  mL	   universal	   tubes,	   incubated	   at	  
37°C,	  200	  rpm.	  Prior	  to	  extraction	  samples	  were	  centrifuged	  at	  5000	  g,	  21°C	  for	  3	  min.	  After	  
centrifugation	  the	  supernatant	  was	  decanted,	  re-­‐suspending	  the	  cell	  pellet	  in	  250	  μL	  ‘buffer	  
P1’	   for	   kit	   extraction.	   DNA	   was	   eluted	   in	   30	  μL	   molecular	   grade	   H2O	   to	   prevent	  
complications	   during	   electroporation	   of	   mycobacteria.	   The	   concentration	   and	   purity	   of	  
isolated	  DNA	  was	  recorded	  prior	  to	  storage	  at	  4°C	  (see	  section	  2.4.1.4).	  	  
2.4.1.2 Episomal	  DNA	  isolation	  
Episomal	  DNA	  extractions	  from	  transformed	  mycobacteria	  were	  carried	  out	  with	  a	  modified	  
protocol	  using	  ‘IntstaGene	  matrix’	  (Bio-­‐Rad).	  A	  cell	  suspension	  was	  made	  by	  suspending	  an	  
isolated	  colony	  in	  1	  mL	  sterile	  dH2O	  or	  using	  1	  mL	  of	  dense	  culture	  grown	  from	  an	  isolated	  
colony.	   Cell	   suspensions	   were	   centrifuged	   at	   16000	  g,	   21°C	   for	   1	   min	   in	   1.5	  mL	  
micro-­‐centrifuge	  tubes.	  Following	  centrifugation,	  cell	  pellets	  were	  re-­‐suspended	  in	  200	  μL	  of	  
‘InstaGene	  matrix’	   (Bio-­‐Rad)	  and	   incubated	  at	  56°C	   for	  15	   to	  30	  min.	  After	   incubation	   the	  
suspension	  was	   vortexed	   at	   high	   speed	   for	   10	   sec	   before	   incubation	   at	   100°C	   for	   8	  min.	  
After	   incubation,	  the	  suspension	  was	  vortexed	  again	  then	  centrifuged	  at	  16000	  g,	  21°C	  for	  
3	  min.	   After	   centrifugation,	   18	  μL	   of	   the	   resulting	   supernatant	  was	   used	   as	   template	   in	   a	  
50	  μL	   PCR	   reaction	   (see	   section	   2.4.6.1).	   The	   remaining	   extraction	   was	   stored	   at	   -­‐20°C,	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repeating	   the	   100°C	   incubation	   and	   subsequent	   centrifugation	   if	   required	   for	   additional	  
PCR.	  
2.4.1.3 Genomic	  DNA	  isolation	  	  
Genomic	  DNA	  (gDNA)	  was	  isolated	  from	  mycobacteria	  by	  harvesting	  culture	  grown	  on	  solid	  
7H11	   agar	   and	   suspending	   in	   300	  µL	   TE	   buffer	   (Qiagen).	   Suspensions	  were	   heat-­‐killed	   for	  
1	  hour	   at	   90°C,	   sealing	   tubes	   with	   plastic	   paraffin	   film	   (Parafilm	   M,	   Sigma).	   Following	  
heat-­‐killing,	   cells	   were	   centrifuged	   at	   16000	  g,	   4°C	   for	   5	   min.	   Following	   centrifugation	  
supernatant	  was	  discarded	  and	  cell	  pellets	  were	  stored	  at	  -­‐20°C	  for	  subsequent	  use. 
After	  thawing,	  heat-­‐killed	  pellets	  were	  re-­‐suspended	  in	  300	  mL	  TE	  buffer	  prior	  to	  addition	  of	  
15	  µL	  fresh	  lysozyme/lipase	  solution	  to	  a	  final	  concentration	  of	  20	  mg/mL	  each	  and	  2	  µL	  of	  
10	  mg/mL	  RNaseA	  (Sigma).	  Re-­‐suspended	  pellets	  were	  then	  incubated	  at	  37°C	  for	  2	  hours.	  
Following	  incubation,	  cells	  were	  placed	  on	  ice	  to	  cool	  rapidly,	  then	  allowed	  to	  warm	  to	  room	  
temperature.	  Once	  at	  room	  temperature,	  7.5	  µL	  of	  20	  µg/mL	  proteinase	  K	  (Sigma),	  25	  µL	  of	  
10%	  SDS	  (w/v)	  and	  was	  added	  to	  extracts	  and	  incubated	  at	  50°C	  for	  1	  hour.	  
Following	   incubation	   extracts	   were	   purified	   by	   phenol-­‐chloroform	   extraction,	   adding	   an	  
equal	   volume	   of	   phenol-­‐chloroform-­‐isoamyl	   alcohol	   (25:24:1,	   Ambion).	   Extracts	   were	  
vortexed	  vigorously	  then	  centrifuged	  at	  16000	  g,	  15°C	  for	  15	  min.	  Following	  centrifugation,	  
the	  aqueous	   layer	  was	   transferred	  to	  a	  new	  1.5	  mL	  micro-­‐centrifuge	   tube	  and	  mixed	  with	  
0.02	  volumes	   5	  M	  NaCl,	   0.1	  volumes	   3	  M	  sodium	   acetate	   and	   3	   volumes	   100%	   ethanol	   by	  
gentle	  inversion.	  Extracts	  were	  precipitated	  at	  -­‐20°C	  over	  18	  hours.	  Following	  precipitation,	  
extracts	   were	   centrifuged	   at	   16000	  g,	   4°C	   for	   30	   min.	   Following	   centrifugation	   the	  
supernatant	   was	   discarded	   the	   pellet	   washed	   with	   1000	  μL	   70%	   ethanol	   (v/v	   in	   DEPC	  
treated	  H2O)	  before	   centrifuging	  again	   at	   16000	  g,	   4°C	   for	  5	  min.	  After	   centrifugation	   the	  
supernatant	   was	   aspirated	   and	   the	   pellet	   allowed	   to	   air	   dry	   on	   ice	   for	   5	   min	   before	  
re-­‐suspending	  in	  DEPC	  treated	  H2O	  to	  a	  concentration	  of	  100	  ng/µL.	  DNA	  concentration	  and	  
purity	  was	  recorded	  prior	  to	  storing	  at	  -­‐20°C	  (see	  section	  2.4.1.4).	  	  
	  Materials	  and	  methods	  |	  43	  
2.4.1.4 Nucleic	  acid	  quantification	  and	  sequencing	  	  
All	  nucleic	  acid	  concentrations	  were	  quantified	  using	  a	  spectrophotometer	  and	  associated	  
software	   (Nanodrop	   2000,	   Thermofisher	   Scientific).	   Nucleic	   acid	   purity	   was	   quantified	   by	  
measuring	  the	  ratio	  of	  absorbance	  at	  260-­‐280	  nm	  (1.80	  for	  DNA	  and	  2.00	  for	  RNA).	  Protein	  
contamination	  was	  recorded	  by	  measuring	  the	  ratio	  of	  absorbance	  at	  230-­‐260	  nm.	  DNA	  was	  
Sanger	   sequenced	   commercially	   by	   Source	  BioScience.	   Sequence	  data	  was	   analysed	  using	  
CLC	  Main	  workbench	  (Version	  7,	  Qiagen).	  
2.4.2 DNA	  restriction	  digestion	  
All	  DNA	  restriction	  digests	  were	  carried	  out	  using	  New	  England	  Biolabs	  restriction	  enzymes.	  
Digests	  were	  carried	  out	  in	  0.5	  mL	  micro-­‐centrifuge	  tubes.	  For	  cloning	  vector	  digests	  750	  ng	  
plasmid	  was	  added	  per	  reaction,	  for	  purified	  PCR	  fragment	  digestion	  or	  fragment	  generation	  
from	   plasmidic	   DNA	   up	   to	   10	  μg	   plasmidic	   DNA	   was	   added.	   DNA	   was	   mixed	   with	   1	  μL	  
restriction	  enzyme	  (1	  μL	  of	  each	  enzyme	  for	  double	  digests)	  and	  5	  µL	  10x	  ‘CutSmart	  buffer’	  
(NEB)	   in	   50	  μL	  with	  molecular	   grade	  H2O.	   Reactions	  were	   incubated	   at	   37°C	   for	   18	   hours	  
before	   heat	   inactivation	   at	   80°C	   for	   5	  min.	  Digested	  DNA	  was	   stored	   at	   4°C	   prior	   to	   use.	  
Cloning	  vector	  digests	  proceeded	  directly	  to	  dephosphorylation	  (see	  section	  2.4.3).	  
2.4.3 DNA	  dephosphorylation	  
Dephosphorylation	   of	   restriction	   digested	   DNA	   was	   carried	   out	   using	   ‘Antarctic	  
phosphatase’	   (NEB).	   In	  a	  0.5	  mL	  micro-­‐centrifuge	   tube	  digested	  DNA	  was	  mixed	  with	  1	  μL	  
enzyme	  and	  5	  µL	  10x	   reaction	  buffer	   (NEB)	   in	  50	  μL	  with	  molecular	   grade	  H2O.	  Reactions	  
were	   incubated	   at	   37°C	   for	   1	   hour	   before	   heat	   inactivation	   at	   70°C	   for	   5	   min.	  
Dephosphorylated	  DNA	  was	  stored	  at	  4°C	  prior	  to	  use.	  	  
2.4.4 Oligonucleotide	  annealing	  and	  phosphorylation	  
Complementary	  oligonucleotides	  were	  designed	  to	  form	  restriction	  digest	  compatible	  ends	  
once	   annealed.	   Each	   reconstituted	   oligonucleotide	   was	   5’phosphorylated	   using	   T4	  
polynucleotide	   kinase	   (NEB)	   separately	   in	   a	   1.5	   mL	   micro-­‐centrifuge	   tube	   by	   combining	  
30	  μL	  100	  μM	  oligonucleotide,	  5	  μL	  10x	   reaction	  buffer	   (NEB),	  5	  μL	  10	  mM	  ATP	   (NEB)	  and	  
1	  μL	  T4	  PNK	  enzyme	  in	  50	  μL	  with	  molecular	  grade	  H2O.	  Reactions	  were	  incubated	  at	  37°C	  
for	  45	  min	  before	  heat	   inactivation	  at	  65°C	   for	  10	  min.	   In	  a	  1.5	  mL	  micro-­‐centrifuge	   tube	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22.5	  μL	   of	   each	   complementary	   phosphorylated	   oligonucleotide	   were	   added	   to	   5	  μL	   10x	  
annealing	  buffer	  (see	  section	  2.3)	  then	  incubated	  at	  95°C	  for	  5	  min	  before	  being	  left	  to	  cool	  
to	  room	  temperature	  over	  >1	  hour.	  Annealed	  oligonucleotides	  were	  stored	  at	  4°C	  prior	  to	  
ligation	  with	  compatible	  restriction	  digested	  DNA.	  	  
2.4.5 DNA	  ligation	  
All	   DNA	   ligations	   were	   carried	   out	   using	   ‘T4	   DNA	   ligase’	   (Promega)	   according	   to	   the	  
manufacturer’s	  specification.	  Ligations	  were	  carried	  out	  in	  a	  0.5	  mL	  micro-­‐centrifuge	  tube	  as	  
a	  10	  μL	  reaction	  composed	  of	  7	  μL	  digested	  DNA	  insert,	  1	  μL	  digested	  and	  dephosphorylated	  
compatible	   DNA	   vector,	   1	  μL	   10x	   ‘DNA	   ligase	   buffer’	   (Promega)	   and	   1	  μL	   T4	   DNA	   ligase.	  
Reactions	  were	   incubated	  at	   16°C	   for	   18	  hours	  before	  being	   transformed	   into	   competent	  
E.	  coli.	  	  
For	  pGEM	  (Promega)	  T-­‐A	  ligations,	  rapid	  ligase	  buffer	  was	  used.	  Ligations	  were	  carried	  out	  
as	  a	  10	  μL	  reaction	  composed	  of	  3	  μL	  3’terminal	  deoxyadenylated	  PCR	  product	  (see	  section	  
2.4.6.2),	  1	  μL	  pGEM	  vector,	  5	  μL	  2x	  Rapid	  Ligation	  buffer	  (Promega)	  and	  1	  μL	  T4	  DNA	  ligase.	  
Reactions	   were	   incubated	   at	   16°C	   for	   1	   hour	   before	   being	   transformed	   into	   competent	  
E.	  coli.	  	  
2.4.6 Polymerase	  chain	  reaction	  DNA	  amplification	  	  
Oligonucleotides	  were	  designed	  to	  flank	  desired	  target	  sequences.	   If	   the	  desired	  amplicon	  
was	   to	   be	   used	   for	   cloning,	   oligonucleotides	   incorporated	   restriction	   digestion	   sites	   with	  
flanking	  nucleotides	  at	  the	  5’end	  to	  facilitate	  digestion.	  PCR	  reactions	  were	  carried	  out	  in	  a	  
thermocycler	   with	   annealing	   temperatures	   corresponding	   to	   3°C	   below	   primer	   melting	  
temperatures	  (Tm)	  as	  predicted	  by	  Sigma.	  For	  primer	  pairs	  with	  disparate	  Tm	  a	  ‘touch	  down’	  
PCR	  was	  carried,	  lowering	  the	  annealing	  temperature	  from	  up	  to	  10°C	  above	  the	  lower	  Tm	  
by	  -­‐1°C	  per	  cycle.	  Extension	  time	  was	  set	  according	  the	   length	  of	  the	  DNA	  fragment	  to	  be	  
amplified.	  Following	  the	  completed	  cycles,	  PCR	  reactions	  were	  stored	  at	  4°C	  and	  analysed	  
by	  agarose	  gel	  electrophoresis.	  5%	  DMSO	  (dimethyl	  sulfoxide,	  v/v	  final,	  Sigma)	  was	  used	  in	  
PCR	  reactions	  to	  facilitate	  DNA	  melting	  and	  improve	  amplification.	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2.4.6.1 Phusion	  GC	  high	  fidelity	  PCR	  
‘Phusion	  GC	  high	   fidelity	  DNA	  polymerase	  master	  mix’	   (NEB)	  was	  used	   to	   amplify	  desired	  
DNA	   sequences	   with	   high	   fidelity	   to	   generate	   amplicons	   for	   cloning	   or	   DNA	   sequencing.	  
Each	   reaction	  was	  carried	  out	   in	  a	  0.25	  μL	  PCR	   tube	  with	  12.5	  µL	  enzyme	  mix	   (NEB),	  1	  µL	  
10	  µM	   forward	   primer,	   1	  µL	   10	  µM	   reverse	   primer,	   2.5	  µL	   50%	   DMSO,	   1	  µL	   10	   ng/µL	  
template	   plasmid	   in	   25	  µL	   with	   molecular	   grade	   H2O.	   Reactions	   were	   amplified	   over	  
30	  repeat	  cycles	  (see	  Table	  2.II)	  
Step	   Temperature	   Time	   Number	  of	  cycles	  
Initial	  denaturation	   98°C	   10	  min	   1	  
Denaturation	   98°C	   30	  sec	  
30	  Annealing	   72	  –	  50°C	   45	  sec	  
Extension	   72°C	   1	  min/kb	  
Final	  extension	   72°C	   10	  min	   1	  
	  
Table	  2.II	  example	  Phusion	  GC	  PCR	  thermocycling	  conditions	  
Fragments	   for	   cloning	   were	   purified	   using	   the	   ‘QIAquick	   PCR	   Purification	   Kit’	   (Qiagen)	  
following	   the	  manufacturer’s	   protocol	   and	   eluting	   in	  molecular	   grade	  H2O.	   Fragments	   for	  
T-­‐A	   ligation	   into	   pGEM	   included	   an	   additional	   2	   cycle	   REDTaq	   PCR	   step	   for	  
3’deoxyadenylated	  end	  generation	  (see	  section	  2.4.6.2).	  
2.4.6.2 REDTaq	  PCR	  
‘REDTaq	   ReadyMix’	   (Sigma)	   was	   used	   for	   colony	   PCR	   and	   the	   production	   of	  
3’deoxyadenylated	   PCR	   products.	   Reactions	   were	   carried	   out	   in	   a	   0.25	  μL	   PCR	   tube	   with	  
12.5	  µL	  enzyme	  mix	  (Sigma),	  1	  µL	  10	  µM	  forward	  primer,	  1	  µL	  10	  µM	  reverse	  primer,	  2.5	  µL	  
50%	  DMSO,	  1	  µL	  10	  ng/µL	   template	  plasmid	   in	  25	  µL	  with	  molecular	   grade	  H2O.	  Bacteria	  
were	  added	  directly	   to	   colony	  PCR	   reactions	  by	   suspending	  an	   isolated	   colony	   in	   the	  PCR	  
reaction,	  releasing	  DNA	  template	  through	  cell	  lysis	  during	  the	  initial	  denaturation.	  Reactions	  
were	  amplified	  over	  30	  repeat	  cycles	  as	  in	  Table	  2.II	  but	  with	  denaturation	  at	  94°C.	  
For	  3’deoxyadenylated	  PCR	  products	   for	  pGEM	  T-­‐A	   ligation,	  after	   the	   initial	  25	  μL	  Phusion	  
GC	  high	  fidelity	  PCR	  reaction	  was	  complete,	  25	  μL	  ‘REDTaq	  ReadyMix’	  PCR	  reaction	  mix	  was	  
added	  to	  reactions	  for	  a	  further	  2	  cycles	  with	  94°C	  denaturation.	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2.4.7 PCR	  mutagenesis	  
2.4.7.1 Q5	  site	  directed	  mutagenesis	  
Site-­‐directed	  mutagenesis	  (SDM)	  was	  carried	  out	  using	  the	  ‘Q5	  SDM	  kit’	  (NEB)	  following	  the	  
manufacturer’s	   protocol.	   Appropriate	   primers	   were	   designed	   using	   the	   ‘NEBasechanger’	  
SDM	  primer	  design	   tool	  with	  additional	   flanking	   regions	   to	  optimise	   for	  high	  G:C	  content.	  
Potential	   clones	   were	   screened	   by	   colony	   PCR,	   plasmid	   DNA	   isolation	   and	   sequencing.	  
Correct	   constructs	   were	   sub-­‐cloned	   into	   an	   un-­‐mutated	   vector	   backbone	   to	   prevent	  
undesired	   mutations,	   confirming	   construction	   by	   colony	   PCR,	   plasmid	   DNA	   isolation	   and	  
sequencing.	  
2.4.7.2 Overlap	  extension	  mutagenesis	  
For	   small	   mutations	   a	   pair	   of	   Phusion	   GC	   polymerase	   PCR	   reactions	   were	   carried	   out:	  
reaction	  (A)	  used	  an	  upstream	  forward	  primer	  and	  a	  mutagenic	  reverse	  primer	  spanning	  the	  
region	   to	   be	   mutated,	   reaction	   (B)	   used	   a	   downstream	   reverse	   primer	   and	   a	   mutagenic	  
forward	   primer	   spanning	   the	   region	   to	   be	  mutated.	   The	   resulting	   amplicons	   contained	   a	  
region	  of	  complementarity	  exploited	  in	  reaction	  (C)	  by	  combining	  1	  μL	  of	  each	  as	  template	  
in	  another	  PCR	  reaction	  with	  the	  non-­‐mutagenic	  primers	  of	  the	  original	  reactions.	  Desired	  
reaction	   (C)	   amplification	   was	   confirmed	   by	   agarose	   gel	   electrophoresis,	   purifying	   the	  
remaining	   reaction	   using	   the	   ‘QIAquick	   PCR	   Purification	   Kit’	   (Qiagen)	   following	   the	  
manufacturer’s	   protocol	   and	   eluting	   in	  molecular	   grade	   H2O.	   After	   purification,	   DNA	  was	  
digested	   with	   restriction	   enzymes,	   ligated	   into	   the	   desired	   vector	   and	   transformed	   into	  
E.	  coli.	   Desired	   mutations	   were	   confirmed	   by	   colony	   PCR,	   plasmid	   DNA	   isolation	   and	  
sequencing.	  
2.4.8 Agarose	  gel	  electrophoresis	  
Agarose	  gel	  electrophoresis	  was	  used	  to	  separate	  nucleic	  acids	  by	  size.	  All	  gels	  were	  run	  at	  
120	  V	  constant	  to	  achieve	  separation.	  Gels	  were	  analysed	  using	  ‘GeneFlash	  Bio	  Imaging	  Gel	  
Documentation	   System’	   (Syngene).	   Gel	   images	   were	   obtained	   using	   ‘Typhoon	   FLA	   9500’	  
(GE).	   Long	  DNA	  oligonucleotides	   (>1000	  bp)	  were	   separated	   on	   1%	   agarose	   (w/v,	  MP	  Bio	  
Science)	   in	   1x	   TAE	   buffer	   (see	   section	   2.3)	   stained	   with	   ethidium	   bromide	   (Sigma),	  
estimating	   size	   with	   5	  μL	   ‘BenchTop	   1	  kb	   DNA	   Ladder’	   (Promega).	   Shorter	   DNA	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oligonucleotides	  (<1000	  bp)	  were	  separated	  on	  2%	  (w/v)	  agarose	  estimating	  size	  with	  5	  μL	  
‘BenchTop	   100	   bp	   DNA	   Ladder’	   (Promega).	   For	   PCR	   amplicon	   analysis,	   5	  μL	   of	   DNA	   was	  
mixed	  with	  1	  μL	  6x	  ‘blue/orange	  loading	  dye’	  (Promega)	  prior	  to	  loading.	  RNA	  was	  analysed	  
using	  1-­‐3%	  ‘QA-­‐Agarose	  High	  Resolution’	  (w/v,	  MP	  Bio	  Science)	  in	  1x	  TAE	  buffer	  stained	  with	  
ethidium	  bromide;	   RNA	  was	   diluted	   in	   up	   to	   5	  μL	  DEPC	   treated	  H2O	   (Ambion)	   and	  mixed	  
with	  1	  μL	  6x	  ’blue/orange	  loading	  dye’	  prior	  to	  loading.	  	  
2.4.8.1 Gel	  extraction	  of	  DNA	  
For	   gel	   extraction	   purification,	   45	  μL	   DNA	   solution	   was	   mixed	   with	   5	  μL	   6x	   ‘blue/orange	  
loading	   dye’	   prior	   to	   1%	   agarose	   gel	   electrophoresis.	   After	   electrophoresis	   the	   desired	  
amplicon	  was	  excised	  under	  UV	   light	  and	  extracted	  using	  the	   ‘QIAquick	  Gel	  Extraction	  Kit’	  
(Qiagen)	  following	  the	  manufacturer’s	  protocol	  and	  eluting	  in	  molecular	  grade	  H2O.	  
2.5 Transformation	  of	  DNA	  
2.5.1 Transformation	  of	  Escherichia	  coli	  
Commercially	  produced	  competent	   cells	   (α-­‐select	  bronze,	  Bioline)	  were	  used	   for	  all	  E.	  coli	  
transformations.	   In	   a	   1.5	  mL	  micro-­‐centrifuge	   tube	   50	  µL	   of	   cells	  were	  mixed	  with	   either	  
1	  µL	  (>50	  ng/µL)	  purified	  plasmid	  or	  10	  µL	  ligation	  reaction	  and	  incubated	  on	  ice	  for	  20	  min.	  
Following	   incubation	   the	   cells	   were	   heat	   shocked	   at	   42°C	   for	   1	   min	   before	   immediately	  
chilling	  on	  ice	  for	  1	  min.	  Once	  cooled,	  900	  µL	  of	  SOC	  media	  was	  added	  for	  recovery	  at	  37°C,	  
200	  rpm	  for	  1	  hour.	  Following	  incubation	  cells	  were	  centrifuged	  at	  16000	  g,	  21°C	  for	  1	  min,	  
700	  µL	   supernatant	   was	   aspirated	   and	   the	   remaining	   200	  µL	   used	   for	   cell	   pellet	  
re-­‐suspension	   and	   inoculation	   of	   LB	   agar	   plates	   with	   appropriate	   selection.	   Plates	   were	  
incubated	  at	  37°C	  overnight.	  
2.5.2 Protocol	  for	  competent	  mycobacteria	  
Competent	   mycobacteria	   were	   made	   using	   exponential	   growth	   phase	   culture.	  
M.	  smegmatis	  was	   grown	   in	   LB	   0.05%	   (v/v	   final)	   Tween80	   at	   37°C,	   200	   rpm.	   Culture	  was	  
inoculated	   with	   a	   dense	   starter	   culture	   for	   growth	   to	   exponential	   phase	   over	  
>6	  generations.	  At	  0.8	  OD600	  nm	  50	  mL	  culture	  was	  decanted	  into	  50	  mL	  centrifuge	  tubes	  and	  
centrifuged	  at	  5000	  g,	  4°C	   for	  10	  min.	  Following	  centrifugation	  supernatant	  was	  decanted	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and	   the	   cell	   pellet	   re-­‐suspend	   in	   decreasing	   volumes	   of	   chilled	   10%	   glycerol	   (v/v),	  
centrifuging	  in-­‐between	  at	  5000	  g,	  4°C	  for	  10	  min.	  Re-­‐suspension	  volume	  was	  halved	  each	  
time	   from	   25	   to	   12.5	   and	   finally	   5	  mL	   (10%	   of	   the	   original	   volume	   of	   culture).	   The	   final	  
suspension	   was	   aliquoted	   and	   stored	   at	   -­‐20°C.	   The	   same	   process	   was	   used	   for	  
M.	  tuberculosis	  using	  7H9	  0.05%	  (v/v	  final)	  Tween80	  instead	  of	  LB	  broth.	  	  
2.5.3 Transformation	  of	  competent	  mycobacteria	  
The	  electroporation	  protocol	  was	  adapted	   from	  Wards	  and	  Collins	   (1996).	  Electroporation	  
cuvettes	   (0.2	   cm	   Gene	   Pulser/MicroPulser,	   Bio-­‐Rad)	   were	   stored	   at	   -­‐20°C	   prior	   to	   use.	  
400	  µL	  competent	  mycobacteria	  were	  added	  to	  the	  electroporation	  cuvette	  along	  with	  4	  µL	  
(>50	  ng/µL)	   construct	   DNA,	   and	   then	   incubated	   on	   ice	   for	   10	   min.	   Following	   incubation,	  
cuvettes	  were	  gently	   agitated	   to	  disperse	   cells	   then	   subjected	   to	   a	   single	  pulse	  of	   2.5	  kV,	  
25	  μF	   and	   1000	   Ω	   in	   the	   electroporator	   (Gene	   Pulser	   Xcell,	   Bio-­‐Rad)	   incubating	   on	   ice	  
immediately	  after	  for	  10	  min.	  
After	   being	   chilled,	   electroporated	  M.	   smegmatis	   were	   suspended	   in	   3.6	   mL	   LB	   0.05%	  
(v/v	  final)	   Tween80	   for	   recovery	   at	   37°C,	   200	   rpm	   for	   3	   hours.	   After	   incubation	   the	   cells	  
were	  centrifuged	  at	  5000	  g,	  21°C	  for	  10	  min,	  decanting	  the	  supernatant	  to	  leave	  ~200	  µL	  for	  
re-­‐suspension	  and	   inoculation	  of	  LB	  agar	  with	  suitable	  selection.	  Plates	  were	   incubated	  at	  
37°C	  for	  1	  week.	  The	  same	  process	  was	  used	  for	  M.	  tuberculosis	  using	  7H9	  0.05%	  (v/v	  final)	  
Tween80	  instead	  of	  LB	  broth.	  As	  a	  slower	  growth	  strain,	  M.	  tuberculosis	  was	  recovered	  over	  
24	  hours,	  at	  37°C,	  100	  rpm.	  Cells	  were	  plated	  onto	  7H11	  agar	  instead	  of	  LB	  and	  incubated	  at	  
37°C	  for	  2	  weeks.	  
2.6 β-­‐galactosidase	  expression	  assay	  
2.6.1 Protein	  extraction	  
Total	   protein	   extracts	   were	   obtained	   from	   M.	   smegmatis	   cultures	   grown	   in	   LB	   0.05%	  
(v/v	  final)	  Tween80	  with	  suitable	  selection.	  At	  0.7	  OD600	  nm	  30	  mL	  of	  culture	  was	  transferred	  
to	  50	  mL	  centrifuge	  tubes	  and	  incubated	  on	  ice	  for	  10	  min	  to	  prevent	  centrifugation	  stress.	  
Following	  incubation	  cells	  were	  centrifuged	  at	  5000	  g,	  4°C	  for	  10	  min.	  After	  centrifugation	  
cells	  were	  re-­‐suspended	  in	  5	  mL	  Z-­‐buffer	  (see	  section	  2.3)	  gently	  vortexed	  then	  centrifuged	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again	  at	  5000	  g,	  4°C	   for	  10	  min.	  Following	  centrifugation	  cells	  were	   re-­‐suspended	   in	  1	  mL	  
Z-­‐buffer	  and	  transferred	  to	  1.5	  mL	  micro-­‐centrifuge	  tubes	  for	  centrifugation	  at	  16000	  g,	  4°C	  
for	  10	  min.	  Cells	  were	   re-­‐suspended	  and	  centrifuged	   in	  1	  mL	  Z-­‐buffer	  a	   further	   two	   times	  
before	   being	   transferred	   to	   2	  mL	   screw	   cap	   tubes	   containing	   ~0.2	  mL	   150-­‐212	   µm	   glass	  
beads	  (Sigma)	  for	  lysis	  in	  a	  sample	  homogeniser	  (FastPrep-­‐24	  5G,	  MP	  Bio	  Science)	  at	  6.5	  m/s	  
for	  30	  sec.	  Following	   lysis	  and	  centrifugation	  at	  16000	  g,	  4°C	   for	  10	  min,	   supernatant	  was	  
aliquoted	  into	  1.5	  mL	  micro-­‐centrifuge	  tubes	  and	  stored	  at	  4°C	  prior	  to	  use.	  
2.6.2 β-­‐galactosidase	  expression	  quantification	  
In	   a	   1.5	  mL	  micro-­‐centrifuge	   tube	   38	  mM	   final	   β-­‐mercaptoethanol	   (Sigma)	  was	   added	   to	  
500	  µL	  total	  protein	  extract	  to	  enhance	  β-­‐galactosidase	  activity	  along	  with	  100	  µL	  4	  mg/mL	  
OPNG	  substrate	  (ortho-­‐nitrophenyl-­‐β-­‐galactoside,	  Sigma)	  prior	  to	  incubation	  at	  28°C.	  Upon	  
production	  of	   strong	   yellow	   colour,	   reactions	  were	   stopped	  by	   adding	  250	  µL	  1	  M	  NaCO3	  
and	  the	  in	  incubation	  time	  noted.	  200	  µL	  of	  each	  sample	  was	  then	  measured	  in	  triplicate	  in	  
a	   96	   well	   plate	   for	   420	   nm	   absorbance	   in	   a	   microplate	   reader	   (FLUOstar	   OPTIMA,	   BMG	  
Labtech).	  	  	  
2.6.3 BCA	  protein	  concentration	  quantification	  
Protein	   concentration	   quantification	   of	   whole	   protein	   extracts	   was	   carried	   out	   using	   by	  
‘Pierce	   BCA	   Protein	   Assay	   Kit’	   (Thermo	   Scientific)	   following	   the	   manufacturer’s	   protocol.	  
25	  µL	  of	  each	  sample	  was	  tested	  in	  triplicate	  in	  a	  96	  well	  microplate	  with	  a	  set	  of	  standards,	  
measuring	   562	   nm	   absorbance	   in	   a	   microplate	   reader	   to	   calculate	   the	   total	   protein	  
concentration	  against	  a	  standard	  curve.	  
2.6.4 β-­‐galactosidase	  assay	  statistics	  	  
Quantification	  of	  β-­‐galactosidase	  expression	  was	  calculated	  in	  Miller	  units:	  𝐴!"#×380min×  𝑚𝑔  𝑡𝑜𝑡𝑎𝑙  𝑝𝑟𝑜𝑡𝑒𝑖𝑛 = 𝑀𝑖𝑙𝑙𝑒𝑟  𝑢𝑛𝑖𝑡𝑠𝑚𝑔  𝑝𝑟𝑜𝑡𝑒𝑖𝑛 	  
Miller	  units	  were	  expressed	  as	  a	  percentage	  of	  the	  average	  WT	  value.	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Statistical	  significance	  was	  calculated	  using	  one-­‐way	  ANOVA	  with	  Tukey	  post	  hoc	  analysis	  in	  
IBM	   SPSS	   ±1	   standard	   deviation.	   Significance	   thresholds	   specified	   as:	   ‘NS’	   (no	   significant	  
difference,	  P	  >	  0.05),	  ‘*’	  (P	  ≤	  0.05),	  ‘**’	  (P	  ≤	  0.01)	  and	  ‘***’	  (P	  ≤	  0.001).	  
2.7 Extraction	  and	  manipulation	  of	  RNA	  
2.7.1 RNA	  extraction	  
Mycobacterial	  RNA	  extraction	  was	  carried	  out	  using	  ‘FastRNA	  Pro	  Blue	  Kit’	  (MP	  Bio	  Science)	  
following	   the	  manufacturer’s	  protocol.	  Roughly	  15	  mL	  of	  chipped	   ice	  was	  added	   to	  50	  mL	  
centrifuge	   tubes	   and	   pre-­‐chilled	   at	   -­‐20°C.	   At	   the	   time	   of	   extraction,	   25	   mL	   of	   bacterial	  
culture	  was	  added	  to	  the	  50	  mL	  pre-­‐chilled	  tube	  on	  ice,	  quickly	  proceeding	  to	  centrifugation	  
at	  5000	  g,	  4°C	  for	  10	  min.	  After	  centrifugation,	  supernatant	  was	  decanted	  and	  the	  pellet	  (or	  
pellets	  of	   larger	  extraction	  volumes)	  re-­‐suspended	   in	   ‘RNApro’	   (MP	  Bio	  Science),	  1	  mL	  per	  
25	  mL	   original	   culture	   and	   transferred	   to	   kit	   Lysing	  Matrix	   B	   2	  mL	   screw	   cap	   tubes.	   The	  
sample	  was	  then	  processed	  using	  a	  sample	  homogeniser	  (FastPrep-­‐24	  5G,	  MP	  Bio	  Science)	  
at	  6.0	  m/s	  for	  40	  sec.	  
After	   homogenisation	   samples	   were	   immediately	   returned	   to	   ice	   then	   centrifuged	   at	  
16000	  g,	  4°C	  for	  5	  min,	  transferring	  the	  upper	  phase	  to	  a	  1.5	  mL	  micro-­‐centrifuge	  tube	  and	  
incubating	  at	  room	  temperature	  for	  5	  min.	  After	  incubation,	  300	  µL	  chloroform	  (Sigma)	  was	  
added;	   samples	  were	   vortexed	   vigorously	   then	   incubated	   again	   at	   room	   temperature	   for	  
5	  min.	   After	   incubation	   samples	   were	   centrifuged	   at	   16000	  g,	   4°C	   for	   5	  min,	   transferring	  
aqueous	   phase	   to	   a	   1.5	   mL	   micro-­‐centrifuge	   tube	   with	   500	  μL	   100%	   ethanol	   for	  
precipitation	  at	  -­‐20°C	  for	  18	  hours.	  
After	   precipitation,	   samples	   were	   centrifuged	   at	   16000	  g,	   4°C	   for	   30	   min,	   decanting	   the	  
supernatant	   and	  washing	   the	   RNA	   pellet	   with	   1000	  μL	   70%	   ethanol	   (v/v	   in	   DEPC	   treated	  
H2O)	   before	   centrifuging	   again	   at	   16000	  g,	   4°C	   for	   5	   min.	   After	   centrifugation	   the	  
supernatant	   was	   aspirated	   and	   the	   pellet	   allowed	   to	   air	   dry	   on	   ice	   for	   5	   min	   before	  
re-­‐suspending	  in	  25	  μL	  DEPC	  treated	  H2O.	  RNA	  concentration	  and	  purity	  was	  recorded	  prior	  
to	   storing	   at	   -­‐80°C	   (see	   section	   2.4.1.4).	   RNA	   integrity	   was	   analysed	   by	   agarose	   gel	  
electrophoresis	  of	  1000	  ng	  extracted	  RNA.	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2.7.2 DNase	  treatment	  of	  total	  RNA	  	  
DNase	   treatment	   was	   carried	   out	   using	   ‘TURBO	   DNase	   I’	   (Ambion)	   adapting	   the	  
manufacturer’s	  protocol.	   In	  a	  1.5	  mL	  micro-­‐centrifuge	  tube	  10	  μg	  total	  RNA	  was	  combined	  
with	   5	  μL	   10x	   reaction	   buffer	   (Ambion),	   1	  μL	   RNase	   inhibitor	   (RNasin	   Plus,	   Promega)	   and	  
2	  μL	  enzyme	  in	  50	  μL	  with	  DEPC	  treated	  H2O.	  Reactions	  were	  incubated	  at	  37°C	  for	  30	  min.	  
After	   30	  min	   another	   2	  μL	   enzyme	  was	   added,	   incubating	   reactions	   for	   a	   further	   30	  min.	  
After	   incubation	   reactions	   were	   stopped	   immediately	   by	   proceeding	   with	   a	  
phenol-­‐chloroform	   extraction	   adapted	   from	   Gehart,	   Wagner	   and	   Vogel	   (2008).	   For	   each	  
50	  μL	  treated	  RNA,	  150	  µL	  DEPC	  treated	  H2O	  and	  200	  µL	  pH	  4.5	  phenol-­‐chloroform-­‐isoamyl	  
alcohol	   (125:24:1,	  Ambion)	  were	   added,	   vortexed	   vigorously	   then	   centrifuged	   at	   16000	  g,	  
15°C	   for	  15	  min.	  After	   centrifugation,	   the	  aqueous	   layer	  was	   transferred	   to	  a	  new	  1.5	  mL	  
micro-­‐centrifuge	  tube	  and	  mixed	  with	  600	  μL	  100%	  ethanol,	  6	  μL	  3	  M	  sodium	  acetate	  and	  
2	  μL	   glycogen	   co-­‐precipitant	   (GlycoBlue	   15	  mg/mL,	   Ambion)	   for	   precipitation	   at	   -­‐20°C	   for	  
18	  hours.	  If	  DNased	  RNA	  was	  to	  be	  used	  directly	  for	  cDNA	  synthesis,	  1	  μL	  50	  ng/µL	  random	  
hexamers	  (Promega)	  were	  added	  during	  precipitation.	  
After	   precipitation,	   samples	   were	   centrifuged	   at	   16000	  g,	   4°C	   for	   30	   min,	   decanting	   the	  
supernatant	   and	  washing	   the	   RNA	   pellet	   with	   1000	  μL	   70%	   ethanol	   (v/v	   in	   DEPC	   treated	  
H2O)	   before	   centrifuging	   again	   at	   16000	  g,	   4°C	   for	   5	   min.	   After	   centrifugation	   the	  
supernatant	  was	  aspirated	  and	   the	  pellet	  allowed	   to	  air	  dry	  on	   ice	   for	  5	  min.	  RNA	  pellets	  
were	   re-­‐suspended	   in	   an	   appropriate	   volume	   of	   DEPC	   treated	   H2O	   for	   downstream	  
processes	  and	  stored	  at	  -­‐80°C	  prior	  to	  use.	  1	  μL	  re-­‐suspended	  RNA	  was	  used	  as	  template	  in	  
a	  REDTaq	  PCR	   reaction	  primed	  with	  oligonucleotides	  5.51	  and	  5.52	   (see	  Appendix	   section	  
10.3)	   to	   check	   for	   genomic	   DNA	   from	   any	   mycobacterial	   species	   by	   agarose	   gel	  
electrophoresis.	   DNase	   treatment	   was	   repeated	   as	   necessary	   until	   no	   genomic	   DNA	  was	  
detectable.	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2.7.3 Rapid	  amplification	  of	  cDNA	  ends	  
The	   rapid	   amplification	  of	   cDNA	  ends	   (RACE)	  protocol	  was	   adapted	   from	  Gehart,	  Wagner	  
and	  Vogel	  (2008)	  and	  GeneRacer	  kit	  (Invitrogen).	  
2.7.3.1 3’polyadenylation	  
All	  3’polyadenylations	  were	  carried	  out	  using	  a	  ‘Poly(A)	  Tailing	  Kit’	  (Ambion)	  modifying	  the	  
manufacturer’s	  protocol.	   In	  a	  1.5	  mL	  micro-­‐centrifuge	   tube	  10	  μg	  DNase	   treated	  RNA	  was	  
re-­‐suspended	   in	   15	  μL	   DEPC	   treated	   H2O	   was	   combined	   with	   kit	   reagents:	   5	  μL	   ‘E-­‐PAP	  
buffer’,	   2	  μL	   25	  mM	  MnCl2,	   2	  μL	   10	  mM	  ATP	   and	   1	  μL	   E.	  coli	   poly(A)	   polymerase	   (E-­‐PAP).	  
Reactions	   were	   incubated	   at	   37°C	   for	   30	  min	   before	   proceeding	   directly	   with	  
phenol-­‐chloroform	   extraction.	   Extraction	   was	   carried	   out	   as	   described	   previously	   (see	  
section	   2.7.2)	   but	  with	   the	   addition	   of	   1	  μL	   GeneRacer	   oligo	   d(T)	   primer	   (oligonucleotide	  
2.07,	   see	  Appendix	   section	  10.3)	  during	  precipitation	   that	   included	  a	  3’adaptor	   sequence.	  
Extracted	   3’polyadenylated	   RNA	   was	   re-­‐suspended	   in	   12	  μL	   DEPC	   treated	   H2O	   for	   cDNA	  
synthesis	  (see	  section	  2.7.4)	  and	  stored	  at	  -­‐80°C	  prior	  to	  use.	  
2.7.3.2 Construction	  of	  RACE	  library	  
RACE	   treated	   cDNA	  was	   amplified	   in	   a	   50	  μL	   REDTaq	   polymerase	   reaction	   over	   40	  cycles	  
using	   an	   adaptor	   specific	   and	   gene	   specific	   primer	   pair.	   Reactions	   for	   3’RACE	   used	   an	  
upstream	   gene	   specific	   primer	   (oligonucleotide	   2.15)	   and	   adaptor	   specific	   primer	  
(oligonucleotide	   2.09,	   see	   Appendix	   section	   10.3),	   which	   complemented	   the	   3’adaptor	  
sequence.	  Gene	  specific	  amplification	  was	  confirmed	  by	  agarose	  gel	  electrophoresis	  of	  5	  μL	  
PCR	   product	   on	   3%	   agarose.	   The	   remaining	   PCR	   product	   was	   used	   for	   RACE	   library	  
construction	  directly.	  
All	  RACE	  amplicons	  were	  ligated	  into	  PCR4	  TOPO	  cloning	  vector	  using	  ‘TOPO	  TA	  Cloning	  Kit’	  
(Invitrogen).	   In	   a	   1.5	   mL	   micro-­‐centrifuge	   tube	   4	  μL	   RACE	   amplicon	   was	   mixed	   with	   kit	  
reagents:	  0.5	  μL	  salt	  solution	  (1.2	  M	  NaCl,	  0.06	  M	  MgCl2)	  and	  0.5	  µL	  vector	  (10	  ng	  plasmid	  in	  
50%	  glycerol,	  50	  mM	  Tris-­‐HCl	  pH	  7.4,	  1	  mM	  EDTA,	  2	  mM	  DTT,	  0.1%	  Triton	  X-­‐100,	  100	  μg/mL	  
BSA	  and	  30	  μM	  phenol	  red).	  Reactions	  were	  incubated	  at	  room	  temperature	  for	  5	  min	  then	  
transformed	   into	   E.	  coli	   as	   previously	   described,	   inoculating	   LB	   agar	   with	   kanamycin	  
selection	  for	   incubation	  at	  37°C	  for	  18	  hours.	   Individual	  colonies	  were	  isolated	  for	  plasmid	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isolation	  and	  sequencing	  using	  M13	  forward	  and	  reverse	  primers	  (oligonucleotides	  2.38	  and	  
2.39,	   see	   Appendix	   section	   10.3)	   to	   generate	   a	   consensus	   sequence	   for	   the	   target	   RNA	  
terminus.	   The	   first	   non-­‐adenosine	   residue	   beyond	   the	   5’end	   of	   the	   3’polyadenlyated	   tail	  
was	  regarded	  as	  the	  3’terminal	  residue	  of	  the	  transcript.	  Where	  the	  3’polyadenlyated	  tail	  of	  
reads	   mapped	   to	   a	   potential	   adenosine	   residue	   the	   nearest	   upstream	   non-­‐adenosine	  
residue	  was	  regarded	  as	  the	  3’terminal	  residue	  of	  the	  transcript	  to	  prevent	  ambiguity.	  	  
2.7.4 cDNA	  synthesis	  
All	   reverse	   transcription	   PCRs	   were	   carried	   using	   out	   using	   ‘SuperScript	   III	   Reverse	  
Transcriptase’	  (Invitrogen).	  The	  protocol	  was	  adapted	  using	  the	  SuperScript	  and	  GeneRacer	  
kit	   (Invitrogen)	   protocols	   as	   well	   as	   Gehart,	   Wagner	   and	   Vogel	   (2008).	   In	   a	   1.5	  mL	  
micro-­‐centrifuge	   tube	   10	  μg	  DNase	   treated	  RNA	  was	   re-­‐suspended	   in	   12	  µL	  DEPC	   treated	  
H2O.	  For	   reverse	   transcriptase	  analysis	  10	  μg	  treated	  RNA	  was	  re-­‐suspended	   in	  24	  µL,	  and	  
split	  into	  duplicate	  12	  μL	  aliquots	  for	  reverse	  transcriptase	  (RT)	  +/-­‐	  reactions.	  All	  RNA	  pellets	  
contained	  primer	  added	  during	  purification	  steps.	  	  
RNA	   was	   mixed	   with	   1	  μL	   dNTP	   mix	   (10	  mM	   of	   each	   dNTP	   in	   DEPC	   treated	   H2O)	   then	  
denatured	   at	   65°C	   for	   5	   min	   before	   being	   stored	   on	   ice.	   After	   denaturing	   the	   RNA	  
suspension	  was	  transferred	  to	  0.25	  mL	  PCR	  tubes	  and	  mixed	  with	  kit	  components:	  4	  μL	  5x	  
reaction	   buffer,	   1	  μL	   0.1	  M	   DTT,	   1	  μL	   RNase	   inhibitor	   (RNasin	   Plus,	   Promega)	   and	   1	  μL	  
enzyme	   (or	   1	  μL	   DEPC	   treated	   H2O	   for	   RT-­‐	   reactions).	   Reactions	   were	   incubated	   in	   a	  
thermocycler	  at	  50°C	  for	  30	  min,	  55°C	  for	  30	  min,	  heat	  inactivated	  at	  70°C	  for	  15	  min	  before	  
being	   immediately	   stored	   on	   ice.	   Once	   cooled,	   1	  μL	   RNase	   H	   (NEB)	   was	   added	   to	   RT+	  
reactions	  only	  and	   then	  all	   reactions	  were	   incubated	  at	  37°C	   for	  20	  min.	  After	   incubation	  
samples	  were	  stored	  at	  -­‐20°C	  prior	  to	  use.	  
2.7.5 Analysis	  of	  RT-­‐PCR	  	  
Co-­‐transcription	   of	   rpfB	   and	  ksgA	  was	   analysed	   using	   2	  μL	   of	   RT+/-­‐	   cDNA	   generated	  with	  
random	   hexamers	   (Promega).	   cDNA	   was	   amplified	   in	   a	   50	  μL	   REDTaq	   PCR	   reaction	   over	  
30	  cycles	   primed	   using	   oligonucleotides	   5.51	   and	   8.04	   (see	   Appendix	   section	   10.3)	  which	  
flanked	   the	   rpfB-­‐ksgA	   overlapping	   region	   complementary	   to	   the	   sequence	   in	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M.	  tuberculosis,	  M.	  bovis	  BCG	  and	  M.	  smegmatis.	  Amplification	  was	   confirmed	  by	  agarose	  
gel	  electrophoresis.	  Gel	  images	  were	  obtained	  using	  ‘Typhoon	  FLA	  9500’	  (GE).	  
2.7.6 Real-­‐time	  quantitative	  PCR	  
‘SensiFast	   SYBR	   Hi-­‐ROX	   master	   mix’	   (Bio-­‐line)	   was	   used	   to	   amplify	   cDNA	   for	   real-­‐time	  
quantitative	   PCR	   (RT-­‐qPCR).	   A	   master	   mix	   consisting	   of	   5	  µL	   enzyme	   mix,	   1.5	   µL	   DEPC	  
treated	  H2O,	  0.25	  µL	  of	  10	  µM	   forward	  primer	  and	  0.25	  µL	  of	  10	  µM	  reverse	  primer	  was	  
distributed	   into	   7	  µL	   aliquots	   in	   a	   96	  well	   plate	   (MicroAmp	   Fast	  Optical	   96-­‐Well	   Reaction	  
Plate,	   Applied	   Biosystems).	  M.	  tuberculosis	   H37Rv	   gDNA	   was	   used	   to	   create	   a	   standard	  
curve	  for	  each	  reaction	  by	  serially	  diluting	  from	  1	  ng/µL	  to	  0.00001	  ng/µL	   in	  DEPC	  treated	  
H2O.	  Wells	  were	  loaded	  with	  either	  1	  µL	  standard	  in	  three	  technical	  replicates	  or	  1	  µL	  RT+/-­‐	  
cDNA	   in	   4	  technical	   replicates.	   Plates	   were	   then	   sealed	   with	   an	   adhesive	   foil	   (MicroAmp	  
Optical	  Adhesive	  Covers,	  Applied	  Biosystems)	  and	  stored	  at	  4°C	  prior	  to	  use.	  	  
Plates	  were	  centrifuged	  at	  1000	  g	  for	  1	  min	  prior	  to	  running.	  All	  reactions	  were	  carried	  out	  
using	  a	  ‘QuantiStudio	  6	  Flex	  Real-­‐Time	  PCR	  System’	  (Applied	  Biosciences)	  and	  analysed	  using	  
QuantiStudio	  Real-­‐time	  PCR	  software	  v1.1	   (Applied	  Biosciences).	  Reactions	  were	  amplified	  
over	   40	   cycles	   with	   a	   high-­‐resolution	   melt	   to	   confirm	   amplicon	   size	   (see	   Table	   2.III)	  
Quantification	   was	   calculated	   according	   to	   the	   cycle	   at	   which	   amplification	   exceeded	   an	  
arbitrary	  threshold	  (typically	  cycle	  13	  to	  15)	  set	  by	  amplification	  of	  a	  M.	  tuberculosis	  gDNA	  
standard	   (serial	   dilution	   from	  1	   to	  0.00001	  ng/µL),	   expressed	  as	   arbitrary	  units	   calculated	  
against	  the	  standard	  curve.	  	  
Step	   Temperature	   Rate	   Time	   Number	  of	  cycles	  
Initial	  denaturation	   95°C	   2.42°C/s	   3	  min	   1	  
Denaturation	   95°C	   2.42°C/s	   5	  sec	  
40	  Annealing	   60°C	   2.42°C/s	   10	  sec	  
Extension	   72°C	   2.42°C/s	   10	  sec	  
Final	  denaturation	   95°C	   2.42°C/s	   15	  sec	   1	  
Annealing	   60°C	   2.42°C/s	   1	  min	   1	  
High	  resolution	  melt	   From	  60	  to	  95°C	   0.05°C/s	   -­‐	   -­‐	  
	  
Table	  2.III	  example	  RT-­‐qPCR	  thermocycling	  conditions	  
None	  of	  the	  cDNA	  analysed	  by	  RT-­‐qPCR	  was	  generated	  in	  a	  strand	  specific	  manner,	  because	  
of	   this	   it	  was	  necessary	   to	  prime	  different	   regions	  of	   the	   rpfB	   locus	   select	  desired	   targets	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specifically	   (see	   Table	   2.IV).	   As	   riboswitch	   amplicons	   might	   originate	   from	   attenuated	  
transcripts	  or	  read-­‐through,	  the	  riboswitch	  was	  primed	  forward	  upstream	  of	  the	  P2	  TSS	  and	  
reverse	   within	   the	   rpfB	   coding	   sequence	   (CDS)	   to	   obtained	   a	   value	   of	   riboswitch	  
read-­‐through	  into	  the	  CDS.	  The	  fraction	  of	  riboswitch	  read-­‐through	  was	  derived	  by	  dividing	  
read-­‐through	   values	   over	   riboswitch	   only	   values	   (see	   Figure	   2.I),	   and	   expressed	   as	   a	  
percentage.	  
Amplicon	   Target	   Forward	  primer	   Reverse	  primer	  
①	  107	  bp	   asRNA	   8.58,	  upstream	  of	  P1	  TSS	   8.53,	  within	  riboswitch	  
②	  72	  bp	   riboswitch	   8.11,	  upstream	  of	  P2	  TSS	   8.53,	  within	  riboswitch	  
③	  332	  bp	   P1	  rpfB	  read-­‐through	   8.56,	  upstream	  of	  P2	  TSS	   8.57,	  within	  rpfB	  CDS	  
④	  235	  bp	   rpfB	  from	  P1	  or	  P2	   8.07,	  within	  rpfB	  CDS	   8.08,	  within	  rpfB	  CDS	  
⑤	  231	  bp	   ksgA	  from	  P1	  or	  P2	   8.09,	  within	  ksgA	  CDS	   8.10,	  within	  ksgA	  CDS	  
	  
Table	  2.IV	  target	  amplicons	  of	  the	  rpfB	  locus	  
Numbers	   in	   circles	   correlate	   to	   amplicons	   depicted	   in	   Figure	   2.I.	   Primer	   oligonucleotides	   are	   detailed	   in	  
Appendix	  section	  10.3.	  
	  
Figure	  2.I	  schematic	  of	  RT-­‐qPCR	  target	  amplification	  
Diagram	   depicts	   the	   target	   amplicons	   within	   the	   rpfB	   locus.	   Circled	   numbers	   correlate	   with	   amplicons	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2.8 Northern	  blotting	  of	  RNA	  
2.8.1 Preparation	  of	  RNA	  for	  gel	  electrophoresis	  
Total	  RNA	  sample	   concentration	  was	   standardised	  at	  either	  0.5	  or	  1	  µg/µL	  by	   suspending	  
the	   required	   mass	   of	   RNA	   in	   200	  µL	   with	   DEPC	   treated	   H2O	   (Ambion)	   in	   a	   1.5	  mL	  
micro-­‐centrifuge	  tube	  precipitating	  with	  600	  µL	  100%	  ethanol	  at	   -­‐20°C	  overnight.	  Samples	  
were	  then	  centrifuged	  at	  16000	  g,	  4°C	  for	  30	  min,	  decanting	  the	  supernatant	  and	  washing	  
the	  pellet	  with	  chilled	  70%	  ethanol	  (v/v	  in	  DEPC	  treated	  H2O,	  Ambion)	  before	  re-­‐suspending	  
the	   RNA	   pellet	   in	   loading	   dye	   (Gel	   Loading	   Buffer	   II,	   Ambion)	   to	   achieve	   the	   desired	  
concentration.	   Before	   loading	   the	   gel,	   the	   required	   volume	   of	   RNA	  was	   aliquoted	   into	   a	  
1.5	  mL	  micro-­‐centrifuge	  tube,	  denatured	  at	  80°C	  for	  2	  min	  then	  stored	  on	  ice.	  Samples	  were	  
loaded	  alongside	  10	  μL	  0.5	  μg/µL	  RNA	  marker	  (Century,	  Ambion)	  suspended	  in	  loading	  dye	  
to	  estimate	  RNA	  size.	  
2.8.2 Urea	  polyacrylamide	  gel	  electrophoresis	  
RNA	   was	   separated	   using	   denaturing	   urea	   denaturing	   urea	   polyacrylamide	   gel	  
electrophoresis	   (PAGE):	  7	  M	  urea,	  1x	  TBE	  buffer	   (see	  section	  2.3)	  and	  8-­‐15%	   (v/v	   final)	  of	  
40%	  19:1	  acrylamide:bis-­‐acrylamide	  (MP	  Bio	  Science)	  in	  50	  mL	  with	  dH2O,	  cross-­‐linked	  with	  
100	   μL	   of	   25%	   APS	   (ammonium	   persulfate,	   w/v	   in	   dH2O)	   and	   25	  μL	   TEMED	  
(N,N,N',N-­‐tetramethylethylenediamine),	   stored	   at	   4°C	   prior	   to	   use.	   Gels	   were	   pre-­‐run	   at	  
15	  W	  constant	   for	  1	  hour	  to	  warm	  the	  gel	  prior	  to	   loading.	  Once	   loaded,	  gels	  were	  run	  at	  
12	  W	  constant	  for	  15	  min	  and	  then	  reduced	  to	  from	  11	  to	  9	  W	  constant,	  using	  loading	  dye	  
to	  estimate	  RNA	  migration.	  
2.8.3 Northern	  electro-­‐blotting	  
Migrated	   gels	   were	   electro-­‐blotted	   onto	   nylon	   membrane	   (BrightStar-­‐Plus	   Positively	  
Charged	  Nylon	  Membrane,	   Ambion)	   between	   six	   layers	   of	  Whatman	   3MM	  paper	   (Sigma)	  
wet	  with	  0.5x	  TBE	  buffer	  (see	  Figure	  2.II).	  	  
Electro-­‐blotting	  was	   carried	   out	   at	   7	  V	   constant	   for	   1	   hour.	   Once	   transferred	   the	   blotted	  
membrane	  was	   cross-­‐linked	   on	   both	   sides	   (120,000	  μJ,	   UV	   Stratalinker	   2400,	   Stratagene)	  
then	  stained	  for	  10	  min	  in	  a	  bath	  of	  0.3	  M	  sodium	  acetate	  with	  0.03%	  (w/v)	  methylene	  blue.	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Scoring	  the	  membrane	  with	  pencil	  before	  de-­‐staining	  with	  dH2O	  enhanced	  the	  RNA	  marker.	  
Membranes	  were	  in	  Whatman	  3MM	  paper	  at	  -­‐20°C	  prior	  to	  hybridisation.	  
	  
Figure	  2.II	  construction	  of	  the	  northern	  electro-­‐blot	  
2.8.4 Ribo-­‐probe	  construction	  
Ribo-­‐probes	  were	  constructed	  using	  the	  ‘mirVana	  miRNA	  Probe	  Construction	  Kit’	  (Ambion)	  
following	   the	   manufacturer’s	   protocol.	   Template	   oligonucleotide	   was	   commercially	  
synthesised	   by	   Sigma	   with	   40	  nt	   of	   target	   RNA	   complementary	   sequence	   with	  
3’incorporated	  T7	  promoter	  primer	  complementary	   sequence	   ‘GCCTGTCTC’	   (see	  Appendix	  
section	   10.3).	   Template	   oligonucleotide	   was	   used	   to	   generate	   dsDNA	   template	   for	  
radiolabelled	  ribo-­‐probes	  construction	  using	  the	  kit,	  incorporating	  32P-­‐αUTP	  (3000	  Ci/mmol	  
10	  mCi/mL,	   Perkin	   Elmer)	   by	   adding	   5	  μL	   to	   the	   reaction	   (doubling	   volume	   with	   each	  
half-­‐life)	   and	   incubating	   with	   T7	   RNAP	   for	   10	   min.	   The	   DNase	   I	   treatment	   step	   was	   not	  
observed.	  Synthesised	  radiolabelled	  ribo-­‐probes	  were	  added	  to	  pre-­‐hybridised	  membranes	  
immediately,	  with	  the	  exception	  of	  5S	  rRNA	  probe	  which	  was	  stored	  at	  -­‐20°C	  using	  2	  μL	  at	  a	  
time	  due	  to	  the	  abundance	  of	  5S	  rRNA	  transcripts.	  
2.8.5 Ribo-­‐probe	  hybridisation	  
Blotted	   membranes	   were	   pre-­‐hybridised	   with	   approximately	   10	  mL	   hybridisation	   buffer	  
(ULTRAhyb	  Ultrasensitive	  Hybridization	  Buffer,	  Ambion),	  in	  hybridisation	  bottles	  at	  rolling	  at	  
68°C	  for	  1	  hour.	  Once	  pre-­‐hybridised	  the	  freshly	  transcribed	  ribo-­‐probe	  was	  added	  directly	  
into	   the	   hybridisation	   buffer	   for	   hybridisation	   at	   68°C	   for	   18	   hours.	   Following	   probe	  
hybridisation	   the	  buffer	  was	  discarded	  and	   the	  membrane	  successively	  washed	  with	  once	  
with	   2x	   SSC	   (salt	   sodium	   citrate	   buffer,	   20x	   stock,	  MP	  Bioscience)	  with	   1%	  SDS	   (w/v)	   and	  
twice	  with	  0.2x	  SSC	  1%	  SDS,	   incubating	  each	  wash	   rolling	  at	  68°C	   for	  at	   least	  30	  min	  and	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being	  dried	  and	  wrapped	  in	  Saran	  wrap	  to	  expose	  to	  a	  phosphor	  screen	  developed	  using	  a	  
Typhoon	  FLA	  9500	  (GE).	  
2.9 Escherichia	  coli	  RNAP	  in	  vitro	  transcription	  system	  	  
2.9.1 In	  vitro	  transcription	  reaction	  
E.	  coli	   RNAP	   in	   vitro	   transcription	   assays	   were	   carried	   out	   using	   previously	   described	  
methods	  for	  producing	  halted	  transcription	  elongation	  complexes	  (TECs)	  (Landick,	  Wang	  &	  
Chan	   1996;	   Grundy,	  Winkler	   &	   Henkin	   2002;	   Sudarsan	   et	   al.	   2003;	  Wickiser	   et	   al.	   2005).	  
Transcription	  templates	  were	  cloned	  into	  pGAMrnnX,	  a	  template	  vector	  derived	  from	  pGEM	  
(Promega)	  containing	  the	  M.	  smegmatis	  rrnB	  P1	  promoter	  region	  with	  extended	  -­‐10	  element	  
(see	  Appendix	  section	  10.2).	  Transcription	  templates	  were	  comprised	  of	  -­‐80	  to	  -­‐1	  of	  the	  PrrnB	  
TSS,	   followed	   downstream	   with	   the	   sequence	   ‘GTAAA’	   fused	   with	   the	   rpfB	   riboswitch	  
sequence	   spanning	   from	   the	   P1	   TSS	   +1	   to	   +176	   bp	   to	   generate	   riboswitch-­‐mediated	  
attenuation	   at	   ~130	  nt	   and	   transcription	   read-­‐through	   as	   template	   run-­‐off	   at	   181	  nt	   or	  
synthetic	  termination	  by	  the	  synB	  terminator	  at	  211	  nt	  (see	  section	  7.2).	  
Templates	  were	   generated	  by	  PCR	  amplification	  with	  oligonucleotides	  5.44	  and	  5.61/8.43	  
(see	  Appendix	  section	  10.3)	  with	  Phusion	  GC	  polymerase.	  Amplified	  template	  was	  purified	  
by	  ethanol	  precipitation	  in	  2.5	  volumes	  100%	  ethanol	  and	  0.1	  volumes	  3	  M	  sodium	  acetate,	  
precipitating	   at	   -­‐20°C	   for	   18	   hours.	   After	   precipitation	   templates	   were	   centrifuged	   at	  
16000	  g,	   4°C	   for	   30	  min,	   decanting	   the	   supernatant	   and	  washing	   the	   pellet	  with	   1000	  μL	  
70%	  ethanol	  (v/v	  in	  DEPC	  treated	  H2O)	  before	  centrifuging	  again	  at	  16000	  g,	  4°C	  for	  5	  min.	  
After	  centrifugation	  the	  supernatant	  was	  aspirated	  and	  the	  pellet	  allowed	  to	  air	  dry	  on	  ice	  
for	  5	  min	  before	   re-­‐suspending	   in	  50	  μL	  DEPC	   treated	  H2O.	  DNA	  concentration	  and	  purity	  
was	   recorded	  prior	   to	   storing	   at	   -­‐20°C	   (see	   section	  2.4.1.4).	   All	   rpfB	   riboswitch	   templates	  
were	  cloned	  with	  an	  additional	  5’sequence	  of	  ‘GTAAA’	  to	  facilitate	  transcriptional	  pausing.	  
The	  dinucleotide	  GpU	  (IBA)	  was	  used	  to	   initiate	  transcription	  whilst	  withholding	  rUTP,	  this	  
caused	  TECs	  to	  halt	  at	  the	  first	  uracil	  at	  U+11	  nt	  (with	  the	  exception	  of	  the	  anti-­‐terminator	  
stabilised	  mutant	  U11C,	  which	  paused	  at	  U+31	  nt).	  	  
All	  E.	  coli	  RNAP	  transcription	  reactions	  were	  carried	  out	  using	  commercially	  produced	  core	  
or	   holoenzyme	   RNAP	   (NEB).	   Halted	   TECs	   were	   assembled	   first	   with	   the	   addition	   of	   5x	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reaction	  buffer	  (40	  mM	  Tris-­‐HCl	  pH	  7.5,	  150	  mM	  KCl,	  10	  mM	  MgCl2,	  1	  mM	  DTT,	  0.01%	  Triton	  
X-­‐100),	  20	  nM	  dsDNA	  template,	  40	  U	   ‘RNasin	  plus’	  RNAse	   inhibitor	   (Promega)	  and	  34	  nM	  
E.	  coli	  holoenzyme	  in	  22.5	  μL	  with	  DEPC	  treated	  H2O.	  Enzyme	  and	  template	  were	  incubated	  
at	  37°C	  for	  5	  min	  before	  adding	  5	  μL	  pre-­‐warmed	  10x	  halt	  mix	  (150	  μM	  GpU	  dinucleotide,	  
25	  μM	   rGTP/rCTP	   with	   10	  μM	   rATP	   (Promega)	   and	   0.04	  μCi/μL	   32P-­‐αATP	   (3000	  Ci/mmol	  
10	  mCi/mL,	   Perkin	   Elmer).	   Reactions	   were	   then	   incubated	   at	   37°C	   for	   5	   min.	   After	  
incubation	  pre-­‐warmed	  heparin	  (Sigma)	  was	  added	  to	  200	  ng/μL	  final	  in	  up	  to	  65	  μL	  with	  1x	  
buffer	  to	  block	  additional	  transcription	  initiation,	  halted	  TEC	  reactions	  were	  then	  stored	  on	  
ice.	   Ligand	  was	   added	   to	   reactions	   in	   0.25	  mL	   tubes	   by	   adding	   65	  μL	   halted	   TEC	   to	  with	  
ligand	   up	   to	   90	  μL	   in	   1x	   buffer.	   Reactions	   were	   incubated	   at	   37°C	   for	   5	   min	   then	  
transcription	  elongation	  activated	  with	  the	  addition	  of	  10	  μL	  10x	  elongation	  mix	  (250	  μM	  of	  
all	  rNTPs	  mix)	  at	  25	  μM	  final	  in	  100	  μL.	  Reactions	  were	  incubated	  at	  37°C	  for	  5	  min	  before	  
being	   stopped	   with	   100	  μL	   2x	   formamide	   stop	   buffer	   loading	   dye	   (see	   section	   2.3).	  
Reactions	  were	  stored	  at	  -­‐20°C	  prior	  to	  use.	  
2.9.2 E.	  coli	  biotin-­‐streptavidin	  roadblock	  assay	  
2.9.2.1 Biotinylated	  template	  coupling	  
Biotinylated	  templates	  were	  generated	  by	  PCR	  amplification	  as	  above	  using	  oligonucleotides	  
5.44	  and	  8.55	  (see	  Appendix	  section	  10.3)	  using	  Phusion	  GC	  polymerase.	  The	  reverse	  primer	  
incorporated	  a	  5’biotin	   tag	  onto	  the	  antisense	  strand	  of	   the	  262	  bp	  template.	  Purification	  
was	   carried	   out	   using	   ‘Qiaquick	   PCR	   purification	   kit’	   with	   ‘MinElute’	   columns	   (Qiagen)	  
following	  the	  manufacture	  protocol	  to	  ensure	  minimum	  contamination	  of	  the	  template	  with	  
un-­‐incorporated	  biotinylated	  primer.	  DNA	  concentration	  and	  purity	  was	   recorded	  prior	   to	  
storing	  at	  -­‐20°C	  (see	  2.4.1.4).	  
Templates	   were	   coupled	   to	   Dynabead	   M-­‐280	   streptavidin	   coated	   magnetic	   beads	  
(Invitrogen)	   following	   the	  manufacture	   protocol.	   Because	   a	   surplus	   is	   required	   relative	   to	  
the	   template,	   initially	   5	   µL	   of	   homogenised	   stock	   bead	   solution	   (10	   µg	   beads/µL	   in	   PBS	  
pH	  7.4,	  0.1%	  BSA	  and	  0.02%	  sodium	  azide)	  was	  aliquoted	  for	  binding	  an	  estimated	  400	  ng	  of	  
template	  (binding	  10	  ng	  dsDNA	  per	  µg	  of	  beads).	  The	  beads	  are	  then	  washed	  in	  1	  mL	  of	  1x	  
binding/washing	  buffer	  (5	  mM	  Tris-­‐HCl	  pH	  7.5,	  0.5	  mM	  EDTA,	  1	  M	  NaCl),	  vortexed	  for	  5	  sec	  
before	  collecting	  the	  beads	  next	  to	  a	  magnet	  for	  1	  min	  and	  discarding	  the	  supernatant.	  To	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decrease	  potential	  RNase	  contamination,	  the	  beads	  were	  then	  washed	  twice	  with	  1	  mL	  of	  
‘solution	  A’	  (DEPC	  treated	  0.1	  M	  NaOH,	  0.05	  M	  NaCl),	  then	  once	  with	  1	  mL	  of	   ‘solution	  B’	  
(DEPC	  treated	  0.1	  M	  NaCl),	  vortexing	  for	  5	  sec	  before	  collecting	  the	  beads	  next	  to	  a	  magnet	  
for	   1	   min	   and	   discarding	   the	   supernatant	   after	   each	   wash.	   Finally	   the	   beads	   were	  
re-­‐suspended	   in	   10	   µL	   2x	   binding/washing	   buffer	   (10	  mM	   Tris-­‐HCl	   pH	   7.5,	   1	  mM	   EDTA,	  
2	  M	  NaCl)	  to	  achieve	  a	  final	  concentration	  of	  5	  µg	  beads/µL.	  	  
To	  couple	  the	  template,	  10	  µL	  of	  200	  nM	  biotinylated	  template	  was	  added	  to	  the	  10	  µL	  of	  
beads,	  diluting	  the	  NaCl	  concentration	  from	  2	  M	  to	  1	  M	  for	  optimal	  binding.	  The	  template	  
and	  beads	  were	  then	  incubated	  at	  room	  temperature	  with	  gentle	  rotation	  for	  15	  min.	  After	  
incubation	  the	  coupled	  beads	  were	  washed	  5	  times	   in	  1	  mL	  of	  1x	  binding/washing	  buffer,	  
vortexing	  for	  5	  sec	  before	  collecting	  the	  beads	  next	  to	  a	  magnet	  for	  2	  min	  and	  discarding	  the	  
supernatant	   after	   each	   wash	   remove	   any	   unbound	   template.	   Finally	   the	   beads	   were	  
re-­‐suspended	  in	  10	  µL	  DEPC	  treated	  H2O	  to	  achieve	  a	  theoretical	  concentration	  of	  200	  nM	  
coupled	  template	  before	  storing	  at	  -­‐20°C.	  
2.9.2.2 Road-­‐blocked	  E.	  coli	  in	  vitro	  transcription	  reaction	  
The	  road-­‐blocked	  in	  vitro	  transcription	  reaction	  was	  carried	  out	  as	  above	  (see	  section	  2.9.1)	  
with	   some	   deviation	   (Chauvier	  et	   al.	   2017).	   A	   total	   reaction	   volume	   of	   200	   µL	  was	   used,	  
allowing	  5	  min	  elongation	  time	  after	  which	  the	  reaction	  was	  split	  into	  two	  aliquots	  of	  100	  µL	  
each	  and	  placed	  next	  to	  a	  magnet	  for	  1	  min	  to	  collect	  the	  beads.	  The	  supernatant	  from	  one	  
aliquot	  was	  collected	  and	  mixed	  in	  equal	  volume	  with	  2x	  formamide	  stop	  buffer	  loading	  dye	  
to	  capture	  released	  transcripts.	  To	  remove	  any	  un-­‐bound	  transcripts,	  the	  beads	  were	  then	  
washed	  5	  times	  with	  100	  µL	  of	  warmed	  1x	  transcription	  buffer,	  mixing	  by	  gentle	  pipetting	  
and	  collecting	  the	  beads	  next	  to	  the	  magnet	  for	  1	  min	  each	  wash.	  After	  washing,	  the	  beads	  
were	  re-­‐suspended	  in	  100	  µL	  of	  warmed	  1x	  transcription	  buffer	  and	  mixed	  in	  equal	  volumes	  
with	  2x	   formamide	   stop	  buffer	   loading	  dye	   (see	   section	  2.3).	   The	   second	   reaction	  aliquot	  
served	  as	  a	  process	  control	  and	  was	  fully	  re-­‐suspended	  before	  being	  mixed	  in	  equal	  volume	  
with	   2x	   formamide	   stop	   buffer	   loading	   dye.	   Reactions	  were	   stored	   at	   -­‐20°C	   prior	   to	   use.	  
Before	  loading	  for	  gel	  electrophoresis	  samples	  were	  denatured	  at	  95°C	  for	  10	  min	  causing	  
the	  template	  to	  uncouple	  from	  the	  beads	  and	  following	  denaturation	  samples	  were	  placed	  
next	  to	  a	  magnet	  to	  separate	  any	  residual	  beads.	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2.9.3 Sequencing	  urea	  polyacrylamide	  gel	  electrophoresis	  
Transcription	  reactions	  were	  separated	  using	  denaturing	  sequencing	  urea	  PAGE:	  7	  M	  urea,	  
1x	  TBE	  buffer	  and	  10%	  (v/v	  final)	  of	  40%	  19:1	  acrylamide:bis-­‐acrylamide	  (Fisher	  Scientific)	  in	  
40	  mL	  with	  dH2O,	  cross-­‐linked	  with	  400	  µL	  of	  10%	  (w/v)	  APS	  and	  40	  µL	  TEMED.	  Gels	  were	  
pre-­‐run	  at	  50	  W	  constant,	  50°C	   for	  1	  hour	  to	  warm	  the	  gel	  prior	   to	   loading.	  Once	   loaded,	  
gels	  were	  run	  at	  15	  W	  constant	  using	  loading	  dye	  to	  estimate	  RNA	  migration.	  Once	  migrated	  
gels	   were	   fixed	   with	   fixing	   solution	   of	   20%	   acetic	   acid	   (v/v,	   Sigma),	   20%	   methanol	   (v/v,	  
Fischer	  Scientific)	  in	  dH2O	  for	  5	  min	  before	  being	  vacuum	  dried	  on	  Whatman	  3MM	  paper	  at	  
80°C	   for	   1	   hour.	   Once	   dried,	   gels	  were	  wrapped	   in	   Saran	  wrap	   to	   expose	   to	   a	   phosphor	  
screen	  developed	  using	  a	  Typhoon	  FLA	  9500	  (GE).	  
2.10 Mycobacterium	  tuberculosis	  RNAP	  in	  vitro	  transcription	  system	  	  
Recombinant	  Mycobacterium	   tuberculosis	   RNAP	   holoenzyme	  was	   generously	   provided	   by	  
Professor	   Sivaramesh	   Wigneshweraraj’s	   group	   at	   the	   MRC	   Centre	   for	   Molecular	  
Bacteriology	   and	   Infection,	   Imperial	   College	   London.	   Single-­‐round	   in	   vitro	   transcription	  
reactions	   were	   carried	   out	   as	   described	   above	   (see	   section	   2.9.1).	   Halted	   TECs	   were	  
assembled	  with	   the	  addition	  of	  1x	   reaction	  buffer	   (20	  mM	  Tris-­‐HCl	  pH	  7.9,	   10	  mM	  MgCl2,	  
100	  mM	   KCl,	   1	  mM	   DTT,	   20	   nM	   dsDNA	   template,	   40	  U	   ‘RNasin	   plus’	   RNase	   inhibitor	  
(Promega)	   and	   400	  nM	  M.	  tuberculosis	   holoenzyme	   22.5	  μL	   total	   with	   DEPC	   treated	   H2O.	  
Reactions	  were	   incubated	   30°C	   for	   5	  min	   before	   adding	   2.5	  μL	   pre-­‐warmed	   10x	   halt	  mix	  
(1500	  μM	  GpU	  dinucleotide,	  25	  μM	  rGTP/rCTP	  with	  7.5	  μM	  rATP	  (Promega)	  and	  0.4	  μCi/μl	  
32P-­‐αATP	  (3000	  Ci/mmol	  10	  mCi/mL,	  Perkin	  Elmer).	  Reactions	  were	  then	  incubated	  at	  37°C	  
for	  15	  min.	  After	   incubation	  pre-­‐warmed	  heparin	  (Sigma)	  was	  added	  to	  200	  ng/μL	  final	   to	  
prevent	   additional	   transcription	   initiation	   in	   45	  μL	   with	   1x	   buffer,	   incubating	   at	   37°C	   for	  
5	  min.	   Transcription	   elongation	   activated	   with	   the	   addition	   of	   5	  μL	   pre-­‐warmed	   10x	  
elongation	  mix	  (2	  mM	  of	  all	  rNTPs)	  at	  200	  μM	  final	  in	  50	  μL.	  Reactions	  extended	  at	  37°C	  for	  
20	  min	  before	  being	  stopped	  with	  50	  μL	  2x	  formamide	  stop	  buffer	  loading	  dye.	  Time-­‐course	  
reactions	   were	   extracted	   as	   indicated.	   Reactions	   were	   stored	   at	   -­‐20°C	   prior	   to	   use.	  
Reactions	  were	  size	  separated	  by	  PAGE	  as	  described	  above	  (see	  section	  2.9.3).	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3 Re-­‐annotation	  of	  rpfB	  translational	  regulation	  
3.1 Mis-­‐annotation	  of	  mycobacterial	  ORFs	  
When	  considering	  regulatory	  nucleic	  acids,	   it	   is	   important	   to	  define	  the	  boundaries	  of	   the	  
gene	   of	   interest	   on	  which	   the	   regulatory	   control	  will	   be	   exerted.	   In	   the	   case	   of	   rpfB,	   the	  
riboswitch	  sequence	  lies	  upstream	  of	  the	  coding	  sequence	  within	  the	  5’untranslated	  region.	  
There	  is	  also	  evidence	  that	  supports	  the	  notion	  of	  an	  antisense	  sRNA	  that	  could	  regulate	  the	  
gene	  (see	  section	  1.10.4).	  For	  an	  accurate	  understanding	  of	  the	  impact	  of	  these	  regulatory	  
features	  it	  is	  important	  to	  ensure	  the	  protein	  coding	  sequence	  (CDS)	  is	  correctly	  annotated.	  
Much	  of	  the	  Mycobacterium	  tuberculosis	  genome	  is	  annotated	  using	  software;	  open	  reading	  
frames	  (ORFs)	  may	  be	  annotated	  by	  identifying	  regions	  between	  start	  and	  stop	  codons,	  or	  
using	   proximity	   of	   start	   codons	   to	   ribosome	   binding	   sites,	   which	   can	   often	   lead	   to	  
mis-­‐annotation	  of	  genes	  (Smollett	  et	  al.	  2009).	  	  
Mycobacteria	  use	  alternative	  start	  codons	  more	  frequently	  than	  other	  bacterial	  species	  –	  as	  
would	  be	  expected	  with	  a	  high	  G:C	  content	   (67%)	  genome	  –	  where	   it	   is	  estimated	  that	   in	  
addition	   to	  ATG,	  coding	  sequences	  are	   initiated	  with	  GTG	   in	  34%	  of	  genes	  and	  TTG	   in	  5%	  
(compared	  with	  14%	  and	  3%	   in	  E.	  coli	   respectively)	   (Blattner	  et	  al.	  1997;	  Cole	  et	  al.	  1998;	  
DeJesus,	  Sacchettini	  &	   Ioerger	  2013).	  Furthermore,	  many	  genes	  encoded	  by	  mycobacteria	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are	  leaderless,	  with	  the	  transcription	  start	  site	  situated	  within	  5	  bp	  of	  the	  translation	  start	  
site,	  and	  therefore	  initiate	  translation	  without	  an	  upstream	  canonical	  ribosome	  binding	  site	  
(Cortes	  et	  al.	  2013).	  	  
Correct	  ORF	  annotation	  can	  be	  achieved	  through	  translational	  start	  site	  mapping	  (TLSM),	  a	  
method	   in	  which	   potential	   ORFs	   are	   fused	  with	   a	   reporter	   gene	   or	   tag	   protein	   and	   then	  
individual	  loci	  are	  mutated	  to	  identify	  in	  which	  ORF	  the	  coding	  sequence	  starts	  (Smollett	  et	  
al.	   2009).	   In	   addition	   to	   the	   annotated	   ATG	   start	   codon,	   rpfB	   has	   a	   further	   two	   possible	  
translational	  start	  sites	  upstream	  in	  M.	  tuberculosis.	  The	  most	  upstream	  is	  GTG	  followed	  by	  
TTG	  and	  finally	  the	  annotated	  ATG	  start	  codon.	  Recently	  Sharma	  et	  al.	  (2015)	  reported	  the	  
rpfB	   ATG	   annotated	   start	   codon	   as	   being	   the	   correct	   translation	   start	   site.	   Using	   a	   lacZ	  
translational	   fusion	  of	  rpfB	   spanning	  -­‐227	  bp	  upstream	  of	  the	  ATG	  down	  to	  +122	  bp,	  they	  
demonstrated	   that	   by	   mutating	   ATG	   to	   AaG	   a	   significant	   loss	   of	   expression	   could	   be	  
observed.	   However,	   the	   authors	   did	   not	   investigate	   the	   two	   additional	   potential	   start	  
codons	   upstream	   of	   the	   annotated	   ATG	   start:	   TTG	   -­‐36	  bp	   upstream	   and	   GTG	   -­‐72	  bp	  
upstream.	  
In	   the	   Mycobacterium	   smegmatis	   rpfB	   homologue	   (MSMEG_5439)	   the	   annotated	   start	  
codon	  (residue	  5522319)	  is	  further	  upstream	  than	  in	  M.	  tuberculosis,	  more	  proximal	  to	  the	  
M.	  tuberculosis	   TTG	   rather	   than	  ATG	   (see	  Appendix	   Figure	   10.I)	   (Kapopoulou,	   Lew	  &	  Cole	  
2011).	   If	   the	   start	   codon	   in	   M.	  tuberculosis	   rpfB	   were	   at	   TTG	   this	   would	   place	   the	  
translational	  start	  site	  closer	  to	  the	  riboswitch	  stem-­‐loop	  terminator	  as	  well	  as	  to	  the	  5’end	  
of	  the	  potential	  asRNA,	  which	  may	  serve	  to	  occlude	  a	  potential	  ribosome	  binding	  site.	  The	  
work	  detailed	  in	  this	  chapter	  aimed	  to	  determine	  the	  translational	  start	  site	  of	  rpfB	  by	  TLSM	  
and	  enabled	  correct	   construction	  of	   transcriptional	  and	   translational	   constructs	   to	   further	  
elucidate	  regulation	  of	  the	  gene.	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3.2 Frameshift	  reporters	  identify	  extended	  rpfB	  ORF	  
To	  investigate	  the	  potential	  start	  codons,	  a	  series	  of	  frameshift	  constructs	  were	  generated	  
containing	   WT	   M.	  tuberculosis	   H37Rv	   rpfB	   5'UTR	   spanning	   -­‐355	   bp	   upstream	   of	   the	  
annotated	  ATG	  start	  codon	  down	  to	  +3	  bp	  (including	  the	  ATG	  codon),	  this	  was	  then	  fused	  
with	   lacZ	   (where	   the	   lacZ	   ATG	   had	   been	   removed).	   Frameshifts	   were	   introduced	   using	  
separate	  deletions	  between	  the	  GTG	  and	  TTG,	  TTG	  and	  ATG	  codons	  and	  finally	  downstream	  
of	  ATG	  within	  the	  lacZ	  CDS	  as	  a	  frameshift	  control.	  These	  constructs	  were	  transformed	  into	  
M.	  smegmatis	  as	  a	  surrogate	  host,	  and	  expression	  was	  measured	  by	  β-­‐galactosidase	  assay.	  	  
Protein	   extracts	   of	   M.	  smegmatis	   transformed	   with	   WT	   translational	   fusion	   showed	   a	  
β-­‐galactosidase	  activity	  of	  37.59	  ±	  5.44	  Miller	  units	  (MU)/mg	  total	  protein,	  representative	  of	  
WT	   translational	   expression	   of	   rpfB	   (see	   Figure	   3.I).	   When	   a	   frameshift	   mutation	   was	  
introduced	   within	   the	   GTG	   ORF,	   between	   the	   GTG	   and	   TTG	   start	   codons,	   no	   significant	  
change	   in	   expression	   relative	   to	   the	  WT	  was	   observed.	   However,	  when	   a	   frameshift	  was	  
introduced	  within	  the	  TTG	  ORF,	  between	  the	  TTG	  and	  ATG	  start	  codons,	  a	  12-­‐fold	  significant	  
decrease	   in	  expression	   to	  3.01	  ±	  2.67	  MU/mg	  total	  protein	  was	  observed.	  A	  similar	   result	  
was	  also	  seen	  when	  a	  frameshift	  was	   introduced	  with	  the	  ATG	  ORF.	  Taken	  together	  these	  
results	  indicated	  the	  rpfB	  ORF	  extends	  up	  to	  the	  TTG	  start	  codon.	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Figure	  3.I	  translational	  start	  site	  mapping	  reporters	  
Diagram	  (A)	  depicts	  mutations	  introduced	  to	  each	  construct,	  where	  ‘*’	  indicates	  basepair	  deletions,	  red	  bases	  
indicate	   substitutions	   and	   ‘RBS*’	   indicates	   ribosome	   binding	   site	   mutation.	   Chart	   (B)	   shows	   results	   of	  
β-­‐galactosidase	  assay	  of	  protein	  extracts	  from	  transformed	  M.	  smegmatis.	  Mean	  of	  biological	  replicates	  (n=6)	  
relative	   to	   WT.	   Statistical	   significance	   relative	   to	   WT	   calculated	   by	   one-­‐way	   ANOVA	   with	   Tukey	   post	   hoc	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3.3 Start	  codon	  substitution	  reporters	  confirm	  correct	  rpfB	  start	  codon	  
The	  frameshift	  constructs	  demonstrated	  the	  rpfB	  ORF	  likely	  extended	  further	  upstream	  than	  
the	  annotated	  ATG	   start	   codon,	  up	   to	   the	  TTG	   start	   codon.	  To	   confirm	   this	   finding,	   three	  
more	  mutants	  were	  derived	  from	  the	  WT	  translational	  reporter.	  Separately	  each	  start	  codon	  
was	   substituted	  with	   a	   synonymous	   non-­‐start	   codon:	   GTG	   substituted	  with	   GTc	   and	   TTG	  
substituted	  with	  TTa.	  Synonymous	  codon	  substitution	   is	  not	  possible	   for	   fMet	  so	  ATG	  was	  
substituted	  with	  AaG	  to	  repeat	  the	  mutation	  used	  by	  Sharma	  et	  al.	  (2015).	  	  
When	   TTG	   was	   substituted	   with	   TTa	   a	   12-­‐fold	   significant	   reduction	   in	   expression	   to	  
3.11	  ±	  0.55	  MU/mg	  total	  protein	  was	  observed	  relative	  to	  the	  WT	  fusion,	  very	  similar	  to	  that	  
observed	  in	  the	  TTG	  ORF	  frameshift	  (see	  Figure	  3.I).	  Mutation	  of	  the	  ATG	  start	  codon	  to	  AaG	  
did	  not	  result	   in	  any	  significant	  change	  of	  expression.	  Mutation	  of	   the	  GTG	  start	  codon	  to	  
GTc	   resulted	   in	   a	   significant	   increase	   in	   expression	   to	   60.68	   ±	   2.67	  MU/mg	   total	   protein,	  
1.6-­‐fold	  greater	  than	  the	  WT;	  this	  was	  surprising	  although	  it	  may	  possibly	  be	  attributed	  to	  
dis-­‐regulation	   of	   other	   proteins	   binding	   (see	   section	   3.5).	   Despite	   this,	   only	   through	  
mutation	  of	  the	  TTG	  start	  codon	  was	  translational	  expression	  decreased	  to	  a	  level	  similar	  to	  
that	   of	   the	   empty	   vector.	   Collectively	   the	   results	   corroborate	   those	   of	   the	   frameshift	  
mutants	  (see	  section	  3.2)	  and	  strongly	  indicate	  the	  translational	  start	  codon	  M.	  tuberculosis	  
rpfB	  is	  TTG	  rather	  than	  ATG.	  
3.4 rpfB	  ribosome	  binding	  site	  validation	  
With	   the	   translational	   start	   codon	   of	   rpfB	   re-­‐annotated	   to	   TTG	   it	   was	   necessary	   to	  
investigate	   if	   rpfB	   required	   a	   ribosome	   binding	   site	   for	   translation.	   No	   obvious	   RBS	   was	  
within	   canonical	   proximity	   of	   the	   TTG	   start	   codon,	   however	   this	   is	   not	   unusual	   in	  
mycobacteria,	  which	  generally	  have	  a	  poor	  RBS	  consensus	  but	  a	  bias	  for	  ~6	  base	  long	  purine	  
rich	  regions	  starting	  at	  around	  -­‐8	  to	  -­‐11	  bp	  upstream	  of	  the	  start	  codon	  (DeJesus,	  Sacchettini	  
&	   Ioerger	   2013).	   An	   ambiguous	   purine	   rich	   sequence	   of	   ‘GAGGTCGGGGA’	   was	  
identified	  -­‐20	  to	  -­‐10	  bp	  upstream	  of	  the	  TTG	  start	  codon.	  This	  sequence	  was	  found	  to	  have	  
some	  complementarity	  to	  the	  16S	  rRNA	  3’end,	  with	  a	  5	  base	  consecutive	  region	  capable	  of	  
basepairing.	   To	   investigate	   if	   this	   sequence	   constituted	   a	   potential	   Shine-­‐Dalgarno	   (SD)	  
sequence	  it	  was	  mutated	  in	  the	  WT	  translational	  fusion	  described	  above,	  substituting	  all	  the	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purines	   with	   pyrimidines	   (GAGGTCGGGGA	   to	   ctccTCcccct)	   to	   disrupt	   ribosome	   binding	  
(Shine	  &	  Dalgarno	  1975).	  	  
Upon	   mutation	   of	   the	   potential	   RBS,	   expression	   of	   β-­‐galactosidase	   in	   transformed	  
M.	  smegmatis	  decreased	  significantly	  relative	  to	  the	  WT	  (see	  Figure	  3.I).	  A	  10-­‐fold	  decrease	  
in	  expression	  to	  3.61	  ±	  0.98	  MU/mg	  total	  protein	  was	  observed.	  As	  the	  frameshift	  mutants	  
described	   previously	   demonstrated	   this	   region	   to	   be	   outside	   of	   the	   CDS,	   this	   decrease	   in	  
expression	  was	  attributed	  to	  reduced	  ribosome	  binding	  upstream	  of	  the	  translational	  start	  
site	   within	   this	   region.	   This	   further	   supported	   the	   notion	   that	   TTG	   was	   the	   correct	  
translational	  start	  site	  as	  this	  RBS	  is	  within	  a	  feasible	  proximity	  to	  the	  start	  codon	  (DeJesus,	  
Sacchettini	  &	  Ioerger	  2013).	  	  	  
3.5 Chapter	  discussion	  
Through	  translational	  start	  site	  mapping,	  the	  β-­‐galactosidase	  assay	  results	  derived	  from	  the	  
ORF	  frameshift	  mutants	  shown	  in	  Figure	  3.I	  demonstrated	  that	  the	  rpfB	  CDS	  extends	  further	  
upstream	  of	  the	  ATG	  start	  codon	  than	  previously	  annotated.	  The	  frameshift	  within	  the	  TTG	  
to	   ATG	   ORF	   was	   the	   most	   upstream	   ORF	   to	   demonstrate	   reduced	   β-­‐galactosidase	  
expression	  relative	  to	  the	  WT.	  This	   indicated	  that	  the	  CDS	  of	  rpfB	  extended	  up	  to	  the	  TTG	  
start	  codon.	  The	  exchange	  of	  the	  potential	  start	  codons	  with	  synonymous	  non-­‐start	  codons	  
corroborated	  this	  finding,	  as	  once	  again	  the	  TTa	  mutation	  was	  the	  most	  upstream	  mutation	  
to	   affect	   expression.	   Although	   other	   start	   codons	   may	   lie	   upstream	   of	   the	   codons	  
investigated	  in	  this	  study,	  none	  could	  allow	  rpfB	  translation;	  the	  next	  codon	  upstream	  of	  the	  
GTG	   is	   a	   stop	   codon	   at	   -­‐73	   bp	   relative	   to	   the	   previously	   annotated	   ATG.	   These	   results	  
indicate	  the	  TTG	  start	  codon	  of	  M.	  tuberculosis	  rpfB	  (Rv1009)	  is	  the	  site	  at	  which	  translation	  
begins.	   This	   allows	   a	   greater	   conservation	  with	   the	   annotated	   start	   in	   the	  M.	  smegmatis	  
homologue	   (MSMEG_5439).	   Therefore,	   it	   is	   strongly	   recommended	   the	   CDS	   of	  
M.	  tuberculosis	  rpfB	  should	  be	  re-­‐annotated	  and	  extended	  up	  to	  the	  TTG	  codon.	  	  
Recently	  Sharma	  et	  al.	  (2015)	  reported	  mutation	  of	  the	  ATG	  start	  codon	  of	  M.	  tuberculosis	  
rpfB	  to	  AaG	  in	  a	  translational	  fusion	  resulted	  significant	  in	  loss	  of	  expression.	  This	  effect	  was	  
not	  observed	  in	  the	  present	  study,	  in	  which	  the	  same	  substitution	  in	  the	  translational	  fusion	  
resulted	   in	   no	   significant	   change	   in	   expression	   relative	   to	   the	   WT.	   The	   cause	   for	   this	  
discrepancy	   is	   unknown;	   however	   it	   is	   clear	   that	   the	   constructs	   employed	   in	   either	   study	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were	   not	   identical.	   The	   reporter	   used	   by	   Sharma	   et	   al.	   was	   fused	   with	   lacZ	   +122	  bp	  
downstream	   of	   the	   ATG	   start	   codon,	  whereas	   reporters	   in	   the	   present	   study	  were	   fused	  
with	   lacZ	   at	   the	   ATG	   codon	   itself	   (+3	   bp).	   It	   has	   previously	   been	   reported	   that	   the	  
N-­‐terminal	  of	  RpfB	  encodes	  a	  possible	  export	  signal	  peptide	  from	  residues	  1-­‐29,	  translated	  
from	  +1	  to	  +87	  bp	  downstream	  relative	  to	  the	  ATG	  start	  codon	  (Ruggiero	  et	  al.	  2009;	  Lew	  et	  
al.	   2011).	   The	   presence	   of	   an	   export	   signal	   peptide	   in	   fusion	   with	   β-­‐galactosidase	  might	  
have	   interfered	   with	   the	   protein	   extraction	   process	   in	   the	   Sharma	   et	   al.	   β-­‐galactosidase	  
assays.	  This	  signal	  sequence	  could	  not	  have	  affected	  results	   in	  the	  present	  study	  as	   it	  was	  
not	   encoded	   by	   the	   reporters	   as	   none	   of	   the	   annotated	   rpfB	   CDS	   was	   included	   in	   the	  
fusions.	  Furthermore,	  the	  constructs	  used	  in	  this	  study	  were	  further	  validated	  by	  observing	  
reporter	  expression	  in	  transformed	  M.	  tuberculosis	  where	  they	  showed	  perfect	  agreement	  
with	  the	  M.	  smegmatis	  β-­‐galactosidase	  assay	  of	  Figure	  3.I.	  	  
One	  intriguing	  finding	  was	  the	  discrepancy	  in	  expression	  between	  the	  frameshift	  in	  the	  GTG	  
to	   TTG	   ORF	   compared	   with	   GTc	   synonymous	   non-­‐start	   codon	   substitution.	   Introducing	   a	  
frameshift	   within	   the	   GTG	   ORF	   resulted	   in	   an	   insignificant	   decrease	   in	   expression	   to	  
28.10	  ±	  5.38	  MU/mg	   total	   protein	   relative	   to	   the	  WT	   (Figure	   3.I).	   Conversely,	   substituting	  
the	   GTG	   start	   codon	   with	   a	   synonymous	   non-­‐start	   GTc	   codon	   resulted	   in	   a	   significant	  
increase	   in	  expression	  to	  60.68	  ±	  2.67	  MU/mg	  total	  protein,	  1.6-­‐fold	  greater	   than	  the	  WT.	  
The	   TLSM	   results	   indicate	   the	   GTG	   ORF	   to	   be	   outside	   of	   the	   rpfB	   CDS	   and	   none	   of	   the	  
mutations	  to	  the	  GTG	  ORF	  were	  within	  the	  identified	  RBS.	  How	  could	  this	  area	  have	  affected	  
expression	  of	  the	  reporters?	  	  
One	   hypothesis	   is	   that	   this	   area	   constitutes	   an	   Lsr2	   binding	   site,	   a	   nucleoide-­‐associated	  
protein,	  and	  that	  these	  mutations	  coincidently	  may	  have	  altered	  the	  affinity	  with	  which	  Lsr2	  
binds	  this	  area	  to	  affect	  expression	  (Galagan	  et	  al.	  2010;	  Gordon	  et	  al.	  2010;	  Gordon	  2013).	  
Alternatively,	   it	   may	   be	   that	   mutations	   within	   this	   region	   interfered	   with	   the	  
two-­‐component	   response	   regulator,	   MtrA,	   which	   Sharma	   et	   al.	   found	   to	   regulate	   rpfB.	  
However,	   none	   the	  mutations	  made	   to	   the	   GTG	   ORF	   in	   this	   study	   lie	   within	   the	   binding	  
footprint	  of	  MtrA	  (-­‐144	  to	   -­‐88	  bp	  upstream	  of	  the	  ATG)	  that	  they	  describe.	   It	  may	  also	  be	  
possible	   that	   the	  mutations	  made	  within	   the	  5’UTR	  may	  have	  affected	   the	  stability	  of	   the	  
mRNA	   transcript	   to	   cause	   changes	   in	   transcript	   secondary	   structure	   or	   susceptibility	   to	  
RNase	  degradation,	  manifesting	  as	  variations	  in	  β-­‐galactosidase	  expression	  (Thomas	  2001).	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Despite	   this,	   validation	   of	   these	   theories	   was	   without	   the	   scope	   of	   identifying	   the	  
translational	   start	   site,	   and	   the	   discrepancy	   in	   the	   trends	   of	   the	   GTG	   codon	   mutations	  
should	   not	   detract	   from	   the	   overall	   data,	  which	   indicate	   TTG	   as	   the	   correct	   translational	  
start	  site.	  	  
3.6 Chapter	  conclusion	  
In	  conclusion,	  these	  results	  indicate	  that	  translational	  start	  site	  of	  rpfB	  has	  been	  incorrectly	  
annotated.	  The	  CDS	  of	  rpfB	  should	  therefore	  be	  re-­‐annotated,	  extending	  up	  to	  and	  including	  
the	   TTG	   start	   codon.	   This	   finding	   is	   further	   supported	   by	   the	   identification	   of	   a	   region	  
complementary	   in	   sequence	   to	   the	   16S	   rRNA	   3’end,	   which	   likely	   constitutes	   a	   ribosome	  
binding	   site.	   As	   the	   re-­‐annotation	   of	   the	  M.	  tuberculosis	   rpfB	   (Rv1009)	   shares	   extended	  
conservation	  with	  the	  annotated	  start	  in	  the	  M.	  smegmatis	  homologue	  (MSMEG_5439)	  it	  is	  
possible	  that	  other	  mycobacterial	  rpfB	  homologues	  with	  strong	  sequence	  identity	  may	  also	  
be	  mis-­‐annotated.	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4 rpfB	  has	  a	  regulatory	  relationship	  with	  ksgA	  
4.1 KsgA	  is	  a	  universally	  conserved	  methyltransferase	  
Ribosome	   biogenesis	   is	   a	   crucial	   process	   that	   has	   evolved	   within	   all	   domains	   of	   life.	  
Biogenesis	  of	  ribosomal	  subunits	  is	  complex,	  involving	  the	  contribution	  of	  multiple	  proteins,	  
ribosomal	  RNAs	  (for	  prokaryotic	  ribosomes	  the	  23S	  and	  5S	  in	  the	  large	  subunit,	  16S	  in	  the	  
small	   subunit)	   and	  modifications	   that	  have	  evolved	  divergently	   across	   the	  domains	  of	   life	  
(Mangat	   &	   Brown	   2008).	   Despite	   this,	   there	   are	   some	   ribosomal	   modifications	   that	   are	  
universally	   conserved,	   such	   as	   methylation	   of	   two	   adjacent	   adenosine	   residues	   in	   the	  
3’terminal	  helix	   (helix	  45)	  of	   the	  16S	   ribosomal	  RNA	   (rRNA)	   (Xu	  et	  al.	  2008;	  Demirci	  et	  al.	  
2010).	   This	  modification	   is	   important	   for	   stable	   folding	  of	   the	  16S	   rRNA	  3’terminus	  which	  
constitutes	   the	   Shine-­‐Dalgarno	   (SD)	   sequence	   (Shine	   &	   Dalgarno	   1975;	   Kaberdina	   et	   al.	  
2009).	  	  	  
In	  1965	  a	  Streptomyces	  strain	  (S.	  kasugiensis)	  was	   isolated	  from	  the	  Kasuga	  shrine	  in	  Nara	  
City,	  Japan	  (Umezawa	  et	  al.	  1965).	  The	  isolate	  produced	  a	  novel	  aminoglycoside	  capable	  of	  
inhibiting	   translation	   initiation	   in	   many	   bacteria.	   Subsequently,	   antibiotic	   resistance	   was	  
identified	  in	  Escherichia	  coli	  that	  lacked	  the	  previously	  described	  16S	  rRNA	  methylation.	  The	  
loss	   of	  methylation	  was	   attributed	   to	  mutations	   in	   a	  methyltransferase	   later	   named	  ksgA	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(Lange	  et	  al.	  2017).	  All	  domains	  of	  life	  encode	  a	  ksgA	  methyltransferase	  that	  is	  responsible	  
for	  this	  methylation	  of	  adjacent	  adenosine	  residues	  in	  rRNA.	  
Whilst	  mutation	  of	  ksgA	  renders	  bacteria	  resistant	  to	  kasugamycin,	  deletion	  is	  not	  lethal	  but	  
impacts	  ribosome	  biogenesis,	  translation	  efficiency	  and	  potential	  virulence	  as	  a	  fitness	  cost	  
(Kaberdina	  et	  al.	  2009;	  Kyuma	  et	  al.	  2015).	  KsgA	  requires	  S-­‐adenosyl-­‐L-­‐methionine	  (SAM)	  as	  
a	   methyl	   group	   donor	   to	   methylate	   rRNA.	   Connolly,	   Rife	   &	   Culver	   (2008)	   found	   that	   a	  
catalytically	   inactive	   mutant	   of	   KsgA,	   incapable	   of	   binding	   SAM,	   was	   unable	   to	   release	  
un-­‐methylated	   16S	   rRNA.	   Results	   indicated	   not	   only	   an	   accumulation	   of	   immature	   small	  
ribosomal	  subunits,	  lacking	  the	  rRNA	  methylations,	  but	  also	  that	  KsgA	  incapable	  of	  binding	  
SAM	  remains	  bound	  to	  the	  small	  ribosomal	  subunit	  where	  the	  large	  subunit	  would	  interact	  
(Xu	   et	   al.	   2008).	   This	   indicates	   KsgA	   serves	   as	   a	   checkpoint	   for	   ribosome	   biogenesis,	  
preventing	   immature	   un-­‐methylated	   ribosomal	   subunits	   from	   forming	   the	   complete	   70S	  
ribosome	   (Connolly,	   Rife	   &	   Culver	   2008;	  Mangat	   &	   Brown	   2008).	   The	   role	   ksgA	   plays	   in	  
ribosome	   biogenesis,	   and	   by	   extension	   protein	   synthesis,	  makes	   ksgA	  methyltransferases	  
promising	   as	   potential	   therapeutic	   drug	   targets.	   Interfering	  with	   KsgA	   activity	   could	   be	   a	  
very	  efficient	  method	  of	  inhibiting	  protein	  synthesis	  as	  part	  of	  a	  combined	  therapy.	  	  
In	  Mycobacterium	  tuberculosis	  there	  is	  a	  28	  bp	  overlap	  between	  the	  3’end	  of	  the	  rpfB	  ORF	  
(Rv1009)	  and	  the	  5’end	  of	  the	  ksgA	  ORF	  (Rv1010)	  which	   is	  annotated	  by	  homology	  to	  the	  
E.	  coli	  ksgA	  (Tufariello,	  Jacobs	  &	  Chan	  2004).	  This	  is	  not	  an	  unusual	  grouping	  (see	  Figure	  4.I),	  
as	   many	   firmicutes	   and	   actinobacteria	   share	   a	   conserved	   arrangement	   of	   a	   tatD	  
homologous	  deoxyribonuclease	  upstream	  of	  a	  cell	  wall	  hydrolase	  and	  a	  downstream	  ksgA	  
methyltransferase	  (Ravagnani,	  Finan	  &	  Young	  2005).	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Figure	  4.I	  rpfB	  gene	  neighbourhood	  
Gene	  neighbourhood	  diagram	  surrounding	  rpfB	  in	  actinobacteria	  generated	  in	  STRING	  (Szklarczyk	  et	  al.	  2017).	  
Starting	   upstream	   for	   Mycobacterium	   tuberculosis;	   metS	   methionine	   tRNA	   ligase	   in	   dark	   green,	   tatD	  
deoxyribonuclease	  in	  light	  green,	  rpfB	  resuscitation	  promoting	  factor	  in	  red,	  ksgA	  methyltransferase	  in	  orange.	  
A	  conserved	  proximity	  of	  genes	  often	  indicates	  a	  regulatory	  or	  functional	  link	  referred	  to	  as	  
“guilt-­‐by-­‐association”,	  where	   it	   is	  beneficial	   to	  have	  genes	  grouped	  by	  function	  (Szklarczyk	  
et	  al.	  2017).	  In	  the	  case	  of	  rpfB	  and	  ksgA	  there	  is	  extensive	  conservation	  in	  proximity,	  which	  
indicates	  a	  potential	  link	  between	  cell	  wall	  synthesis	  and	  protein	  synthesis	  (Ravagnani,	  Finan	  
&	  Young	  2005).	  The	  work	  detailed	  in	  this	  chapter	  aimed	  to	  determine	  the	  relevance	  of	  this	  
link	  in	  regards	  to	  the	  regulation	  exerted	  by	  the	  rpfB	  riboswitch.	  	  
4.2 rpfB	  and	  ksgA	  form	  a	  bi-­‐cistron	  
Returning	   to	   the	   transcription	   start	   site	   mapping	   published	   by	   Cortes	   et	   al.	   (2013)	   (see	  
section	  1.8)	  it	  was	  apparent	  that	  ksgA	  did	  not	  have	  any	  strong	  transcription	  start	  site	  (TSS)	  
signal	  sequence	  of	  its	  own	  (see	  Figure	  4.II).	  The	  only	  clear	  TSSs	  were	  those	  of	  rpfB	  P1	  and	  P2	  
promoters,	   situated	   upstream.	   A	   hypothesis	   was	   developed	   that	   rpfB	   and	   ksgA	   are	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Figure	  4.II	  transcription	  start	  site	  mapping	  of	  rpfB	  locus	  	  
Chart	  (A)	  shows	  global	  transcriptional	  start	  site	  analysis	  of	  sense	  (blue)	  and	  antisense	  (red)	  primary	  transcript	  
abundance	  normalised	  to	  total	   reads	   in	  M.	  tuberculosis	   (Cortes	  et	  al.	  2013).	  The	  bottom	  diagram	  (B)	  depicts	  
the	  organisation	  of	  genetic	  elements	  in	  alignment	  with	  the	  chart	  above	  it.	  
cDNA	   was	   generated	   through	   reverse	   transcription	   of	   exponential	   phase	  M.	  tuberculosis,	  
Mycobacterium	  bovis	  BCG	  and	  Mycobacterium	  smegmatis	  total	  RNA	  extracts.	  Genomic	  DNA	  
(gDNA)	  was	  extracted	  as	  a	  control	  for	  M.	  tuberculosis	  and	  M.	  bovis	  BCG,	  which	  share	  100%	  
sequence	  identity	  for	  the	  rpfB-­‐ksgA	  locus.	  A	  separate	  extract	  was	  made	  for	  M.	  smegmatis	  in	  
which	   rpfB	  and	  ksgA	   are	   proximal	   but	   do	  not	   have	   an	   annotated	  ORF	  overlap.	   cDNA	  and	  
gDNA	  were	  subsequently	  PCR	  amplified,	  priming	  either	  side	  of	  the	  region	  between	  rpfB	  and	  
ksgA	  (see	  section	  2.7.5).	  	  
	  
Figure	  4.III	  RT-­‐PCR	  analysis	  of	  rpfB-­‐ksgA	  
RT-­‐PCR	  analysis	  or	  the	  rpfB-­‐ksgA	  overlapping	  region.	  From	  left	  to	  right:	  M.	  tuberculosis	  H37Rv	  gDNA	  followed	  
by	  exponential	  phase	  cDNA,	  M.	  bovis	  BCG	  exponential	  phase	  cDNA,	  and	  M.	  smegmatis	  gDNA	  and	  exponential	  
phase	   cDNA.	   Results	   show	   a	   single	   amplicon	   for	   rpfB-­‐ksgA	   of	   ~850	  bp,	   ±	   reverse	   transcriptase	   (RT).	   gDNA	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Figure	   4.III	   shows	   a	   single	   ~850	   bp	   amplicon	   generated	   by	   reverse	   transcription	   PCR	  
(RT-­‐PCR)	  in	  all	  three	  species.	  This	  is	  strong	  evidence	  that	  rpfB	  and	  ksgA	  are	  co-­‐transcribed	  as	  
a	  bi-­‐cistron	  from	  the	  rpfB	  promoters	  upstream.	  Such	  a	  transcriptional	  link	  between	  the	  two	  
genes	   re-­‐enforces	   the	  previously	  proposed	   functional	   link	  between	  cell	  wall	   synthesis	  and	  
protein	   synthesis	   (Ravagnani,	   Finan	  &	  Young	  2005).	  Moreover,	   for	   the	  pathogenic	   species	  
such	  as	  M.	  tuberculosis	  and	  M.	  bovis	  BCG	  that	  encode	  the	  rpfB	  riboswitch	  upstream	  of	  the	  
bi-­‐cistron,	   this	   transcriptional	   link	   is	   further	   re-­‐enforced	   by	   the	   regulation	   exerted	   by	   the	  
riboswitch.	  	  
4.3 rpfB	  and	  ksgA	  are	  not	  co-­‐translated	  
ksgA	  has	  no	  apparent	  proximal	  purine	   rich	   ribosome	  binding	  site	  of	   its	  own.	  As	  described	  
previously	   (see	   section	   3.3)	   this	   is	   not	   unusual	   for	  mycobacteria,	   which	   generally	   have	   a	  
poor	  RBS	  consensus	  (DeJesus,	  Sacchettini	  &	  Ioerger	  2013).	  However,	  following	  the	  discovery	  
of	  the	  riboswitch	  regulated	  co-­‐transcriptional	  link	  described	  above,	  it	  was	  hypothesised	  the	  
regulatory	  link	  between	  the	  proteins	  may	  extend	  to	  the	  translational	  level.	  
To	  test	  this	  theory,	  three	  constructs	  were	  made	  in	  fusion	  with	  the	  heterologous	  constitutive	  
PCLI	   promoter	   (Gonzalez-­‐y-­‐Merchand	   et	   al.	   1997);	   spanning	   from	   -­‐1120	   bp	   (inclusive	   of	  
native	  rpfB	  RBS),	  -­‐75	  and	  -­‐25	  bp	  upstream	  of	  the	  ksgA	  start	  codon	  down	  to	  +150	  bp	  in	  fusion	  
with	   lacZ	   (see	   Figure	   4.IV).	   For	   all	   three	   constructs,	   transformed	  M.	  smegmatis	   extracts	  
exhibited	   reporter	   expression	   when	   assayed	   for	   β-­‐galactosidase	   activity.	   The	   -­‐1220	  bp	  
fusion	   included	   the	   native	   rpfB	   RBS	   upstream	   of	   the	   fusion	   as	   described	   previously	   (see	  
section	   3.3).	   However,	   for	   the	   -­‐75	   and	   -­‐25	   bp	   fusions,	   translation	   was	   indicated	   by	   the	  
expression	  of	  β-­‐galactosidase,	  despite	  the	  absence	  of	  any	  RBS	  sequence.	  This	  demonstrated	  
translation	  of	  ksgA	   is	  possible	   in	   the	  absence	  of	   the	   rpfB	  RBS,	  and	   therefore	   that	   the	   two	  
proteins	  are	  not	  co-­‐translated.	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Figure	  4.IV	  ksgA	  translational	  reporters	  
Translational	  fusions	  of	  ksgA	  upstream	  regions.	  Top	  diagram	  depicts	  the	  fragments	  of	  the	  rpfB-­‐ksgA	  bi-­‐cistron	  
fused	  between	  the	  heterologous	  constitutive	  PCLI	  promoter	  TSS	  upstream	  and	  downstream	  lacZ	  reporter.	  The	  
image	  beneath	  shows	  the	  expression	  of	  β-­‐galactosidase	  on	  X-­‐gal	  LB	  agar	   in	  transformed	  M.	  smegmatis,	  with	  
controls	  of	  empty	  vector	  and	  promoter	  only	  with	  no	  insert	  and	  native	  lacZ	  RBS.	  
4.4 Chapter	  discussion	  
The	  highly	  conserved	  proximity	  of	  rpfB	  and	  ksgA	   throughout	  actinobacteria	  and	  firmicutes	  
has	  been	  identified	  previously	  with	  theories	  of	  a	  regulatory	  or	  functional	   link	  between	  cell	  
wall	  synthesis	  and	  protein	  synthesis	  (Ravagnani,	  Finan	  &	  Young	  2005).	  In	  this	  study,	  through	  
RT-­‐PCR,	   such	   a	   theorised	   regulatory	   link	   has	   been	   further	   substantiated.	   The	   amplicons	  
shown	  in	  Figure	  4.III	   indicated	  that	  rpfB	  and	  ksgA	  form	  a	  single	  transcript	  as	  a	  bi-­‐cistron	  in	  
M.	  tuberculosis,	  M.	  bovis	   BCG	   and	  M.	  smegmatis.	   Such	   an	   operon	  may	   also	   be	   present	   in	  
other	   actinobacteria	   where	   the	   proximity	   of	   the	   genes	   is	   conserved.	   Moreover,	   in	   the	  
pathogenic	  mycobacteria	  that	  encode	  the	  rpfB	  riboswitch,	  this	  co-­‐transcriptional	  link	  has	  an	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The	   biological	   relevance	   of	   this	   link	   remains	   to	   be	   understood.	   For	   mycobacteria	  
particularly,	   there	   is	   a	   clear	   inference	   of	   a	   regulatory	   link	   between	   resuscitation	   from	  
dormancy	  by	  RpfB	  cell	  wall	  hydrolase	  activity	  and	  the	  production	  of	  mature	  ribosomes	  by	  
KsgA	  methylation	  of	  16S	  rRNA.	  Potentially	   the	  two	  proteins	  may	   interact	  with	  each	  other;	  
however	   investigation	   of	   any	   potential	   interaction	   was	   without	   the	   scope	   of	   this	   study	  
regarding	   characterisation	   of	   the	   rpfB	   riboswitch.	   In	   future	   it	   could	   be	   worthwhile	  
investigating	   if	   there	   is	   any	   interaction	   between	   RpfB	   and	   KsgA	   at	   the	   protein	   level.	  
Although	   this	   would	   be	   would	   be	   unlikely	   as	   ribosomal	   maturation	   occurs	   within	   the	  
cytoplasm	   and	   RpfB	  may	   be	   both	   cell	   wall	   anchored	   or	   secreted	   (Kana	   &	  Mizrahi	   2010).	  
Potentially	   there	   may	   be	   a	   secondary	   function	   that	   requires	   protein-­‐protein	   interaction.	  
Nevertheless,	  there	  is	  still	  potential	  for	  ksgA	  to	  have	  relevance	  to	  the	  riboswitch.	  
Structural	  models	  of	  the	  riboswitch	  predict	  that	  it	  has	  a	  default	  conformation	  of	  an	  intrinsic	  
terminator	   (see	   section	   1.9),	   making	   it	   a	   rarer	   example	   of	   a	   transcriptional	   ‘on-­‐switch’	  
where	   it	   is	   predicted	   that	   ligand	   interaction	   would	   enhance	   transcriptional	   read-­‐through	  
(Zuker	   2003;	   Tucker	   &	   Breaker	   2005).	   Most	   riboswitches	   discovered	   to	   date	   employ	   a	  
feedback	   loop,	   recognising	  a	   ligand	  generated	  by	   the	  gene	  or	  operon	  which	   they	   regulate	  
(Dambach	  &	  Winkler	  2009).	  For	  the	  rpfB	  riboswitch	  this	  would	  require	  a	  feedback	  produced	  
by	  the	  cell	  wall	  hydrolase	  activity	  of	  RpfB.	  This	  is	  not	  unprecedented;	  in	  the	  case	  of	  the	  ydaO	  
riboswitch,	  the	  secondary	  messenger	  c-­‐di-­‐AMP	  is	  sensed	  by	  the	  riboswitch	  as	  an	  indication	  
of	   osmotic	   stress,	   but	   as	   an	   ‘off-­‐switch’	   (Block,	   Hammond	  &	   Breaker	   2010;	   Nelson	   et	   al.	  
2013).	   In	  actinobacteria	  this	  c-­‐di-­‐AMP	  sensing	  riboswitch	   is	  commonly	  associated	  with	  cell	  
wall	   enzyme	   regulation,	   and	   potentially	   rpfA	   in	  M.	  tuberculosis,	   therefore	   c-­‐di-­‐AMP	   may	  
serve	  to	  modulate	  rpfA	  expression	  as	  an	  intermediate	  signal	  that	  is	  indirectly	  affected	  by	  the	  
cell	  wall	  hydrolase	  activity	  (Nelson	  et	  al.	  2013;	  Commichau	  et	  al.	  2015).	  	  
Considering	   the	   rpfB	   riboswitch	   is	   a	   predicted	   ‘on-­‐switch’,	   increased	   concentrations	   of	  
ligand	  would	  theoretically	  increase	  the	  expression	  of	  the	  cell	  wall	  hydrolase	  RpfB	  and	  cause	  
increased	   digestion	   of	   the	   cell	   wall	   peptidoglycan,	   a	   process	   for	  which	   tight	   regulation	   is	  
crucial	  to	  cell	  survival.	  However,	  as	  the	  riboswitch	  has	  been	  demonstrated	  to	  regulate	  the	  
rpfB-­‐ksgA	   bi-­‐cistron,	   regulatory	   control	   of	   ksgA	   expression	  must	   also	   be	   considered.	   As	   a	  
ribosome	   maturation	   checkpoint,	   KsgA	   binds	   16S	   rRNA	   and	   methylates	   two	   adjacent	  
adenosine	  residues	  using	  SAM	  as	  a	  methyl	  donor	  to	  produce	  a	  mature	  30S	  small	  ribosomal	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subunit	   (Connolly,	   Rife	   &	   Culver	   2008).	   In	   the	   absence	   of	   SAM	   KsgA	   does	   not	   release	  
un-­‐methylated	   16S	   rRNA	   but	   remains	   bound	   to	   the	   30S	   small	   ribosomal	   subunit	   at	   the	  
interaction	  plane	  of	  the	  50S	  large	  ribosomal	  subunit,	  precluding	  the	  assembly	  of	  immature	  
70S	  ribosomes.	  	  
SAM	  is	  used	  as	  a	  major	  methyl	  group	  donor	  in	  bacteria	  for	  a	  range	  of	  cellular	  processes;	  16S	  
rRNA	  methylation,	  biosynthesis	  of	   cell	   envelope	  mycolic	  acids	  and	  adhesion	  modifications	  
(Parveen	  &	  Cornell	  2011).	  Mycobacteria	  have	  been	  found	  to	  tightly	  control	  SAM	  synthesis,	  
encoding	  multiple	  SAM	  synthases	  and	  methyltransferases	  (Cole	  et	  al.	  1998;	  Berger	  &	  Knodel	  
2003).	   Increased	   concentrations	   of	   SAM	   could	   certainly	   be	   used	   as	   a	   signal	   indicative	   of	  
suitable	   growth	   conditions	   for	   both	   resuscitation	   from	   dormancy	   and	   protein	   synthesis	  
(Batey	  2011).	  Indeed,	  SAM	  is	  one	  of	  the	  most	  common	  riboswitch	  ligands,	  with	  an	  extended	  
superfamily	  of	  riboswitches	  capable	  of	  detecting	  either	  SAM	  or	  its	  un-­‐methylated	  derivative	  
S-­‐adenosyl-­‐L-­‐homocysteine	  (SAH)	  (Price,	  Grigg	  &	  Ke	  2014).	  In	  addition	  to	  the	  fact	  that	  in	  the	  
absence	   of	   SAM,	   KsgA	   effectively	   inhibits	   the	   formation	   of	   functional	   ribosomes,	   it	   is	  
feasible	  either	  SAM	  or	  its	  precursors/derivatives	  may	  serve	  as	  a	  ligand	  for	  the	  riboswitch,	  a	  
hypothesis	  that	  is	  further	  investigated	  in	  this	  study	  (see	  section	  7.2).	  	  
Whilst	  a	  strong	  regulatory	  link	  was	  inferred	  by	  the	  discovery	  of	  the	  rpfB-­‐ksgA	  bi-­‐cistron,	  the	  
translational	   fusions	  described	   in	  Figure	  4.IV	  demonstrated	  there	  was	  no	  translational	   link	  
between	   the	   two	   genes.	   Transformed	   M.	  smegmatis	   were	   capable	   of	   translating	   the	  
ksgA-­‐lacZ	  reporter	  fusion	  in	  the	  absence	  of	  the	  native	  rpfB	  ribosome	  binding	  site	  upstream,	  
despite	  any	  clear	  RBS	  within	  proximity	  of	  the	  ksgA	  start	  codon.	  Mycobacteria	  do	  not	  have	  a	  
strong	  RBS	  consensus	  (DeJesus,	  Sacchettini	  &	  Ioerger	  2013),	  however	  the	  upstream	  region	  
of	  ksgA	  is	  relatively	  purine	  rich,	  therefore	  it	  may	  still	  be	  possible	  for	  the	  ribosome	  to	  bind	  in	  
this	  region	  to	  translate	  ksgA.	  	  
Recently	  Yamamoto	  et	  al.	   (2016)	  described	  a	  novel	  method	  of	  translation	   initiation	  where	  
assembled	   70S	   ribosomes	   may	   initiate	   translation	   of	   ORFs	   without	   any	   proximal	   RBS	   by	  
means	   of	   “70S-­‐scanning”.	   Following	   translation	   termination,	   the	   70S	   ribosome	   does	   not	  
necessarily	   dissociate,	   but	   may	   freely	   translocate	   along	   the	   mRNA	   away	   from	   the	   stop	  
codon,	   scanning	   for	   another	   start	   codon	   to	   initiate	   translation	  again.	   Evidence	   shows	   this	  
method	   of	   translation	   initiation	   is	   widely	   conserved	   in	   all	   domains	   of	   life	   and	   has	   been	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shown	   to	  be	  particularly	  effective	  within	  bi-­‐cistronic	  mRNAs.	  Potentially	   this	  70S-­‐scanning	  
mechanism	  could	  allow	  translation	  of	  ksgA	  in	  the	  absence	  of	  a	  RBS	  (Yamamoto	  et	  al.	  2016).	  	  
Finally,	   the	  discovery	  of	  a	   riboswitch	   regulated	   rpfB-­‐ksgA	  bi-­‐cistron	  not	  only	   links	   the	   two	  
genes,	  but	  increases	  the	  impact	  of	  the	  upstream	  riboswitch.	  With	  the	  developing	  healthcare	  
threat	   of	   multi-­‐drug	   resistant	   tuberculosis	   and	   a	   limited	   availability	   of	   effective	  
antimycobacterial	   drugs,	   there	   is	   a	   growing	   need	   for	   novel	   therapeutic	   targets	   in	  
M.	  tuberculosis	   (Hett	   &	   Rubin	   2008).	   Both	   resuscitation	   from	   dormancy	   and	   ribosomal	  
assembly	  processes	  have	  previously	  been	   identified	  as	  potential	   targets	   (Mangat	  &	  Brown	  
2008;	  Seidi	  &	   Jahanban-­‐Esfahlan	  2013).	  Not	  only	  has	   this	  work	  has	   identified	  a	   riboswitch	  
that	   regulates	   the	   transcription	  of	  both	   rpfB	  and	  ksgA	  –	  proteins	   implicit	   in	   to	  both	   these	  
processes	   –	   but	   the	   riboswitch	   itself	   is	   highly	   conserved	   in	   pathogenic	   mycobacteria.	  
Riboswitches	  themselves	  make	  excellent	   therapeutic	   targets	   for	  rational	  drug	  design;	   they	  
are	  well	  conserved	  between	  species	  and	  have	  evolved	  over	  thousands	  of	  years	  to	  identify	  a	  
single	  cognate	  ligand	  with	  a	  high	  specificity	  and	  affinity	  (Blount	  &	  Breaker	  2006).	  Although	  
the	  current	  understanding	  of	  the	  biological	  process	  of	  resuscitation	  is	  limited,	  there	  can	  be	  
no	  doubt	  that	  it	  contributes	  towards	  the	  development	  of	  an	  active	  infection	  from	  dormant	  
bacteria.	   The	   rpfB	   riboswitch	   –	   capable	   of	   regulating	   two	   potential	   therapeutic	   targets	  
related	   to	   resuscitation	  and	  ribosome	  maturation	  –	  could	  offer	  a	  highly	   specific	   target	   for	  
rational	  drug	  design	  of	  antimycobacterials	  for	  a	  disease	  which	  is	  very	  much	  in	  need	  of	  novel	  
therapeutics	  (Kana	  et	  al.	  2014).	  
4.5 Chapter	  conclusion	  
In	  conclusion,	  these	  results	  further	  substantiate	  a	  functional	  link	  between	  resuscitation	  from	  
dormancy	  and	  ribosome	  maturation.	  The	  discovery	  of	  a	  conserved	  mycobacterial	  rpfB-­‐ksgA	  
bi-­‐cistron	   suggests	   that	   comparable	   operons	   may	   exist	   in	   other	   actinobacteria	   and	  
firmicutes	   that	   encode	   genes	   with	   homologous	   function	   and	   proximity.	   Moreover,	   this	  
co-­‐transcriptional	  link	  offers	  potential	  insight	  into	  candidate	  ligands	  associated	  with	  rpfB	  or	  
ksgA	  which	   could	  be	   recognised	  by	   the	   transcriptional	   riboswitch	  upstream	  and	  exploited	  
for	  rational	  drug	  design	  of	  novel	  therapeutics.	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5 Riboswitch-­‐mediated	  transcription	  attenuation	  in	  vivo	  	  
5.1 RNA-­‐seq	  reveals	  potential	  riboswitch	  upstream	  of	  rpfB	  
Global	  transcription	  start	  site	  mapping	  (TSSM)	  of	  Mycobacterium	  tuberculosis	  indicates	  that	  
there	  are	  large	  5’UTR	  upstream	  regions	  to	  some	  rpf	  mRNAs	  (Cortes	  et	  al.	  2013).	  By	  mapping	  
primary	  5’triphosphorylated	  transcripts	  to	  the	  rpfB	  locus,	  two	  transcription	  start	  sites	  (TSSs)	  
were	  identified.	  These	  TSSs	  were	  used	  to	  annotate	  two	  putative	  promoters	  (see	  Figure	  5.I)	  
designated	   P1	   and	   P2,	   which	   have	   sequence	   identity	   similar	   to	   the	   SigA	  
promoter	  -­‐10	  element	  ‘TANNNT’	  consensus	  (Cortes	  et	  al.	  2013).	  Transcripts	  initiated	  at	  the	  
P1	  TSS	  may	  be	  expected	  to	  yield	  a	  large	  5’UTR	  characteristic	  of	  a	  cis-­‐acting	  regulatory	  RNA,	  
encoding	   a	   potential	   intrinsic	   terminator,	   a	   stem-­‐loop	   immediately	   followed	   by	   a	   poly(U)	  
tract	   downstream	   (see	   section	   1.9).	   Intrinsic	   termination	   upstream	   of	   the	   rpfB	   coding	  
sequence	   (CDS)	   would	   prevent	   expression	   of	   RpfB,	   therefore	   it	   was	   hypothesised	   the	  
proposed	  intrinsic	  terminator	  might	  constitute	  an	  expression	  platform	  of	  a	  riboswitch.	  	  
Riboswitch-­‐mediated	   regulation	   of	   rpfs	   is	   not	   unprecedented	   as	   a	   ydaO	   riboswitch	  
homologue	  has	  already	  been	  described	  within	  the	  rpfA	  5’UTR	  (Block,	  Hammond	  &	  Breaker	  
2010;	  Arnvig	  &	  Young	  2012;	  Nelson	  et	  al.	  2013;	  St-­‐Onge	  et	  al.	  2015).	  RNA-­‐seq	  data	  shown	  in	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Figure	   5.I	   indicates	   there	   may	   be	   processing	   of	   the	   5’UTR	   beyond	   the	   potential	   intrinsic	  
terminator,	  with	  transcript	  abundance	  increasing	  downstream	  of	  the	  poly(U)	  tract.	  	  
	  
Figure	  5.I	  diagram	  of	  rpfB	  RNA	  expression	  
Chart	  (A)	  shows	  global	  transcriptional	  start	  site	  analysis	  of	  sense	  (blue)	  and	  antisense	  (red)	  primary	  transcript	  
abundance	  in	  M.	  tuberculosis	  (Cortes	  et	  al.	  2013).	  Chart	  (B)	  shows	  the	  RNA-­‐seq	  transcript	  abundance	  of	  sense	  
(blue)	   and	   antisense	   (red)	   transcripts	   normalised	   to	   total	   reads	   (Cortes	  et	   al.	   2013).	  Diagram	   (C)	   shows	   the	  
organisation	   of	   genetic	   elements	   in	   alignment	   with	   the	   charts	   above	   it.	   Black	   arrows	   indicate	   putative	  
transcription	  start	  sites.	  
The	  M.	  tuberculosis	  RNA-­‐seq	  data	  Cortes	  et.	  al	  (2015)	  analysed	  was	  a	  representation	  of	  the	  
entire	   transcriptome.	  To	   further	  understand	   individual	   components	   that	   contribute	   to	   the	  
regulation	  of	   the	  rpfB	   locus	  would	   therefore	  require	  a	  more	  targeted	  approach.	  The	  work	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5.2 rpfB	  transcription	  attenuation	  is	  abundant	  in	  exponential	  growth	  
In	   the	   present	   study,	   it	   was	   hypothesised	   that	   it	   might	   be	   possible	   to	   detect	  
riboswitch-­‐mediated	   attenuation	   through	   northern	   blotting	   with	   a	   riboswitch	  
complementary	   ribo-­‐probe.	   Accordingly,	   total	   RNA	   was	   extracted	   from	   M.	  tuberculosis	  
during	  both	  exponential	  and	  stationary	  growth	  phases,	  size	  separated	  by	  polyacrylamide	  gel	  
electrophoresis	  (PAGE)	  and	  blotted	  onto	  a	  nylon	  membrane	  to	  be	  probed	  (see	  section	  2.8).	  
	  
Figure	  5.II	  northern	  blot	  of	  exponential	  and	  stationary	  growth	  phases	  
Northern	  blot	  of	  total	  RNA	  was	  extracted	  from	  M.	  tuberculosis	  H37Rv	  during	  both	  exponential	  and	  stationary	  
growth	  phases	  (see	  section	  2.2.2).	  RNA	  was	  probed	  within	  the	  rpfB	  P1	  5’UTR	  (oligonucleotide	  5.22)	  and	  for	  5S	  
rRNA	  as	  a	  loading	  control	  (oligonucleotide	  1.48,	  see	  Appendix	  section	  10.3).	  	  
An	  absence	  of	  P1	   transcription	   in	   stationary	  growth	  phase	  was	  demonstrated	  by	  northern	  
blot	  in	  Figure	  5.II.	  The	  length	  of	  the	  rpfB	  riboswitch	  transcript	  from	  the	  P1	  TSS	  to	  the	  end	  of	  
the	  intrinsic	  terminator	  poly(U)	  tract	  is	  predicted	  to	  be	  approximately	  130	  nt,	  depending	  on	  
the	   position	   at	  which	   transcription	   attenuates.	   Therefore	   the	   ~130	  nt	   transcript	   detected	  
using	   the	   riboswitch	   complementary	   ribo-­‐probe	   likely	   represented	   riboswitch	   attenuated	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5.3 Promoter	  element	  reporter	  fusions	  
As	  the	  P2	  promoter	  is	  situated	  within	  the	  riboswitch	  sequence	  (see	  Figure	  5.I),	  investigation	  
of	   the	   P1	   and	   P2	   promoters	   separately	   would	   require	   truncation	   of	   the	   riboswitch.	  
Therefore,	  a	  reporter	  system	  was	  devised	  to	  explore	  promoter	  function	  within	  the	  context	  
of	  the	  riboswitch.	  A	  translational	  reporter	  fusion	  was	  made	  (identical	  to	  that	  employed	  for	  
mapping	  of	  the	  translation	  start	  site	  (see	  section	  3.2),	  containing	  WT	  M.	  tuberculosis	  H37Rv	  
rpfB	  5'UTR	  spanning	  -­‐316	  bp	  upstream	  of	  the	  re-­‐annotated	  TTG	  start	  codon,	  with	  the	  first	  14	  
codons	  of	  rpfB	  CDS	  fused	  with	  lacZ	  (see	  Figure	  5.III,	  A).	  	  
The	  proposed	  -­‐10	  elements	  were	  mutated	  from	  ‘TANNNT’	  to	  ‘cANNNc’	  (see	  section	  2.4.7),	  
to	  make	  them	  less	  amenable	  to	  promoter	  melting.	  Mutations	  were	  made	  separately	  to	  the	  
P1	   and	   P2	   -­‐10	   elements,	   changing	   ‘TAGGGT’	   to	   ‘cAGGGc’,	   and	   ‘TACCGT’	   to	   ‘cACCGc’	  
respectively.	  A	  third	  construct	  was	  made	  where	  both	  P1	  and	  P2	  were	  disrupted	  to	  scrutinise	  
if	  any	  other	  regions	  capable	  of	  promoting	  transcription	  were	  encoded	  within	  the	  rpfB	  locus.	  
In	  addition	  to	   investigating	  the	  sense	  strand	  promoters,	  another	  reporter	  was	  constructed	  
to	   explore	   potential	   Pas	   asRNA	   promoter	   activity.	   A	   transcriptional	   fusion	   was	   made	  
spanning	  -­‐100	  bp	  upstream	  of	  the	  Pas	  TSS	  down	  to	  +2	  bp;	  this	  was	  fused	  to	  a	  lacZ	  reporter	  in	  
the	  absence	  of	  a	  vector	  encoded	  promoter	  (see	  Figure	  5.III,	  B).	  Constructs	  were	  transformed	  
into	  M.	  tuberculosis	  and	  plated	  onto	  X-­‐gal	  agar	  to	  assess	  promoter	  activity	  qualitatively	  as	  
represented	  by	  β-­‐galactosidase	  expression.	  	  
The	   WT	   reporter	   shown	   in	   Figure	   5.III	   corroborated	   previously	   observed	   expression	   in	  
transformed	   M.	  smegmatis	   (see	   section	   3.2).	   Compared	   to	   the	   empty	   vector,	   the	   WT	  
reporter	   showed	   substantial	   expression.	  Where	   the	   P1	   promoter	   had	   been	   compromised	  
there	   was	   diminished	   expression	   of	   the	   β-­‐galactosidase	   reporter.	   Surprisingly,	   the	   P2	  
promoter	  substitution	  resulted	  in	  an	  increase	  in	  expression,	  perceived	  to	  be	  exhibiting	  more	  
β-­‐galactosidase	  activity	  than	  in	  the	  WT.	  Mutation	  of	  both	  promoter	  elements	  resulted	  in	  a	  
distinct	  lack	  of	  expression	  equal	  to	  the	  empty	  vector	  indicating	  no	  other	  regions	  capable	  of	  
promoting	  transcription	  within	  the	  fused	  rpfB	  5’UTR	  fragment.	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Figure	  5.III	  promoter	  reporters	  
β-­‐galactosidase	  reporter	   fusions	  of	  rpfB	  promoters.	  Diagram	  (A)	  depicts	  the	  construction	  of	  the	  translational	  
fusion	  employed	  to	   investigate	  the	  sense	  strand	  promoters	  P1	  and	  P2,	   ‘14	  aa’	  denotes	  the	  first	  14	  codons	  of	  
rpfB	   included	   in	   the	   fusion.	   Diagram	   (B)	   depicts	   the	   construction	   of	   the	   transcriptional	   fusion	   used	   to	  
investigate	   the	   antisense	   strand	  promoter	   Pas,	   drawn	   in	   a	   3’	   to	   5’	   direction	   in	   reference	   to	   the	   sense	   stand	  
shown	   faded	   above	   it.	   Image	   (C)	   shows	   the	   expression	   of	   the	   β-­‐galactosidase	   reporter	   in	   transformed	  
M.	  tuberculosis	  where	  blue	  colour	   indicated	  promoter	  activity.	  From	  greatest	  to	   least,	  perceived	  activity	  was	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Regarding	   the	   antisense	   reporter,	   a	   weak	   level	   of	   expression	   was	   observed,	   further	  
substantiating	   the	   Cortes	   et	   al.	   (2013)	   TSSM	   where	   a	   weak	   antisense	   signal	   was	   also	  
indicated.	   Collectively	   results	   indicated	   the	   P2	   promoter	   makes	   an	   unsubstantial	  
contribution	   to	   rpfB	   expression	   during	   exponential	   growth	   (as	   demonstrated	   by	   northern	  
blot,	   Figure	   5.II)	   or	   within	   a	   mixed	   population	   on	   agar	   (Figure	   5.III).	   Consequently	   the	  
majority	  of	  expression	  appears	   to	  be	  driven	  by	   the	  P1	  promoter	  and	  subject	   to	   riboswitch	  
regulatory	  control.	  
5.4 Mapping	  of	  riboswitch	  attenuated	  transcripts	  
The	   3’termini	   of	   transcripts	   were	   mapped	   to	   identify	   the	   location	   of	   potential	  
riboswitch-­‐mediated	   attenuation.	   Rapid	   amplification	   of	   cDNA	   ends	   (RACE)	   was	   adapted	  
from	  Gehart,	  Wagner	  and	  Vogel	  (2008).	  Briefly,	  M.	  tuberculosis	  exponential	  phase	  total	  RNA	  
was	  tailed	  by	  3’polyadenylation	  to	  identify	  the	  3’teminal,	  reverse	  transcribed,	  PCR	  amplified	  
then	  cloned	  and	  sequenced	  (see	  section	  2.7.3).	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Figure	  5.IV	  3’RACE	  mapping	  
Diagram	   shows	  mapped	  3’termini	   of	   rpfB	   transcripts	   from	  M.	   tuberculosis	  H37Rv	  exponential	   growth	  phase	  
total	   RNA.	   Top	   chart	   shows	   total	   3’termini	   mapped	   within	   the	   rpfB	   locus.	   Bottom	   chart	   shows	   3’termini	  
mapped	  within	  the	  riboswitch	  at	  single	  nucleotide	  resolution	  relative	  to	  the	  P1	  TSS.	  
A	   total	   of	   66	   unique	   clones	   were	   sequenced,	   of	   these	   54.54%	   (36/66)	   mapped	   to	   the	  
riboswitch	   region,	   with	   42.42%	   (28/66)	   mapping	   specifically	   to	   the	   intrinsic	   terminator	  
poly(U)	   (see	   Figure	   5.IV).	   Within	   the	   poly(U)	   tract	   itself	   10.61%	   (7/66)	   mapped	   to	   U123	  
(relative	   to	   the	  P1	   TSS),	  with	  multiple	  other	   clones	  mapping	  elsewhere	  within	   the	  poly(U)	  
tract	  (see	  Figure	  5.V).	  The	  most	  downstream	  poly(U)	  tract	  attenuation	  event	  was	  mapped	  to	  
U129	   (1.52%,	   1/66),	   which	   was	   therefore	   used	   as	   evidence	   to	   annotate	   the	   riboswitch	  
poly(U)	   tract	   as	   far	   as	   U130,	   the	   final	   uracil	   encoded	   within	   a	   relatively	   un-­‐interrupted	  
stretch.	   Downstream	   of	   the	   riboswitch,	   31.81%	   (21/66)	   mapped	   to	   rpfB	   CDS,	   with	   a	  
relatively	  high	  7.58%	  (5/66)	  mapping	  to	  G179,	  the	  last	  nucleotide	  of	  the	  re-­‐annotated	  TTG	  
start	   codon	   (see	   section	   3.2),	   indicating	   potential	   start	   codon	   proximal	   transcriptional	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Figure	  5.V	  mapped	  riboswitch	  attenuation	  
A	  graphical	  representation	  of	  the	  3’RACE	  results	  mapped	  onto	  the	  riboswitch	  structure	  as	  predicted	  by	  Mfold	  
(Zuker	  2003).	  Red	  bars	  represent	  the	  percentage	  of	  total	  mapped	  clone	  sequences	  at	  each	  nucleotide	  of	  the	  
riboswitch	  poly(U)	  tract.	  
The	   results	   of	   the	   northern	   blot	   (Figure	   5.II)	   and	   3’RACE	   (Figure	   5.IV)	   both	   demonstrated	  
riboswitch-­‐mediated	  attenuation	  at	  the	  potential	  intrinsic	  terminator.	  Multiple	  attenuation	  
events	  mapped	  to	  the	  poly(U)	  tract	  itself,	  indicative	  of	  intrinsic	  termination	  at	  these	  sites.	  In	  
both	  experimental	  approaches	  there	  appeared	  to	  be	  roughly	  equal	  instances	  of	  attenuation	  
and	  read-­‐through,	  which	  was	  thought	  to	  be	  the	  result	  of	  differing	  riboswitch	  conformations.	  
However,	   this	   alone	   was	   insufficient	   evidence	   of	   conformational	   switching,	   a	   defining	  
characteristic	  of	  riboswitch	  function.	  
Output of sir_graph (©)
mfold_util 4.7
Created Tue Jul  4 09:06:30 2017
dG = -50.20 [Initially -48.00] 17Jul04-09-06-29
























































































































	  Riboswitch-­‐mediated	  transcription	  attenuation	  in	  vivo	  |	  89	  
5.5 Riboswitch	   conformational	   equilibrium	   likely	   affects	   transcription	  
attenuation	  
Structural	   modelling	   of	   the	   riboswitch	   predicts	   two	   possible	   conformations:	   a	   more	  
thermodynamically	  favourable	  intrinsic	  terminator	  conformation	  and	  an	  anti-­‐terminator	  or	  
read-­‐through	   conformation	   (see	   section	   1.9).	   Riboswitches	   often	   exist	   in	   an	   equilibrium	  
between	   a	   thermodynamically	   favourable	   default	   conformation	   and	   a	   less	   favourable	  
conformation	   permissive	   through	   ligand	   interaction	   (Roth	   &	   Breaker	   2009).	   However,	  
transcriptional	  riboswitches	  may	  rely	  on	  ligand	  binding	  kinetics	  to	  dictate	  regulatory	  output,	  
rather	  than	  conformational	  thermodynamics,	  especially	  if	  the	  equilibrium	  is	  slow	  to	  equate	  
(Wickiser	  et	  al.	   2005).	  The	   regulatory	  decision	  must	  be	  made	  before	   the	  RNA	  polymerase	  
(RNAP)	   reaches	   the	   transcriptional	   expression	   platform.	   But	   by	   manipulating	   the	  
thermodynamic	   stability	   of	   the	   riboswitch,	   it	   might	   be	   possible	   to	   assay	  
riboswitch-­‐mediated	   attenuation	   in	   vivo	   and	   potentially	   facilitate	   candidate	   ligand	  
interaction.	  
5.5.1 Identification	  of	  potential	  mutation	  sites	  within	  the	  riboswitch	  sequence	  
Riboswitches	  are	  highly	  specialised	  regulatory	  RNAs	  with	  nucleic	  acid	  sequences	  that	  have	  
evolved	   to	   allow	   more	   than	   one	   functional	   conformation	   (Blount	   &	   Breaker	   2006).	  
Accordingly,	   basepair	   interactions	   in	   any	   given	   conformation	   may	   vary	   greatly	   between	  
conformations.	   For	   example,	   basepairing	   will	   be	   different	   in	   a	   terminator	   conformation	  
versus	   the	   alternative	   read-­‐through	   conformation.	   This	  makes	   it	   challenging	   to	  mutate	   a	  
riboswitch	   sequence	   whilst	   maintaining	   functionality	   as	   mutations	   to	   one	   conformation	  
must	   not	   have	   an	   unintended	   effect	   on	   the	   other,	   otherwise	   an	   affected	   conformation	  
would	   require	   a	   compensatory	   mutation,	   which	   would	   in	   turn	   likely	   affect	   the	   previous	  
conformation.	  
The	  rpfB	  riboswitch	  was	  scrutinised	  for	  residues	  capable	  of	  manipulating	  the	  free	  energy	  of	  
one	  conformation	  with	  negligible	  impact	  to	  the	  alternative	  conformation.	  A	  limited	  number	  
of	  sites	  were	   identified	   that	  could	  be	  exploited	  to	  strengthen	  basepairing	  within	   the	  stem	  
regions	   of	   the	   conformations.	  Many	   of	   these	   sites	   were	   disregarded	   as	   the	   substitutions	  
would	  affect	  loop	  regions	  in	  the	  alternative	  conformation,	  which	  could	  impact	  functionality	  
as	  many	  riboswitches	  use	  complex	  ligand-­‐loop	  or	  loop-­‐loop	  interactions	  (Tucker	  &	  Breaker	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2005;	  Wickiser	  et	  al.	  2005;	  Montange	  &	  Batey	  2008;	  Serganov	  2010).	  Exhaustive	  inspection	  
identified	   mutations	   capable	   achieving	   the	   desired	   impact	   on	   predicted	   folding	  
thermodynamics	  with	  minimal	  impact	  to	  the	  riboswitch	  conformations.	  
First,	  a	  mutation	  capable	  of	  increased	  transcription	  attenuation	  and	  decreased	  read-­‐through	  
was	  devised.	  During	  intrinsic	  termination	  hairpin	  nucleation	  occurs,	  forming	  the	  terminator	  
stem-­‐loop	  which	  affects	   transcription	   termination	   (Peters,	  Vangeloff	  &	  Landick	  2011;	  Ray-­‐
Soni,	   Bellecourt	  &	   Landick	   2016).	   In	   theory,	   increased	   hairpin	   sequence	   complementarity	  
could	   strengthen	   the	   secondary	   structure	  of	   the	  proposed	   intrinsic	   terminator,	   increasing	  
the	   likelihood	  of	   transcription	  attenuation	  events.	   Inspection	  of	   the	   riboswitch	   terminator	  
stem	   identified	  non-­‐complementary	  basepairing	  between	   the	  adjacent	  G94:G112	   residues	  
(see	   Figure	   5.VI).	   Modelling	   predicted	   a	   G112C	   substitution	   could	   strengthen	   terminator	  
stem	  complementarity	  to	  lower	  stable	  folded	  free	  energy	  for	  the	  terminator	  conformation	  
(-­‐54.80	  kcal/mol,	   -­‐4.60	  kcal/mol	   below	   the	   WT	   terminator	   conformation).	   Moreover,	   the	  
G112C	   substitution	   destabilised	   the	   C2:G112	   basepair	   within	   the	   anti-­‐terminator	  
conformation	  with	  structural	  models	  predicting	  no	  possible	  anti-­‐terminator	  conformation.	  	  
For	  the	  anti-­‐terminator	  or	  read-­‐through	  conformation,	  the	  U6:G107	  adjacent	  residues	  (see	  
Figure	  5.VI)	  within	  the	  initial	  5’stem	  of	  the	  anti-­‐terminator	  conformation	  were	  identified	  as	  
a	   potential	   mutation	   site.	   Modelling	   predicted	   a	   U6C	   substitution	   could	   increase	  
complementarity	   within	   the	   stem	   resulting	   in	   a	   marginally	   decreased	   free	   energy	  
(-­‐46.40	  kcal/mol,	   -­‐1.70	  kcal/mol	  below	  the	  WT	  anti-­‐terminator	  conformation).	  Additionally	  
U6C	  substitution	  disrupted	  the	  U6:A51	  basepair	  within	  terminator	  conformation	  resulting	  in	  
an	   increased	   free	   energy	   (-­‐48.30	  kcal/mol,	   +1.90	  kcal/mol	   above	   the	   WT	   terminator	  
conformation).	  Although	  modelling	  still	  predicted	  the	  terminator	  conformation	  to	  be	  more	  
thermodynamically	   favourable	   for	   stable	   folding,	   the	   predicted	   initial	   folding	   free	   energy	  
(initial	  folding	  of	  a	  linear	  RNA	  molecule	  into	  a	  secondary	  structure)	  was	  marginally	  lower	  for	  
the	  anti-­‐terminator	  conformation	  (-­‐47.40	  kcal/mol,	  -­‐1.1	  kcal/mol	  below	  the	  U6C	  terminator	  
at	   -­‐46.10	  kcal/mol).	   It	   was	   therefore	   decided	   the	   U6C	   substitution	  might	   be	   sufficient	   to	  
observe	  an	  effect	  on	  the	  conformational	  equilibrium	  when	  compared	  to	  the	  WT	  riboswitch.	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Figure	  5.VI	  riboswitch	  conformational	  mutations	  
Structural	   modelling	   predictions	   of	   riboswitch	   sequence	   (Zuker	   2003).	   WT	   terminator	   and	   anti-­‐terminator	  
structures	  are	  shown	  on	  the	   left,	  with	   identical	  red	  and	  green	  sequences	  highlighted	  for	  comparison.	  G112C	  
terminator	   shows	   the	   terminator	   structure	   with	   stabilising	   mutation.	   U6C	   anti-­‐terminator	   shows	   the	  
anti-­‐terminator	  structure	  with	  terminator	  destabilising	  mutation.	  U117-­‐119A	  shows	  the	  terminator	  structure	  
with	  poly(U)	  tract	  disrupting	  mutation.	  Mutation	  sites	  highlighted	  in	  purple	  for	  comparison.	  
A	   further	   mutation	   was	   devised	   to	   disrupt	   the	   poly(U)	   tract	   of	   the	   potential	   intrinsic	  
terminator	   to	   explore	   the	   mechanism	   of	   attenuation.	   Transcriptional	   pausing	   within	   the	  
poly(U)	   tract	   facilitates	   intrinsic	   termination	  by	  providing	   time	   for	   the	   terminator	   stem	   to	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riboswitch	  poly(U)	   tract	   is	   not	   a	  perfect	  poly(U)	   tract,	   but	   an	   interrupted	   stretch	  of	  uracil	  
residues	  (UUUUGCUUUUGUU)	  not	  uncommon	  for	  mycobacterial	  intrinsic	  terminators	  (Czyz	  
et	   al.	   2014).	   It	   was	   hypothesised	   that	   increased	   transcriptional	   read-­‐through	   could	  
potentially	   be	   achieved	   through	   further	   interruption	   of	   this	   poly(U)	   tract.	   This	   would	  
interfere	  with	  intrinsic	  termination	  either	  preventing	  the	  duration	  with	  which	  RNAP	  paused	  
at	   the	   site	   or	   distancing	   the	   pause	   site	   from	   the	   forming	   terminator	   stem	   to	   prevent	  
disruption	  to	  the	  elongation	  complex.	  Therefore	  the	  U117-­‐119A	  substitution	  was	  identified	  
as	   a	   suitable	   mutation	   (see	   Figure	   5.VI),	   with	   structural	   modelling	   showing	   no	   predicted	  
effect	  to	  either	  riboswitch	  conformation	  and	  a	  negligible	  effect	  on	  the	  predicted	  free	  energy	  
(+0.20	  kcal/mol	  increase	  relative	  to	  the	  WT	  terminator	  conformation).	  
5.5.2 Riboswitch	  mutants	  demonstrate	  a	  shift	  in	  conformational	  equilibrium	  
A	  riboswitch	  translational	  reporter	  fusion	  was	  made	  (identical	  to	  that	  employed	  for	  mapping	  
of	   the	   translation	   start	   site	   (see	   section	   3.2),	   containing	   WT	  M.	  tuberculosis	   H37Rv	   rpfB	  
5'UTR	  spanning	  -­‐316	  bp	  upstream	  of	  the	  re-­‐annotated	  TTG	  start	  codon	  down,	  with	  the	  first	  
14	   codons	   of	   rpfB	   CDS	   fused	  with	   lacZ	   (see	   Figure	   5.VII,	   A).	   The	   construct	   was	   mutated	  
individually	   at	   U6C,	   G112C	   and	   U117-­‐119A	   relative	   to	   the	   P1	   TSS.	   Constructs	   were	  
transformed	   into	   M.	  smegmatis	   as	   a	   surrogate	   host,	   and	   expression	   was	   measured	   by	  
β-­‐galactosidase	  assay.	  	  
Protein	   extracts	   of	   M.	  smegmatis	   transformed	   with	   WT	   translational	   fusion	   showed	   a	  
β-­‐galactosidase	  activity	  of	  57.05	  ±	  2.27	  Miller	  units	  (MU)/mg	  total	  protein,	  representative	  of	  
WT	   riboswitch	   read-­‐through	   (see	   Figure	   5.VII,	   B).	   The	   terminator	   stabilising	   G112C	  
substitution	  showed	  a	  near	  2-­‐fold	  significant	  decrease	  in	  expression	  to	  30.33	  ±	  4.79	  MU/mg	  
total	  protein	  relative	  to	  the	  WT.	  Conversely	  the	  anti-­‐terminator	  stabilising	  U6C	  substitution	  
showed	  a	  significant	  increase	  in	  expression	  to	  76.38	  ±	  10.39	  MU/mg	  total	  protein	  relative	  to	  
the	  WT.	   A	   similar	   result	  was	   seen	  with	   the	   terminator	   disrupting	  U117-­‐119A	   substitution	  
where	  expression	  increased	  significantly	  to	  84.05	  ±	  2.94	  MU/mg	  total	  protein	  relative	  to	  the	  
WT.	   Taken	   together	   these	   results	   demonstrated	   the	   conformational	   mutations	   had	   the	  
predicted	   effect	   as	   terminator	   conformation	   stabilisation	   increased	   attenuation	   but	  
anti-­‐terminator	  conformation	  stabilisation	  increased	  read-­‐through.	  To	  confirm	  these	  results	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were	   due	   to	   variation	   in	   riboswitch	   attenuation	   itself,	   total	   RNA	   was	   extracted	   from	  
transformed	  M.	  smegmatis	  for	  northern	  blot	  analysis.	  	  
	  
Figure	  5.VII	  β-­‐galactosidase	  assay	  of	  riboswitch	  conformational	  mutants	  
Diagram	   (A)	   shows	   the	   construction	   of	   the	   translational	   fusion	   employed.	   Chart	   (B)	   shows	   β-­‐galactosidase	  
assay	  results	  of	  transformed	  M.	  smegmatis	  protein	  extracts.	  Mean	  of	  biological	  replicates	  (n=6)	  relative	  to	  WT.	  
Statistical	  significance	  relative	  to	  WT	  calculated	  by	  one-­‐way	  ANOVA	  with	  Tukey	  post	  hoc	  analysis	  in	  IBM	  SPSS	  
±1	  standard	  deviation,	  *	  P	  ≤	  0.05,	  ***	  P	  ≤	  0.001.	  
The	  resulting	  northern	  blot	  in	  Figure	  5.VIII	  showed	  the	  same	  ~130	  nt	  riboswitch	  attenuated	  
transcript	   was	   present	   in	   the	   transformed	   M.	  smegmatis,	   WT	   M.	  tuberculosis	   and	  
Mycobacterium	  bovis	  BCG.	  Evidently	  M.	  smegmatis	  did	  not	  express	  the	  riboswitch	  from	  the	  
native	  rpfB	  P1	  promoter	  to	  the	  same	  extent	  as	  the	  other	  two	  species.	  This	  may	  be	  attributed	  
to	  a	  lack	  of	  genetic	  context,	  as	  it	  has	  been	  shown	  that	  two-­‐component	  response	  regulator	  
MtrA	  and	  nucleoid	  associating	  protein	  Lsr2	  are	  capable	  of	  binding	  within	  the	  M.	  tuberculosis	  
rpfB	   locus,	   both	   of	   which	   have	   homologous	   M.	  smegmatis	   sequences	   but	   unverified	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Figure	  5.VIII	  northern	  blot	  of	  riboswitch	  reporters	  
Total	   RNA	   extracted	   from	  M.	   tuberculosis	  H37Rv	   and	  M.	  bovis	  BCG	   during	   both	   exponential	   and	   stationary	  
growth	   phases	   on	   the	   left,	   on	   the	   right	   total	   RNA	   extracted	   during	   exponential	   growth	   phase	   from	  
M.	  smegmatis	   transformed	   with	   riboswitch	   translational	   fusion	   reporter	   constructs	   containing	   U6C	  
anti-­‐terminator	   stabilising	   substitution,	  G112C	   terminator	   stabilising	   substitution	  and	  U117-­‐119A	   terminator	  
disrupting	  substitution.	  RNA	  was	  probed	  within	  the	  rpfB	  P1	  5’UTR	  (oligonucleotide	  5.22)	  and	  for	  5S	  rRNA	  as	  a	  
loading	  control	  (oligonucleotide	  1.48,	  see	  Appendix	  section	  10.3).	  
Corresponding	  with	  decreased	  expression	  in	  the	  β-­‐galactosidase	  assay	  above	  (Figure	  5.VII),	  
M.	  smegmatis	   extracts	   with	   the	   terminator	   stabilising	   G112C	   substitution	   resulted	   in	  
increased	   abundance	   of	   the	   ~130	  nt	   riboswitch	   attenuated	   transcript	   compared	   to	   WT.	  
Moreover,	  the	  terminator	  disrupting	  U117-­‐119A	  substitution	  had	  no	  detectable	  attenuated	  
transcript,	  likely	  due	  to	  decreased	  efficiency	  of	  intrinsic	  termination	  at	  the	  disrupted	  poly(U)	  
tract.	   Collectively	   the	   northern	   blot	   of	   the	   M.	  smegmatis	   reporter	   strains	   and	   the	  
β-­‐galactosidase	   assay	   results	   further	   substantiate	   the	   proposition	   that	   the	   riboswitch	  
regulates	   expression	   of	   downstream	   genes	   through	   transcription	   attenuation,	   likely	  
achieved	  by	  intrinsic	  termination	  at	  the	  poly(U)	  tract.	  
5.5.3 Riboswitch	  deletion	  demonstrates	  a	  strong	  downstream	  transcriptional	  control	  
A	   further	   construct	  was	  devised	   to	  ascertain	   the	  magnitude	  of	   regulation	  on	  downstream	  
gene	   expression.	   The	  WT	   reporter	   described	   above	  was	  mutated,	   deleting	   the	   riboswitch	  
sequence	  from	  +1	  to	  +127	  bp	  relative	  to	  the	  P1	  TSS	  (this	  deletion	  was	  made	  prior	  to	  3’RACE	  
analysis	   (see	   section	   5.4)	   and	   G128-­‐U130	   remained	   in	   the	   fusion).	   Riboswitch	   deletion	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152	  ±	  19.58	  MU/mg	  total	  protein	  relative	  to	  the	  WT	  (see	  Figure	  5.VII).	  This	  large	  increase	  in	  
expression	   indicated	   that	   the	   riboswitch	   exerts	   a	   strong	   control	   on	   transcription	   of	  
downstream	  genes,	  principally	  the	  rpfB-­‐ksgA	  bi-­‐cistron	  in	  the	  context	  of	  M.	  tuberculosis	  (see	  
section	  4.2).	  	  
5.6 Chapter	  discussion	  
Northern	  blot	  analysis	  of	  total	  RNA	  from	  M.	  tuberculosis	  and	  M.	  bovis	  BCG	  demonstrated	  a	  
distinct	  lack	  of	  riboswitch	  complementary	  sequence	  during	  stationary	  phase	  growth	  (Figure	  
5.VIII).	  This	  was	  not	  surprising	  as	  resuscitation	  promoting	  factors	  serve	  to	  stimulate	  growth	  
during	   favourable	  conditions,	   thus	  expression	  during	  stationary	  growth	  phase	  would	   likely	  
be	   disadvantageous	   to	   cells.	   Decreased	   expression	   of	   rpfB	   into	   early	   and	   late	   stationary	  
growth	  phase	  has	  been	  described	  in	  the	  literature	  previously,	  it	  is	  therefore	  unlikely	  rpfB	  is	  
expressed	   as	   cells	   continue	   into	   late	   stationary	   growth	   phase	   (Tufariello,	   Jacobs	   &	   Chan	  
2004;	  Gupta,	  Srivastava	  &	  Srivastava	  2010).	  	  
Unlike	  M.	  tuberculosis,	  M.	  bovis	  BCG	  stationary	  growth	  phase	  RNA	  yielded	  a	  faint	  signal	  of	  
~130	  nt	  attenuated	  transcript.	  As	  the	  two	  species	  share	  100%	  sequence	  identity	  within	  the	  
rpfB	  locus,	  this	  discrepancy	  cannot	  be	  attributed	  to	  the	  riboswitch	  itself.	  Additionally,	  the	  5S	  
rRNA	   loading	   control	   appeared	   to	   be	   consistent	   between	   the	   two	   species.	   In	   the	  
experiments	  above,	   stationary	  growth	  phase	  RNA	  extraction	  was	  carried	  out	  1	  week	  after	  
cultures	   achieved	   turbidity	   in	   excess	   of	   1.0	   OD600	   nm.	   For	   the	   strains	   used	   in	   this	   study	  
M.	  bovis	  BCG	  was	  observed	  to	  have	  a	  slightly	  longer	  generation	  time	  of	  24	  hours	  compared	  
to	  that	  of	  M.	  tuberculosis	  at	  approximately	  16	  hours.	  Therefore	  the	  stationary	  growth	  phase	  
cultures	  may	   not	   have	   been	   directly	   comparable	   between	   the	   two	   species;	  M.	  bovis	  BCG	  
cultures	  may	  have	  been	  slightly	  earlier	  in	  stationary	  phase	  than	  M.	  tuberculosis	  at	  the	  time	  
of	   sample	   extraction.	   It	   is	   probable	   this	   disparity	  may	   be	   associated	  with	   the	   phenotypic	  
heterogeneity	   associated	   with	   entry	   into	   stationary	   growth	   phase.	   Regardless,	   it	   is	   clear	  
both	   species	   demonstrated	   a	  marked	   reduction	   in	   transcription	   during	   stationary	   growth	  
phase	   with	   little	   riboswitch	   attenuated	   transcript	   and	   no	   read-­‐through	   transcripts	  
detectable.	  
In	   contrast,	   the	   abundance	   of	   signal	   in	   exponential	   growth	   phase	   RNA	   on	   the	   analysed	  
northern	  blot	  (Figure	  5.VIII)	  supported	  the	  theory	  that	  the	  riboswitch	  expression	  regulates	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resuscitation	  promoting	  factors	  under	  advantageous	  growth	  conditions.	  As	  the	  P2	  promoter	  
is	   situated	   within	   the	   riboswitch,	   it	   is	   incapable	   of	   yielding	   a	   riboswitch	   attenuated	  
transcript	   of	   ~130	  nt.	   Reporter	   fusions	   (Figure	   5.III)	   demonstrated	   expression	   is	   likely	  
promoted	  by	  P1	  as	  P2	  appeared	  to	  make	  an	  unsubstantial	  contribution	  to	  expression	  when	  
the	  P1	  promoter	  is	  compromised.	  	  
Notwithstanding,	  it	  was	  surprising	  to	  observe	  that	  disruption	  to	  the	  P2	  -­‐10	  element	  resulted	  
in	   increased	   reporter	   expression	   compared	   with	   the	   WT.	   The	   cause	   of	   this	   increase	   is	  
unknown.	   One	   theory	   is	   that	   disruption	   to	   the	   P2	   -­‐10	   element	   could	   have	   resulted	   in	  
decreased	   RNAP	   association	   at	   the	   P2	   promoter.	   An	   alternative	   explanation	   is	   that	   the	  
mutations	  made	   to	   the	   P2	   -­‐10	   element	   had	   unforeseen	   effects	   to	   the	   riboswitch	   itself	   in	  
which	   the	   P2	   promoter	   is	   situated.	   Structural	   modelling	   did	   not	   predict	   any	   deviation	   to	  
either	   of	   the	   riboswitch	   conformations	   or	   the	   folding	   free	   energy	   associated	   with	   the	  
substitutions.	  However,	   the	  U73C	   substitution	   (relative	   to	   the	  P1	   TSS)	  used	   to	   change	   the	  
downstream	  thiamine	  of	  the	  P2	  -­‐10	  element	  would	  have	  substituted	  a	  residue	  within	  a	  loop	  
region	   of	   both	   riboswitch	   conformations	   which	   may	   have	   impacted	   functionality.	   In	   this	  
instance,	  such	  a	  disruption	  was	  unavoidable,	  but	  its	  potential	  to	  contribute	  to	  this	  increased	  
expression	  cannot	  be	  disregarded.	  
All	   of	   the	   reporters	   fusions	   employed	   within	   this	   study	   were	   initially	   constructed	   in	  
Escherichia	  coli.	  Generally,	  E.	  coli	  is	  a	  poor	  host	  for	  mycobacterial	  genetics	  where	  promoters	  
generally	   have	   a	   poor	   -­‐35	  promoter	   element	   consensus	   making	   sigma	   factor	   recognition	  
difficult	   (Cortes	   et	   al.	   2013).	   In	   preliminary	   experiments	   the	   promoter	   reporters	   were	  
transformed	   into	  M.	  smegmatis	   for	   validation	  prior	   to	  experimentation	   in	  M.	  tuberculosis.	  
Within	  an	  M.	  smegmatis	  background	  there	  was	  no	  detectable	  P2	  expression,	  but	  subsequent	  
experiments	   proved	   limited	   P2	   expression	   occurred	  within	   an	  M.	  tuberculosis	   background	  
(Figure	  5.III).	  Consequently,	  M.	  smegmatis	  makes	  an	  excellent	  host	   in	  which	  to	   investigate	  
the	   riboswitch	   function	   because	   the	   vast	   majority	   of	   transcripts	   made	   will	   encode	   the	  
riboswitch	  promoted	  by	  the	  upstream	  P1	  promoter.	  Despite	  this,	  the	  question	  was	  raised	  as	  
to	   what	   the	   biological	   function	   of	   the	   P2	   promoter	   was	   in	   the	   wider	   context	   of	   rpfB	  
expression.	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As	   experiments	   have	   shown	   the	   P2	   promoter	   has	   scarce	   activity	   in	   either	   exponential	   or	  
stationary	   growth	   phase	   cultures	   of	  M.	  tuberculosis,	   it	   is	   possible	   that	   the	   P2	   promoted	  
expression	   might	   be	   associated	   with	   physiological	   stress.	   The	   sequence	   of	   the	  
P2	   -­‐10	  element	   bears	   close	   resemblance	   to	   the	   SigA	   -­‐10	   element	   ‘TANNNT’	   consensus	  
(Cortes	   et	   al.	   2013).	   SigA	   is	   the	   primary	   sigma	   factor	   of	   M.	  tuberculosis	   and	   promotes	  
expression	  during	  normal	  growth	  conditions	  (Newton-­‐Foot	  &	  Gey	  Van	  Pittius	  2013).	  A	  lack	  
of	   P2	   promoted	   expression	   suggests	   the	   P2	   promoter	   may	   be	   subjected	   to	   additional	  
regulation	  such	  as	  the	  two-­‐component	  response	  regulator	  MtrA	  or	  the	  nucleoid	  associating	  
protein	  Lsr2	  which	  are	  known	  to	  associate	  with	  the	  region	  (Lew	  et	  al.	  2011;	  Gordon	  2013;	  
Sharma	  et	  al.	  2015).	  Perhaps	  under	  certain	  conditions	   it	  may	  be	  advantageous	  for	  cells	   to	  
express	   the	   rpfB-­‐ksgA	  bi-­‐cistron	   separately	   from	   riboswitch	   regulatory	   control	   through	   P2	  
promoted	  transcription.	  This	   is	  certainly	  a	  potential	  area	  for	  future	   investigation,	  although	  
not	  pursued	  in	  the	  present	  study	  concerned	  with	  the	  riboswitch-­‐mediated	  regulation.	  
Recently	   Sharma	   et	   al.	   (2015)	   described	   a	   SigB	   promoter	   -­‐10	   element	   upstream	   from	   a	  
potential	  transcription	  start	  site	  for	  rpfB	  identified	  through	  5’RACE.	  The	  5’end	  identified	  was	  
situated	  immediately	  downstream	  of	  the	  riboswitch	  described	  in	  this	  study	  at	  G128	  (relative	  
to	  the	  P1	  TSS)	  indicating	  the	  possibility	  of	  a	  processed	  5’end.	  Sharma	  et	  al.	  investigated	  the	  
SigB	  element	  through	  reporter	  assays	  using	  transformed	  M.	  tuberculosis	  cell	  extracts	  grown	  
to	  mid-­‐exponential	  growth	  phase.	  The	  SigB	  sigma	  factor	  is	  primarily	  associated	  with	  stresses	  
connected	   to	   stationary	   phase	   growth	   in	  M.	  tuberculosis	   (Newton-­‐Foot	  &	  Gey	  Van	   Pittius	  
2013).	   Assaying	   potential	   SigB	   activity	   in	   mid-­‐exponential	   growth	   phase	   is	   therefore	  
somewhat	   inappropriate.	  Moreover,	   Sharma	  et	   al.	   deduced	   there	  were	  no	  other	   possible	  
promoters	   within	   the	   rpfB	   locus.	   They	   proceeded	   to	   test	   the	   rpfB	   locus	   using	   in	   vitro	  
transcription	  assays	  consisting	  of	  M.	  tuberculosis	  core	  RNAP	  in	  the	  presence	  and	  absence	  of	  
SigB	   using	   a	   template	   spanning	   +45	   to	   +187	  bp	   (relative	   to	   the	   P1	   TSS),	   excluding	   the	   P1	  
promoter	   described	   in	   the	   present	   study.	   The	   transcription	   reaction	   generated	   a	   single	  
transcript,	   which	   was	   not	   sized	   with	   a	   molecular	   marker	   and	   therefore	   is	   not	   sufficient	  
evidence	  to	  determine	  functionality	  of	  the	  proposed	  SigB	  promoter.	  	  
In	  the	  present	  study	  two	  promoters	  have	  been	  validated,	  both	  of	  which	  are	  corroborated	  by	  
existing	   TSSM	   data	   published	   by	   Cortes	   et	   al.	   (2013)	   prior	   to	   the	   study	   by	   Sharma	   et	   al.	  
(2015).	   By	   digesting	   with	   terminal-­‐exonuclease	   (TEX),	   an	   RNase	   capable	   of	   degrading	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truncated	   5’monophosphorylated	   RNA,	   Cortes	   et	   al.	   enriched	   their	   samples	   for	   primary	  
5’triphosphorylated	   transcripts	   prior	   to	   sequencing.	   The	   5’RACE	   method	   Sharma	   et	   al.	  
employed	  did	  not	  differentiate	  between	  primary	  5’transcripts	  and	  processed	  5’ends,	  which	  
are	  relatively	  more	  abundant.	  For	  this	  reason	  it	  is	  likely	  the	  TSS	  identified	  by	  Sharma	  et	  al.	  is	  
an	  artefact	  of	  post-­‐transcriptional	  processing	  rather	   than	  a	   true	  TSS.	   In	   the	  present	  study,	  
exhaustive	   efforts	   were	   made	   to	   carry	   out	   5’RACE	   through	   a	   wide	   variety	   of	   5’RACE	  
methods.	  Unfortunately,	  none	  of	  the	  techniques	  used	  successfully	  identified	  a	  5’terminus	  to	  
the	   rpfB	   5’UTR.	   Potentially	   the	   low	   expression	   and	   highly	   structured	   nature	   of	   the	  
riboswitch	   may	   have	   confounded	   5’adapter	   ligation	   and	   reverse	   transcriptase	   efficiency.	  
Regardless,	  the	  results	  from	  the	  P1	  and	  P2	  double	  mutant	  (Figure	  5.III)	  indicated	  there	  were	  
no	  other	   regions	   capable	   of	   promoting	   transcription	   in	   the	   rpfB	   locus,	   in	   agreement	  with	  
TSSM	  published	  by	  Cortes	  et	  al.	  (2013).	  	  
In	   addition	   to	   verifying	   the	   sense	   strand	   promoters	   proposed	   for	   the	   rpfB	   locus,	  
transcriptional	   fusion	   of	   the	   putative	   Pas	   promoter	   verified	   it	   is	   capable	   of	   promoting	  
transcription	   in	   vivo.	   Figure	   5.III	   shows	   there	   was	   a	   discernible	   level	   of	   β-­‐galactosidase	  
reporter	   expression	   from	   the	   transcriptional	   fusion	   of	   the	   Pas	   promoter.	   Considering	   the	  
construction	  of	  this	  transcriptional	  reporter	  differs	  from	  that	  of	  the	  sense	  strand	  promoter	  
translational	  reporters,	   it	  would	  be	   inappropriate	  to	  compare	  promoter	  strength	  based	  on	  
reporter	   expression	   alone	   because	   the	   experimental	   set	   up	   is	   not	   comparable	   (Thomas	  
2001).	  It	  is	  likely	  the	  asRNA	  transcript	  is	  not	  highly	  expressed	  as	  efforts	  to	  map	  the	  asRNA	  by	  
3’RACE	   or	   detect	   its	   expression	   by	   northern	   blot	   analysis	   repeatedly	   proved	   unsuccessful	  
throughout	  this	  study.	  	  
Taken	  in	  consideration	  with	  the	  weak	  signal	  observed	  in	  RNA-­‐seq	  data	  (Figure	  5.I)	  it	  is	  likely	  
that	  the	  asRNA	  transcript	   is	   less	  abundant	  than	  rpfB	  sense	  strand	  transcripts.	   It	   is	  possible	  
this	   may	   be	   attributed	   to	   comparably	   weaker	   promoter	   activity,	   transcript	   stability	   and	  
turnover	   or	   potentially	   the	   function	   of	   the	   antisense	   transcript	   itself	  which	  may	   serve	   to	  
basepair	   with	   the	   rpfB	   sense	   transcript	   as	   an	   RNA:RNA	   duplex	   susceptible	   to	   RNase	  
degradation	   (Wagner,	   Altuvia	   &	   Romby	   2002).	   Potentially	   the	   asRNA	   may	   have	   greater	  
relevance	  under	  certain	   stress	  conditions.	   In	  a	   similar	  manner	   to	   the	  P2	  promoter,	   the	  Pas	  
promoter	   resembles	   the	   SigA	   -­‐10	   element	   ‘TANNNT’	   consensus	   sequence,	   but	   does	   not	  
appear	  to	  be	  highly	  expressed	  during	  exponential	  growth.	  As	  discussed	  in	  previous	  chapters	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(see	   section	   3.4),	   it	   is	   feasible	   the	   asRNA	   transcript	   may	   down-­‐regulate	   rpfB	   expression	  
through	  occlusion	  of	  the	  ribosome	  binding	  site.	  This	  could	  make	  a	  promising	  facet	  of	  future	  
investigation	   with	   the	   potential	   to	   elucidate	   further	   complexity	   in	   rpfB	   expression	  
regulation.	  
The	  3’temini	  of	  riboswitch	  attenuated	  transcripts	  were	  mapped	  to	  the	  poly(U)	  tract	  of	  the	  
riboswitch	   intrinsic	   terminator	   through	   3’RACE.	  Of	   the	   clones	   sequenced	   42.42%	  mapped	  
specifically	  to	  the	  poly(U)	  tract	  itself	  (Figure	  5.IV),	  consistent	  with	  transcription	  attenuation	  
in	   this	   region	   either	   through	   intrinsic	   termination	   or	   long-­‐lived	   transcriptional	   pausing.	  
Interestingly,	  a	  relatively	  high	  7.58%	  of	  clones	  sequenced	  mapped	  to	  G179	  (relative	  to	  the	  
P1	  TSS),	  the	  last	  nucleotide	  of	  the	  re-­‐annotated	  TTG	  start	  codon	  (see	  section	  3.2).	  Recently,	  a	  
thiamine	  phosphate	  (TPP)	  sensing	  riboswitch	  was	  described	  in	  E.	  coli	  that	  uses	  a	  translation	  
initiation	   proximal	   pause	   as	   an	   “intramolecular	   lock”,	   a	   failsafe	  mechanism	   to	   ensure	   the	  
regulatory	  decision	  riboswitch	  expression	  platform	  is	  adhered	  to	  (Chauvier	  et	  al.	  2017).	  It	  is	  
tempting	   to	   speculate	   such	  a	   secondary	   function	  may	  be	  achieved	  by	   the	   rpfB	   riboswitch	  
where	  results	  indicated	  the	  possibility	  of	  start	  codon	  proximal	  pausing	  (see	  Appendix	  Figure	  
10.IV).	  
With	   regards	   to	   the	  mechanism	  by	  which	   the	   riboswitch	  exerts	   its	   regulatory	   control,	   the	  
conformational	   reporter	  mutants	   (Figure	  5.VII)	   strongly	   indicated	   the	   riboswitch	   functions	  
as	   an	   intrinsic	   terminator.	   Upon	   stabilising	   the	   predicted	   terminator	   conformation	   of	   the	  
riboswitch	  with	   the	  G112C	  substitution,	   there	  was	  a	  significant	  decrease	   in	   transcriptional	  
read-­‐through	  as	   indicated	  by	  decreased	  β-­‐galactosidase	  expression.	  Through	  northern	  blot	  
analysis	   of	   transformed	  M.	  smegmatis	   total	   RNA	   extracts,	   a	   marked	   increase	   in	   ~130	  nt	  
riboswitch	  attenuated	  transcript	  was	  detected	  compared	  to	  the	  WT	  reporter,	   indicative	  of	  
increased	   attenuation.	   Combined	   with	   the	   U117-­‐119A	   terminator	   disrupting	   mutation,	  
which	   displayed	   a	   significant	   increase	   in	   transcriptional	   read-­‐through,	   the	   results	   strongly	  
indicate	  the	  rpfB	  riboswitch	  uses	  the	  proposed	  intrinsic	  terminator	  to	  affect	  transcriptional	  
attenuation	  of	  downstream	  genes.	  	  
It	   is	   encouraging	   that	   the	   both	   the	   terminator	   stabilising	   G112C	   substitution	   and	   the	  
anti-­‐terminator	   stabilising	   U6C	   substitution	   resulted	   in	   significant	   deviations	   from	   WT	  
reporter	  expression,	   fitting	  trends	  predicted	  by	  the	  structural	  modelling	   (Figure	  5.VII
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absence	  of	  any	  empirical	  structural	  observations	  of	  the	  riboswitch	  is	  a	  noteworthy	  limitation	  
to	   the	  present	  study.	  Although	  extensive	  endeavours	  were	  made	  to	  attempt	  to	  probe	  the	  
structure	   of	   the	   riboswitch,	   isolation	   of	   highly	   purified,	   homogenously	   sized	   riboswitch	  
transcript	   proved	   elusive	   to	   generate.	   Despite	   this	   it	   is	   probable	   the	   predicted	   rpfB	  
riboswitch	   terminator	   conformation	   represents	   a	   functional	   transcription	   attenuating	  
structure,	   as	   demonstrated	   by	   3’RACE	   (Figure	   5.IV),	   conformational	   reporter	   mutants	  
(Figure	  5.VII)	  and	  northern	  blot	  (Figure	  5.VIII).	  Although,	  it	  is	  possible	  the	  anti-­‐terminator	  or	  
read-­‐through	   conformation	   could	   be	   quite	   different	   in	   the	   presence	   of	   bound	   ligand.	  
Nevertheless,	  the	  two	  predicted	  rpfB	  riboswitch	  conformations	  demonstrate	  a	  hallmark	  of	  
riboswitch	   function,	   a	   mutually	   exclusive	   switch	   where	   formation	   of	   one	   conformation	  
precludes	  that	  of	  the	  other	  (Batey	  2011;	  Millman	  et	  al.	  2017).	  
Figure	  5.IX	  demonstrates	  how	  the	  stem-­‐loop	  region	  of	   the	   intrinsic	   terminator	   is	  mutually	  
exclusive	   to	   the	   terminator	   conformation,	   precluding	   formation	   of	   the	   predicted	  
anti-­‐terminator	  conformation	  and	  vice	  versa.	  This	  is	  further	  ratified	  by	  the	  observation	  that	  
both	   the	   G112C	   and	   U6C	   substitutions	   strengthen	   the	   basepairing	   of	   one	   conformation	  
whilst	  simultaneously	  weakening	  the	  other	  (Figure	  5.VI).	  This	  attribute	  made	  both	  of	  these	  
substitutions	   elegant	   solutions	   to	   investigate	   the	   potential	   conformational	   equilibrium	   of	  
the	   riboswitch	   without	   compromising	   the	   overall	   structure.	   In	   future	   chapters	   these	  
mutations	   will	   be	   validated	   yet	   further	   by	   demonstrating	   their	   effect	   on	  
riboswitch-­‐mediated	  attenuation	  in	  vitro	  (see	  section	  7.2.4).	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Figure	  5.IX	  a	  mutually	  exclusive	  switching	  mechanism	  
The	   top	   diagrams	   show	   the	   predicted	   rpfB	   riboswitch	   conformations	   with	   the	   stem	   region	   of	   the	   intrinsic	  
terminator	   stem-­‐loop	   highlighted	   in	   yellow	   (Zuker	   2003).	   The	   bottom	   diagram	   demonstrates	   how	   one	  
conformation	   precludes	   the	   formation	   of	   another	   in	   a	   riboswitch	  mutually	   exclusive	   switch	   (adapted	   from	  
Batey	  2011).	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5.7 Chapter	  conclusion	  
In	   conclusion,	   the	   results	  described	   in	   this	   chapter	  provided	  substantial	  evidence	   that	   the	  
proposed	   rpfB	   riboswitch	   exerts	   regulatory	   control	   on	   downstream	   genes	   through	  
transcription	   attenuation,	   likely	   achieved	   by	   intrinsic	   termination	   or	   a	   very	   long-­‐lived	  
transcriptional	   pause.	   The	   ability	   for	   the	   riboswitch	   to	   switch	   between	   its	   terminating	  
conformation	   to	  a	  mutually	  exclusive	  alternative	   conformation	  permissive	  of	   transcription	  
read-­‐through	  was	  demonstrated	  through	  minimal	  perturbation.	  In	  addition,	  the	  putative	  P1,	  
P2	  and	  Pas	  promoters	  were	  experimentally	  validated,	  corroborating	  published	  transcription	  
start	   site	  mapping	  and	   indicating	   the	  potential	   for	  an	  extra	   facet	  of	   rpfB	   regulation	   in	   the	  
form	  of	  an	  antisense	  sRNA.	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6 In	  vivo	  riboswitch-­‐associated	  expression	  
6.1 Diversity	  of	  growth	  environments	  
The	  work	  described	   in	  previous	  chapters	  provides	   insight	   into	  expression	  of	  the	  rpfB	   locus	  
throughout	   exponential	   and	   stationary	   phase	   growth.	   However,	   these	   growth	   states	   are	  
laboratory	  models,	  controlled	  environments	  in	  which	  microorganisms	  may	  be	  investigated.	  
In	  natural	  environments,	  Mycobacterium	  tuberculosis	  experiences	  a	   range	  of	  physiological	  
stresses	   throughout	  transmission,	   infection,	   immune	  evasion,	  dormancy	  and	  resuscitation.	  
Consequently,	  the	  diverse	  environmental	  conditions	  and	  stimuli	  require	  multiple	  phenotypic	  
sub-­‐populations	  with	  varied	  gene	  expression.	  	  
The	  work	  detailed	   in	  this	  chapter	  aimed	  to	  further	  understanding	  of	  how	  the	  rpfB	   locus	   is	  
regulated	  under	  varying	  growth	  conditions,	  and	  to	  what	  extent	  expression	  is	  controlled	  by	  
the	  riboswitch	  itself.	  	  	  
6.2 Rapid	  riboswitch	  expression	  upon	  exiting	  stationary	  growth	  phase	  
As	   demonstrated	   in	   previous	   chapters	   (see	   section	   5.2)	   the	   riboswitch	   is	   not	   expressed	  
during	   stationary	   phase	   growth.	   However,	   RpfB	   functions	   to	   facilitate	   resuscitation	   from	  
dormancy	   under	   advantageous	   conditions.	   It	   was	   therefore	   hypothesised	   it	   might	   be	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possible	   to	   detect	   riboswitch	   expression	   as	   cells	   resumed	   exponential	   growth	   by	  
re-­‐suspending	   late	   stationary	   growth	   phase	   culture	   in	   fresh	   media.	   Accordingly,	  
M.	  tuberculosis	  H37Rv	  was	   grown	   to	   late	   stationary	   phase	   (two	  weeks	   after	   1.0	  OD600	  nm)	  
before	  being	  re-­‐suspended	  in	  fresh	  media.	  Total	  RNA	  was	  extracted	  from	  the	  re-­‐suspended	  
culture	   as	   a	   time-­‐course	   from	   0	   to	   7.5	   hours,	   size	   separated	   by	   polyacrylamide	   gel	  
electrophoresis	  (PAGE)	  and	  blotted	  onto	  a	  nylon	  membrane	  to	  be	  probed.	  
	  
Figure	  6.I	  northern	  blot	  re-­‐growth	  from	  stationary	  growth	  phase	  
Image	   (A)	   shows	   northern	   blot	   of	   total	   RNA	   extracted	   from	  M.	  tuberculosis	   H37Rv	   during	   re-­‐growth	   from	  
stationary	  growth	  phase.	  Late	  stationary	  growth	  phase	  culture	  was	  re-­‐suspended	  in	  fresh	  media	  (see	  section	  
2.2.2).	  Total	  RNA	  was	  extracted	  from	  samples	  as	  a	  time-­‐course	  from	  0	  hours	  following	  re-­‐suspension.	  ~130	  nt	  
attenuation	  represents	  riboswitch-­‐mediated	  attenuation	  (see	  section	  5.2).	  Image	  (B)	  is	  a	  replica	  of	  Figure	  5.II	  
for	  comparison	  of	  the	  ratio	  of	  attenuated	  transcript.	  RNA	  was	  probed	  within	  the	  rpfB	  P1	  5’UTR	  (oligonucleotide	  
5.22)	  and	  for	  5S	  rRNA	  as	  a	  loading	  control	  (oligonucleotide	  1.48,	  see	  Appendix	  section	  10.3).	  
The	  resulting	  northern	  blot	   (see	  Figure	  6.I,	  A)	   showed	  riboswitch	  expression	  was	  resumed	  
within	  1	  hour	  of	  cells	  being	  re-­‐suspended	  in	  fresh	  media,	  as	  represented	  by	  visualisation	  of	  
the	  ~130	  nt	  riboswitch	  attenuated	  transcript	  (see	  section	  5.2).	  In	  contrast	  to	  northern	  blots	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attenuated	  transcript	  compared	  to	  read-­‐through.	  This	  suggested	  that	  read-­‐through	  beyond	  
the	   terminator	   did	   not	   occur	   immediately	   as	   cells	   resumed	   exponential	   growth,	   as	   there	  
appeared	  to	  be	  relatively	  more	  terminated	  transcripts.	  	  
6.3 Riboswitch	  transcripts	  are	  not	  expressed	  during	  nutrient	  starvation	  
A	   previous	   study	   by	   Gupta,	   Srivastava	   &	   Srivastava	   (2010)	   investigated	   expression	   of	  
M.	  tuberculosis	   rpf(A-­‐E)	   under	   multiple	   physiological	   stresses	   and	   growth	   conditions.	  
Expression	   was	   measured	   by	   real-­‐time	   quantitative	   PCR	   (RT-­‐qPCR),	   using	   cDNA	   reverse	  
transcribed	  from	  extracted	  mRNA.	  Values	  were	  normalised	  to	  16S	  ribosomal	  RNA	  (rRNA).	  In	  
addition	   to	   exponential	   and	   stationary	   growth	   phases,	   samples	   were	   collected	   during	  
nutrient	   starvation,	   acid	   stress,	   and	   hypoxia	   as	   well	   as	   non-­‐culturable	   and	   resuscitation	  
cultures.	   Gupta,	   Srivastava	   &	   Srivastava	   (2010)	   reported	   the	   largest	   change	   in	   rpfB	  
expression	   occurred	   within	   cultures	   subjected	   to	   24	  hour	   nutrient	   starvation,	   where	   a	  
19-­‐fold	   increase	   was	   reported.	   To	   investigate	   if	   increased	   rpfB	   expression	   could	   be	   the	  
result	   of	   increased	   riboswitch	   read-­‐through,	   a	   nutrient	   starvation	   experiment	   was	  
conducted	  in	  the	  present	  study.	  
Exponential	   growth	   phase	  M.	  tuberculosis	   culture	  was	   pelleted	   and	  washed	   in	   phosphate	  
buffered	  saline	  (PBS)	  with	  0.05%	  Tween80	  (v/v	  final)	  twice	  before	  being	  re-­‐suspended	  in	  an	  
equal	   volume	   of	   PBS	  Tween80	   (see	   section	   2.2.3)	   (Gengenbacher	   et	   al.	   2010;	   Gupta,	  
Srivastava	  &	  Srivastava	  2010).	  Total	  RNA	  was	  extracted	  from	  the	  re-­‐suspended	  culture	  as	  a	  
time-­‐course	  from	  0-­‐24	  hours,	  size	  separated	  by	  PAGE	  and	  blotted	  onto	  a	  nylon	  membrane	  
to	  be	  probed.	  
Figure	  6.II	  shows	  riboswitch-­‐associated	  expression	  of	  rpfB	  was	  substantially	  reduced	  during	  
nutrient	   starvation.	   There	   was	   a	   rapid	   decrease	   in	   both	   read-­‐through	   and	   attenuated	  
transcript	  in	  later	  time-­‐points	  compared	  to	  samples	  taken	  immediately	  after	  re-­‐suspension.	  
After	   24	  hours	   there	   was	   only	   a	   marginal	   restoration	   of	   ~130	  nt	   riboswitch	   attenuated	  
transcript,	   although	   the	   5S	   rRNA	   loading	   control	   was	   also	   comparatively	   weaker.	  
Nevertheless,	   this	  data	   indicated	  any	  potential	   increase	   in	   rpfB	   expression	  as	   reported	  by	  
Gupta,	  Srivastava	  &	  Srivastava	  (2010)	  was	  unlikely	  to	  be	  promoted	  by	  the	  rpfB	  P1	  promoter	  
or	  regulated	  by	  the	  riboswitch.	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Figure	  6.II	  northern	  blot	  of	  nutrient	  starvation	  
Northern	   blot	   of	   total	   RNA	   extracted	   from	  M.	  tuberculosis	   H37Rv	   during	   nutrient	   starvation.	   Exponential	  
growth	  phase	  culture	  was	  re-­‐suspend	  in	  PBS	  +	  0.05%	  Tween80	  for	  nutrient	  starvation	  (see	  section	  2.2.3).	  Total	  
RNA	  was	  extracted	  from	  samples	  as	  a	  time-­‐course	  from	  0	  hours	  following	  re-­‐suspension.	  ~130	  nt	  attenuation	  
represents	   riboswitch-­‐mediated	   attenuation	   (see	   section	   5.2).	   RNA	   was	   probed	   within	   the	   rpfB	   P1	   5’UTR	  
(oligonucleotide	  5.22)	  and	  for	  5S	  rRNA	  as	  a	  loading	  control	  (oligonucleotide	  1.48,	  see	  Appendix	  section	  10.3).	  	  
6.4 Riboswitch	  transcripts	  are	  subject	  to	  rapid	  turnover	  
For	   any	   actively	   growing	   cell,	   transcript	   abundance	   in	   vivo	   is	   representative	   of	   transcript	  
turnover,	   a	   balance	   between	   transcript	   synthesis	   and	   degradation.	   Transcripts	   that	   are	  
detectable	   through	   molecular	   techniques	   always	   have	   a	   higher	   rate	   of	   synthesis	   than	  
degradation,	   but	   if	   transcripts	   are	   particularly	   stable,	   with	   structures	   less	   accessible	   to	  
RNase	   degradation,	   this	   can	   lead	   to	   transcript	   accumulation	   (Moores	   et	   al.	   2017).	   To	  
investigate	  if	  the	  abundance	  of	  riboswitch	  attenuated	  transcript	  observed	  through	  northern	  
blot	   analysis	   was	   representative	   of	   low	   transcript	   turnover,	   a	   transcription	   inhibition	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M.	  tuberculosis	  culture	  was	  grown	  to	  exponential	  phase	  before	  adding	  rifampicin	  to	  inhibit	  
transcription	  (see	  section	  2.2.3).	  An	  untreated	  culture	  was	  grown	  in	  parallel	  and	  total	  RNA	  
was	  sampled	  over	  24	  hours	  for	  northern	  blot	  analysis.	  
	  
Figure	  6.III	  northern	  blot	  of	  transcription	  inhibition	  
Northern	   blot	   of	   total	   RNA	   extracted	   from	  M.	  tuberculosis	   H37Rv	   during	   transcription	   inhibition.	   Total	   RNA	  
was	  extracted	  from	  samples	  as	  a	  time-­‐course	  from	  0	  hours	  ±	  200	  µg/mL	  rifampicin	  (see	  section	  2.2.3).	  ~130	  nt	  
attenuation	  represents	  riboswitch-­‐mediated	  attenuation	  (see	  section	  5.2).	  RNA	  was	  probed	  within	  the	  rpfB	  P1	  
5’UTR	  (oligonucleotide	  5.22)	  and	  for	  5S	  rRNA	  as	  a	  loading	  control	  (oligonucleotide	  1.48,	  see	  Appendix	  section	  
10.3).	  
Within	   1	  hour	   of	   addition	   of	   rifampicin	   (Figure	   6.III,	   right)	   there	   was	   total	   loss	   of	   any	  
detectable	   signal	   for	   ~130	  nt	   attenuated	   transcripts	   or	   read-­‐through.	   This	   indicated	  
transcript	   abundance	   was	   not	   the	   result	   of	   low	   transcript	   decay	   but	   rather	   continual	  
transcript	  synthesis.	  In	  the	  absence	  of	  rifampicin	  expression	  remains	  constant,	  albeit	  with	  a	  
marginal	  increase	  of	  read-­‐through	  transcripts	  at	  2	  and	  4	  hour	  time-­‐points	  (Figure	  6.III,	  left).	  
Unlike	   some	  small	  RNAs	   (sRNAs)	  previously	   reported	   (Moores	  et	  al.	   2017),	   the	   riboswitch	  
attenuated	  transcript	  likely	  decays	  quickly.	  In	  future,	  a	  more	  accurate	  measure	  of	  riboswitch	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6.5 Expression	  of	  the	  rpfB	  locus	  throughout	  biofilm	  formation	  
Bacterial	   biofilms	   represent	   a	   heterogeneous	   population	   of	   growth	   phenotypes,	   a	   state	  
distinct	   from	   planktonic	   growth	   or	   growth	   on	   solid	   agar	   media	   (Ojha	   et	   al.	   2008).	  
Mycobacterial	   biofilms	   utilise	   secreted	   mycolic	   acids	   to	   create	   a	   structured	   extracellular	  
microenvironment	  that	  requires	  extensive	  changes	  in	  gene	  expression	  to	  form	  and	  colonise	  
(Ojha	   et	   al.	   2005;	   Richards	   &	   Ojha	   2014);	   modulation	   of	   cell	   wall	   biosynthesis	   has	   been	  
shown	   to	   be	   particularly	   important	   for	   biofilm	   formation	   in	  Mycobacterium	   smegmatis.	  
However,	   in	   pathogenic	   mycobacteria,	   the	   rpfB	   riboswitch	   regulates	   the	   rpfB-­‐ksgA	  
bi-­‐cistron,	   controlling	   expression	   of	   both	   the	   rpfB	   cell	   wall	   hydrolase	   and	   ksgA	  
methyltransferase	   involved	   in	   ribosome	   biogenesis.	   It	   was	   therefore	   hypothesised	   that	  
riboswitch-­‐mediated	   regulation	   might	   be	   relevant	   to	   expression	   of	   either	   rpfB	   or	   ksgA	  
during	  biofilm	  formation.	  	  	  
To	   explore	   this	   hypothesis,	   biofilms	   were	   cultured	   using	   Mycobacterium	  bovis	   BCG,	   a	  
tractable	   model	   of	  M.	  tuberculosis	   that	   shares	   100%	   sequence	   conservation	   for	   the	   rpfB	  
locus.	  Biofilm	  formation	  was	  carried	  out	  in	  50	  mL	  polypropylene	  tubes,	  inoculating	  10	  mL	  of	  
7H9	  media	  without	  the	  addition	  of	  Tween80,	  which	  would	  have	  disrupted	  aggregation	  (see	  
section	   2.2.4).	   Cultures	   were	   inoculated	   with	   an	  M.	  bovis	   BCG	   starter	   culture	   to	   a	   final	  
density	  of	  0.2	  OD600	  nm	  before	  allowing	  biofilm	   formation	  under	   static	  non-­‐aerated	  culture	  
conditions.	  Biofilms	  formed	  as	  pellicles	  at	  the	  air-­‐liquid	  interface,	  developing	  within	  the	  first	  
3	  weeks.	  Pellicle	  layers	  were	  harvested	  from	  separate	  cultures	  over	  the	  course	  of	  12	  weeks.	  
Total	   RNA	   was	   extracted	   from	   pellicle	   layers	   to	   generate	   cDNA	   through	   reverse	  
transcription,	  which	  was	  used	  as	  template	  for	  RT-­‐qPCR.	  Reactions	  were	  primed	  for	  multiple	  
targets	   within	   the	   rpfB	   locus:	   riboswitch	   and	   riboswitch-­‐mediated	   read-­‐through,	   asRNA,	  
rpfB,	  and	  ksgA	  (see	  section	  2.7.6).	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Figure	  6.IV	  detection	  values	  of	  M.	  bovis	  BCG	  biofilm	  RT-­‐qPCR	  
Chart	  (A)	  shows	  detected	  amplicons	  of	  individual	  M.	  bovis	  BCG	  biofilm	  cDNA	  targets.	  Values	  are	  expressed	  as	  
arbitrary	   units	   calculated	   against	   a	   gDNA	   standard	   curve.	   Chart	   (B)	   shows	   detection	   relative	   to	   riboswitch	  
amplicons	   (see	  section	  2.7.6).	  Data	   represents	  mean	  of	   technical	   replicates	   (n=4)	  of	   the	  biological	   replicates	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There	  was	   roughly	   a	   50%	  decrease	   in	   the	   expression	  of	   all	   target	   amplicons	   during	   initial	  
biofilm	   formation	   from	   0	   to	   3	   weeks	   post-­‐inoculation	   (see	   Figure	   6.IV,	   A).	   However,	  
expression	   of	   all	   targets	   increased	   during	   subsequent	   weeks	   as	   biofilms	   continued	   to	  
mature.	   Intriguingly	   the	  variation	  between	  biological	   replicates	  across	  all	   target	  amplicons	  
appeared	  to	  decrease	  as	  biofilms	  matured.	  This	  represents	  conditions	  that	  favour	  a	  biofilm	  
forming	   phenotype,	   with	   increased	   variation	   of	   later	   time-­‐points	   being	   indicative	  
established	  sub-­‐populations	  within	  the	  matured	  biofilm	  (Richards	  &	  Ojha	  2014).	  
Amplicons	  generated	  by	  priming	  reactions	  within	  the	  riboswitch	  itself	  may	  represent	  either	  
riboswitch-­‐attenuated	   transcripts	   or	   read-­‐through	   transcripts,	   as	   both	   contain	   the	  
riboswitch	  sequence	  (see	  section	  2.7.6).	  By	  priming	  reactions	  forward	  within	  the	  riboswitch	  
and	   reverse	  within	   rpfB	  coding	   sequences	   (CDS),	   the	   ‘P1	   rpfB	   read-­‐through’	   amplicon	  was	  
theoretically	   representative	   of	   transcripts	   that	   were	   not	   subject	   to	   riboswitch-­‐mediated	  
attenuation	   but	   continued	   read-­‐through	   into	   rpfB.	   Therefore	   expressing	   ‘P1	   rpfB	  
read-­‐through’	   results	   as	   a	   percentage	   of	   riboswitch	   transcripts	   provided	   a	   measure	   of	  
riboswitch	  attenuation	  of	  P1	  promoted	  transcripts.	  	  
Prior	   to	   biofilm	   formation	   at	   week	   0,	   P1	   rpfB	   read-­‐through	   amplicons	   were	   detected	   at	  
73.68%	  ±	  8.35	  relative	  to	  detected	  riboswitch	  transcripts	  (see	  Figure	  6.IV,	  B).	  After	  3	  weeks	  
of	  static	  growth,	  thin	  pellicle	  layers	  were	  observed	  in	  cultures,	  where	  RT-­‐qPCR	  indicated	  P1	  
rpfB	   read-­‐through	   decreased	   to	   56.65%	  ±	  3.84.	   However,	   by	   8	  weeks,	   mature	   biofilms	  
exhibited	   P1	   rpfB	   read-­‐through	   at	   64.25%	  ±	  1.51.	   Conversely,	   results	   for	   amplicons	  
generated	   by	   priming	   alone	   within	   the	   rpfB	   CDS	   indicated	   total	   rpfB	   expression	   at	  
82.42%	  ±	  1.56	  in	  week	  8	  biofilms.	  Transcripts	  of	  the	  rpfB	  CDS	  may	  originate	  from	  either	  of	  
the	  P1	  or	  P2	  transcription	  start	  sites	  (TSS)	  upstream,	  but	  only	  P1	  promoted	  transcripts	  would	  
be	  subjected	  riboswitch	  regulatory	  control.	  As	  total	  rpfB	  expression	  appeared	  to	  exceed	  that	  
of	  P1	  rpfB	   read-­‐through,	   these	  results	  suggested	  that	   the	  P2	  promoter	  made	  an	   increasing	  
contribution	  to	  the	  expression	  of	  rpfB	  as	  biofilms	  matured.	  
Whilst	   total	   ksgA	   expression	   appeared	   to	   follow	   a	   similar	   trend	   to	   that	   of	   total	   rpfB	  
expression,	  unlike	  other	   targets	  ksgA	  expression	  did	  not	  resume	  the	  same	   level	   in	  mature	  
biofilms.	   In	   fact,	   although	   not	   statistically	   significant,	   a	   declining	   trend	   in	   total	   ksgA	  
expression	   relative	   to	   total	   rpfB	  expression	  was	  observed	   (see	  Appendix	  Figure	  10.V).	  The	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mechanism	  through	  which	  relative	  ratios	  of	  rpfB	  and	  ksgA	  might	  vary	  individually	  within	  the	  
rpfB-­‐ksgA	  bi-­‐cistron	  is	  unknown.	  Potentially,	  the	  nutrient	  depleted	  media	  may	  have	  caused	  
a	   reduction	   in	   available	   nucleotides	   that	   would	   have	   decreased	   RNA	   polymerase	  
processivity.	  This	  would	  explain	  decreased	  transcription	  of	  ksgA	  as	  it	  is	  further	  downstream	  
from	  the	  promoter	  than	  rpfB.	  
6.6 Chapter	  discussion	  
Upon	  resuming	  exponential	  growth,	  northern	  blot	  analysis	  of	   late	  stationary	  growth	  phase	  
cultures	  exhibited	  rapid	  expression	  of	  attenuated	  transcripts	  within	  1	  hour	  of	  re-­‐suspension	  
in	  fresh	  media	  (Figure	  6.I,	  A).	  Comparatively,	  read-­‐through	  transcripts	  were	   less	  expressed	  
until	   approximately	   5	   hours	   after	   re-­‐suspension.	   Further	   biological	   replicates	   would	   be	  
required	  to	  confirm	  this	  is	  not	  a	  stochastic	  effect,	  especially	  as	  the	  5S	  rRNA	  loading	  control	  
indicated	   some	   variation	   between	   time-­‐points.	   Despite	   this,	   delayed	   expression	   of	  
read-­‐through	   transcripts	   could	   be	   indicative	   of	   riboswitch	   function	   as	   an	   intrinsic	  
terminator.	  As	  a	  transcriptional	  ‘on-­‐switch’,	  it	  is	  predicted	  ligand	  interaction	  would	  enhance	  
read-­‐through	  beyond	  the	  rpfB	  riboswitch	  (see	  section	  1.9).	  Riboswitches	  can	  be	  sensitive	  to	  
ligand	  abundance;	  it	  has	  been	  shown	  some	  may	  only	  switch	  at	  specific	  ligand	  concentration	  
thresholds	  (Lutz	  et	  al.	  2014).	  In	  the	  early	  stages	  of	  transition	  from	  stationary	  to	  exponential	  
phase	   growth,	   cells	  may	  have	  had	   insufficient	   concentrations	  of	   cognate	   ligand	   to	  permit	  
conformational	  switching	  and	  subsequent	  transcriptional	  read-­‐through.	  Therefore	  it	  may	  be	  
that	   the	   ligand	   is	   present	   during	   exponential	   growth	   phase,	   but	   read-­‐through	   is	   only	  
achieved	  at	  a	  concentration	  threshold.	  	  
The	  sequence	  homology	  of	  the	  M.	  tuberculosis	  rpfB	  riboswitch	  appears	  to	  be	  conserved	  in	  
pathogenic	  mycobacteria	  only	  (see	  section	  1.9).	  As	  M.	  tuberculosis	  is	  an	  obligate	  pathogen,	  
it	   is	   plausible	   the	   cognate	   ligand	   may	   be	   associated	   with	   pathogenesis,	   perhaps	   a	   host	  
derived	  signal	  of	  infection	  or	  weakened	  immunity	  used	  to	  indicate	  conditions	  advantageous	  
to	   resuscitation	   by	   RpfB.	  Whilst	   it	  would	   be	   intriguing	   to	   investigate	   riboswitch-­‐mediated	  
expression	  of	  the	  rpfB-­‐ksgA	  bi-­‐cistron	  within	  an	  infection	  model	  such	  as	  macrophage	  tissue	  
culture,	  results	  of	  the	  work	  described	  in	  this	  chapter	  suggested	  cognate	  ligand	  may	  not	  be	  
associated	  with	  pathogenicity.	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Limited	  riboswitch	  expression	  was	  detected	  during	  nutrient	  starvation	  conditions.	  Northern	  
blot	   analysis	   of	   exponential	   growth	   phase	   cultures	   re-­‐suspended	   in	   PBS	   demonstrated	   a	  
rapid	  down-­‐regulation	  of	  both	  riboswitch	  attenuation	  and	  read-­‐through	  transcripts	  (Figure	  
6.II).	  Riboswitch	  expression	  was	  marginally	  resumed	  within	  24	  hours	  of	  nutrient	  starvation.	  
This	   suggests	   the	   19-­‐fold	   increase	   in	   rpfB	   expression	   observed	   by	   Gupta,	   Srivastava	   &	  
Srivastava	   (2010)	  was	   unlikely	   the	   result	   of	   riboswitch-­‐mediated	   regulation.	  Moreover,	   as	  
both	  riboswitch	  attenuated	  and	  read-­‐through	  transcripts	  require	  P1	  promoted	  transcription,	  
it	   is	   also	   unlikely	   this	   increased	   rpfB	   expression	   would	   have	   been	   promoted	   by	   the	   P1	  
promoter.	  
The	   ribo-­‐probe	   used	   to	   visualise	   transcripts	   by	   northern	   blot	   analysis	   (Figure	   6.II)	   was	  
complementary	   to	   the	   riboswitch,	   capable	   of	   binding	   transcripts	   upstream	   of	   the	   P2	  
promoter	   TSS	   and	   therefore	   unable	   to	   bind	   P2	   promoted	   transcripts.	   As	   described	   in	  
previous	  chapters,	   the	  P2	  promoter	  does	  not	  appear	   to	  make	  any	  substantial	  contribution	  
rpfB	  expression	  during	  exponential	  growth	  or	  growth	  on	  solid	  agar	  media	  (see	  section	  5.3).	  
P2	  promoted	  transcription	  of	  the	  rpfB	  locus	  independent	  of	  riboswitch-­‐mediated	  regulatory	  
control	   could	   be	   more	   relevant	   under	   starvation	   conditions.	   This	   theory	   would	   not	   only	  
explain	   the	   increased	   rpfB	  expression	   described	   by	  Gupta,	   Srivastava	  &	   Srivastava	   (2010)	  
during	   nutrient	   starvation,	   but	  would	   corroborate	   increased	   expression	   of	   total	   rpfB	  CDS	  
observed	  in	  mature	  M.	  bovis	  BCG	  biofilms	  where	  cells	  would	  likely	  also	  experience	  nutrient	  
depletion	  (Figure	  6.IV,	  B).	  In	  future,	  it	  would	  be	  worthwhile	  investigating	  expression	  of	  both	  
P1	   promoted	   riboswitch	   transcripts	   as	   well	   as	   P2	   transcripts	   using	   RT-­‐qPCR.	   Additional	  
physiological	  stresses	  could	  also	  be	  explored	  such	  as	  osmotic	  stress	  similar	  to	  the	  rpfA	  ydaO	  
riboswitch	  homologue	   (St-­‐Onge	  et	  al.	   2015),	   acid	   stress	   like	   the	  pH	   sensing	   ribo-­‐regulator	  
(Nechooshtan	   et	   al.	   2009;	   Dambach	   et	   al.	   2015),	   and	   resuscitation	   from	   dormancy	   by	  
supplementation	  of	  cell-­‐free	  exponential	  growth	  phase	  culture	  supernatant	   (Mukamolova,	  
Turapov,	  Kazarian,	  et	  al.	  2002;	  Gupta,	  Srivastava	  &	  Srivastava	  2010)	  to	  further	  understand	  
expression	  and	  regulation	  of	  the	  rpfB	  locus.	  
Northern	   blot	   analysis	   of	   cultures	   subjected	   to	   transcription	   inhibition	   (Figure	   6.III)	  
demonstrated	   riboswitch	   transcripts	   were	   turned	   over	   within	   1	  hour	   of	   inhibition.	   A	  
potential	  cause	  of	  rapid	  turnover	  of	  riboswitch	  transcripts	  may	  be	  interaction	  with	  antisense	  
transcripts	  promoted	  by	  Pas.	  Attempts	  to	  characterise	  expression	  of	  the	  putative	  asRNA	  by	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3’rapid	   amplification	   of	   cDNA	   ends	   or	   northern	   blot	   analysis	   proved	   unsuccessful	   in	   this	  
study.	  Reporter	   fusions	  of	   the	  asRNA	  promoter	   region	   indicated	   low	  promoter	  activity	  on	  
solid	   agar	   media	   (see	   section	   5.3).	   Despite	   this,	   it	   was	   possible	   to	   detect	   asRNA	   target	  
amplicons	  by	  RT-­‐qPCR	  of	  biofilm	  extracts	  described	  above	  (Figure	  6.IV,	  B).	  Results	  indicated	  
the	   putative	   asRNA	   to	   be	   the	   least	   expressed	   of	   all	   amplified	   targets,	   consistently	  
approximately	   4-­‐fold	   lower	   than	   detected	   riboswitch	   expression.	   Potentially	   this	   is	  
indicative	   of	   asRNA	   function,	   where	   antisense	   transcripts	  might	   basepair	   with	   riboswitch	  
sense	   transcripts	   to	   form	   RNA:RNA	   duplexes	   as	   substrate	   for	   RNase	   degradation.	  
Alternatively,	   antisense	   Pas	   promoter	   activity	   may	   simply	   serve	   to	   reduce	   template	  
availability	   for	   the	  P1	  and	  P2	   sense	  strand	  promoters,	  as	   the	  convergent	  promoters	  would	  
cause	  polymerase	  clashing.	  	  
Multicellular	   structures	   have	   been	   described	   in	   caseous	   granulomas	   of	   mycobacterial	  
infections	   (Canetti	   1965,	   reviewed	   in	   Ojha	   &	   Hatfull	   2012)	   and	   many	   mycobacteria,	  
including	  M.	  tuberculosis,	   readily	   form	  biofilms	   in	   static	   culture	   (Zambrano	  &	  Kolter	  2005;	  
Ojha	   et	   al.	   2008).	  Multiple	  models	   have	   been	   proposed	   for	   the	   cultivation	   of	   biofilms	   as	  
pellicles,	  solid	  attachments	  or	   flow	  cells	   (Branda	  et	  al.	  2005).	  Pellicle	  formation	  provides	  a	  
three	  dimensional	  structured	  microenvironment	  where	  multiple	  phenotypic	  sub-­‐types	  may	  
grow.	   The	   RT-­‐qPCR	   results	   obtained	   from	   M.	  bovis	   BCG	   biofilms	   in	   the	   present	   study	  
demonstrated	   large	   variability	   resulting	   in	   statistical	   insignificance	   for	   trends	   observed	   in	  
expression	  of	  amplified	  targets	  (Figure	  6.IV).	  Variability	  in	  samples	  extracted	  at	  week	  0	  may	  
have	  been	  the	  result	  of	  heterogeneity	  of	  the	  starter	  culture	  inoculum.	  For	  later	  time-­‐points,	  
variability	   may	   have	   been	   due	   to	   the	   heterogeneity	   associated	   with	   established	   biofilms	  
(Richards	  &	  Ojha	  2014).	  It	  is	  also	  possible	  the	  precision	  of	  the	  sample	  extraction	  process	  (see	  
section	  2.2.4)	  may	  have	  contributed	  to	  this	  variation1.	  Independent	  of	  these	  considerations,	  
RT-­‐qPCR	   technical	   replicates	  demonstrated	  excellent	   reproducibility	  within	  each	  biological	  
replicate.	   In	   future,	   to	   substantiate	   rpfB	   locus	   expression	   during	   biofilm	   formation	   with	  
statistical	  significances	  would	  require	  a	  greater	  sample	  size	  of	  biological	  replicates.	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1	  Personal	   communication,	   Dr	   Jim	  Huggett,	   LGC	  UK	  National	  Measurement	   Laboratory/University	   of	   Surrey,	  
2017.	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6.7 Chapter	  conclusion	  
In	  conclusion,	  the	  work	  described	  in	  this	  chapter	  demonstrated	  cultures	  transitioning	  from	  
late	   stationary	   phase	   into	   exponential	   growth	   exhibit	   delayed	   riboswitch-­‐mediated	  
transcription	   read-­‐through,	   indicative	   of	   potential	   ligand	   concentration	   dependent	  
riboswitch	   conformational	   switching.	   Contrastingly,	   during	   nutrient	   starvation	   and	   biofilm	  
formation	  rpfB	  expression	  appeared	  to	  be	  independent	  of	  riboswitch	  expression,	  potentially	  
promoted	  by	  the	  rpfB	  P2	  promoter.	  Finally,	  transcription	  inhibition	  indicated	  that	  riboswitch	  
transcripts	  are	  rapidly	  turned	  over.	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7 Optimisation	  of	  a	  riboswitch	  in	  vitro	  transcription	  system	  
7.1 Investigating	  riboswitch	  function	  in	  vitro	  	  
The	  work	   described	   in	   previous	   chapters	   investigated	   the	  mechanism	   through	  which	   the	  
rpfB	   riboswitch	   exerts	   its	   regulatory	   control	   in	   vivo.	   The	   culmination	   of	   these	   findings	  
strongly	   indicated	  the	  riboswitch	  operates	  on	  a	  transcriptional	   level,	   regulating	  expression	  
of	   downstream	   genes	   through	   transcriptional	   attenuation.	   The	   riboswitch	   encodes	   a	  
potential	   intrinsic	   terminator,	   a	   stem-­‐loop	   followed	  by	  a	  downstream	  poly(U)	   tract.	  Many	  
riboswitches	   exist	   in	   a	   thermodynamic	   equilibrium	   between	   two	   possible	   conformations,	  
however	  the	  regulatory	  output	  of	  transcriptional	  riboswitches	  are	  often	  dictated	  by	   ligand	  
binding	   kinetics	   rather	   than	   conformational	   thermodynamics	   (Wickiser	  et	  al.	   2005).	   It	   has	  
been	  demonstrated	   that	   conformational	   switching	   is	   likely	  achieved	  within	  discrete	   ligand	  
concentration	   thresholds	   (Lutz	   et	   al.	   2014).	   Many	   riboswitches	   respond	   to	   critical	  
metabolites	  such	  as	  S-­‐adenosyl-­‐L-­‐methionine	   (SAM)	  or	  nucleotide	  derivatives	   (Smith	  et	  al.	  
2010;	  St-­‐Onge	  et	  al.	  2015)	   therefore	  perturbation	  of	   transcriptional	   riboswitches	   in	  vivo	   is	  
particularly	   challenging	   as	   cells	   have	   multiple	   mechanisms	   of	   regulating	   intracellular	  
concentrations	   of	   such	   metabolites.	   In	   vivo	   systems	   are	   further	   compounded	   by	   culture	  
heterogeneity	   and	   extended	   growth	   times	   particularly	   for	   mycobacteria.	   In	   vitro	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transcription	   systems	   offer	   a	   controlled	   environment	   in	   which	   the	   concentration	   of	  
candidate	  ligand	  can	  be	  varied	  to	  investigate	  possible	  effects	  on	  riboswitch	  function.	  	  
The	  work	  described	  in	  this	  chapter	  details	  the	  development	  and	  optimisation	  of	  an	   in	  vitro	  
transcription	   system	   capable	   of	   exploring	   the	   riboswitch	   transcription	   attenuation	  
regulatory	  mechanism.	  	  
7.2 Optimisation	  of	  an	  in	  vitro	  transcription	  system	  using	  E.	  coli	  RNAP	  
7.2.1 Development	  of	  a	  riboswitch	  in	  vitro	  transcription	  template	  	  
The	   first	   step	   in	   the	   development	   of	   the	   in	   vitro	   transcription	   system	   was	   to	   design	   a	  
suitable	   transcription	   template.	   For	   the	  purpose	  of	  developing	  and	  optimising	   the	   in	   vitro	  
transcription	  system	  it	  was	  decided	  commercially	  produced	  Escherichia	  coli	  RNA	  polymerase	  
(RNAP)	  would	  be	  preferable	  as	  a	  consistent	  and	  highly	  purified	  source	  of	  RNAP	  for	  the	  assay.	  
Therefore	   a	   promoter	   capable	   of	   transcription	   in	   both	  E.	  coli	   and	  mycobacteria	  would	   be	  
ideal.	  Preliminary	  experiments	   in	   vivo	   had	  demonstrated	   the	  native	   rpfB	  P1	  promoter	  had	  
relatively	  week	  activity,	  which	  was	  poorly	   recognised	   in	  E.	   coli	   due	   to	   the	  absence	  of	   any	  
defined	   -­‐35	   promoter	   element.	   Previously,	   the	   P1	   promoter	   of	   the	   Mycobacterium	  
smegmatis	  ribosomal	  RNA	  rrnB	  operon	  was	  identified	  as	  a	  highly	  active	  promoter	  capable	  of	  
recognition	  by	  RNAP	   in	  E.	  coli	  and	  mycobacterial	   species	  due	   to	   the	  presence	  of	  both	   -­‐10	  
and	   -­‐35	  promoter	  elements,	  making	   it	  a	  promising	  candidate	   for	   the	   in	  vitro	   transcription	  
system	  (Arnvig	  et	  al.	  2005).	  	  
An	   M.	  smegmatis	   rrnB	   P1	   promoter	   (PrrnB)	   fragment	   spanning	   -­‐80	   to	   -­‐1	  bp	   of	   the	   PrrnB	  
transcription	  start	  site	  (TSS)	  was	  fused	  with	  +1	  to	  +176	  of	  the	  riboswitch	  (relative	  to	  the	  rpfB	  
P1	  TSS).	   The	  entire	   construction	  was	   cloned	   into	   the	   sub-­‐cloning	   vector	  pGEM	   (Promega).	  
Initially	   the	   template	   was	   isolated	   and	   purified	   by	   restriction	   digestion,	   however	   this	  
resulted	  in	  an	  abundance	  of	  non-­‐specific	  transcripts,	  likely	  due	  to	  the	  presence	  of	  cleavage	  
overhangs	   (Artsimovitch	  &	   Santangelo	   2015).	   Subsequently	   templates	  were	   generated	   by	  
PCR	   amplification.	   Preliminary	   experiments	   indicated	   the	   PrrnB	   promoter	   was	   poorly	  
recognised	  by	  E.	  coli	  holoenzyme	  as	  non-­‐specific	  ‘end-­‐to-­‐end’	  transcription	  of	  the	  template	  
occurred	  frequently	  (see	  Appendix	  Figure	  10.VI).	  Consequently	  the	  promoter	  was	  modified	  
to	   include	   an	   extended	   -­‐10	   element	   with	   the	   ‘TGN’	   motif	   (Agarwal	   &	   Tyagi	   2003;	   Ruff,	  
	  Optimisation	  of	  a	  riboswitch	  in	  vitro	  transcription	  system	  |	  117	  
Record	   &	   Artsimovitch	   2015)	   substituting	   ‘ACGTAACTT’	   with	   ‘tggTAACTT’	   to	   enhance	  
promoter	  activity	  (Arnvig	  2001).	  The	  extended	  -­‐10	  PrrnB	  template	  demonstrated	  significantly	  
reduced	  non-­‐specific	  transcription	  and	  increased	  promoter	  specificity	  (see	  Appendix	  Figure	  
10.VII).	   Moreover,	   a	   substantial	   proportion	   of	   transcripts	   generated	   were	   approximately	  
~130	  nt	  long,	  indicating	  probable	  riboswitch-­‐mediated	  attenuation	  as	  this	  size	  corresponded	  
with	  the	  sequence	  of	  the	  riboswitch.	  The	  presence	  of	  a	   large	  discrete	  signal	  also	  indicated	  
transcription	  read-­‐through	  as	  template	  run-­‐off.	  	  
It	   was	   hypothesised	   that	   addition	   of	   candidate	   ligand	   could	   affect	   a	   shift	   in	   signal	   from	  
attenuation	   to	   read-­‐through	   as	   run-­‐off	   if	   the	   ligand	   were	   recognised	   by	   the	   riboswitch.	  
Following	   the	   discovery	   of	   the	   rpfB-­‐ksgA	   bi-­‐cistron	   described	   in	   previous	   chapters	   (see	  
section	  4.2)	  it	  was	  thought	  the	  riboswitch	  might	  be	  more	  closely	  associated	  with	  regulation	  
of	   the	  methyltransferase	   ksgA	   than	   rpfB.	   Therefore	   SAM,	   the	   essential	   co-­‐factor	   of	   KsgA,	  
was	   selected	   as	   a	   rational	   candidate	   ligand	   for	   initial	   screening.	   However,	   reactions	  with	  
SAM	   indicated	   ligand	   addition	   had	   a	   deleterious	   effect	   on	   transcription	   initiation2,	   with	  
transcription	  substantially	  decreased	  across	  all	  concentrations	  of	  SAM	  tested	  (see	  Appendix	  
Figure	  10.VIII).	  Therefore	  a	  system	  was	  developed	  where	  candidate	   ligand	  could	  be	  added	  
to	  reactions	  after	  initiation.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
2	  Personal	  communication,	  Dr	  Wade	  C.	  Winkler,	  University	  of	  Maryland	  (2016).	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7.2.2 Single-­‐round	  transcription	  of	  the	  rpfB	  riboswitch	  
Withholding	   any	   given	   rNTP	   from	   a	   transcription	   reaction	   allows	   the	   formation	   of	   halted	  
transcription	  elongation	   complexes	   (TECs)	   that	   stall	   upon	  encountering	   the	   corresponding	  
template	  base	  for	  which	  rNTP	  is	  unavailable.	  The	  ability	  to	  halt	  TECs	  allows	  multiple	  aspects	  
of	   in	   vitro	   transcription	   reactions	   to	   be	   modulated	   without	   affecting	   initiation	   (Landick,	  
Wang	  &	  Chan	  1996;	  Grundy,	  Winkler	  &	  Henkin	  2002;	  Sudarsan	  et	  al.	  2003;	  Wickiser	  et	  al.	  
2005):	  	  
§ Radiolabelled	   nucleotide	   can	   be	   utilised	   during	   initiation	   and	   subsequently	   out-­‐competed	   with	   high	  
concentrations	   of	   non-­‐labelled	   nucleotide	   during	   elongation,	   effectively	   end-­‐labelling	   transcripts.	  
Uniform	   radiolabelling	   allows	   accurate	   detection	   of	   different	   sized	   transcripts,	   rather	   than	   biasing	  
detection	  towards	  longer	  transcripts,	  which	  have	  more	  radiolabelled	  nucleotide	  incorporated.	  	  
§ High	   concentrations	   of	   heparin	   can	   be	   added	   to	   the	   halted	   TECs	   without	   affecting	   initiation.	   Any	  
dissociated	   RNAP	   will	   be	   unable	   to	   re-­‐initiate,	   limiting	   reactions	   to	   single-­‐round	   transcription.	   As	   a	  
result,	  transcripts	  are	  representative	  of	  single	  transcription	  events.	  	  
§ The	   concentration	   of	   the	   full	   complement	   of	   rNTPs	   can	   be	   varied	   to	   affect	   TEC	   processivity	   as	  
elongation	  resumes.	  Moreover,	  transcription	  is	  resumed	  as	  a	  synchronised	  event,	  allowing	  samples	  to	  
be	  taken	  chronologically	  as	  a	  time-­‐course.	  	  
§ Transcription	   can	   be	   initiated	   with	   high	   concentrations	   of	   dinucleotide	   corresponding	   to	   +1	   and	   +2	  
positions	  of	  the	  template	  TSS.	  This	  allows	  substantially	  increased	  initiation	  efficiency	  as	  the	  dinucleotide	  
increases	   stability	   of	   initiating	   RNAP	   and	   specificity	   to	   the	   desired	   TSS	   (Phillips	   et	   al.	   2001).	   Low	  
concentrations	   of	   rNTPs	   during	   initiation	   also	   serve	   to	   reduce	   read-­‐through	   beyond	   the	   stall	   site	   by	  
decreasing	  TEC	  processivity	  (Artsimovitch	  &	  Santangelo	  2015).	  	  
§ Reactions	   can	   be	   initiated	   as	   a	   batch	   so	   that	   halted	   TEC	   aliquots	   can	   be	   used	   individually	   to	   reduce	  
variability	   between	   reactions.	   Thus,	   candidate	   ligand	   or	   transcription	   factors	   can	   be	   added	   to	   the	  
reactions	  and	  allowed	  to	  interact	  without	  affecting	  initiation	  before	  resuming	  elongation.	  
The	  formation	  of	  stable	  halted	  TECs	  requires	  at	  least	  10	  nt	  of	  initially	  transcribed	  sequence	  
(Landick,	  Wang	   &	   Chan	   1996;	   Artsimovitch	   &	   Henkin	   2009).	   As	   the	   riboswitch	   sequence	  
utilises	   all	   four	   bases	  within	   the	   first	   6	  nt,	   the	   template	   required	  modification	   to	  make	   it	  
suitable	   for	   the	   formation	  of	  halted	  TECs.	   Through	   careful	   scrutiny,	   the	  addition	  of	   a	  5	  nt	  
‘GTAAA’	  sequence	  to	  the	  5’end	  of	  the	  riboswitch	  sequence	  was	  devised	  to	  increase	  initially	  
transcribed	  sequence	  length.	  The	  addition	  of	  5’GTAAA	  showed	  no	  change	  to	  the	  predicted	  
structural	  modelling	  (Zuker	  2003)	  of	  either	  riboswitch	  conformation	  (see	  Figure	  7.I).	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Figure	  7.I	  5’modified	  riboswitch	  conformations	  
Predicted	  structural	  modelling	  of	  the	  riboswitch	  modified	  for	  the	  formation	  of	  halted	  transcription	  elongation	  
complexes	  with	  the	  addition	  of	  ‘GTAAA’	  to	  the	  5’terminus.	  Identical	  red	  and	  green	  sequences	  highlighted	  for	  
comparison.	  Mutation	  sites	  highlights	  in	  purple	  for	  comparison.	  
With	  the	  addition	  of	   the	  5’GTAAA	  sequence	  to	  the	  template,	  UTP	  could	  be	  withheld	   from	  
reactions	  initiated	  with	  GpU	  dinucleotide	  to	  halt	  transcription	  at	  U+11	  (U+6	  relative	  to	  rpfB	  
P1	  TSS).	  Whilst	  this	  would	  yield	  a	  very	  short	  initially	  transcribed	  sequence,	  more	  substantial	  
modification	  would	  only	  further	  increase	  probability	  of	  affecting	  the	  riboswitch	  structure	  or	  
function.	  Therefore	  the	  5’GTAAA	  sequence	  was	  added	  to	  the	  template	  between	  the	  PrrnB	  TSS	  
and	  riboswitch	  5’terminus.	  The	  template	  was	  subsequently	  used	  to	  generate	  halted	  TECs	  in	  
an	   in	  vitro	   transcription	  reaction	  as	  described	   in	   (see	  section	  2.9),	  withholding	  UTP	  during	  
initiation	   and	   radiolabelling	   with	   32P-­‐αATP.	   With	   the	   5’GTAAA	   additional	   sequence	   the	  
revised	   template	  was	   theoretically	   capable	  of	   riboswitch-­‐mediated	  attenuation	  at	  ~130	  nt	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Figure	  7.II	  in	  vitro	  transcription	  with	  ligand	  candidates	  
Single-­‐round	   in	  vitro	   transcription	  of	   the	   riboswitch	  using	  core	  E.	   coli	  RNAP	  and	  holoenzyme	  with	  candidate	  
ligand.	   From	   left	   to	   right:	   300	  μM	   S-­‐adenosyl-­‐L-­‐methionine	   (SAM),	   200	  μM	   L-­‐methionine,	   200	  μM	  
L-­‐homocysteine,	   200	  μM	   S-­‐adenosyl-­‐L-­‐homocysteine	   (SAH),	   200	  μM	   folate	   in	   1	   M	   NaOH,	   and	   1	  M	   NaOH	  
control.	   Reactions	  were	   carried	  out	   at	   37°C	  with	  17	  nM	  E.	   coli	   RNAP	   (NEB),	   initiated	  with	  GpU	  dinucleotide	  
(IBA),	   labelled	   with	   32P-­‐αUTP	   (Perkin	   Elmer),	   limited	   to	   single-­‐round	   transcription	   with	   200	  ng/μL	   heparin.	  
Elongation	  was	  resumed	  with	  10	  μM	  rNTPs,	  incubating	  for	  20	  min	  before	  stopping	  reactions	  with	  the	  addition	  
of	   formamide	   loading	   dye.	   Template	   amplified	   with	   oligonucleotides	   5.31	   and	   5.23	   (see	   Appendix	   section	  
10.3).	  
To	   confirm	   promoter	   specificity,	   the	   template	   was	   tested	   with	   E.	   coli	   core	   RNAP	   (NEB).	  
Figure	   7.II	   shows	   neither	   the	   ~130	  nt	   attenuation	   or	   the	   191	  nt	   run-­‐off	   transcripts	   were	  
generated	  by	  core	  RNAP.	  Comparatively,	  the	  E.	  coli	  holoenzyme	  (core	  RNAP	  with	  E.	  coli	  σ70)	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there	  was	  a	  distinct	  absence	  of	  non-­‐specific	  transcripts,	  most	  likely	  achieved	  by	  dinucleotide	  
initiation	  and	  addition	  of	  high	  concentrations	  of	  heparin	  (200	  ng/µL)	  following	  initiation.	  	  
Unfortunately	  neither	  SAM	  nor	  any	  associated	  methyl	  cycle	  intermediate	  (Parveen	  &	  Cornell	  
2011)	   candidate	   ligand	   tested	   resulted	   any	   variation	   to	   the	   ratio	   of	  
attenuation:read-­‐through.	   Although	   SAM	   did	   not	   have	   any	   effect	   on	   attenuation,	   there	  
appeared	  to	  be	  transcripts	  specific	  to	  the	  addition	  of	  SAM.	  This	  was	  further	  investigated	  and	  
found	  to	  be	  due	  to	  an	  additional	  10	  nt	  of	  vector	  sequence	  on	  the	  3’terminus	  of	  the	  template	  
included	  to	  increase	  the	  size	  of	  run-­‐off	  transcripts.	  Subsequently	  the	  template	  was	  amplified	  
without	   the	   additional	   vector	   sequence,	   which	   abrogated	   these	   transcripts	   (data	   not	  
shown).	   The	   revised	   261	  bp	   template	   (shown	   in	   Figure	   7.III)	   demonstrated	  
riboswitch-­‐mediated	   attenuation	   at	   ~130	  nt	   and	   transcription	   read-­‐through	   as	   template	  
run-­‐off	  at	  181	  nt.	  	  
7.2.3 Addition	  of	  NusA	  reveals	  long-­‐lived	  pauses	  during	  riboswitch	  transcription	  
Co-­‐transcriptional	   ligand	  interaction	  can	  be	  very	   important	  for	  transcriptional	  riboswitches	  
(Wickiser	   et	   al.	   2005),	   with	   transcriptional	   pausing	   allowing	   correct	   folding	   of	   riboswitch	  
domains	   (Nechooshtan	   et	   al.	   2009;	   Frieda	   &	   Block	   2012;	   Perdrizet	   et	   al.	   2012).	   Discrete	  
pausing	  can	  also	   favour	   formation	  of	  one	   riboswitch	  conformation	  over	   the	  other,	  even	   if	  
less	   thermodynamically	   stable	   (Steinert	   et	   al.	   2017).	   In	   many	   instances,	   transcriptional	  
pausing	   is	   mediated	   by	   transcription	   factors,	   principally	   NusA	   which	   has	   been	   shown	   to	  
increase	  the	  frequency	  and	  duration	  of	  pausing	  (Artsimovitch	  &	  Landick	  2000).	  	  
In	  the	  presence	  of	  NusA	  reduced	  RNAP	  processivity	  could	  facilitate	  nascent	  RNA	  folding	  and	  
ligand	   binding	   during	   in	   vitro	   transcription	   of	   the	   rpfB	   riboswitch	   (Ha	   et	   al.	   2010).	  
Preliminary	   experiments	   indicated	   an	   optimum	   molar	   ratio	   of	   1:5	   E.	  coli	   holoenzyme	   to	  
recombinant	  E.	  coli	  NusA	  (NEB)	  respectively	   (see	  Appendix	  Figure	  10.IX).	  Subsequently	  the	  
riboswitch	  was	  transcribed	   in	  vitro	   in	  a	  batch	  single-­‐round	  reaction,	  adding	  NusA	  to	  halted	  
TECs	   prior	   to	   elongation.	   Aliquots	   were	   taken	   periodically	   over	   a	   20	   minute	   elongation	  
period	  and	  mixed	  with	   formamide	   loading	  dye	   to	   inhibit	   further	   transcription	   (see	  section	  
2.9).	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Figure	  7.III	  E.	  coli	  in	  vitro	  transcription	  time-­‐course	  
Single-­‐round	   in	  vitro	   transcription	  time-­‐course	   in	  the	  presence	  and	  absence	  of	  NusA.	  Reactions	  were	  carried	  
out	   at	   30°C	   to	   decrease	   processivity,	  with	   17	  nM	  E.	   coli	   RNAP	   (NEB),	   initiated	  with	  GpU	  dinucleotide	   (IBA),	  
labelled	  with	  32P-­‐αUTP	  (Perkin	  Elmer),	  limited	  to	  single-­‐round	  transcription	  with	  200	  ng/µL	  heparin.	  Reactions	  
were	  carried	  out	  ±	  85	  nM	  NusA	  (NEB).	  Elongation	  was	  resumed	  with	  25	  µM	  NTPs,	  incubating	  for	  up	  to	  20	  min	  
before	   stopping	   reactions	   with	   the	   addition	   of	   formamide	   loading	   dye.	   Template	   amplified	   with	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Figure	  7.III	  demonstrates	  the	  transcription	  of	  the	  riboswitch	  over	  time.	  Three	  intense	  bands	  
indicative	   of	   halted	   TEC	   abortive	   transcripts	   were	   observed	   at	   the	   bottom	   of	   the	   gels.	  
Abortive	   transcripts	   did	   not	   appear	   to	   resume	   elongation	   throughout	   the	   time-­‐course.	  
Above	  the	  abortive	  transcripts	  a	  series	  of	  discrete	  pauses	  occurred	  over	  the	  time-­‐course.	  As	  
expected,	  pausing	  was	   substantially	  enhanced	   in	   the	  presence	  of	  NusA.	   Long-­‐lived	  pauses	  
were	  identified	  at	  41	  and	  43	  nt	  (G+36	  and	  G+38	  less	  5’GTAAA),	  which	  increased	  in	  duration	  
5-­‐fold	  in	  the	  presence	  of	  NusA.	  
Two	  bands	  were	  visible	  at	  the	  site	  of	  the	  predicted	  terminator.	  The	  smaller	  of	  these	  bands	  
decreased	   in	   abundance	  over	   time,	   resulting	   in	   increased	   abundance	  of	   both	   the	   ~130	  nt	  
attenuation	   and	   181	  nt	   run-­‐off	   transcripts.	   This	   indicated	   terminator	   proximal	   pausing	   is	  
required	  prior	  to	  attenuation	  or	  read-­‐through,	  a	  pre-­‐requisite	  of	  intrinsic	  terminators	  which	  
require	   poly(U)	   tract	   pausing	   to	   facilitate	   hairpin	   formation	   (Zhang	   &	   Landick	   2016).	  
Collectively,	   the	   results	   indicated	  NusA	  might	  be	   required	   in	   vivo	   to	  enhance	  pausing	  and	  
hence	   facilitate	   folding	   of	   riboswitch	   intermediates	   within	   a	   timeframe	   permissive	   of	  
cognate	  ligand	  interaction.	  	  
7.2.4 Riboswitch	  mutants	  demonstrate	  a	  shift	  in	  conformational	  equilibrium	  in	  vitro	  
Through	  single	  point	  mutations	  the	  riboswitch	  conformational	  equilibrium	  can	  be	  shifted	  in	  
favour	  of	  transcription	  attenuation	  or	  read-­‐through	  (see	  section	  5.5).	  It	  was	  theorised	  that	  
the	  same	  mutations	  could	  be	  made	  to	  the	  transcription	  template	  to	  explore	  the	  effect	  on	  
riboswitch	   transcripts.	  Accordingly,	  mutations	  were	  made	   to	   the	   riboswitch	   sequence	  and	  
cloned	   into	   the	   template	   to	   form	   halted	   TECs.	   Separate	   mutations	   consisted	   of	   the	  
terminator	  conformation	  stabilising	  G112C	  (C+117	  relative	  to	  the	  PrrnB	  TSS),	  anti-­‐terminator	  
conformation	   stabilising	   U6C	   (C+11)	   and	   intrinsic	   terminator	   poly(U)	   tract	   disrupting	  
U117-­‐119A	  (U+122	  to	  U+124).	  Structural	  modelling	  predicted	  no	  change	  to	  the	  structure	  or	  
stable	  folding	  free	  energy	  with	  the	  required	  5’GTAAA	  addition	  (Zuker	  2003).	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Figure	  7.IV	  E.	  coli	  in	  vitro	  transcription	  of	  riboswitch	  mutants	  
Single-­‐round	   in	   vitro	   transcription	   of	   riboswitch	   conformational	  mutants.	   Left)	   the	  WT	   riboswitch	   template,	  
followed	  by	  the	  G112C	  terminator	  stabilising	  substitution,	  the	  U6C	  anti-­‐terminator	  stabilising	  substitution	  and	  
U117-­‐119A	   intrinsic	   terminator	   disrupting	   substitution.	   Right)	   templates	   with	   additional	   synB	   synthetic	  
terminator	  added	  downstream.	  Grey	  arrows	  denote	  G112C	  transcription	  artefact.	  Reactions	  were	  carried	  out	  
at	  30°C	  to	  decrease	  processivity,	  with	  17	  nM	  E.	  coli	  RNAP	  (NEB),	  initiated	  with	  GpU	  dinucleotide	  (IBA),	  labelled	  
with	  32P-­‐αUTP	   (Perkin	   Elmer),	   limited	   to	   single-­‐round	   transcription	  with	  200	  ng/µL	  heparin.	   Reactions	  were	  
carried	  out	   in	  the	  presence	  of	  85	  nM	  NusA	  (NEB).	  Elongation	  was	  resumed	  with	  25	  µM	  rNTPs,	   incubating	  for	  
20	  min	  before	  stopping	  reactions	  with	  the	  addition	  of	  formamide	  loading	  dye.	  Run-­‐off	  template	  amplified	  with	  
oligonucleotides	   5.31	   and	   5.23	   (see	   Appendix	   section	   10.3).	   Synthetic	   terminator	   template	   amplified	   with	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The	   mutant	   templates	   demonstrated	   definite	   variations	   in	   transcript	   abundance	   when	  
compared	   to	   the	   WT	   (see	   Figure	   7.IV,	   left).	   The	   poly(U)	   tract	   disrupting	   U117-­‐119A	  
substitutions	   indicated	   near	   complete	   disruption	   to	   riboswitch-­‐mediated	   attenuation	   at	  
~130	  nt.	  Similarly,	  the	  anti-­‐terminator	  conformation	  stabilising	  U6C	  substitution	  resulted	  in	  
decreased	   termination	   in	   favour	   of	   increased	   read-­‐through,	   albeit	   to	   a	   lesser	   extent.	  
Conversely,	   the	   intrinsic	   terminator	   stabilising	  G112C	  substitution	   resulted	   in	   substantially	  
increased	  attenuation	  generating	  multiple	  discrete	  attenuated	  transcripts,	  thought	  to	  be	  the	  
result	   of	   increased	   intrinsic	   termination	   efficiency.	   However,	   the	   G112C	   substitution	   also	  
exhibited	  a	  read-­‐through	  transcript	  much	  larger	  than	  any	  other	  template	  generated.	  	  
At	   approximately	   220	  nt,	   the	   G112C	   run-­‐off	   exceeded	   the	   theoretical	   maximum	   possible	  
run-­‐off	  by	  approximately	  40	  nt.	  This	  G112C	  run-­‐off	  artefact	  was	  similar	  in	  size	  to	  the	  261	  bp	  
dsDNA	  template.	  It	  was	  suggested3	  the	  artefact	  could	  be	  the	  result	  of	  32P-­‐αATP	  labelling	  of	  
template	   DNA	   as	   a	   minor	   activity	   of	   RNAP.	   A	   series	   of	   experiments	   were	   carried	   out	   to	  
explore	  the	  hypothesis:	  	  
§ The	  3’end	  of	  the	  transcription	  template	  was	  shortened	  by	  19	  bp	  so	  that	  template	  run-­‐off	  would	  occur	  
at	  162	  nt.	  Transcripts	  generated	  from	  this	  template	  decreased	  in	  size	  proportionally	  to	  the	  WT	  run-­‐off,	  
remaining	  approximately	  40	  nt	  longer	  than	  theoretically	  possible	  (see	  Appendix	  Figure	  10.X).	  	  
§ Following	   elongation	   and	   heat	   denaturation,	   transcription	   reactions	   were	   subjected	   to	   DNase	  
treatment	   to	   degrade	   any	   potentially	   labelled	   dsDNA	   template,	   but	   the	   G112C	   artefact	   remained	  
unaffected	  (see	  Appendix	  Figure	  10.XI).	  	  
§ RNAP	   was	   incubated	   with	   WT	   template	   with	   32P-­‐αATP	   in	   the	   absence	   of	   any	   other	   rNTPs	   for	  
20	  minutes	   to	   select	   for	   any	   potential	   template	   labelling	   activity,	   but	   no	   affect	   was	   observed	   (see	  
Appendix	  Figure	  10.XI).	  
§ Both	  template	  vectors	  as	  well	  as	  PCR	  amplified	  DNA	  templates	  were	  sequenced	  and	  found	  correct.	  	  
§ A	  transcription	   time-­‐course	  was	  carried	  out	  with	   the	  G112C	   template	  over	  a	  period	  of	  20	  minutes	   to	  
explore	  potential	  deviations	  in	  transcription	  pausing	  pattern	  (see	  Appendix	  Figure	  10.XII).	  The	  pausing	  
pattern	   appeared	   identical	   between	   the	   G112C	   and	   WT	   template	   up	   to	   the	   riboswitch	   intrinsic	  
terminator.	   Besides	   the	   differences	   between	   the	   WT	   ~130	  nt	   attenuation	   and	   discrete	   G112C	  
attenuated	  transcripts	   (Figure	  7.IV)	   there	  were	  no	  transcripts	   larger	  apart	   from	  discrepant	   the	  G112C	  
artefact.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
3	  Personal	  communication,	  Professor	  Nikolay	  Zenkin,	  Newcastle	  University	  (2017).	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Collectively,	  investigations	  indicated	  the	  G112C	  artefact	  was	  occurring	  within	  the	  rpfB	  5’UTR	  
between	  the	  riboswitch	  intrinsic	  terminator	  and	  the	  template	  3’terminus.	   It	  was	  therefore	  
decided	   that	   inclusion	   of	   a	   terminal	   synthetic	   terminator	   could	   negate	   requirement	   of	   a	  
template	  run-­‐off	  by	  using	  synthetic	  termination	  as	  an	  indication	  of	  riboswitch	  read-­‐though.	  
Czyz	   et	   al.	   (2014)	   demonstrated	   the	   synB	   synthetic	   terminator	   to	   be	   a	   strong	   intrinsic	  
terminator	   with	   both	   E.	  coli	   RNAP	   and	   recombinant	   Mycobacterium	   bovis	   BCG	   RNAP.	  
Therefore	   the	   synB	   synthetic	   terminator	   was	   cloned	   into	   the	   template	   3’terminus	   to	  
generate	   a	   revised	   302	  bp	   template	   theoretically	   capable	   of	   riboswitch-­‐mediated	  
attenuation	   at	   ~130	  nt,	   synthetic	   termination	   at	   211	  nt	   (according	   synB	   termination	  
described	  by	  Czyz	  et	  al.	  or	  possible	  template	  run-­‐off	  at	  222	  nt).	  
It	  was	   thought	   the	  presence	  of	  a	   terminal	   synthetic	   terminator	  would	   limit	   the	  maximum	  
transcript	  length	  of	  transcript,	  but	  the	  G112C	  artefact	  remained	  unaffected	  and	  produced	  a	  
synB-­‐terminated	   transcript	   approximately	   40	  nt	   longer	   than	   theoretically	   possible	   (see	  
Figure	  7.IV,	  right).	  It	  is	  probable	  the	  cause	  of	  the	  G112C	  artefact	  occurs	  between	  the	  site	  of	  
riboswitch-­‐mediated	   attenuation	   and	   synthetic	   termination.	   The	   process	   by	   which	   the	  
G112C	  artefact	  arises	  remains	  unknown	  (see	  section	  7.4).	  Regardless	  of	  the	  G112C	  artefact,	  
it	   is	   evident	   the	   riboswitch	   conformational	   mutants	   corroborated	   the	   results	   observed	  
in	  vivo	   (see	   section	   5.5).	   Both	   the	   anti-­‐terminator	   stabilising	   U6C	   and	   poly(U)	   tract	  
disrupting	  U117-­‐119A	  substitutions	  resulted	  in	  discernible	  decreases	  in	  riboswitch-­‐mediated	  
attenuation	   and	   increased	   read-­‐through.	   Together	   these	   results	   strongly	   indicate	   the	  
riboswitch	   intrinsic	   terminator	   is	   functional	   and	   sufficient	   to	   actuate	   riboswitch-­‐mediated	  
transcription	  attenuation.	  	  
7.2.5 Transcriptional	  road-­‐blocking	  validates	  intrinsic	  terminator	  function	  
A	   transcription	   road-­‐blocking	   assay	   was	   devised	   to	   ascertain	   whether	   the	   riboswitch	  
attenuated	  transcription	  through	  intrinsic	  termination	  or	  long-­‐lived	  transcriptional	  pausing.	  
The	   transcription	   template	  was	   biotinylated	   on	   the	   5’end	   of	   the	   antisense	   strand	   by	   PCR	  
amplification	  with	  a	  5’biotinylated	  reverse	  primer	   (see	  section	  2.9.2).	  Purified	  biotinylated	  
template	   was	   coupled	   to	   streptavidin	   coated	   magnetic	   beads	   (Invitrogen)	   to	   create	   a	  
biotin-­‐streptavidin-­‐bead	   conjugate.	   This	   conjugate	   presents	   a	   mechanical	   road-­‐block	   to	  
TECs,	  preventing	   template	   run-­‐off	   so	   that	   TECs	   to	   remain	  bound	   to	   the	   template	  without	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RNAP	  dissociating.	  However,	  TECs	  subject	  to	  intrinsic	  termination	  would	  dissociate	  from	  the	  
template	   releasing	   terminated	   transcript.	   Template-­‐bound	   TECs	   can	   be	   separated	   from	  
reaction	  supernatant	  using	  a	  strong	  magnet,	  allowing	  terminated	  transcripts	  to	  be	  isolated.	  	  
The	   261	  bp	   biotinylated	   template	   was	   theoretically	   capable	   of	   riboswitch-­‐mediated	  
attenuation	   at	   ~130	  nt,	   read-­‐through	   to	   the	   biotin-­‐streptavidin	   road-­‐block	   at	   ~166	  nt	  
assuming	  a	  30	  nt	  RNAP	  footprint	  with	  a	  7-­‐9	  nt	  DNA:RNA	  hybrid	  upstream	  from	  the	  centre	  of	  
the	   footprint	   (Darst	   2001;	   Greive	   &	   von	   Hippel	   2005;	   Frieda	   &	   Block	   2012)	   or	   possible	  
template	  run-­‐off	  at	  181	  nt	  if	  bead	  and	  template	  uncoupled	  during	  the	  reaction	  (see	  Figure	  
7.V).	   Reactions	   were	   carried	   out	   in	   the	   presence	   and	   absence	   of	   NusA	   which	   is	   known	  
enhance	   attenuation	   at	   intrinsic	   terminators	   (Ha	   et	   al.	   2010).	   Following	   a	   5	  minute	  
elongation	  period,	   reaction	   supernatant	   and	   template-­‐bound	  TECs	  were	   separated	  with	   a	  
strong	  magnet	  and	  isolated.	  Aliquots	  of	  un-­‐separated	  reactions	  were	  also	  taken	  as	  a	  control.	  
Although	  NusA	   did	   not	   appear	   to	   enhance	   intrinsic	   termination,	   Figure	   7.V	   demonstrates	  
~130	  nt	   attenuated	   transcript	  was	   detected	   in	   both	   supernatant	   samples	   (sup),	   indicating	  
riboswitch-­‐mediated	   intrinsic	   termination	   as	   released	   transcript.	   Conversely,	   pelleted	  
samples	  (pel)	  indicated	  some	  TECs	  remained	  bound	  to	  the	  bead-­‐coupled	  template	  collected	  
by	   the	  magnet,	   suggesting	  a	   long-­‐lived	  pause	  at	   the	   riboswitch.	  The	   road-­‐blocked	  ~166	  nt	  
transcript	   confirms	   TECs	   remained	   template-­‐bound.	   However,	   the	   presence	   of	   a	   larger	  
transcript	   at	   ~180	  nt	   indicated	   probable	   template	   run-­‐off,	   possibly	   due	   to	   template	  
uncoupling	  during	  the	  reaction	  as	  it	  was	  detected	  in	  both	  the	  supernatant	  and	  un-­‐separated	  
(mix)	  samples.	  At	  the	  bottom	  of	  the	  gel,	  halted	  TEC	  abortive	  transcripts	  were	  present	  in	  the	  
supernatant	  samples	  only,	  confirming	  these	  released	  transcripts	  were	  abortive	  products.	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Figure	  7.V	  E.	  coli	  in	  vitro	  transcription	  road-­‐blocking	  
Biotin-­‐streptavidin	  road-­‐blocking	  of	  single-­‐round	  in	  vitro	  transcription	  of	  the	  riboswitch.	  Left)	  reactions	  carried	  
out	  in	  the	  absence	  of	  NusA;	  supernatant	  (sup),	  pelleted	  magnet-­‐bound	  template	  (pel),	  un-­‐separated	  reaction	  
mixture	   (mix).	   Right)	   reactions	   carried	   out	   in	   the	   presence	   of	   NusA.	   Reactions	  were	   carried	   out	   at	   30°C	   to	  
decrease	   processivity,	   with	   17	  nM	   E.	   coli	   RNAP	   (NEB),	   initiated	   with	   GpU	   dinucleotide	   (IBA),	   labelled	   with	  
32P-­‐αUTP	  (Perkin	  Elmer),	  limited	  to	  single-­‐round	  transcription	  with	  200	  ng/µL	  heparin.	  Reactions	  were	  carried	  
out	   ±	  85	  nM	  NusA	   (NEB).	   Elongation	  was	   resumed	  with	   50	  µM	  rNTPs,	   incubating	   for	   5	  min	   until	   separating	  
reactions	  with	   strong	  magnet	   to	  harvest	   supernatant	  and	  pellet	   samples	  before	   stopping	   reactions	  with	   the	  
addition	  of	  formamide	  loading	  dye.	  Road-­‐blocked	  template	  was	  amplified	  with	  oligonucleotides	  5.44	  and	  8.43	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Collectively	   the	   road-­‐block	   assay	   results	   demonstrated	   the	   riboswitch	   attenuates	  
transcription	   through	   both	   intrinsic	   terminator	   and	   long-­‐lived	   pausing.	   However,	   the	  
riboswitch	   poly(U)	   tract	   is	   imperfect,	   containing	   an	   interrupted	   series	   of	   uracil	   residues.	  
Whilst	  this	  may	  be	  sufficient	  for	  intrinsic	  termination	  with	  mycobacterial	  RNAP,	  it	  may	  not	  
be	  as	  effective	  in	  terminating	  transcription	  with	  E.	  coli	  RNAP.	  	  
7.3 Preliminary	  application	  of	  M.	  tuberculosis	  RNAP	  
By	   using	   commercially	   manufactured	   E.	  coli	   enzyme	   as	   a	   consistent	   and	   highly	   purified	  
source	  of	  RNAP,	   it	  was	  possible	   to	  develop	  and	  optimise	   the	   in	   vitro	   transcription	  system	  
described	  above.	  However,	  as	  the	  riboswitch	  is	  encoded	  by	  mycobacteria	  it	  was	  desirable	  to	  
use	  a	  cognate	  in	  vitro	  transcription	  system.	  Recombinant	  M.	  tuberculosis	  RNAP	  holoenzyme	  
was	   generously	   provided	   by	   Professor	   Sivaramesh	   Wigneshweraraj	   (Imperial	   College	  
London).	   This	   enabled	   the	   preliminary	   application	   of	   M.	  tuberculosis	   to	   the	   in	   vitro	  
transcription	  system.	  	  
The	   recombinant	  M.	  tuberculosis	   RNAP	   was	   provided	   as	   a	   purified	   enzyme	   generated	   by	  
co-­‐expression	  in	  E.	  coli.	  The	  holoenzyme	  was	  essentially	  produced	  as	  described	  by	  Banerjee	  
et	   al.	   (2014)	   consisting	   of	  M.	  tuberculosis	   sigma	   factor	   (SigA)	   in	   complex	  with	   RNAP	   core	  
(α2ββ’)	  but	  lacking	  the	  rpoZ	  or	  omega	  (ω)	  subunit.	  Whilst	  this	  enzyme	  has	  been	  shown	  to	  be	  
transcriptionally	  functional	  (Banerjee	  et	  al.	  2014,	  2015;	  Sharma	  et	  al.	  2015;	  du	  Plessis	  et	  al.	  
2017),	  complex	  stability	  and	  function	  has	  been	  disputed	  in	  recent	  studies	  (see	  section	  7.4).	  
Nevertheless,	  M.	  tuberculosis	   RNAP	   subunits	   have	   been	   shown	   to	   have	   roughly	   only	   50%	  
conservation	  to	  E.	  coli	  subunits	  (du	  Plessis	  et	  al.	  2017).	  Therefore	  it	  was	  decided	  it	  would	  be	  
beneficial	   to	   experiment	   with	   transcription	   of	   the	   riboswitch	   using	   recombinant	  
M.	  tuberculosis	   RNAP,	   albeit	   lacking	   the	   ω	   subunit.	   The	   in	   vitro	   transcription	   system	  was	  
optimised	   for	   M.	  tuberculosis	   RNAP,	   identifying	   suitable	   nucleotide	   concentrations	   and	  
buffering	  conditions	  (see	  section	  2.10).	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7.3.1 M.	  tuberculosis	  RNAP	  recognises	  riboswitch	  conformational	  mutants	  
To	   complement	   experiments	   carried	   out	   using	   E.	  coli	   RNAP	   (see	   Figure	   7.IV)	   the	  
conformational	  equilibrium	  of	  the	  riboswitch	  was	  explored	  using	  M.	  tuberculosis	  RNAP.	  The	  
same	   mutant	   templates	   containing	   the	   terminator	   conformation	   stabilising	   G112C,	  
anti-­‐terminator	   conformation	   stabilising	   U6C	   and	   terminator	   poly(U)	   tract	   disrupting	  
U117-­‐119A	   substitutions	   were	   used	   to	   generate	   transcripts	   in	   single-­‐round	   in	   vitro	  
transcription	  reactions.	  
Figure	   7.VI	   demonstrates	   M.	  tuberculosis	   RNAP	   was	   capable	   of	   riboswitch-­‐mediated	  
termination,	   generating	   the	   same	   ~130	  nt	   transcript	   as	   observed	   using	   E.	  coli	   RNAP.	   In	  
comparison	   to	   E.	  coli	   RNAP	   (see	   Figure	   7.IV),	   the	   M.	  tuberculosis	   RNAP	   appeared	   to	  
recognise	  the	  riboswitch	  intrinsic	  terminator	  more	  efficiently.	  The	  terminator	  conformation	  
stabilising	   G112C	   substitution	   exhibited	   near	   complete	   termination	   whilst	   the	   intrinsic	  
terminator	   poly(U)	   tract	   disrupting	   U117-­‐119A	   substitutions	   resulted	   in	   near	   complete	  
read-­‐through.	  This	  strengthened	  the	  hypothesis	  that	  the	  E.	  coli	  RNAP	  is	  comparatively	   less	  
efficient	  at	  intrinsic	  termination	  at	  the	  riboswitch	  intrinsic	  terminator	  due	  to	  the	  imperfect	  
poly(U)	  tract.	  Unfortunately	  M.	  tuberculosis	  RNAP	  also	  produced	  the	  same	  G112C	  artefact,	  
generating	  a	   run-­‐off	   transcript	   longer	   than	   theoretically	  possible	   (grey	  arrow,	  Figure	  7.VI).	  
Regardless,	   this	   data	   further	   substantiates	   the	   conclusion	   that	   the	   riboswitch	   mediates	  
transcription	  through	  intrinsic	  termination	  to	  regulate	  downstream	  gene	  expression.	  
Interestingly,	   the	   reproducibility	   of	   the	   ~130	  nt	   riboswitch	   attenuated	   transcript	   and	  
template	   run-­‐off	   between	   the	   M.	  tuberculosis	   and	   E.	  coli	   holoenzymes	   indicated	  
transcription	   was	   singularly	   promoted	   at	   the	   PrrnB	   TSS	   in	   both	   systems.	   Whilst	   E.	  coli	  
promoter	  recognition	  requires	  both	  -­‐10	  and	  -­‐35	  elements,	  M.	  tuberculosis	  promoters	  often	  
have	   poor	   -­‐35	   element	   identity	   (Cortes	   et	   al.	   2013).	   As	   the	  M.	  tuberculosis	   holoenzyme	  
contains	  SigA	  for	  promoter	  recognition,	  a	  lack	  of	  any	  P2	  promoted	  transcripts	  suggests	  the	  
P2	   promoter	   likely	   requires	   additional	   transcription	   factors	   to	   allow	   initiation.	  Whilst	   it	   is	  
possible	  extended	  -­‐10	  PrrnB	  out-­‐competes	  P2,	  this	  finding	  supports	  previous	  observations	  of	  
the	   P2	   promoter	   in	   vivo	   where	   P2	   was	   found	   to	   have	   a	   much	   lower	   activity	   during	  
exponential	  growth	  phases	  compared	  to	  P1	  (see	  section	  5.2).	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Figure	  7.VI	  M.	  tuberculosis	  in	  vitro	  transcription	  of	  riboswitch	  mutants	  
Single-­‐round	   in	   vitro	   transcription	   of	   riboswitch	   conformational	  mutants.	   From	   left	   to	   right;	  WT	   riboswitch	  
template,	   followed	   by	   the	   G112C	   terminator	   stabilising	   substitution,	   the	   U6C	   anti-­‐terminator	   stabilising	  
substitution	  and	  U117-­‐119A	   intrinsic	  terminator	  disrupting	  substitution.	  Grey	  arrow	  denotes	  G112C	  artefact.	  
Reactions	  were	  carried	  out	  at	  37°C	  with	  400	  nM	  M.	  tuberculosis	  RNAP,	  initiated	  with	  GpU	  dinucleotide	  (IBA),	  
labelled	   with	   32P-­‐αUTP	   (Perkin	   Elmer),	   limited	   to	   single-­‐round	   transcription	   with	   200	  ng/µL	   heparin.	  
Elongation	  was	  resumed	  with	  200	  µM	  rNTPs,	  incubating	  for	  20	  min	  before	  stopping	  reactions	  with	  the	  addition	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7.3.2 M.	  tuberculosis	  exhibits	  a	  different	  transcriptional	  pausing	  pattern	  
Differences	  in	  polymerase	  processivity	  have	  been	  found	  to	  influence	  transcriptional	  pausing	  
and	   folding	   of	   nascent	   RNA,	   therefore	   it	   may	   be	   important	   to	   match	   riboswitches	   with	  
suitable	   polymerase	   for	   heterologous	   in	   vitro	   transcription	   systems	   (Steinert	  et	   al.	   2017).	  
Distantly	   related	   polymerases	   may	   generate	   or	   interact	   with	   intermediate	   nascent	   RNA	  
structures	  differently	  (Zhang	  &	  Landick	  2016).	  This	  could	  interfere	  with	  regulatory	  function	  
as	  aptamer	  folding	  may	  be	  co-­‐ordinated	  with	  ligand	  recognition	  or	  pausing	  may	  be	  required	  
for	   intrinsic	   termination.	   The	   riboswitch	   was	   transcribed	   in	   vitro	   in	   a	   batch	   single-­‐round	  
reaction	   using	   M.	  tuberculosis	   RNAP,	   taking	   aliquots	   periodically	   over	   a	   20	  minute	  
elongation	  period	  and	  mixed	  with	  formamide	  loading	  dye	  to	  inhibit	  further	  transcription.	  
Figure	  7.VII	  shows	  M.	  tuberculosis	  RNAP	  rapidly	  (<10	  seconds)	  transcribed	  to	  the	  end	  of	  the	  
template,	  as	   indicated	  by	  the	  abundance	  of	  synthetically	   terminated	  transcript	  at	  ~211	  nt.	  
By	   comparison,	   this	   is	  much	   faster	   than	   the	  E.	  coli	   time-­‐course	   (see	   Figure	  7.III),	   however	  
the	   E.	  coli	   RNAP	   was	   intentionally	   constrained	   to	   slow	   elongation	   rate,	   limiting	   available	  
rNTP	  concentration	  and	  decreasing	  reaction	  temperature	  to	  mimic	  the	  slower	  processivity	  
of	   the	   M.	  tuberculosis	   RNAP.	   Even	   in	   the	   absence	   of	   M.	  tuberculosis	   NusA,	   the	  
M.	  tuberculosis	  RNAP	  in	  vitro	  transcription	  system	  appears	  to	  be	  a	  more	  relevant	  system	  for	  
riboswitch	  transcription.	  On	  comparison,	  the	  41	  and	  43	  nt	  dominant	  pauses	  observed	  using	  
E.	  coli	   RNAP	   were	   completely	   absent	   in	   the	  M.	  tuberculosis	   RNAP	   reaction	   (grey	   arrows,	  
Figure	  7.VII).	  Rather	  a	  distinct	  long-­‐lived	  pause	  was	  seen	  at	  36	  nt	  (black	  arrow,	  Figure	  7.VII).	  
This	  discrepancy	  in	  pausing	  pattern	  indicated	  the	  riboswitch	  interacts	  differently	  with	  E.	  coli	  
and	  M.	  tuberculosis	  polymerases.	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Figure	  7.VII	  M.	  tuberculosis	  in	  vitro	  transcription	  time-­‐course	  
Single-­‐round	   in	   vitro	   transcription	   time-­‐course	   of	   the	   riboswitch.	   Grey	   arrows	   denote	   the	   41	   and	   43	  nt	  
dominant	   pauses	   observed	   with	   E.	  coli	   RNAP	   in	   Figure	   7.III.	   Black	   arrow	   denotes	   M.	  tuberculosis	   specific	  
pausing.	   Reactions	   were	   carried	   out	   at	   37°C,	   with	   400	  nM	   M.	  tuberculosis	   RNAP,	   initiated	   with	   GpU	  
dinucleotide	  (IBA),	  labelled	  with	  32P-­‐αUTP	  (Perkin	  Elmer),	  limited	  to	  single-­‐round	  transcription	  with	  200	  ng/µL	  
heparin.	   Elongation	  was	   resumed	  with	  200	  µM	  NTPs,	   incubating	   for	  up	   to	  20	  min	  before	   stopping	   reactions	  
with	   the	   addition	   of	   formamide	   loading	   dye.	   Synthetic	   terminator	   template	   amplified	  with	   oligonucleotides	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7.4 Chapter	  discussion	  
Using	  commercially	  produced	  E.	  coli	  holoenzyme,	  it	  was	  possible	  to	  develop	  and	  optimise	  an	  
in	  vitro	  transcription	  system	  capable	  of	  investigating	  the	  rpfB	  riboswitch	  regulatory	  control	  
mechanism	   at	   the	   transcriptional	   level.	   A	   template	   was	   devised,	   capable	   of	   pausing	  
transcription	   following	   initiation	   to	   allow	   the	   formation	   of	   halted	   TECs	   (Figure	   7.II).	   This	  
template	   demonstrated	   robust	   reproducibility	   and	   efficient	   promoter	   specific	   initiation	  
using	   the	   M.	  smegmatis	   ribosomal	   rrnB	   operon	   P1	   promoter	   with	   extended	   ‘TGN’	   -­‐10	  
element.	  By	  withholding	  UTP	  from	  reactions	  and	  initiating	  with	  GpU	  dinucleotide,	  TECs	  were	  
uniformly	  halted	  at	  U+11	  (U+6	  relative	  to	  rpfB	  P1	  TSS).	  Upon	  addition	  of	  the	  full	  complement	  
of	  rNTPs,	  halted	  TECs	  resumed	  elongation	  as	  a	  single-­‐round	  transcription	  event.	  	  
Synchronicity	   of	   transcription	  was	   exploited	   to	   explore	   TEC	  processivity	   during	   riboswitch	  
transcription	   over	   time.	   E.	  coli	   holoenzyme	   time-­‐course	   series	   identified	   a	   reproducible	  
transcriptional	  pausing	  pattern	  for	  the	  riboswitch	  (Figure	  7.III).	  Dominant	  long-­‐lived	  pauses	  
were	  observed	  at	  41	  and	  43	  nt	  (G+36	  and	  G+38	  relative	  to	  rpfB	  P1	  TSS).	  Intermediate	  41	  and	  
43	  nt	  transcript	  sequences	  were	  studied	  in	  structural	  models	  (data	  not	  shown),	  however	  no	  
strong	  secondary	  structures	  were	  predicted	  (Zuker	  2003),	  indicating	  these	  pauses	  are	  likely	  
caused	  by	  interaction	  with	  the	  E.	  coli	  RNAP	  itself.	  Indeed,	  when	  a	  similar	  time-­‐course	  series	  
was	  carried	  out	  using	  M.	  tuberculosis	  RNAP	  these	  41	  and	  43	  nt	  pauses	  did	  not	  occur,	  rather	  
a	  separate	  long-­‐lived	  pause	  was	  observed	  at	  36	  nt	  (Figure	  7.VII).	  	  
This	   discrepancy	   in	   pausing	   pattern	   highlights	   the	   importance	   of	   using	   a	   cognate	  
transcription	  system	  for	  riboswitch	  investigation.	  E.	  coli	  RNAP	  subunits	  have	  been	  shown	  to	  
have	   roughly	   only	   50%	   conservation	  with	  M.	  tuberculosis	   subunits	   (du	  Plessis	  et	   al.	   2017)	  
which	  exhibits	  a	   lower	  processivity	   than	  E.	  coli	   (Herrera-­‐Asmat	  et	  al.	   2017).	  Template	  and	  
transcript	   nucleotide	   composition	   can	   also	   influence	   pause	   duration	   (Zhang	   &	   Landick	  
2016).	   This	   is	   an	   important	   consideration	  when	  using	  polymerase	   from	  E.	  coli,	   a	   relatively	  
A:T	   rich	   organism,	   to	   transcribe	   a	   G:C	   rich	   riboswitch.	   Not	   only	   can	   varied	   processivity	  
influence	   transcriptional	   pausing	   and	   folding	   of	   nascent	   RNA,	   but	   distantly	   related	  
polymerases	   can	   interact	   differently	  with	   nascent	   RNA	   structures	   (Zhang	  &	   Landick	   2016;	  
Steinert	  et	  al.	  2017).	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In	  this	  study,	  rNTP	  concentration	  and	  reaction	  temperature	  were	  purposely	  constrained	  to	  
simulate	  reduced	  processivity	  with	  E.	  coli	  RNAP.	  This	  was	  somewhat	  successful,	  producing	  a	  
series	   of	   discrete	   transcriptional	   pauses	   that	  were	   further	   enhanced	  with	   the	   addition	   of	  
NusA	   (Figure	   7.III),	   a	   transcription	   factor	   known	   to	   increase	   duration	   of	   pausing	  
(Artsimovitch	   &	   Landick	   2000).	   However,	   as	  M.	  tuberculosis	   RNAP	   produced	   a	   different	  
pausing	  pattern,	  the	  relevance	  of	  these	  E.	  coli	  RNAP	  pauses	  is	  contentious,	  especially	  if	  they	  
represent	   different	   intermediate	   nascent	   RNA	   structures.	   For	   riboswitches	   especially,	  
folding	  intermediates	  can	  be	  crucial	  for	  ligand	  interaction	  (Nechooshtan	  et	  al.	  2009;	  Frieda	  
&	  Block	  2012;	  Perdrizet	  et	  al.	  2012).	  	  
Nevertheless,	   with	   application	   of	   NusA,	   E.	  coli	   RNAP	   demonstrated	   a	   decreased	  
transcription	  rate.	  Co-­‐transcriptional	  ligand	  interaction	  can	  be	  important	  for	  transcriptional	  
riboswitches	  and	   influenced	  by	  elongation	  rate	  (Wickiser	  et	  al.	  2005).	  A	  1:5	  molar	  ratio	  of	  
E.	  coli	  NusA	  was	  added	  to	  the	  M.	  tuberculosis	  RNAP	  time-­‐course	  in	  an	  attempt	  to	  replicate	  
this	   effect	   (data	   not	   shown).	   Whilst	   the	   RNAP	   interacting	   N-­‐terminal	   of	   NusA	   is	   well	  
conserved	  between	   the	   two	  species,	   the	  C-­‐terminal	   is	  quite	  different	   (Arnvig	  et	  al.	   2004).	  
Consequently,	  E.	  coli	  NusA	  did	  not	  decrease	  M.	  tuberculosis	  RNAP	  processivity.	   In	   future	   it	  
would	   be	   beneficial	   to	   purify	   M.	  tuberculosis	   NusA,	   which	   would	   be	   more	   biologically	  
relevant	  to	  M.	  tuberculosis	  RNAP.	  As	  a	  homologous	  in	  vitro	  transcription	  system	  this	  would	  
likely	  facilitate	  nascent	  RNA	  folding	  to	  affect	  pausing	  and	  termination	  (Beuth	  et	  al.	  2005).	  	  
Despite	   the	  discrepant	  pausing	  patterns	  observed,	   the	   riboswitch	  conformational	  mutants	  
demonstrated	   both	   enzymes	   were	   capable	   of	   recognising	   the	   riboswitch	   sequence	   to	  
generate	   similar	   transcripts.	   Comparing	   the	   E.	  coli	   RNAP	   results	   (Figure	   7.IV)	   with	   the	  
M.	  tuberculosis	   (Figure	   7.VI),	   both	   polymerases	   recognised	   the	   riboswitch	   intrinsic	  
terminator	  to	  yield	  identical	  ~130	  nt	  attenuated	  transcripts.	  In	  both	  systems,	  the	  terminator	  
conformation	   stabilising	   G112C	   substitution	   (C+117	   relative	   to	   the	   PrrnB	   TSS)	   resulted	   in	  
increased	   attenuation	   and	   the	   intrinsic	   terminator	   poly(U)	   tract	   disrupting	   U117-­‐119A	  
substitution	  (U+122	  to	  U+124	  relative	  to	  the	  PrrnB	  TSS)	  resulted	  in	  increased	  read-­‐through.	  	  
Interestingly	   these	   trends	  were	   even	  more	   apparent	   in	   the	  M.	  tuberculosis	   system	  where	  
the	  G112C	  substitution	  resulted	  in	  near	  total	  attenuation	  and	  the	  U117-­‐119A	  substitution	  in	  
near	  total	  read-­‐though.	  This	  further	  highlights	  the	  need	  for	  a	  cognate	   in	  vitro	  transcription	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system.	   It	   is	   likely	   E.	  coli	   RNAP	   did	   not	   efficiently	   attenuate	   transcription	   at	   the	   intrinsic	  
terminator	   due	   to	   the	   imperfect	   poly(U)	   tract.	   Whereas	   M.	  tuberculosis	   RNAP	   is	   more	  
promiscuous	   and	   may	   terminate	   at	   imperfect	   poly(U)	   tracts	   of	   ≥4U	   residues,	   even	   if	  
subsequent	   nucleotides	   contain	   other	   bases	   (Czyz	   et	   al.	   2014),	   as	   in	   the	   rpfB	   riboswitch	  
(UUUUGCUUUUGUU).	  	  
The	   transcriptional	   road-­‐block	   assay	   (Figure	   7.V)	   established	   the	   proposed	   riboswitch	  
intrinsic	  terminator	  is	  functional	  and	  sufficient	  to	  actuate	  riboswitch-­‐mediated	  transcription	  
attenuation.	   Riboswitch	   attenuated	   transcript	   was	   detected	   in	   both	   the	   supernatant	   and	  
template-­‐bound	   fractions	   of	   the	   reaction,	   indicating	   attenuation	   occurs	   by	   both	   intrinsic	  
termination	   and	   long-­‐lived	   transcriptional	   pausing	   at	   the	   terminator.	   Given	   the	   inherent	  
instability	   that	  weak	  A:U	  basepairs	  of	   the	  DNA:RNA	   impose	  on	   the	  paused	   complex,	   such	  
long-­‐lived	   pause	   would	   likely	   result	   in	   further	   termination	   over	   time	   through	   RNAP	  
dissociation.	  	  
Although	  E.	  coli	  RNAP	  demonstrated	  NusA	  had	  no	  effect	  on	  intrinsic	  termination	  efficiency	  
(Figure	  7.V),	   it	  possible	  an	  effect	  could	  be	  observed	  using	  M.	  tuberculosis	  RNAP	  and	  NusA.	  
Alternatively,	   intrinsic	   termination	  might	   require	   additional	   transcription	   factors.	   NusG	   is	  
known	  to	  stabilise	  the	  RNAP	  clamp,	  increasing	  processivity	  to	  enhance	  intrinsic	  termination	  
through	  hyper-­‐translocation	  of	  nascent	  RNA	  from	  RNAP	  active	  site	  (Czyz	  et	  al.	  2014).	  RNAP	  
can	   freely	   utilise	   both	   NusA	   and	   NusG	   co-­‐operatively	   as	   they	   bind	   at	   different	   sites	  
(Artsimovitch	  &	  Landick	  2000).	  It	  may	  be	  that	  both	  of	  these	  factors	  are	  required	  for	  correct	  
processivity	  to	  fold	  the	  nascent	  RNA	  for	  ligand	  interaction	  or	  termination.	  
Despite	   extensive	   investigation,	   no	   explanation	   was	   found	   for	   the	   G112C	   transcription	  
artefact	  observed	  in	  both	  E.	  coli	  (Figure	  7.IV),	  and	  M.	  tuberculosis	  systems	  to	  a	  lesser	  extent	  
(Figure	  7.VI).	  In	  all	  instances,	  templates	  with	  the	  G122C	  substitution	  generated	  a	  transcript	  
approximately	   40	  nt	   longer	   than	   the	   theoretical	   possible	  maximum.	   Perhaps	   this	  was	   the	  
result	  of	  in	  vitro	  transcription	  in	  the	  absence	  of	  additional	  transcription	  factors.	  Time-­‐course	  
experiments	   showed	   that	   the	  WT	  and	  G122C	   templates	  exhibited	   identical	   transcriptional	  
pausing	  patterns	  (Appendix	  Figure	  10.XII),	  indicating	  the	  G112C	  artefact	  occurs	  downstream	  
of	   the	   riboswitch	   intrinsic	   terminator	   sequence.	   Potentially,	   non-­‐template	   nucleotide	  
incorporation	  could	  have	  occurred	  by	  backtracking	  following	  pausing.	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Long-­‐lived	   transcriptional	   pausing	   can	   induce	   backtracked	   transcription,	   a	  mechanism	   for	  
rescuing	  stalled	   transcription	  complexes	  whereby	  the	  nascent	  RNA	   is	   translocated	  out	   the	  
elongation	  complex	   through	  a	  polymerase	  secondary	  exit	   channel	   (Marr	  &	  Roberts	  2000).	  
Transcription	   factors	   GreA	   and	   GreB	   stimulate	   endonucleolytic	   cleavage	   of	   the	   extruded	  
RNA	  and	  transcription	  is	  subsequently	  resumed	  with	  the	  nascent	  RNA	  3’terminus	  within	  the	  
RNAP	   active	   site	   (Tetone	   et	   al.	   2017).	   Gre	   factor	   homologues	   have	   been	   identified	   in	  
mycobacteria	  (China	  et	  al.	  2012).	  In	  the	  absence	  of	  Gre	  factor,	  backtracking	  without	  nascent	  
RNA	   cleavage	   could	   have	   resulted	   in	   non-­‐template	   nucleotide	   addition,	   lengthening	   the	  
G112C	   transcript.	   However,	   adding	   additional	   factors	   to	   the	   transcription	   reaction	  would	  
only	  serve	  to	  increase	  system	  complexity	  for	  investigation	  of	  an	  experimental	  artefact	  that	  
likely	   bears	   little	   relevance	   in	   vivo,	   as	   demonstrated	   by	   the	   G112C	   reporter	   construct	   in	  
previous	  chapters	  (see	  section	  5.5).	  
With	  evidence	  indicating	  M.	  tuberculosis	  RNAP	  transcribes	  and	  interacts	  with	  the	  riboswitch	  
uniquely,	  it	  was	  decided	  the	  M.	  tuberculosis	  in	  vitro	  transcription	  system	  would	  be	  the	  more	  
relevant	   system	   to	   use	   for	   candidate	   ligand	   screening.	   Preliminary	   experiments	   were	  
conducted	   using	   the	  M.	  tuberculosis	   system	  with	   the	   candidate	   ligand	   SAM	  at	   a	   range	   of	  
concentrations	  but	  no	  change	   in	   riboswitch-­‐mediated	  attenuation	  was	  observed	   (data	  not	  
shown).	   Certainly	   this	   may	   indicate	   SAM	   is	   not	   recognised	   as	   ligand	   by	   the	   riboswitch,	  
despite	   rational	   reasoning.	   However,	   it	   may	   also	   accentuate	   inadequacies	   with	   the	  
M.	  tuberculosis	  system	  itself.	  	  
Recently	   Herrera-­‐Asmat	   et	   al.	   (2017)	   demonstrated	   omission	   of	   the	   ω	   subunit	   from	  
M.	  tuberculosis	  core	  polymerase	  results	  in	  complex	  degradation	  during	  protein	  purification,	  
incorrect	  subunit	  stoichiometry	  and	  β’	  subunit	  shearing	  (Herrera-­‐Asmat	  et	  al.	  2017).	  Whilst	  
complexes	  retained	  DNA	  binding	  capacity,	  transcriptional	  activity	  was	  limited.	  Therefore,	  in	  
the	   absence	   of	   the	   ω	   subunit,	   molar	   concentration	   of	   transcriptionally	   functional	   RNAP	  
cannot	  be	  accurately	  determined.	  In	  the	  present	  study,	  single-­‐round	  transcription	  reactions	  
with	  M.	  tuberculosis	  RNAP	  lacking	  the	  ω	  subunit	  exhibited	  varied	  processivity	  in	  preliminary	  
experiments	  whereby	  TECs	  took	  between	  10	  seconds	  to	  40	  minutes	  to	  transcribe	  the	  entire	  
template	   (data	   not	   shown).	   This	   is	   indicative	   of	   a	   heterologous	   polymerase	   preparation,	  
likely	  due	  to	  subunit	  degradation	  during	  protein	  purification	  (Herrera-­‐Asmat	  et	  al.	  2017).	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Although	  there	  is	  a	  precedence	  in	  literature	  for	  excluding	  ω	  during	  recombinant	  expression	  
(Banerjee	   et	   al.	   2014),	   subsequent	   studies	   have	   chosen	   to	   include	   it	   in	   core	   polymerase	  
expression	  (Herrera-­‐Asmat	  et	  al.	  2017;	  Lin	  et	  al.	  2017).	  Indeed	  there	  is	  increasing	  evidence	  
of	   its	   importance	   as	   part	   of	   the	   polymerase	   complex	   as	   deletion	   of	   rpoZ	   leads	   to	   β’	  
misfolding	   and	   degradation	   in	   M.	  smegmatis	   (Mathew	   et	   al.	   2005)	   and	   E.	  coli	   (Ghosh,	  
Ishihama	  &	  Chatterji	  2001).	   In	   rpoZ	  deletion	  strains	  of	  Staphylococcus	  aureus	  not	  only	  did	  
RNAP	  lacking	  the	  ω	  subunit	  exhibit	  decreased	  sigma	  factor	  recruitment	  specificity,	  but	  rpoZ	  
deletion	  was	  found	  to	  affect	  biofilm	  formation,	  stress	  adaptation	  and	  the	  stringent	  response	  
(Weiss	  et	  al.	  2017).	  	  
During	   transcription,	   nascent	   RNA	   experiences	   specific	   interactions	  with	   exit	   channel	   and	  
surface	   of	   RNAP	  which	  may	   in	   turn	   undergo	   transcriptional	   pauses	   necessary	   for	   correct	  
folding	  (Lutz	  et	  al.	  2014;	  Zhang	  &	  Landick	  2016).	  In	  the	  present	  study	  M.	  tuberculosis	  RNAP	  
and	  riboswitch	  nascent	  RNA	  appeared	  to	  interact	  uniquely,	  however	  results	  might	  be	  quite	  
different	  using	  M.	  tuberculosis	  RNAP	  inclusive	  of	  the	  ω	  subunit.	  For	  this	  reason,	  no	  further	  
candidate	  ligands	  were	  tested,	  as	  results	  of	  such	  assays	  would	  have	  been	  inconclusive.	  	  
For	   further	   experimentation	   in	   the	   future	   it	   would	   be	   essential	   to	   purify	   protein	   for	   the	  
entire	   canonical	   core	   polymerase	   (α2ββ’ω)	   as	   well	   as	   transcription	   factors,	   NusA	   in	  
particular.	   Following	   optimisation	   of	   such	   a	   system,	   candidate	   ligands	   could	   be	   explored,	  
principally	  SAM	  precursors/derivatives	  of	  the	  methyl	  cycle	  (Parveen	  &	  Cornell	  2011),	  as	  well	  
as	  other	  frequently	  identified	  riboswitch	  ligands	  such	  as	  nucleotide	  derivatives	  (Nelson	  et	  al.	  
2013;	  Kellenberger	  et	  al.	  2015;	  St-­‐Onge	  et	  al.	  2015)	  and	  cellular	  metabolites	  (Frieda	  &	  Block	  
2012;	  Polaski	  et	  al.	  2017).	  However,	  as	  a	  regulatory	  ‘on-­‐switch’,	  ligand	  identification	  for	  the	  
rpfB	  riboswitch	  may	  be	  more	  challenging,	  especially	  if	  the	  ligand	  is	  a	  secondary	  messenger	  
indirectly	  associated	  with	  downstream	  gene	  expression,	  which	  has	  proven	  to	  be	  the	  case	  for	  
some	  orphaned	  riboswitches	  (Meyer	  et	  al.	  2011).	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7.5 Chapter	  conclusion	  
In	   conclusion,	   a	   robust	   single-­‐round	   in	   vitro	   transcription	   assay	   has	   been	   developed	   and	  
optimised	  to	  evaluate	  the	  riboswitch	  mechanisms	  of	  regulatory	  control	  on	  a	  transcriptional	  
level.	   Conformational	   mutants	   have	   demonstrated	   yet	   further	   the	   capacity	   for	   the	  
riboswitch	   to	   affect	   transcription	   attenuation,	   likely	   through	   conformational	   switching.	  
Transcriptional	   road-­‐blocking	   established	   attenuation	   is	   achieved	   through	   intrinsic	  
termination	   and	   long-­‐live	   transcriptional	   pausing	   at	   the	   riboswitch	   intrinsic	   terminator.	  
Time-­‐course	   series	   demonstrated	   transcription	   of	   the	   riboswitch	   undergoes	   discrete	  
transcriptional	  pausing.	  Moreover,	  results	  indicated	  M.	  tuberculosis	  RNAP	  interacts	  uniquely	  
with	  the	  riboswitch,	  which	  may	  be	  crucial	  in	  cognate	  ligand	  identification	  in	  the	  future.	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8 Discussion	  and	  conclusions	  
8.1 Overall	  discussion	  
Mycobacterium	  tuberculosis	  can	  reactivate	  to	  develop	  active	  disease	  years	  after	  the	  primary	  
infection,	   which	   is	   thought	   to	   be	   achieved	   through	   resuscitation	   from	   dormancy	   by	  
resuscitation	   promoting	   factors	   (Rosser	   et	   al.	   2017).	   M.	  tuberculosis	   encodes	   five	  
resuscitation	   promoting	   factors	   rpf(A-­‐E).	   At	   present,	   only	   two	   riboswitches	   have	   been	  
described	   in	  M.	  tuberculosis;	   the	   cobalamin	   sensing	  metE	  methionine	   synthase	   riboswitch	  
(Warner	   et	   al.	   2007)	   and	   the	   c-­‐di-­‐AMP	   sensing4	  ydaO	   riboswitch	   homologue	   upstream	   of	  
rpfA	  (Block,	  Hammond	  &	  Breaker	  2010;	  Arnvig	  &	  Young	  2012;	  Nelson	  et	  al.	  2013;	  St-­‐Onge	  et	  
al.	  2015).	  The	  five	  M.	  tuberculosis	  Rpfs	  are	  thought	  to	  be	  functionally	  redundant	  to	  a	  certain	  
extent	   (Zhonghe	   &	   Zhang	   1999;	   Tufariello,	   Jacobs	   &	   Chan	   2004;	   Downing	   et	   al.	   2005;	  
Tufariello	   et	   al.	   2006),	   yet	   it	   is	   intriguing	   that	   two	   of	   the	   five	   rpfs	   genes	  have	   now	   been	  
found	   to	  be	  subject	   to	   riboswitch-­‐mediated	   regulation	  by	  very	  different	   riboswitches.	  The	  
work	   described	   in	   this	   thesis	   is	   the	   first	   instance	   of	   a	   riboswitch	   having	   been	   identified	  
upstream	  of	  rpfB	  in	  any	  species.	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
4	  Personal	  communication,	  Dr	  Galina	  V.	  Mukamolova,	  University	  of	  Leicester	  (2017).	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In	   previous	   chapters	   a	   novel	   transcriptional	   riboswitch	  was	   characterised	   upstream	   of	   an	  
rpfB-­‐ksgA	   bi-­‐cistron.	   This	   riboswitch	   appears	   be	   conserved	   in	   pathogenic	   species	   alone,	  
drawing	   a	   potential	   link	   to	   pathogenesis.	   Riboswitch-­‐mediated	   attenuation	  was	   observed	  
through	  northern	  blot	  analysis,	  mapped	  by	  3’rapid	  amplification	  of	  cDNA	  ends	  (RACE)	  and	  
manipulated	   both	   in	   vitro	   and	   in	   vivo.	   Transcriptional	   road-­‐blocking	   was	   used	   to	  
demonstrate	   this	   attenuation	   is	   achieved	   through	   intrinsic	   termination	   at	   the	   riboswitch	  
terminator.	   Moreover,	   in	   vitro	   transcription	   time-­‐course	   series	   revealed	   the	   riboswitch	  
interacts	   uniquely	   with	  M.	  tuberculosis	   RNA	   polymerase	   (RNAP)	   to	   generate	   a	   series	   of	  
discrete	  pauses	  that	  may	  be	  important	  for	  ligand	  binding	  or	  nascent	  RNA	  folding.	  	  
Structural	   modelling	   of	   the	   rpfB	   riboswitch	   predicts	   two	   possible	   conformations:	   a	  
terminator	   conformation	   and	   an	   anti-­‐terminator	   conformation	   (Zuker	   2003).	   The	   stable	  
folded	  free	  energy	  of	  these	  conformations	  predicts	  the	  riboswitch	  exists	   in	  the	  terminator	  
conformation	   by	   default,	   as	   a	   transcriptional	   ‘on-­‐switch’,	   where	   it	   is	   presumed	   ligand	  
interaction	   would	   enhance	   transcriptional	   read-­‐through.	   Close	   inspection	   of	   the	   two	  
conformations	  shows	  they	  operate	  under	  a	  paradigm	  of	   riboswitch	   function	  as	  a	  mutually	  
exclusive	   switch	   (Batey	   2011;	  Millman	   et	   al.	   2017).	   Formation	   of	   the	   intrinsic	   terminator	  
stem-­‐loop	  precludes	  the	  formation	  of	  the	  anti-­‐terminator	  conformation	  and	  vice	  versa	  (see	  
Figure	  8.I).	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Figure	  8.I	  a	  mutually	  exclusive	  switching	  mechanism	  
The	   top	   diagrams	   show	   the	   predicted	   rpfB	   riboswitch	   conformations	   with	   the	   stem	   region	   of	   the	   intrinsic	  
terminator	   stem-­‐loop	   highlighted	   in	   yellow	   (Zuker	   2003).	   The	   bottom	   diagram	   demonstrates	   how	   one	  
conformation	   precludes	   the	   formation	   of	   another	   in	   a	   riboswitch	  mutually	   exclusive	   switch	   (adapted	   from	  
Batey	  2011).	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Reverse	   transcription	   PCR	   (RT-­‐PCR)	   demonstrated	   co-­‐transcription	   of	   rpfB	   and	   ksgA	   in	  
Mycobacterium	   tuberculosis	   and	   Mycobacterium	   bovis	   BCG	   (see	   section	   4.2);	   therefore	  
pathogens	   that	  encode	  the	  riboswitch	  also	  subject	   this	  bi-­‐cistron	  to	   its	   regulatory	  control.	  
The	   function	   of	   the	   rpfB-­‐ksgA	   bi-­‐cistron	   is	   uncertain;	   perhaps	   it	   is	   a	   regulatory	   link	   that	  
enables	  a	  co-­‐ordinated	  restoration	  of	  active	  growth,	  achieved	  through	  resuscitation	  by	  the	  
RpfB	  cell	  wall	  hydrolase	  and	  ribosome	  biogenesis	  by	  the	  KsgA	  methyltransferase.	  Whilst	   it	  
has	   previously	   been	   observed	   that	   actinobacteria	   frequently	   encode	   a	   cell	   wall	   enzyme	  
proximal	  to	  ksgA	  (Ravagnani,	  Finan	  &	  Young	  2005),	  it	  remains	  unclear	  as	  to	  why	  pathogenic	  
mycobacteria	  would	  also	  encode	  riboswitch-­‐mediated	  regulation	  of	   this	  arrangement.	  The	  
rpfB	  riboswitch	  cognate	  ligand	  may	  be	  particularly	  relevant	  to	  pathogenesis.	  Perhaps	  it	  is	  a	  
host-­‐derived	  signal	  that	  indicates	  an	  opportunistic	  environment	  in	  which	  resuscitation	  from	  
dormancy	  would	  be	  beneficial	   to	   the	  pathogen.	   In	  Listeria	  monocytogenes	   the	  prfA	  5’UTR	  
thermosensor	  allows	  expression	  of	  virulence	  genes	  under	  such	  conditions,	  revealing	  the	  SD	  
sequence	   by	  melting	   at	   37°C	   inside	   the	   infected	   host	   (Johansson	  et	   al.	   2002).	   If	   the	   rpfB	  
riboswitch	  indicates	  host	  presence	  to	  mycobacteria,	  then	  it	  would	  crucial	  for	  future	  research	  
to	   focus	   on	   riboswitch	   expression	   within	   infection	   models	   such	   as	   macrophage	   tissue	  
culture	  or	  animal	  models.	  	  
Northern	   blot	   analysis	   of	  M.	  tuberculosis	   exponential	   growth	   phase	   total	   RNA	   indicated	  
roughly	  an	  equal	  ratio	  of	  riboswitch	  attenuation	  and	  read-­‐through	  in	  vivo	  (see	  section	  5.2).	  
As	   a	   predicted	   transcriptional	   ‘on-­‐switch’	   this	  would	   suggest	   the	   ligand	  might	   be	   present	  
during	   culture	   to	   a	   certain	   extent.	   Perhaps	   the	   ligand	   is	   therefore	   a	   secondary	   signalling	  
molecule	   that	   is	   up-­‐regulated	   by	   stimuli	   indicative	   of	   environments	   conducive	   to	  
resuscitation.	   Certainly	   this	   could	   account	   for	   some	   of	   the	   challenges	   that	   have	   been	  
encountered	  in	  attempting	  to	  identify	  the	  cognate	  ligand.	  Indeed	  it	  has	  been	  theorised	  that	  
several	  orphan	  riboswitches	  likely	  interact	  with	  secondary	  signalling	  molecules	  in	  the	  same	  
manner	  as	  c-­‐di-­‐AMP	  and	  c-­‐di-­‐GMP	  sensing	  riboswitches	  (Sudarsan	  et	  al.	  2008;	  McCown	  et	  
al.	  2017).	  	  
Dormant	  M.	  tuberculosis	  exhibit	  very	  thick	  heavily	  cross-­‐linked	  cell	  walls	  that	   likely	  restrict	  
the	   cells	   from	   normal	   division	   and	   growth.	   It	   is	   thought	   that	   action	   of	   resuscitation	  
promoting	  factors	  is	  required	  for	  digestion	  and	  restoration	  of	  normal	  cell	  wall	  homeostasis	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(Hett	  &	  Rubin	  2008).	  The	  RpfB	  cell	  wall	  hydrolase	  interacts	  with	  another	  hydrolase,	  RipA,	  for	  
increased	  digestion	  of	  the	  cell	  wall	  (Hett	  et	  al.	  2007).	  It	  has	  been	  shown	  that	  RpfB/RipA	  cell	  
wall	   digests	   can	   act	   as	   an	   extremely	   potent	   resuscitation	   signal	   for	   other	   dormant	  
mycobacteria	   (Nikitushkin	  et	  al.	  2015).	  Perhaps	   this	   is	  achieved	  through	  the	  generation	  of	  
secondary	   signalling	   molecules	   as	   digest	   fragments	   bind	   at	   the	   cell	   surface	   to	   the	   PknB	  
serine-­‐threonine	   kinase	   (Nikitushkin,	   Demina	   &	   Kaprelyants	   2016).	   Potentially	   such	  
secondary	   signalling	   molecules	   could	   be	   identified	   by	   the	   rpfB	   riboswitch	   as	   a	   signal	   of	  
neighbouring	  cells	  undergoing	  resuscitation	  to	  subsequently	  express	  rpfB-­‐ksgA.	  
An	   alternative	   theory	   that	   has	   been	   explored	   in	   this	   thesis	   is	   that	   the	   riboswitch	  may	   be	  
more	  applicable	   to	  ksgA	   expression	   rather	   than	   rpfB.	  As	  a	  methyltransferase	  KsgA	  utilises	  
S-­‐adenosyl-­‐L-­‐methionine	   (SAM)	   as	   an	   essential	   methyl	   donor	   for	   the	   methylation	   of	  
ribosomal	   rRNA	   (Connolly,	   Rife	   &	   Culver	   2008).	   Not	   only	   do	   mycobacteria	   encode	   an	  
increased	   number	   of	   SAM	   synthases	   and	  methyltransferases	   (Cole	   et	   al.	   1998;	   Berger	   &	  
Knodel	  2003),	  but	  they	  also	  use	  the	  molecule	  for	  biosynthesis	  of	  cell	  envelope	  mycolic	  acids	  
and	  adhesion	  modifications	  (Parveen	  &	  Cornell	  2011).	  Certainly	  it	  is	  feasible	  that	  SAM	  would	  
serve	   as	   an	   excellent	   indicator	   of	   advantageous	   growth	   conditions	   for	   the	   regulation	   of	  
resuscitation.	  Disappointingly,	  in	  vitro	  transcription	  of	  the	  riboswitch	  in	  the	  presence	  of	  SAM	  
did	   not	   show	   any	   changes	   in	   riboswitch-­‐mediated	   attenuation	   that	   would	   have	   been	  
indicative	  of	   ligand	   recognition	   (see	   section	  7.2.2).	   This	  may	  be	  because	   the	   riboswitch	   is	  
incapable	   of	   interacting	   with	   SAM,	   or	   perhaps	   in	   the	   absence	   of	   the	   ω	   subunit	   the	  
M.	  tuberculosis	   RNAP	   does	   not	   interact	   with	   nascent	   RNA	   in	   a	  manner	   that	   would	   allow	  
riboswitch	  interaction	  with	  SAM.	  This	  remains	  an	  area	  for	  future	  study.	  	  
Unlike	   the	   rpfB	   P1	   promoter,	   the	   P2	   promoter	   is	   encoded	   by	   both	   pathogens	   and	  
non-­‐pathogens.	  P2	  promoted	  transcripts	  are	  not	  subjected	  to	  the	  regulatory	  control	  of	  the	  
riboswitch	   that	   is	   encoded	   upstream.	   In	   this	   study,	   promoter	   fusions	   demonstrated	   P2	  
makes	   an	   unsubstantial	   contribution	   to	   rpfB	   expression	   during	   exponential	   growth	   in	  
M.	  tuberculosis	  (see	  section	  5.3).	  In	  addition,	  real-­‐time	  quantitative	  PCR	  (RT-­‐qPCR)	  of	  cDNA	  
generated	   from	  biofilm	  extracts	   showed	  P2	   expression	  might	  well	   be	   increased	   in	  mature	  
biofilms	  (see	  section	  6.5).	  Not	  only	  does	  it	  seem	  that	  expression	  from	  the	  P2	  promoter	  likely	  
requires	  the	  involvement	  of	  transcription	  factors	  or	  activators,	  but	  it	  appears	  that	  there	  are	  
some	  conditions	  under	  which	  mycobacteria	  express	  the	  rpfB-­‐ksgA	  bi-­‐cistron	  independently	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of	  riboswitch-­‐mediated	  regulation.	  Indeed,	  non-­‐pathogenic	  species	  do	  so	  in	  all	  conditions	  as	  
they	  encode	  neither	  the	  riboswitch	  nor	  the	  P1	  promoter.	  	  
The	   regulatory	   control	   the	   riboswitch	   enables	   is	   specific	   to	   a	   subset	   of	   pathogenic	  
mycobacteria,	   specifically	   the	  M.	  tuberculosis	   complex.	   Such	   tight	   regulation	   of	   the	   rpfB	  
locus	   is	   further	   controlled	   by	   the	   expression	   of	   a	   potential	   asRNA.	   Although	   it	   was	   not	  
possible	   to	   detect	   the	   asRNA	   by	   northern	   blot	   or	   map	   it	   with	   3’RACE,	   reporter	   fusions	  
indicated	   the	  Pas	  promoter	   to	  be	   transcriptionally	  active.	  Furthermore,	  RT-­‐qPCR	  of	  biofilm	  
cDNA	  demonstrated	  it	  has	  a	  relatively	  low	  expression	  (see	  section	  6.5).	  Perhaps	  the	  asRNA	  
functions	   to	   down-­‐regulate	   spurious	   riboswitch	   read-­‐through,	   either	   through	  
complementary	   basepairing	   as	   a	   regulatory	   asRNA	   or	   to	   reduce	   transcription	   through	  
polymerase	  clashing.	  An	  alternative	   theory	   that	  has	  been	  proposed	   in	   this	   thesis	   is	   that	   it	  
may	  serve	   to	  occlude	   the	   rpfB	   ribosome	  binding	  site	   (RBS)	   that	  has	  been	  verified	   through	  
translational	  reporters.	  RBS	  occlusion	  would	  present	  an	  additional	  translational	  checkpoint	  
for	  rpfB	  expression.	  Maybe	  under	  advantageous	  conditions	  the	  Pas	  promoter	  is	  repressed	  for	  
optimal	  riboswitch-­‐mediated	  expression,	  but	  activated	  under	  disadvantageous	  conditions	  to	  
rapidly	   down-­‐regulate	   rpfB	   translation	   through	   RBS	   occlusion.	   Re-­‐annotation	   of	   the	   rpfB	  
translation	   start	   codon	   from	  ATG	   to	   the	  upstream	  TTG	   in	  M.	  tuberculosis,	   as	   identified	   in	  
this	  study	  (see	  section	  3.2),	  allows	  for	  a	  more	  typical	  view	  of	  the	  rpfB	  5’UTR.	  The	  rpfB	  CDS	  
5’end	   is	  within	  a	   feasible	  distance	   from	  the	  verified	  RBS	  and	  makes	   the	  asRNA	  5’end	  well	  
placed	  for	  regulation	  of	  the	  region	  as	  described.	  	  
The	   riboswitch	   controls	   the	   expression	   of	   two	   classical	   drug	   targets	   involved	   in	   cell	   wall	  
homeostasis	   and	   ribosome	   biogenesis.	   Riboswitches	  make	   excellent	   drug	   targets	   as	   they	  
have	  evolved	   to	  bind	   a	   single	   cognate	   ligand	  with	   a	  high	   affinity	   and	   specificity	   using	   the	  
limited	  repertoire	  of	  RNA	  nucleotides	  for	  secondary	  structure	  (Blount	  &	  Breaker	  2006).	  As	  
such	   their	   capacity	   to	  mutate	   and	  develop	  antibiotic	   resistance	  without	   affecting	   cognate	  
ligand	  recognition	  is	  limited.	  The	  rpfB	  riboswitch	  therefore	  represents	  a	  highly	  selective	  drug	  
target,	   specific	   to	  pathogenic	  mycobacteria.	   Such	  a	   target	   could	  be	  used	   for	   rational	  drug	  
design,	  a	  development	  process	   largely	  absent	   for	  antimycobacterials	  currently	   (Kana	  et	  al.	  
2014).	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Treatments	   capable	   of	   repressing	   resuscitation	   from	   dormancy	   could	   be	   capable	   of	  
preventing	  the	  development	  of	  an	  active	  infection	  from	  latency.	  Indeed,	  an	  inhibitor	  of	  the	  
RpfB	  enzyme	  was	  recently	  described	  that	  is	  capable	  of	  significantly	  decreasing	  the	  ability	  of	  
M.	  tuberculosis	   to	  resuscitate	   (Demina	  et	  al.	  2017).	  The	  riboswitch	  described	   in	   this	   thesis	  
regulates	   the	   expression	   of	   both	   rpfB	   and	   ksgA	   at	   the	   transcriptional	   level.	   As	   a	  
transcriptional	   ‘on-­‐switch’	   it	   is	   presumed	   that	   ligand	   interaction	   would	   enhance	  
read-­‐through	   into	   downstream	   genes.	   Given	   the	   highly	   specific	   nature	   of	   riboswitches,	  
rational	   design	   of	   an	   inhibitor	   or	   competitor	   could	   therefore	   enable	   strong	   expression	  
inhibition.	  	  
In	   the	   absence	  of	   empirically	   validated	   riboswitch	   structures,	   the	   riboswitch	  may	   adopt	   a	  
rather	  different	  structure	  in	  the	  presence	  of	  bound	  ligand.	  It	  could	  therefore	  be	  contested	  
that	  the	  riboswitch	  might	  function	  as	  an	  ‘off-­‐switch’,	  terminating	  in	  the	  presence	  of	  ligand.	  
Although	  this	  seems	   improbable	  as	   termination	  was	  observed	  during	   in	  vitro	   transcription	  
reactions	   where	   it	   is	   unlikely	   any	   of	   the	   components	   present	   would	   serve	   as	   a	   ligand.	  
Nevertheless,	   as	   a	   transcriptional	   ‘off-­‐switch’	   the	   rpfB	   riboswitch	   could	   still	   represent	   a	  
viable	  drug	  target.	  In	  such	  a	  scenario	  ligand	  competitors	  could	  facilitate	  over-­‐expression	  of	  
the	   rpfB-­‐ksgA	   bi-­‐cistron,	   potentially	   preventing	   establishment	   of	   dormant	   populations	  
during	  infection.	  	  
Research	   within	   this	   study	   used	   basic	   techniques	   to	   explore	   individual	   aspects	   that	  
contribute	   to	   the	  expression	  of	   the	   rpfB	   locus	  as	  demonstrated	   in	  Figure	  8.II.	  Prior	   to	   this	  
study,	   global	   transcription	   start	   site	  mapping	   (TSSM)	  had	  been	  used	   to	   annotate	  putative	  
promoters	   for	   the	   region	   (Cortes	   et	   al.	   2013).	   These	   promoter	   elements	   have	   now	   been	  
verified	  through	  reporter	  fusions.	  Similarly,	  only	  the	  annotated	  ATG	  start	  codon	  of	  rpfB	  had	  
previously	   been	   investigated	   (Sharma	   et	   al.	   2015),	   but	   through	   translational	   start	   site	  
mapping	  (TLSM)	  this	  study	  has	  demonstrated	  the	  upstream	  TTG	  start	  codon	   is	  the	  correct	  
5’end	  of	  the	  CDS	  with	  a	  verified	  RBS	  upstream.	  Furthermore	  the	  theorised	  link	  between	  rpfB	  
and	   ksgA	   (Ravagnani,	   Finan	   &	   Young	   2005)	   has	   been	   substantiated	   through	   RT-­‐PCR	   and	  
identified	   as	   a	   bi-­‐cistron.	   All	   of	   these	   findings	   are	   very	   likely	   to	   be	   reciprocated	   in	   other	  
related	  mycobacteria	  species	  where	  the	  rpfB	  locus	  is	  highly	  conserved.	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Figure	  8.II	  diagrammatic	  summary	  of	  study	  findings	  
8.2 Future	  perspectives	  
Whilst	  this	  study	  has	  exposed	  many	  characteristics	  of	  the	  rpfB	  riboswitch	  that	  may	  qualify	  it	  
as	   a	   riboswitch,	   the	   only	   assured	   test	   of	   riboswitch	   function	   is	   to	   demonstrate	   ligand	  
dependent	   conformational	   switching.	   This	   can	  only	  be	  achieved	  with	   the	  discovery	  of	   the	  
cognate	  ligand.	  In	  future,	  with	  the	  use	  of	  M.	  tuberculosis	  NusA	  and	  canonical	  RNAP	  inclusive	  
of	  the	  ω	  subunit,	  the	  in	  vitro	  transcription	  system	  developed	  in	  this	  study	  could	  be	  used	  to	  
screen	   candidate	   ligands	   capable	   of	   affecting	   transcription	   attenuation	   at	   the	   riboswitch	  
intrinsic	  terminator.	  	  
Another	   approach	   that	   could	   be	   considered	   is	   the	   use	   of	   an	  M.	  tuberculosis	   transposon	  
mutant	  library.	  With	  each	  conditionally	  non-­‐essential	  gene	  knocked	  out	  through	  transposon	  
insertion,	  transposon	  libraries	  transformed	  with	  a	  riboswitch	  reporter	  fusion	  could	  indicate	  
increased	   or	   decreased	   riboswitch	   read-­‐through	   through	   β-­‐galactosidase	   expression	   on	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genes	   contributing	   to	   altered	   expression.	   Potentially	   this	   could	   reveal	   genes	   or	   pathways	  
associated	   with	   the	   ligand	   and	   allow	   for	   a	   more	   targeted	   application	   of	   the	   in	   vitro	  
transcription	  assay	  screening.	  	  
Further	  focus	  on	  structural	  probing	  of	  the	  riboswitch	  would	  allow	  additional	  constraints	  to	  
be	   applied	   to	   structural	  models	   to	   increase	   confidence	   in	   predicted	   structures.	   Structural	  
probing	  could	  also	  be	  carried	  out	  on	  discovery	  of	  the	  cognate	  ligand	  to	  identify	  riboswitch	  
regions	   crucial	   to	   ligand	   recognition.	   Such	   advancements	   would	   greatly	   aid	   the	   rational	  
development	  of	  inhibitors	  or	  competitors.	  
By	  targeting	  different	  regions	  of	  the	  rpfB	   locus	  for	  RT-­‐qPCR	  of	  the	  biofilm	  extract	  cDNA,	   it	  
was	  apparent	  that	  the	  P1	  and	  P2	  promoters	  likely	  contribute	  to	  the	  expression	  of	  rpfB	  under	  
different	  conditions.	  To	  further	  understand	  how	  rpfB	  is	  expressed	  it	  would	  be	  advantageous	  
to	  conduct	  RT-­‐qPCR	  on	  cDNA	  generated	  from	  multiple	  growth	  condition	  extracts.	  This	  would	  
help	   elucidate	   conditions	   conducive	   to	   resuscitation	   or	   conditions	   where	   the	  
riboswitch-­‐mediated	  regulation	  is	  bypassed	  by	  P2	  promoted	  transcription.	  
8.3 Overall	  conclusion	  
Overall,	  this	  work	  has	  identified	  a	  novel	  riboswitch	  that	  regulates	  expression	  of	  an	  rpfB-­‐ksgA	  
bi-­‐cistron	   at	   the	   transcriptional	   level	   through	   intrinsic	   termination.	   Only	   pathogenic	  
mycobacteria	   encode	   this	   riboswitch.	   This	   riboswitch	   regulation	   of	   resuscitation	   from	  
dormancy	   and	   ribosome	   biogenesis	   presents	   a	   strong	   candidate	   for	   the	   development	   of	  
antimycobacterial	  therapeutics.	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10.1 Constructs	  
Below	  is	  a	  detailed	  list	  of	  constructs	  employed	  in	  this	  study:	  
Construct	   Source	   Oligonucleotides	  
pGEM	   pGEM	  T-­‐easy	  II	  (Promega)	   -­‐	  
pCR4	  TOPO	   TOPO	  TA	  Cloning	  Kit	  with	  PCR4	  TOPO	  (Invitrogen)	   -­‐	  
pKA425	   (Moores	  et	  al.	  2017)	   -­‐	  
pKA425p	   pKA425	  with	  PCLI	  heterologous	  promoter	  (Moores	  et	  al.	  2017)	  
inserted	  between	  XbaI	  and	  HindIII	  restriction	  
3.64	  and	  3.65	  
pEJ414-­‐P1RpfB	   Translational	  fusion	  of	  rpfB	  from	  -­‐355	  bp	  upstream	  to	  +1087	  bp	  
downstream	  of	  the	  annotated	  ATG	  start	  codon.	  Following	  +1087	  bp	  
downstream	  of	  ATG	  (Miah	  2014)	  
-­‐	  
425L-­‐RpfB-­‐ATG	   pKA425	  translational	  fusion	  of	  RpfB	  from	  -­‐355	  bp	  upstream	  of	  and	  
including	  the	  annotated	  ATG	  start	  codon	  in	  fusion	  with	  lacZ	  
2.20	  and	  2.34	  
425L-­‐TLSM-­‐2	   425L-­‐RpfB-­‐ATG	  with	  single	  basepair	  deletion	  +151	  bp	  downstream	  of	  
the	  P1	  TSS	  
5.08	  and	  5.09	  
425L-­‐TLSM-­‐1	   425L-­‐RpfB-­‐ATG	  with	  single	  basepair	  deletion	  +191	  bp	  downstream	  of	  
the	  P1	  TSS	  
2.49	  and	  2.50	  
425L-­‐TLSM+1	   425L-­‐RpfB-­‐ATG	  with	  double	  basepair	  deletion	  in	  lacZ	  CDS	  at	  +139	  to	  
+140	  bp	  downstream	  of	  the	  ATG	  start	  codon	  
2.64	  and	  2.65	  
425L-­‐TLSM-­‐GTc	   425L-­‐RpfB-­‐ATG	  with	  GTG	  to	  GTc	  substitution	  +143	  bp	  downstream	  of	  
the	  P1	  TSS	  
5.17	  with	  2.40,	  and	  
5.16	  with	  2.73	  
425L-­‐TLSM-­‐TTa	   425L-­‐RpfB-­‐ATG	  with	  TTG	  to	  TTa	  substitution	  +179	  bp	  downstream	  of	  
the	  P1	  TSS.	  Disrupts	  TTG	  start	  codon	  
5.19	  with	  2.40,	  and	  
5.18	  with	  2.73	  
425L-­‐TLSM-­‐AaG	   425L-­‐RpfB-­‐ATG	  with	  ATG	  to	  AaG	  substitution	  +217	  bp	  downstream	  of	  
the	  P1	  TSS	  
2.70	  and	  2.71	  
425L-­‐TLSM-­‐RBS*	   425L-­‐RpfB-­‐ATG	  with	  GAGGTCGGGGA	  to	  ctccTCcccct	  substitution	  +156	  
to	  +166	  bp	  downstream	  of	  the	  P1	  TSS	  
2.74	  and	  2.75	  
425L-­‐RpfB-­‐RBSWterm	   425L-­‐RpfB-­‐ATG	  with	  G	  to	  C	  substitution	  +112	  bp	  downstream	  of	  the	  P1	  
TSS	  
2.79	  and	  2.80	  
425L-­‐RpfB-­‐RBSWanti	   425L-­‐RpfB-­‐ATG	  with	  U	  to	  C	  substitution	  +6	  bp	  downstream	  of	  the	  P1	  
TSS	  
5.02	  and	  5.03	  
425L-­‐RpfB-­‐RBSWdel	   425L-­‐RpfB-­‐ATG	  with	  deletion	  spanning	  +1	  bp	  to	  +127	  bp	  of	  the	  P1	  TSS	  	   5.37	  and	  5.38	  
425L-­‐RpfB-­‐RBSWpolA	   425L-­‐RpfB-­‐ATG	  with	  U	  to	  A	  substitutions	  at	  +117	  to	  +119	  bp	  
downstream	  of	  the	  P1	  TSS	  
5.33	  with	  2.40,	  and	  
5.32	  with	  2.73	  
425L-­‐RpfB-­‐P1*P2	   425L-­‐RpfB-­‐ATG	  with	  TAGGGT	  to	  cAGGGc	  substitution	  -­‐12	  to	  -­‐7	  bp	  
upstream	  of	  the	  P1	  TSS	  
8.37	  with	  2.40,	  and	  
8.36	  with	  2.73	  
425L-­‐RpfB-­‐P1P2*	   425L-­‐RpfB-­‐ATG	  with	  TACCGT	  to	  cACCGc	  substitution	  +68	  to	  +73	  bp	  
downstream	  of	  the	  P1	  TSS	  	  
8.39	  with	  2.40,	  and	  
8.38	  with	  2.73	  
425L-­‐RpfB-­‐P1*P2*	   425L-­‐RpfB-­‐P1*P2	  with	  TACCGT	  to	  cACCGc	  substitution	  +68	  to	  +73	  bp	  
downstream	  of	  the	  P1	  TSS	  
8.39	  with	  2.40,	  and	  
8.38	  with	  2.73	  
425S-­‐RpfB-­‐asRNA100	   pKA425	  transcriptional	  fusion	  of	  rpfB	  asRNA	  spanning	  -­‐100	  bp	  
upstream	  of	  the	  asRNA	  TSS	  to	  +2	  bp	  
2.68	  and	  2.69	  
425P-­‐KsgA-­‐25bp	   pKA425p	  translational	  fusion	  spanning	  -­‐25	  to	  +150	  bp	  downstream	  of	  
the	  ksgA	  ATG	  start	  codon,	  fused	  with	  lacZ	  	  
5.50	  and	  5.49	  
425P-­‐KsgA-­‐75bp	   pKA425p	  translational	  fusion	  spanning	  -­‐75	  to	  +150	  bp	  downstream	  of	  
the	  ksgA	  ATG	  start	  codon,	  fused	  with	  lacZ	  
8.01	  and	  5.49	  
425P-­‐KsgA-­‐1120bp	   pKA425p	  translational	  fusion	  spanning	  -­‐1120	  to	  +150	  bp	  downstream	  
of	  the	  ksgA	  ATG	  start	  codon,	  fused	  with	  lacZ	  
5.48	  and	  5.49	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10.2 In	  vitro	  transcription	  template	  vectors	  
Construct	   Characteristics	   Oligonucleotides	  
pGAMrrnX_haltRBSW	   pGEM	  containing	  M.	  smegmatis	  ribosomal	  rrnB	  P1	  
promoter	  spanning	  -­‐80	  to	  -­‐8	  bp	  of	  the	  TSS	  (Cortes	  et	  
al.	  2013;	  Moores	  et	  al.	  2017),	  inclusive	  of	  extended	  
‘TGN’	  -­‐10	  motif.	  GTAAA	  insertion	  downstream	  if	  P-­‐
rrnB	  TSS.	  Transcriptional	  fusion	  of	  +1	  to	  +176	  of	  the	  
rpfB	  P1	  TSS	  fused	  downstream	  of	  the	  GTAAA	  
insertion.	  The	  entire	  template	  was	  inserted	  within	  
T-­‐A	  cloning	  site.	  Construction	  resulted	  in	  a	  42	  bp	  
deletion	  of	  the	  pGEM	  backbone	  between	  the	  vector	  
NdeI	  restriction	  site	  and	  T-­‐A	  cloning	  site	  and	  was	  
therefore	  renamed	  pGAM	  
5.59	  and	  5.60	  (ext_rrnB),	  
5.15	  and	  5.23	  (RBSW),	  
5.79	  and	  5.23	  (halt)	  
pGAMrrnX_haltRBSWanti	   pGAMrrnX_haltRBSW	  with	  U	  to	  C	  substitution	  at	  
+11	  bp	  downstream	  of	  PrrnB	  TSS	  
8.03	  and	  5.23	  
pGAMrrnX_haltRBSWterm	   pGAMrrnX_haltRBSW	  with	  G	  to	  C	  substitution	  at	  
+117	  bp	  downstream	  of	  PrrnB	  TSS	  
5.79	  and	  5.23	  
pGAMrrnX_haltRBSWpolA	   pGAMrrnX_haltRBSW	  with	  U	  to	  A	  substitutions	  at	  
+122	  to	  124	  bp	  downstream	  of	  PrrnB	  TSS	  
5.79	  and	  5.23	  
pGAMrrnX_haltRBSW_STOP	   pGAMrrnX_RBSW	  with	  synB	  synthetic	  terminator	  
(Czyz	  et	  al.	  2014)	  inserted	  +186	  bp	  downstream	  of	  
the	  PrrnB	  TSS	  
8.44	  and	  8.45	  	  
pGAMrrnX_haltRBSWanti_STOP	   pGAMrrnX_haltRBSW_STOP	  with	  U	  to	  C	  
substitution	  at	  +11	  bp	  downstream	  of	  PrrnB	  TSS	  
8.44	  and	  8.45	  	  
pGAMrrnX_haltRBSWterm_STOP	   pGAMrrnX_haltRBSW_STOP	  with	  G	  to	  C	  
substitution	  at	  +117	  bp	  downstream	  of	  PrrnB	  TSS	  
8.44	  and	  8.45	  	  
pGAMrrnX_haltRBSWpolA_STOP	   pGAMrrnX_haltRBSW_STOP	  with	  U	  to	  A	  
substitutions	  at	  +122	  to	  124	  bp	  downstream	  of	  PrrnB	  
TSS	  
8.44	  and	  8.45	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10.3 Oligonucleotides	  
All	  oligonucleotides	  were	  commercially	  synthesised	  by	  Sigma,	  re-­‐suspending	  the	  lyophilised	  stock	  in	  
molecular	  grade	  H2O	  to	  100	  μM.	  	  
Number	   Sequence	   Use	  
1.48	   GTCCCATTCCGAACCCGGAAGCTAAGCCTGCCAGCGCCTGTCTC	   Northern	  
probe	  
2.07	   GCTGTCAACGATACGCTACGTAACGGCATGACAGTGTTTTTTTTTTTTTTTTTTTTTTTT	   3’RACE	  
2.09	   GCTGTCAACGATACGCTACGTAACGGC	   3’RACE	  
2.15	   ATTGGCCGGTTCGTTACC	   3’RACE	  	  
2.20	   GCAGTCGATCGTACGCTAGT	   Cloning	  
2.34	   ATATATCCATGGGTGATTGGGTCTGATGAA	   Cloning	  
2.40	   ACGAGGGGCATTCACACCAGATTG	   Cloning	  
2.49	   CAAACTTCATCAGACCCAATC	   Cloning	  
2.50	   TAAGTAGAGTCAACGCGC	   Cloning	  
2.64	   CGTTTTACAACGTCGTGACTGGGAA	   Cloning	  
2.65	   CGGGATCATCCATGGGTGATTG	   Cloning	  
2.68	   TAATAAGCTTCGCGTTGACTCTACTTACCAAAC	   Cloning	  
2.69	   ATTATCTAGACATAGCCACCGGCGAACG	   Cloning	  
2.70	   CCAATCACCCAAGGATGATCCCG	   Cloning	  
2.71	   GTCTGATGAAGTTTGGTAAGTAGAG	   Cloning	  
2.73	   GCAGTTTGAGGGGACGACGACAGTATC	   Cloning	  
2.74	   CCCCTTATAGCGCGTTGACTCTAC	   Cloning	  
2.75	   GAGGAGGGCAACACTCAACCACCT	   Cloning	  
2.79	   GTTTCGGAGGCCCCATTTTGCTTTTTG	   Cloning	  
2.80	   CTAGAGGCCCCACCCGTT	   Cloning	  
3.64	   CTAGACGCTGACCACCCCCAGAACCCGAAGTTGACTCAAGTTCATTGGACTTGGTACAGTGA	   Cloning	  
3.65	   AGCTTCACTGTACCAAGTCCAATGAACTTGAGTCAACTTCGGGTTCTGGGGGTGGTCAGCGT	   Cloning	  
5.02	   GATGCGCCAACGAGCGCGCCG	   Cloning	  
5.03	   CACCCTAGCCCATAAGCTCGG	   Cloning	  
5.08	   TTGCCGAGGTCGGGGATATAGC	   Cloning	  
5.09	   ACTCAACCACCTACACAGCGAAC	   Cloning	  
5.15	   ATTAACTAGTGCCAATGAGCGCGCCG	   Cloning	  
5.16	   GTTCGCTGTGTAGGTCGTTGAGTGTT	   Cloning	  
5.17	   AACACTCAACGACCTACACAGCGAAC	   Cloning	  
5.18	   GGGGATATAGCGCGTTAACTCTACTTACC	   Cloning	  
5.19	   GGTAAGTAGAGTTAACGCGCTATATCCCC	   Cloning	  
5.22	   CGCGCCGAGCGGCCCATAACACCCGCGCGCCGGAGTTGCTCCTGTCTC	   Northern	  
probe	  
5.23	   ATTACTCGAGCGCGCTATATCCCCGACC	   Cloning/IVT	  
template	  
5.31	   CATATGGGTGACCGCGTCTGA	   Cloning/IVT	  
template	  	  
5.32	   GGCCCAAAATGCTTTTTGTTCGCTG	   Cloning	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Number	   Sequence	   Use	  
5.33	   CAGCGAACAAAAAGCATTTTGGGCC	   Cloning	  
5.37	   GTTCGCTGTGTAGGTGGTTGAGTGTTGC	   Cloning	  
5.38	   GCATCCACCCTAGCCCATAAGCTCG	   Cloning	  
5.48	   ATTAAAGCTTGAGGTCGGGGATATAGCGCGTTG	   Cloning	  
5.49	   TAATCCATGGCAACCACCCGTCGCACCGTG	   Cloning	  
5.50	   ATTAAAGCTTGTCAAGGTTGGGGCGCCTGG	   Cloning	  







5.79	   ACTTACTAGTGTAAAGCCAATGAGCGCGCCGAGCGGCCCA	   Cloning	  
8.01	   ATTAAAGCTTCCTCGCCACCCGCGAAGAGC	   Cloning	  
8.03	   ACTTACTAGTGTAAAGCCAACGAGCGCGCCGAGCGGCCCA	   Cloning	  
8.04	   GTCTTGCGCCGCTGCGCGAA	   RT-­‐qPCR	  
8.06	   CGCGCTATATCCCCGACCTCG	   IVT	  template	  
amplification	  
8.07	   GGACCCAGGATGTGACGTTC	   RT-­‐qPCR	  
8.08	   TGCACACCACCGTAATACCC	   RT-­‐qPCR	  
8.09	   ATCTGCTTGTCGAGTTCCCG	   RT-­‐qPCR	  
8.10	   AGGGCGAGGTCTCATATCGA	   RT-­‐qPCR	  
8.11	   GAGCGGCCCATAACACCC	   RT-­‐qPCR	  
8.27	   CGGCAACACTCAACCACCTACACAG	   IVT	  template	  
amplification	  
8.36	   CTTATGGGCCAGGGCGGATGCGCCA	   Cloning	  
8.37	   TGGCGCATCCGCCCTGGCCCATAAG	   Cloning	  
8.38	   GCCGGTTCGTCACCGCCTTGTGATC	   Cloning	  
8.39	   GATCACAAGGCGGTGACGAACCGGC	   Cloning	  
8.43	   CCGCGTTGAAAAAAAAAAGCGCC	   IVT	  template	  
amplification	  
8.44	   TCGAGCGCCGCAACTGCGGCGCTTTTTTTTTTCAACGCGGATCCTAATAATCG	   Cloning	  
8.45	   AATTCGATTATTAGGATCCGCGTTGAAAAAAAAAAGCGCCGCAGTTGCGGCGC	   Cloning	  
8.53	   CGTTCGATCACAAGACGGTA	   RT-­‐qPCR	  
8.56	   TCAACATTGGCCGGTTCGTT	   RT-­‐qPCR	  
8.57	   GACTACCAGGCGCAACATCG	   RT-­‐qPCR	  
8.58	   TTATGGGCTAGGGTGGATGC	   RT-­‐qPCR	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10.4 Supplemental	  figures	  
	  
Figure	  10.I	  extended	  sequence	  alignment	  of	  rpfB	  promoter	  regions	  and	  5’UTR	  
Sequence	   alignment	   of	   M.	   tuberculosis	   (M.	  tb),	   three	   strains	   of	   M.	   canettii:	   CIPT	   140010059	   (M.	   ca0059),	   CIPT	  
140070017	  (M.	  ca0017)	  and	  CIPT	  140070010	  (M.	  ca0010),	  Mycobacterium	  marinum	  (M.	  ma),	  Mycobacterium	  ulcerans	  
(M.	  ul),	   Mycobacterium	   shinjukuense	   (M.	  sh),	   Mycobacterium	  avium	   (M.	  av),	   Mycobacterium	   kansasii	   (M.	  ka),	  
Mycobacterium	  leprae	  (M.	  le),	  Mycobacterium	  abscessus	  (M.	  ab)	  and	  Mycobacterium	  smegmatis	  (M.	  sm)	  constructed	  in	  
Jalview.	   Adapted	   from	   (Schwenk	   et	   al.	   2018).	   Residues	   coloured	   by	   percentage	   sequence	   conservation	   (darker	   blue	  
indicates	  higher	  conservation).	  Putative	  P1,	  P2	  and	  Pas	  -­‐10	  promoter	  elements	  are	  highlighted	  in	  black.	  First	  ten	  codons	  
of	  rpfB	  CDS	  highlighted	  in	  green,	  with	  alternative	  start	  codons	  highlighted	  with	  dashed	  lines.	  Proposed	  SD	  sequence	  is	  
highlighted	  in	  orange	  (see	  section	  3.4).	  Red	  annotations	  denote	  the	  stem-­‐loop	  poly(U)	  tract	  of	  the	  proposed	  riboswitch	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Figure	  10.II	  full	  sequence	  of	  the	  M.	  tuberculosis	  H37RV	  rpfB	  locus	  
Positions	  1127766	  to	  1130129	  shown,	  experimentally	  validated	  rpfB	  TTG	  start	  codon	  annotated	  (see	  seciton	  3).	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Figure	  10.II	  continued	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Figure	  10.II	  continued	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Figure	  10.III	  translational	  reporters	  in	  M.	  tuberculosis	  
Top	  diagram	  depicts	   the	  mutations	   introduced	   to	   each	   construct,	  where	   red	  bases	   indicate	   substitutions	   and	   ‘RBS*’	  
indicates	   ribosome	   binding	   site	   mutation.	   Constructs	   match	   those	   described	   in	   section	   3.3.	   Bottom	   image	   shows	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Figure	  10.IV	  extended	  3'RACE	  mapping	  
Chart	  showing	  mapped	  3’termini	  of	  rpfB	  transcripts	  from	  M.	  tuberculosis	  H37Rv	  exponential	  growth	  phase	  total	  RNA.	  
Total	  3’termini	  mapped	  at	  single	  nucleotide	  resolution	  within	  the	  rpfB	  locus	  from	  +77	  to	  +256	  bp	  relative	  to	  the	  P1	  TSS.	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Figure	  10.V	  M.	  bovis	  BCG	  biofilm	  RT-­‐qPCR	  detection	  of	  ksgA	  relative	  to	  rpfB	  
Detected	  ksgA	   amplicons	  of	  M.	  bovis	  BCG	  biofilm	  cDNA	  expressed	  as	  a	  percentage	  of	  detected	   total	   rpfB	  amplicons.	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Figure	  10.VI	  preliminary	  in	  vitro	  transcription	  with	  template	  digest	  
PAGE	  of	  multi-­‐round	   in	  vitro	  transcription	  reactions.	  WT	  M.	  smegmatis	  PrrnB	  promoted	  transcription	  of	  the	  riboswitch,	  
with	   titration	   of	   heparin	   from	   0	   to	   100	   ng/μL.	   Reactions	   were	   carried	   out	   at	   37°C	   with	   17	  nM	   E.	   coli	   RNAP	   (NEB),	  
200	  nM	  template	  and	  500	  μM	  NTP,	   labelling	  with	  32P-­‐αUTP	  (Perkin	  Elmer).	  Template	  amplified	  with	  oligonucleotides	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Figure	  10.VII	  preliminary	  in	  vitro	  transcription	  with	  PCR	  template	  
PAGE	   of	   multi-­‐round	   in	   vitro	   transcription	   reactions.	   Template	   with	   added	   G:C	   basepair,	   M.	  smegmatis	  
extended	   -­‐10	  PrrnB	   promoted	   transcription	   of	   the	   riboswitch,	  with	   titration	   of	   heparin	   from	  0	   to	   20	   ng/μL.	   Reactions	  
were	  carried	  out	  at	  37°C	  with	  17	  nM	  E.	  coli	  RNAP	  (NEB),	  200	  nM	  template	  and	  500	  μM	  NTP,	   labelling	  with	  32P-­‐αUTP	  
(Perkin	  Elmer).	  Reactions	  were	  stopped	  after	  20	  min	  with	  the	  addition	  of	  formamide	  loading	  dye.	  Template	  amplified	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Figure	  10.VIII	  preliminary	  in	  vitro	  transcription	  with	  candidate	  ligand	  
Multi-­‐round	   in	   vitro	   transcription	   of	   the	   riboswitch	   in	   the	   presence	   of	   S-­‐adenosyl-­‐L-­‐methionine	   titration	   from	   0	   to	  
100	  μM.	  Reactions	  were	  carried	  out	  at	  37°C	  with	  17	  nM	  E.	  coli	  RNAP	  (NEB),	  200	  nM	  template	  and	  500	  μM	  NTP,	  labelling	  
with	   32P-­‐αUTP	   (Perkin	   Elmer).	   Reactions	   were	   stopping	   after	   20	   min	   with	   the	   addition	   of	   formamide	   loading	   dye.	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Figure	  10.IX	  preliminary	  in	  vitro	  transcription	  with	  NusA	  
Single-­‐round	  in	  vitro	  transcription	  time-­‐course	  in	  the	  presence	  and	  absence	  of	  NusA.	  Reactions	  were	  carried	  out	  at	  30°C	  
to	  decrease	  processivity,	  with	  17	  nM	  E.	  coli	  RNAP	  (NEB),	  initiated	  with	  GpU	  dinucleotide	  (IBA),	  labelled	  with	  32P-­‐αUTP	  
(Perkin	  Elmer),	   limited	  to	  single-­‐round	  transcription	  with	  200	  ng/µL	  heparin.	  Reactions	  were	  carried	  out	  ±	  NusA	  (NEB)	  
at	  molar	   ratios	  of	  1:0,	  1:1	  and	  1:5	   relative	   to	  RNAP.	  Elongation	  was	   resumed	  with	  25	  µM	  NTPs,	   incubating	   for	  up	   to	  
5	  min	  before	  stopping	  reactions	  with	  the	  addition	  of	  formamide	  loading	  dye.	  Template	  amplified	  with	  oligonucleotides	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Figure	  10.X	  162	  nt	  run-­‐off	  template	  	  
Single-­‐round	   in	  vitro	  transcription	  of	  riboswitch	  conformational	  mutants	  with	  3’truncated	  template	  for	  162	  nt	  run-­‐off	  
Left	   to	   right:	   WT	   riboswitch	   template,	   G112C	   terminator	   stabilising	   substitution,	   U6C	   anti-­‐terminator	   stabilising	  
substitution	   and	   U117-­‐119A	   intrinsic	   terminator	   disrupting	   substitution.	   Grey	   arrow	   denotes	   G112C	   transcription	  
artefact.	  Reactions	  were	  carried	  out	  at	  30°C	  to	  decrease	  processivity,	  with	  17	  nM	  E.	  coli	  RNAP	  (NEB),	  initiated	  with	  GpU	  
dinucleotide	  (IBA),	  labelled	  with	  32P-­‐αUTP	  (Perkin	  Elmer),	  limited	  to	  single-­‐round	  transcription	  with	  200	  ng/µL	  heparin.	  
Elongation	   was	   resumed	   with	   25	  µM	  rNTPs,	   incubating	   for	   20	   min	   before	   stopping	   reactions	   with	   the	   addition	   of	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Figure	  10.XI	  DNase	  treatment	  of	  in	  vitro	  transcription	  reactions	  
Single-­‐round	   in	   vitro	   transcription	   of	   riboswitch	   subsequently	   treated	   with	   DNase	   I	   (Ambion).	   Left	   to	   right:	   WT	  
riboswitch	   template	   with	   32P-­‐αUTP	   (Perkin	   Elmer)	   alone	   to	   encourage	   potential	   DNA	   labelling	   RNAP	   activity,	   WT	  
template	  ±	  DNase	  treatment	  following	  20	  min	  elongation,	  G112C	  terminator	  stabilising	  substitution	  ±DNase	  treatment.	  
Grey	   arrow	  denotes	  G112C	   transcription	   artefact.	   Reactions	  were	   carried	   out	   at	   30°C	   to	   decrease	   processivity,	  with	  
17	  nM	   E.	  coli	   RNAP	   (NEB),	   initiated	   with	   GpU	   dinucleotide	   (IBA),	   labelled	   with	   32P-­‐αUTP	   (Perkin	   Elmer),	   limited	   to	  
single-­‐round	   transcription	  with	  200	  ng/µL	  heparin.	  Elongation	  was	   resumed	  with	  25	  µM	  rNTPs,	   incubating	   for	  20	  min	  
before	  stopping	  reactions	  by	  heating	  to	  95°C	  for	  5	  min.	  Once	  cooled	  reactions	  were	  incubated	  with	  1	  µL	  DNase	  at	  37°C	  
for	   30	  min	   before	   addition	   of	   formamide	   loading	   dye.	   Template	   amplified	  with	   oligonucleotides	   5.31	   and	   5.23	   (see	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Figure	  10.XII	  G112C	  in	  vitro	  transcription	  time-­‐course	  
Single-­‐round	  in	  vitro	  transcription	  time-­‐course	  in	  the	  presence	  of	  NusA	  with	  3’truncated	  template	  for	  162	  nt	  run-­‐off	  for	  
WT	   riboswitch	   template	   (left)	   and	   G112C	   terminator	   stabilising	   substitution	   (right).	   Grey	   arrow	   denotes	   G112C	  
transcription	   artefact.	   Reactions	   were	   carried	   out	   at	   30°C	   to	   decrease	   processivity,	   with	   17	  nM	   E.	   coli	   RNAP	   (NEB),	  
initiated	  with	  GpU	  dinucleotide	  (IBA),	  labelled	  with	  32P-­‐αUTP	  (Perkin	  Elmer),	  limited	  to	  single-­‐round	  transcription	  with	  
200	  ng/µL	   heparin.	   Reactions	  were	   carried	   out	   in	   the	   presence	   of	   85	  nM	  NusA	   (NEB).	   Elongation	  was	   resumed	  with	  
25	  µM	  NTPs,	   incubating	   for	   up	   to	   20	  min	   before	   stopping	   reactions	   with	   the	   addition	   of	   formamide	   loading	   dye.	  
Template	  amplified	  with	  oligonucleotides	  5.31	  and	  8.27	  (see	  Appendix	  section	  10.3).	  
100(nt(
162(nt((
run3oﬀ(
~130(nt(
afenuaKon(((
WT(
200(nt(
100(nt(
90(nt(
80(nt(
70(nt(
60(nt(
50(nt(
40(nt(
30(nt(
Kme(
~130(nt(riboswitch(afenuaKon(transcript(
162(nt(run3oﬀ(
P2(PrrnB-ext(310(
(((((((((((((((((((riboswitch(((((((((((((((UUUUU(((((5’UTR((((((((((GTAAA(
150(nt(
G112C(term(
Kme(
